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Palmitoylation is a post-translational modification that has been implicated in the 
control of multiple proteins, including ion channels. S-Palmitoylation is a lipophilic 
modification that involves the attachment of palmitate through a thioester linkage to 
a cysteine residue in a target protein. By increasing the hydrophobicity of the target 
region, palmitoylation can promote membrane targeting. Here, palmitoylation is 
shown to play an important role in regulating large conductance calcium- and 
voltage- activated (BK) potassium channels. 
The STREX splice variant of the BK channel contains a 58 amino acid insert at the 
splice site C2 within the intracellular C-terminal RCK1-RCK2 linker that confers 
increased calcium sensitivity to the channel and determines PKA inhibition of 
channel activity. The cysteine rich STREX domain was predicted to be 
palmitoylated, and using an imaging assay STREX was shown to act as a 
membrane targeting domain through palmitoylation of a di-cysteine motif 
(C645:C645). A membrane potential assay and electrophysiological analysis 
demonstrates that palmitoylation at the C645:C646 site in STREX is important in 
mediating the increased calcium sensitive properties inherent to the STREX 
channel. Palmitoylation is also shown to modulate PKA channel inhibition. 
The stability of palmitoylation can often be reliant on the local environment within the 
protein. Generally in most proteins; lipidated regions, basic domains or 
transmembrane domains are found adjacent to a palmitoylation site. In STREX, a 
polybasic domain composed of 11 basic residues just upstream from the C645:C646 
palmitoylation site, functions to control the palmitoylation status of the STREX insert. 
A site directed mutagenesis approach to disrupt the polybasic domain revealed an 
important role in controlling membrane targeting of the STREX C-terminus, 
mediating the increased calcium sensitivity inherent to STREX channels and 
controlling the palmitoylation status of the C645:C646 palmitoylation site using 
multiple techniques involving electrophysiology, fluorescent imaging and 
biochemical assays. Further to this, using imaging to examine the membrane 




function as a physiological electrostatic switch to regulate the polybasic region in 
controlling palmitoylation of the STREX insert. 
Finally, an additional palmitoylation site that is constitutively expressed in all BK 
channels was identified to be located in the S0-S1 linker (C53:C54:C56). Mutation of 
the C53:C54:C56 palmitoylation site in the S0-S1 linker was shown to abolish all 
palmitoylation in BK channels that did not contain the STREX insert. Palmitoylation 
allows the S0-S1 linker to associate with the plasma membrane however the 
mutated de-palmitoylated channels did not affect channel conductance or the 
calcium/voltage sensitivity of the channel. Palmitoylation of the S0-S1 linker was 
shown to be a critical determinant of cell surface expression of BK channels, as 
steady state surface expression levels were reduced by ~55% in the C53:C54:C56 
mutant. STREX channels that could not be palmitoylated in the S0-S1 linker also 
showed decreased surface expression even through STREX insert palmitoylation 
was unaffected.  
Palmitoylation is rapidly emerging as an important post-translational mechanism to 
control ion channel behaviour. This work reveals that palmitoylation of the BK 
channel can control channel function of the STREX splice variant channel and can 
regulate cell surface expression in all other channel variants. Palmitoylation appears 
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1.1 The evolution of the ion channel 
 
Amongst the numerous proteins that are vital to life are the ion channels, membrane 
proteins that allow rapid movement of ions through a pore, across an otherwise 
impermeable lipid cell membrane. The movement of ions through channels that 
cross the cell membrane is at least three orders of magnitude faster than pumps or 
carrier proteins and eleven orders faster than simple diffusion (Moczydlowski, 1986), 
making ion channels extremely efficient at regulating physiological function.  
Membrane ion channel proteins differ markedly from water soluble proteins by the 
presence of hydrophobic segments that are able to insert into the lipid membrane as 
transmembrane (TM) domains. These TM domains have evolved to be just long 
enough to span the lipid bilayer, being ~21 amino acids in length and comprised 
largely of hydrophobic residues (Stryer, 1997). If we step back in the evolutionary 
timescale to postulate what the primitive ion channels might have been like, we can 
look to the simple structure of the bacterial channels in the potassium channel family 
for clues. The bacterial potassium channel, KcsA, is composed of 2 transmembrane 
domains, which is considered to be the minimal structural requirement for a 
functioning ion channel (Doyle et al., 1998; MacKinnon et al., 1998). This 2-TM 
channel may not be too dissimilar to the very early ion channels, the ancestors of 
today’s ion channels. Modern day mammalian 6-TM domain potassium channels 
may well have evolved from similar primitive 2-TM channels, whereby acquisitions of 
additional domains incorporating a voltage sensor and regulatory domains have 
developed over an evolutionary timescale.  
It is fascinating to speculate how the ion channels may have arisen. Certainly the 
most basic ion channels are the 2-TM channels (such as KcsA), that form a tetramer 
of four individual α-subunits around a central conducting pore. The voltage-gated 
potassium channels are 6-TM polypeptides that also form symmetrically as a 
tetramer around a central pore. However, in contrast to the potassium channels, the 
genes that encode the calcium and sodium channels contain four internal repeats 
that include all four domains of the channel within one polypeptide (Figure 1.1). This 
illustrates beautifully the theory that the calcium ion channel genes and sodium ion
2
Figure 1.1
The evolution of ion channels
Figure 1.1. The evolution of ion channels.  Schematic diagram illustrating the 
2-transmembrane (TM) channels that form a tetramer of four individual α-subunits 
around a central conducting pore. 2-TM’s are thought to be the basic requirement for 
a functional channel. Through evolution the 2-TM channels acquire additional 
domains such as a voltage sensing region characteristic of the 6-TM voltage gated K+ 
channels that also form a tetramer around a central pore region. Through sequential 
gene duplications, channels with four subunit domains linked together in a single large 
polypeptide evolved, such as in Ca2+ and Na+ channels. The pore regions are 
indicated by solid black shading.
2TM 
6TM 
4 x 6TM 
2x sequential gene duplications
acquisition of additional TM domains






channel genes most probably evolved from potassium channel genes through a 
process of two sequential gene duplication events (Ranganathan, 1994).
Additionally, it is postulated that sodium channels may have emerged from calcium 
channels after further random mutation as they are only found in higher organisms 
(Franciolini & Petris, 1989; Strong et al., 1993). Indeed sodium channels have more 
sequence identity to corresponding calcium channel subunit domains (61%) than 
they do to subunits within the same polymer (50%) or to the single subunit domain 
of the potassium channels (27%) (Hille, 1989). It has been demonstrated that 
artificially linked subunits of voltage-gated potassium channels can form functional 
channels however there is no evidence of such potassium channels in existence 
(Liman et al., 1992). It is all too possible considering the evidence we have seen in 
the genome, that potassium may have been the first charge carrier across the 
impermeable cell membrane. Since sodium channels appear later in the 
evolutionary timescale and calcium in high concentrations is toxic without 
intracellular chelation, it would seem that they would be unlikely candidates for the 
first ion to have been initially carried across the cell membrane. Indeed, the 
regulation of internal potassium milieu in primitive cells is known to be crucial to cell 
survival (Biggin et al., 2000) and so it is plausible that the potassium channel may 
contain the remnants of the earliest ion channel. 
Across the evolutionary lineage, the retention of specific amino acids within a 
protein’s primary sequence can indicate regions of structural and functional 
importance to the higher vertebrates. Those regions retained under heavy 
evolutionary selection pressure conserve important motifs necessary for protein 
function whereby homology can be sought through alignment techniques across the 
vertebrate phylum. The subtle changes in the genome and the highly conserved 
nature of functional residues and motifs reveal the finite precision by which ion 
channels have advanced over billions of years.  
It is only through the duplication and divergence of ion channel genes along with 
random mutation and splice variation that a diverse family of ion channels was born 
from that ancestral ion channel. Internal signalling, resetting of membrane and ionic 
potentials and communication between cells, drove the early channels by trial and 
error to achieve the diversity required for complex life. The modern day ion channels 
have survived several hundred million years of evolution (prokaryotes appeared 
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about 3500 million years ago) (Franciolini & Petris, 1989) and whilst they probably 
do not reflect the early ion channels, the remains of their earliest ancestors probably 
still lie buried as small sequences within the genetic code of each modern day ion 
channel. 
 
1.2 The potassium channel family 
 
1.2.1 Potassium channels with phenotypic behaviour 
Seymour Benzer, one of the founders of neurogenetics in the late 1960’s, proposed 
that mutant behavioural and neurological phenotypes might reflect defects in the 
genome (Benzer, 1967). He suggested that these defects may occur in ion channels 
that he correctly surmised would be conserved across metazoans (Benzer, 1971; 
Salkoff et al., 2006).  
The molecular nature of ion channels has only been elucidated in the last 25 years. 
The first potassium channel gene (a voltage-gated K+
 
 channel) was first cloned from 
the Drosophila Shaker locus (Kamb et al., 1987; Papazian et al., 1987; Pongs et al., 
1988), identified almost 20 years previously as an ether-induced leg shaking 
phenotype in mutant Drosophila melanogaster (Kaplan & Trout, 1969). 
Subsequently a large number of potassium channel genes have been cloned.  
1.2.2 The potassium channel family 
Potassium-selective (K+) channels are the largest and most diverse group of ion 
channels represented by some 70 known loci in the mammalian genome (Gutman et 
al., 2005). They have been observed in virtually all cell types and demonstrate an 
extensive structural diversity creating a wide heterogeneous functionality. Potassium 
channels are highly selective cation channels that have an equilibrium potential 
close to the cellular resting potential of many cells, making them important 
determinants in maintaining the resting membrane potential (Salkoff et al., 2006).
5
Figure 1.2
The potassium channel family
Figure 1.2. The potassium channel family.  A hierarchical classification scheme for 
potassium channel genes. Potassium channels belong to the ion channel superfamily. 
They can be grouped into four main structural classes encoding 2 transmembrane 
(2TM), 4 transmembrane (4TM), 6 transmembrane (6TM) and 8 transmembrane 
(8TM) subunits. There are six families within the 6TM class, conserved between verte-
brate and invertebrate species. These families can also be further subdivided into 
subfamilies. About 40% amino acid sequence identity is present between subfamilies. 
Significantly higher amino acid identity (50-70%) is shared within subfamilies.
Voltage-Gated   KQT   Eag            CNG   SK
Kir1 Kir2 Kir3 Kir4 Kir5 Kir6
 Slo1      Slo2      Slo3   
6TM 4TM
2TM
 Shaker  Shab  Shaw  Shal





TWIK THIK1 TREK TALK TASK
TOK1   YORK
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The diverse array of K+ channels can now be classified into four major structural 
classes; those processing two transmembrane domains (2TM) (eg. the inward 
rectifier channels Kir1-6) around a conserved pore domain, four transmembrane 
domains (4TM) associated with two pore domains (including TWIK, THIK1, TREK, 
TALK and TASK channels), the six transmembrane domains (6TM) associated with 
one pore domain (such as the voltage gated Kv channels) and the eight 
transmembrane domains (8TM) with two pore domains, which comprise a 
6TM+2TM structure and have only been found in yeast cells (TOK1 and YORK 
channels) (Figure 1.2). Within structural classes are conserved gene families 
populated by subfamilies defined by common functional and structural features. 
Within the 6TM K+
Isolation of the Slo multigene family by sequence analysis identified a module 
resembling a voltage-gated channel with an additional intracellular C-terminal 
domain that can respond to a host of intracellular and extracellular factors (Atkinson 
et al., 1991; Salkoff et al., 2006). Studies have identified four genes encoding the 
Slo family of channels in the mammalian genome that comprise: the Slo1 channel, 
two very similar Slo2 channels termed Slo2.1 (Slick) and Slo2.2 (Slack) and the Slo3 
channel. All four genes independently form a homotetrameric channel, whereby 
each subunit that forms the functioning channel is identical and can conduct K
 channel class is a subfamily of channels that are distinguished by 
an unusually large single-channel conductance and have been named as ‘big’ 
potassium (BK) channels (Blatz & Magleby, 1986), also known as maxi-K channels 
(Latorre et al., 1983) or Slo1 channels (Atkinson et al., 1991). 
+ 
selective currents. SLO-1 channels are activated by voltage but are different to 
purely voltage-gated K+ channels because they are also activated by intracellular 
Ca2+ (Atkinson et al., 1991). SLO-2 channels are sensitive to a host of intracellular 
factors including Cl - and Ca2+ in C.elegans (Yuan et al., 2000) and Cl - and Na+ in 
mammalian orthologues (Yuan et al., 2003) with evidence of negative regulation by 
ATP in Slo2.1 channels (Bhattacharjee et al., 2002). SLO-3 channels have only 
been identified in spermatocytes and mature spermatozoa and are sensitive to pH 
 
(Schreiber et al., 1998; Salkoff et al., 2006). 
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1.2.3 The identification of a calcium- and voltage- sensitive K+
In 1958 George Gardos a Hungarian haematologist, described a potassium 
conductance across the plasma membrane that responded to minor increases in 
intracellular calcium (Gardos, 1958). By buffering extracellular free calcium with 
EDTA (a calcium chelator), potassium diffusion across the plasma membrane was 
substantially reduced. This was the first indication of the existence of a calcium 
activated potassium channel. The channel which was identified in human 
erthrocytes, has since been implicated in sickle cell anaemia (Maher & Kuchel, 
2003) and has the distinction of being named after its discoverer, as the Gardos 
channel or in the nomenclature, SK4. However, it wasn’t until 1970 that an actual 
ionic current activated by a rise in intracellular calcium was identified (Meech & 
Strumwasser, 1970) confirming the initial observations by Gardos. In the decades 
that followed, a calcium-dependant K
 current 
+
In the late 1980’s and early 1990’s with the development of neurogenetics and novel 
techniques to isolate and clone specific genes, the gene responsible for the calcium 
sensitive large potassium conductance was identified. Following on from the work 
which led to the molecular cloning of the first K
 channel was isolated and characterised in 
chromaffin cells, with a reversal potential of lower than -60 mV in normal Ringers 
and a large unitary conductance (Marty, 1981). Further studies revealed that the 
channel could be uniquely regulated by calcium and membrane potential 




 channel from the Shaker locus in 
Drosophila melanogaster, the gene responsible for the Slowpoke phenotype was 
isolated and cloned (Atkinson et al., 1991). Slowpoke describes a mutation that 
confers behavioural lethargy in Drosophila and was found to be mediated by a 
calcium sensitive potassium current (Elkins et al., 1986). It was subsequently named 
the Slo gene. The human homologue hSlo was later cloned from brain (Dworetzky 
et al., 1994) and mouse mSlo was isolated from brain and skeletal muscle (Butler et 
al., 1993). This gene encodes what we call today, the BK channel. 
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1.3 The BK channel 
 
1.3.1 Characteristics of the BK channel 
The BK channel is a large conductance potassium channel that is uniquely 
regulated by both voltage and intracellular calcium. The gene that codes the channel 
is located on human chromosome 10, 49% of the distance from the centromere to 
the telomere of the chromosome arm 10q, corresponding to a band, 10q22.3 
(Tseng-Crank et al., 1994). The open reading frame encodes for a single pore-
forming subunit of approximately 125 kDa molecular weight and can range from 
between ~1154 to >1200 amino acids in length. The modular design of the BK 
channel in the evolutionary lineage suggests that the channel may have evolved 
from a core module representing a voltage-dependant channel which then acquired 
an additional C-terminal domain that is responsive to multiple intracellular and 
extracellular factors. The large conductance unique to the BK channel averages 
around 250 pS (Marty, 1981; Latorre et al., 1982; Latorre et al., 1983; Farley & 
Rudy, 1988) in equimolar K+ gradients (~120 pS in physiological gradients, 
(Bielefeldt et al., 1992)), markedly larger than other voltage-gated K+
BK channels can assemble from 2 distinct subunits that form a 1:1 stoichiometry 
(Knaus et al., 1994a; Toro et al., 1998), they are the pore forming α-subunits and 
regulatory β-subunits (Garcia-Calvo et al., 1994; McManus et al., 1995). The BK 
channel pore-forming α-subunit is uniquely encoded by a single gene, KCNMA1, 
and the regulatory β-subunits are encoded by a family of four genes, KCNMB1-4. 
The α-subunit is the single product of one gene and therefore tetramerisation of the 
channel is largely homogenous with each subunit being symmetrically identical in 
the conducting central pore region. Evolutionary pressure has perhaps maintained 
this quirk in response to retaining absolute symmetry within the conduction pore of 
the BK channel, a feature that could possibly underlie part of the large conductive 
properties of the channel in contrast to the other asymmetrical channel pores, for 
example in the Na
 channels that 
average less than a tenth of that conductance. This would suggest that major 
structural rearrangements must also have occurred in the selectivity filter and pore 
region to accommodate an ionic flux an order of magnitude larger than its 
evolutionary ancestors.  
+ and Ca2+ channels (Salkoff & Jegla, 1995).  
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1.3.2 The physiological role of the BK channel 
BK channels are expressed in all cells throughout the body largely with the 
exception of cardiac tissue. Although, as with all exceptions in science there is some 
evidence to suggest BK channels may also be present in cardiac tissue as well (Ko 
et al., 2009; Imlach et al., 2010 ).  
BK channels sense and regulate membrane voltage and intracellular Ca2+ thereby 
linking cellular excitability with signalling and metabolism. With the reversal potential 
of potassium being close to the resting membrane potential in excitable cells, the BK 
channel acts as an effective modulator of the resting membrane potential. The 
channel’s dynamic regulation by calcium also allow it additionally to function as a 
negative-feedback regulator for Ca2+
In smooth muscle cells the BK channel has been shown to be dynamically regulated 
by vasodilators and vasoconstrictors that potently regulate contractile tone (Brenner 
et al., 2000b; Sausbier et al., 2005). The BK channel regulates contractility firstly, 
through activation by small local increases in calcium (Ca
 entry in many different cell types (Salkoff et al., 
2006).  
2+
The BK channel’s role in regulation of contractile tone in smooth muscle is evident in 
pathophysiologies such as cardiovascular disease, characterised by elevated blood 
 sparks) released from 
ryanodine receptors in the intracellular sarcoplasmic reticulum, that appear to be 
responsive to circulating hormones (Jeffries et al., 2010b), to induce vasodilation. 
Secondly, BK channels can be activated by influx of calcium across the plasma 
membrane through calcium channels activated during depolarisation (Nelson et al., 
1995; Jeffries et al., 2010b), not to mention depolarisation itself, which activates the 
channels leading to dilation of the vessel. Hence calcium can indirectly lead to 
vasodilation through the activation of the BK channel. BK channels are also 
responsive to a host of other factors such as protein kinases (Schubert & Nelson, 
2001), endothelial-derived relaxant substances (Tanaka et al., 2004), growth factors 
(Weaver et al., 2004), hypoxia [that includes three proposed mechanisms: i) the 
Hemoxygenase-2 mechanism (Williams et al., 2004); ii) regulation via the STREX 
splice variant (McCartney et al., 2005); and iii) the AMP kinase mechanism (Peers, 
1990; Evans et al., 2009; Peers et al., 2010) and regulation by β-subunits (Brenner 
et al., 2000b). 
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pressure whereby dysfunction of the BK channel fails to regulate the resting 
membrane potential or act as a ‘brake’ of calcium entry (Brenner et al., 2000b; 
Sausbier et al., 2005). In bladder smooth muscle, BK channel dysfunction leads to 
an overactive bladder and urinary incontinence (Meredith et al., 2004), in the colon 
removal of regulatory β-subunits leads to differences in bowel structure and 
function, manifested by atypically loose fecal matter (Hagen et al., 2003) and in 
penile arterial and corpus cavernosum smooth muscle, where the BK channel 
mediates relaxation important for penile erection, dysfunction leads to impaired 
erectile function (Christ et al., 2004; Werner et al., 2005). 
BK channels also play an important role in the regulation of neuronal excitability 
(Raffaelli et al., 2004; Sausbier et al., 2004). The BK channel is particularly 
prevalent in the central nervous system (CNS) where it is localised to cell somas, 
dendrites and presynaptic terminals (Marrion & Tavalin, 1998; Gribkoff et al., 2001a; 
Salkoff et al., 2006). They have been implicated in controlling the frequency and 
duration of action potentials such as those generated in dendrites (Womack & 
Khodakhah, 2004). In the neuronal soma they contribute to the fast after-
hyperpolarisation that determines the firing rate of the neuron (Faber & Sah, 2003). 
Presynaptically, BK channels have been identified in the modulation of 
neurotransmitter release and can act a braking mechanism under conditions of 
excessive depolarisation, maintaining homeostasis for regulating synaptic 
transmission (Raffaelli et al., 2004). The importance of the BK channel in the CNS is 
highlighted by distinct channelopathies implicated in various pathophysiological 
conditions including epilepsy and paraoxysmal dyskinesia (Brenner et al., 2005; Du 
et al., 2005), deficient motor co-ordination (Sausbier et al., 2004) and high frequency 
hearing loss (Ruttiger et al., 2004). Additionally, the BK channel has been 
demonstrated to function in immunity (Ahluwalia et al., 2004) and in the promotion of 
tumor cell proliferation (Weaver et al., 2004; Bloch et al., 2007). 
 
1.3.3 The BK channel knock-out mouse 
The ability to knockout genes in mice, developed in the 1980’s (Goldstein, 2001), 
has led to a greater understanding of gene function. The challenge to create the BK 
(α-subunit) knockout mouse was completed only in the last six years by two 
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independent labs – Peter Ruth in Europe (Sausbier et al., 2004) and Richard Aldrich 
in USA (Meredith et al., 2004). Interestingly, despite the prevalence of the BK 
channel throughout the body and the important role it is believed to play, the BK 
knockout mice are viable and exhibit a spectrum of subtle abnormalities. The mice 
have been described with ataxia and abnormal gait (Sausbier et al., 2004), high 
frequency hearing loss (Ruttiger et al., 2004), vascular hypertension (Sausbier et al., 
2005), incontinence due to over active bladder function (Meredith et al., 2004) and 
erectile dysfunction (Werner et al., 2005) 
 
consistent with defects in brain and 
smooth muscle excitability. The mutant mice have a normal life expectancy, are able 
to produce offspring and when compared to wild-type mice do not show gross 
morphological differences in young or adult mutant brains (Sausbier et al., 2004). 
The apparent non-lethal phenotype of the knockout animals suggest that there may 
be compensatory mechanisms (Sprossmann et al., 2009) or that the channel may 
play more important roles under conditions of stress and in deleterious conditions 
(Sausbier et al., 2004; Chatterjee et al., 2009).  
1.3.4 BK channel pharmacology 
Indeed, the diversity of BK channels across many different cell types has made 
them attractive therapeutic targets. However the widespread expression of the BK 
channel, as previously described, has hampered the specificity with which targeting 
of this protein could be made possible for pharmacological intervention. 
BK channel activators have been proposed in potential treatments for hypertension, 
pre-term labour and ischaemic stroke (Liu et al., 1998; Song et al., 1999; Brenner et 
al., 2000b; Gribkoff et al., 2001b; Sobey, 2001) whereby they increase potassium 
efflux leading to hyperpolarisation of the cell limiting excitability. Activators can 
modulate calcium binding, strengthen the role of β-subunit modulation or may bind 
directly to sites within the channel. They can modulate BK channel properties by 
increasing mean channel open time or by shifting the voltage- and/or calcium- 
sensing properties. Two examples of BK channel activators are the NS1619 and 
NS004 drugs which are benzimidazolone derivatives and are α-subunit selective 
(Olesen et al., 1994). 
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BK channel blockers are valuable pharmacological tools for examining the structural 
and functional properties of BK channels (Ghatta et al., 2006). These include 
peptide pore blockers iberiotoxin and charybdotoxin (Candia et al., 1992) from 
spider venoms, quaternary ammonium compounds eg TEA (Li & Aldrich, 2004) and 
non-peptide fungal alkaloids e.g. paxilline isolated from the fungus Penicillium paxilli 
(Knaus et al., 1994e). Their mechanisms of action are different and have been 
informative of the nature of the channel. TEA operates by a flickery-block that sits in 
the pore and hastens deactivation (Li & Aldrich, 2004). The toxins, charybdotoxin (all 
K+
Interestingly, sulphatides, a group of glycosphingolipids located in the plasma 
membrane have been suggested to activate BK channels through possible lipid-
membrane interactions. Moreover, it has been proposed that the STREX sequence 
(to be discussed later in section 1.6.2.2) may mediate part of this activation through 
the local membrane environment (Chi & Qi, 2006), postulating a role for STREX 
interaction with the lipid membrane. 
 channels) and iberiotoxin (highly selective) (Candia et al., 1992) bind to the 
external vestibule blocking the channel pore (Giangiacomo et al., 1992). 
Tremorgenic mycotoxins such as paxilline verruculogen and penitrem A, reversibly 
block the channel (Knaus et al., 1994e) inhibiting conductance by an allosteric 
mechanism inside the pore. Blockers although a useful tool, have been limited in 
their therapeutic application largely due to depression or memory impairment 
(Olesen et al., 1994). 
 
1.4 The structural composition of the BK channel 
 
The pore forming α-subunit of the BK channel consists of 7 transmembrane 
spanning domains (S0-S6) that make up the core region including a central pore 
between S5 and S6, and an extracellular amino (N) terminus at the S0 domain. The 
channel also contains a large intracellular carboxyl (C) terminus made up of four 
hydrophobic segments (S7-S10) (Meera et al., 1997) (Figure 1.3). 
The α-subunit forms a tetramer, whereby four α-subunits arrange around a central 
conducting pore. The tetrameric composition of the BK channel was initially
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Figure 1.3
Features of the BK channel
Figure 1.3. Features of the BK channel. Transmembrane topology of the pore forming 
α-subunit 7-TM core region (S0-S6), the extracellular amino (NH2) terminus, large 
intracellular carboxyl (COOH or C-) terminus including regulators of K+ conductance 
RCK1 & RCK2, are illustrated. The voltage sensing region is illustrated with positive 
and negative charges (+/- in white), along with the pore region and sites of alternative 





























demonstrated in oocytes injected with a mixture of RNAs encoding wild-type BK 
channel subunits and TEA-insensitive BK channel subunits (Y308V) and showing 
unitary currents of four discrete amplitudes in the presence of 3 mM TEA (BK 
blocker) corresponding to inhibitions of approximately 80%, 55%, 25% and 10% 
(Shen et al., 1994). Later, the biogenesis of tetrameric potassium channels was 
described involving a complex series of events. Initially, individual pore forming 
subunits are targeted to the ER membrane whereby compatible subunits can then 
assemble (Papazian, 1999). Tetramerisation is mediated by a conserved domain, 
which in voltage-gated K+
 
 channels is located in the amino terminus and in BK 
channels has been located just C-terminal to the channel pore. This association 
domain, in the region between the S6 transmembrane domain and the S7 
hydrophobic C-terminal domain and RCK1, is called BK-TI (tetramerisation domain 
1) and is required for functional channel expression (Quirk & Reinhart, 2001). This 
region alone is capable of tetramerisation and is the only region in the channel 
capable of doing so making it the likely candidate for functional channel assembly. 
1.4.1 The core region 
Alignment of the predicted primary sequence and hydrophilicity profiles of the 
Murine and Drosophila Slo (BK) gene sequence reveal a core domain that shares 
much homology with voltage-gated K+ channels (Wei et al., 1990; Jan & Jan, 1992; 
Salkoff et al., 1992) (Figure 1.4). The core region of the BK channel contains 7 
transmembrane domains incorporating a voltage sensor of conserved charged 
residues and a pore region. The S0 transmembrane domain later identified in the BK 
channel is additional to the 6-TM core of the voltage-gated K+
 
 channel and was 
demonstrated to have an extracellular amino terminus (Wallner et al., 1996; Meera 
et al., 1997). 
1.4.1.1 The voltage sensing domain 
The S1-S4 segments comprise the voltage sensing domain (VSD) of the BK channel 
that contain high density charged residues that can respond to changes in 
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Figure 1.4
Hydrophilicity profile for the mSlo BK channel sequence
Figure 1.4. Hydrophilicity profile for the mSlo BK channel sequence. Schematic repre-
sentation showing the primary sequence of the murine BK (mSlo) channel’s predicted 
hydrophilicity profile. Evident are eleven hydrophobic domains (illustrated by solid 

















mSlo amino acid primary sequence
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transmembrane potential (Figure 1.3). Almost 4 decades ago now, Armstrong and 
Bezanilla identified small gating currents in response to changes in membrane 
potential and proposed that these gating currents, first measured in sodium 
channels, signified opening of the channel pore (Armstrong & Bezanilla, 1974). 
Membrane proteins have learnt to sense these changes in transmembrane potential, 
whereby charged residues are able re-orientate in response to changes in the 
electric field, leading to conformational changes in the protein. Much of our recent 
understanding of voltage-sensing domains has been advanced by the development 
of the crystal structure of the voltage-gated K+
In contrast to voltage-gated K
 channel and through optical 
investigations examining the movement of the voltage sensing domains (Bezanilla, 
2008a).  
+ channels, BK channels have a relatively weak 
voltage dependence corresponding to a fivefold smaller gating charge (Ma et al., 
2006). In the absence of Ca2+, the voltage required to half maximally activate the 
channel is estimated to be around +200 mV (Horrigan & Aldrich, 1999; Horrigan et 
al., 1999). It is relatively unclear as to why this difference exists, however limitations 
in voltage sensor movement or a reduced contribution of residues to gating charge 
have been proposed. The pattern of charged residues in the BK channel is similar to 
voltage-gated K+ 
Recent studies indicate that perhaps only 4 residues in the BK channel contribute to 
the voltage-sensing component of the channel and that only one of these residues is 
located in S4 (Diaz et al., 1998; Ma et al., 2006). Therefore it would seem that 
charged residues outside of S4 make significant contributions to gating charge, 
unlike the voltage-gated channels where the major component of gating charge 
movement is through S4 (Papazian et al., 1995). Indeed it has been suggested that 
there may in fact be mechanical and functional coupling of S2 to S4 in gating 
movements, suggesting that both domains can influence each other’s voltage-
sensing ability (Pantazis et al., 2010).  
channels, with the S2 and S3 domains containing acidic residues 
alongside a series of three regularly spaced basic (arginine) residues in S4 (Ma et 
al., 2006).  
Much speculation underlies the mechanism of voltage sensor activation in both the 
BK channel and in the voltage-gated K+ channels. It has been proposed by Roderick 
MacKinnon’s group that in voltage-gated K+ channels the S4 segment undergoes a 
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large movement in what is known as the paddle model. This model proposes that 
the S4 domain undertakes a large 15-20 Å perpendicular movement across the lipid 
bilayer during voltage sensing (Jiang et al., 2003b; Lee et al., 2009b; Tao et al., 
2010), to put this into perspective the membrane bilayer is between 10-40 Å in 
diameter (Mackinnon, 2004b; Bezanilla, 2008b). However, Francisco Bezanilla’s 
group have controversially argued using FRET (fluorescence resonance energy 
transfer) technologies to examine fluorophores in the S4 segment, that movement of 
the S4 segment is limited (Chanda et al., 2005; Posson et al., 2005), but that there 
is significant rotation and tilting of the S4 segment, but by no more than ~2 Å 
perpendicular movement (Bezanilla, 2008a).  
Fundamental differences in the structure and the contribution of charge residues to 
voltage sensor activation may exist between the voltage-gated K+ channels and the 
BK channel. In the BK channel the voltage sensor would appear to be a more 
dynamic structure whose activation involves changes in position and a greater 
interaction with adjacent S1-S3 transmembrane domains (Ma et al., 2006). It will be 
interesting to see how developments in future techniques help explain the 
differences of voltage dependence between BK channels and the rest of the 
voltage-gated K+
 
 channel family. 
1.4.1.2 The S0 transmembrane domain 
BK channels share much of the topological design conserved across the voltage-
gated potassium channel family. However, they carry an additional hydrophobic 
transmembrane region (S0) and an extracellular N-terminus (Wallner et al., 1996; 
Meera et al., 1997)(Figure 1.3). Sequence conservation of several residues in the 
S0 transmembrane domain among BK channel orthologues suggest that it may 
have an important role in channel structure and function (Koval et al., 2007). 
Interestingly, channels lacking the S0 domain appear to be neither functional 
(Wallner et al., 1996; Morrow et al., 2006) nor biochemically detectable on the cell 
surface (Liu et al., 2008). Additionally, mutations of key residues in the S0 domain 
have been shown to shift the activation curves of the channel when compared to the 
wild-type channel, suggesting it may also play a role in voltage-dependant gating of 
the BK channel (Koval et al., 2007). Recent structural studies have identified that the 
18
S0 domain is located outside of the S1-S4 domains (Liu et al., 2008; Liu et al., 2010) 
(Figure 1.9) and can form a major contact with the transmembrane domain 2 (TM2) 
of the regulatory β1 subunits (Liu et al., 2008) and β4 subunits (Wu et al., 2009). 
The proximity of the S0 domain to the β-subunits correlates well with other studies 
that suggest that the proposed role of the S0 domain is in facilitating the regulatory 
effects of β-subunits (Wallner et al., 1996; Meera et al., 1997) (this will be discussed 
in section 1.6.1). It has also been shown that alternative splicing within the S0-S1 
loop can regulate cell surface expression, suggesting that this region may be 
important for trafficking and that alternative splicing may generate novel trafficking 
motifs by inclusion of new sites or the uncovering of sites important for channel 
expression at the plasma membrane (Korovkina et al., 2001; Zarei et al., 2004). It is 
apparent that the S0 domain is important in facilitating the influence of the β-
subunits, controlling cell surface expression and even in regulating voltage-
dependence of the channels and therefore it has a unique role to play in modulating 
the BK channel. 
 
1.4.2 The pore region 
The pore region is located at the centre of the four α-subunits of the BK channel, 
with the narrowest part incorporating the selectivity filter. In each α-subunit the pore 
forming motif consists of the P-loop and the S5 and S6 domains which line the 
conductance pore.  
The BK channel is able to carry a large selective K+ current with a slope 
conductance in the range of 250 pS in symmetrical potassium gradients (Marty, 
1981; Latorre et al., 1983; Farley & Rudy, 1988) an order of magnitude greater than 
other K+ channels. It is thought that major structural rearrangements within the pore 
must have occurred to allow the BK channel to carry such a large and yet highly 
selective current and yet the pore architecture of the BK channel has been 
suggested to be similar to other K+ conducting channels (MacKinnon et al., 1998; 
Jiang et al., 2002b). However, studies with quaternary ammonium and sugars of 
different sizes suggest that the inner vestibule is likely to be much larger, which may 
contribute to the large current carried by the channel (Li & Aldrich, 2004; Brelidze & 
Magleby, 2005). The channel pore, described from the intracellular to extracellular
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Figure 1.5
The crystal structure of the KcsA K+ channel pore and selectivity filter 
Figure 1.5. The crystal structure of the K+ channel pore and selectivity filter. (A) Ribbon 
representation of KcsA K+ channel showing the pore lining S5 and S6 domains. The 
pore helices are shown in red with the selectivity filter in yellow. Hydrated K+ ions are 
seen in the large inner vestibule, K+ ions are dehydrated in the narrow selectivity filter. 
(B) Electron density derived from high-resolution (2Å) structure of the KcsA K+ chan-
nel. Features the selectivity filter with K+ ions and water along the ionic pathway. K+ 
ions could be visualised in the grasp of the selectivity filter protein atoms. (C) Detailed 
structure of the K+ selectivity filter (two subunits). Oxygen atoms (red) coordinate K+ 
ions (green spheres) at positions 1 to 4. Single amino acid code identifies signature 
sequence unique to all potassium selective channels. Green and grey dashed lines 
show O---K+ and hydrogen-bonding interactions respectively. (D) Channel sequences 
are aligned to the Drosophila Shaker voltage gated K+ channel (top) across the K+ 














Adapted from R. MacKinnon’s Nobel Lecture 2004
D    Shaker  DAFWWAVVTMTTVGYGDMT 
    Kv1.1   DAFWWAVVSMTTVGYGDMY 
    Shab    EAFWWAGITMTTVGYGDIC 
    Kv2.1   ASFWWATITMTTVGYGDIY 
    Shaw    LGLWWALVTMTTVGYGDMA 
    Kv3.1   IGFWWAVVTMTTLGYGDMY 
    Shal    AAFWYTIVTMTTLGYGDMV 
    Kv4.1   AAFWYTIVTMTTLGYGDMV 
    mSlo    ECVYLLMVTNSTVGYGDVY 
    eag     TALYFTMTCMTSVGFGNVA 
    AKT1    TSMYWSITTLTTVGYGDLH 
    KAT1    TALYWSITTLTTYGYGDFH 
    ROMK1   SAFLFSLETQVTIGYGFRF 
    IRK1    AAFLFSIETQTTIGYGFRF 








aspect, is comprised of the channel mouth controlled by the inner helices of the S6 
transmembrane domains, a large inner vestibule, the selectivity filter which is the 
narrowest part of the pore, before opening up to the external vestibule and exit of 
the channel (Figure 1.5). 
The universal feature amongst all potassium selective channels is a hyperconserved 
signature sequence, GY/FG, which forms the K+ selective filter of the pore 
(Heginbotham & MacKinnon, 1992; Heginbotham et al., 1994). The pore region is so 
highly conserved that all potassium channels can be aligned based on the sequence 
homology of the pore lining selectivity filter, TXXTXGYG motif (Figure 1.5D). 
Mutagenesis of residues in the signature sequence, have identified it as key to 
controlling the channel’s selectivity to K+ (Heginbotham et al., 1994). The seminal 
work of Nobel Prize laureate, Roderick MacKinnon, in mapping for the first time at 
high resolution the crystal structure of the selectivity filter in bacterial KcsA K+ 
channels, revealed the mechanism of selectivity for potassium ions over smaller 
ions (MacKinnon, 2004a)(Figure 1.5). Sequence conservation of the pore region and 
additional structural studies from the MacKinnon laboratory, reveal that the 
architecture is retained in different types of K+ channels and would probably reflect a 
similar structural arrangement in the BK channel (Doyle et al., 1998; Jiang et al., 
2002a; Jiang et al., 2003a; Kuo et al., 2003). The MacKinnon lab have produced 
incredible images at 2Å resolution, visualising K+ ions in the “grasp of the selectivity 
filter protein atoms” (MacKinnon, 2004a) illustrating how hydrated K+ ions gather in 
the large internal vestibule (Figure 1.5A & B), held in place by negative charges at 
the base of the pore helixes before entering the selectivity filter where oxygen atoms 
(each binding site is a cage formed by eight oxygen atoms) compensate for the 
energetic cost of dehydration of the K+ ions and therefore providing the selectivity 
required for the passing of K+ ions (for example, Na+
When looking elsewhere in the BK channel for unique structural differences in the 
pore region, two negatively charged rings at the intracellular entrance to the pore 
vestibule are visible (Brelidze et al., 2003) (Figure 1.6). This ring of 8 negatively 
charged glutamate residues at the entrance to the inner vestibule is absent in lower 
conductance K
 ions are too small and the 
dehydration energy is not compensated) (Figure 1.5C).  
+ channels and may increase the concentration of permeating ions in 
the vestibules through an electrostatic mechanism, leading to an increased
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Figure 1.6
Negatively charge residues line the entrance and exit to the pore
Figure 1.6. Negatively charge residues line the entrance and exit to the pore. The BK 
channel contains 8 negatively charged glutamate residues at the entrance to the inner 
vestibule of the pore, making two negatively charged rings that are absent in K+  chan-
nels with smaller conductance. Additionally, on the extracellular aspect the BK chan-
nel there is a single ring of negative charge thought to enhance the entry rate of K+ 
ions into the pore. Negative charges are illustrated in the pore model and amino acid 
sequence in yellow. The GYG selectivity filter is shown by the grey circle and potas-











availability of ions to transit the selectivity filter which could increase single channel 
conductance (Brelidze et al., 2003). Mutagenesis of the inner negative ring from +8 
to -8 has been shown to systematically alter the single-channel conductance, 
reducing it by half (Brelidze et al., 2003). Additionally, on the extracellular aspect of 
the BK channel there is a single ring of negative charge thought to enhance the 
entry rate of K+
 
 ions into the pore (Li & Aldrich, 2004). Mutations of the negative ring 
on extracellular vestibule, that decrease the external surface charge density have 
been shown to also reduce conductance substantially and reduce inward 
rectification at negative potentials (Haug et al., 2004) (Figure 1.6). Even within the 
intracellular vestibule, disruption of aromatic residues have been shown to affect 
single channel conductance (Lippiat et al., 2000). It would appear therefore that the 
environment within and around the inner vestibule is very important for maintaining 
the high unitary conductance associated with the BK channel and that several 
factors may indeed contribute to mediating this large conductance. 
1.4.3  The intracellular C-terminus 
The BK channel contains a large intracellular carboxyl (C) terminus that 
encompasses two-thirds of the total length of the channel protein (Toro et al., 1998). 
It has four additional hydrophobic regions (S7-S10), although the hydrophobicity is 
lower than the S0-S6 core/pore domains and do not appear to be membrane 
spanning (Meera et al., 1997) (Figure 1.3). Crystal structural studies have since 
confirmed that the C-terminus resides intracellularly (Wang & Sigworth, 2009; Wu et 
al., 2010; Yuan et al., 2010). The channel’s structural organisation with a core region 
homologous to voltage-gated channels, suggest that the subsequent addition of the 
C-terminal domain may mediate many of the attributes of the channel that are 
unique to BK channels. The crystal structure of the C-terminus of the BK channel 
will be discussed in the next section (see section 1.5 and Figure 1.10). 
It is now understood that the C-terminus consists of 2 regulators of potassium 
conductance (RCK 1&2) on each subunit, connected to the pore region by a short 
linker. Between each RCK domain is a non conserved linker that contains multiple 
sites of alternative splicing (Tseng-Crank et al., 1994; Toro et al., 1998; Chen et al., 
2005) with the remaining portion of the C-terminus represented by the highly 
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conserved calcium bowl that may or may not reside within RCK2 (Kim et al., 2006; 
Yusifov et al., 2008) and an additional region of extensive splicing (Wei et al., 1994; 
Kim et al., 2007a; Chiu et al., 2010). The C-terminus contains multiple regulatory 
sites including the calcium bowl (Schreiber & Salkoff, 1997), several leuzine zipper 
domains (Tian et al., 2003), multiple phosphorylation sites for cAMP- and cGMP- 
dependant protein kinases (Zhou et al., 2001), haem binding domains (Tang et al., 
2003; Horrigan et al., 2005) and protein kinase C and tyrosine kinase sites 
(Schubert & Nelson, 2001; Tian et al., 2008b). 
The C-terminal region has also been proposed to have an important role in channel 
tetramerization, whereby truncation of the C-terminus prevents correct assembly of 
functional channels (Quirk & Reinhart, 2001) (see section 1.4). However to directly 
contradict the important role the C-terminus is thought to play, there is evidence that 
the core region of the BK channel (amino acids 1-343) is sufficient for channel 
tetramerisation (Schmalhofer et al., 2005). Further to this, there is controversial 
evidence that suggests that truncation of C-terminus does not even affect normal 
channel function (Piskorowski & Aldrich, 2002). Despite these studies a wealth of 
information reinforces the importance of the C-terminus particularly in controlling 
trafficking to the plasma membrane, the control of cell surface expression and 
modulating the calcium sensitivity of the channel (Kwon & Guggino, 2004). 
 
1.4.3.1 The RCK domains 
Two domains that regulate potassium conductance have been proposed in the BK 
channel, RCK1 and RCK2. The first RCK domain (RCK 1) encompasses a high 
affinity calcium sensor (D362/D367 and M513), which when mutated neutralises the 
calcium sensing affinity of the site (Bao et al., 2002; Xia et al., 2002; Zeng et al., 
2005). The RCK1 domain also contains an additional site sensitive to divalent cation 
binding, a low affinity site for calcium in the 10-100 µM range (Salkoff et al., 2006). 
Recently a gain-of-function mutation causing an epileptic phenotype has been 
localised to this region (Du et al., 2005). 
A candidate RCK2 region of ~160 amino acids (Kim et al., 2006) excluding the high 
affinity Ca2+ bowl and based on sequence alignment to RCK homologous regions, 
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has been put forward built upon comparisons to the bacterial MthK channels that 
have two RCK domains, despite the sequence identity between BK RCK domains 
and prokaryotic RCK domains being very low (<20%) (Yuan et al., 2010). 
Considering this, the location boundaries are still fairly uncertain and several studies 
have included the high affinity Ca2+
 
 bowl within RCK2 (Yusifov et al., 2008; Wu et 
al., 2010; Yuan et al., 2010). RCK2 contains a similar predicted secondary structure 
to RCK1 despite being smaller and has conserved hydrophobic residues that form a 
dimeric interface between the two RCK domains. This interface is strong and highly 
specific and crucially important for regulation of the channel (Yuan et al., 2010). 
Deletion studies involving the RCK2 domain demonstrate a failure to generate ionic 
current however this could be restored by co-transfecting separate core and tail 
regions and was not due to decreased cell surface expression (Kim et al., 2006) 
therefore it would appear that the RCK2 domain is essential for a functioning 
channel but not necessarily important for channel assembly. 
1.4.3.2 The calcium bowl 
The BK channel is dynamically regulated by calcium binding which modulates the 
voltage required to activate the channel inducing a leftward shift to more negative 
potentials and into a more physiological range. These unique properties that make 
the voltage-sensitive component of the channel additionally sensitive to intracellular 
calcium have been attributed to the large intracellular C-terminus. Even though the 
entire channel α-subunit does not contain any established calcium binding motifs, 
the channel is still responsive to a few hundred nanomolar of calcium (Bao et al., 
2004). The tail region which comprises the last one-third portion of the C-terminus 
(S9-S10), shows the highest sequence conservation in the entire channel peptide 
among species (Wei et al., 1994). This region has a series of highly conserved 
negatively charged aspartate (D) residues that determine the calcium sensitivity of 
the channel, hence this region has been termed, the calcium bowl (Schreiber & 
Salkoff, 1997). Mutations in the calcium bowl alter the high-affinity sensing of 
calcium by the channel by approximately half (Bian et al., 2001; Bao et al., 2002; Xia 
et al., 2002). Experiments have demonstrated that transferring the portion of the C-
terminus that contains the calcium bowl to a calcium insensitive channel, such as 
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SLO-3, confers calcium sensitivity to the channel (Schreiber et al., 1999). Binding 
assays have additionally proven that calcium does indeed bind to the tail region of 
the BK channel, as mutation of the five calcium bowl aspartic acids inhibit binding 
(Bian et al., 2001). It was proposed that a direct correlation was found between the 
biochemical measurement of Ca2+ binding to the tail domain and the Ca2+-
dependent activation of a BK channel. However, mutations in the calcium bowl 
revealed that the BK channel must contain a second calcium binding site, which was 
subsequently identified to be located in the RCK1 domain (Bao et al., 2002; Xia et 
al., 2002; Zeng et al., 2005). Mutations in both high affinity calcium sites (residue 
M513 in RCK1 and D895 and D897 in the calcium bowl) eliminate all high affinity 
Ca2+ binding (Bao et al., 2004; Yuan et al., 2010). Physiologically, the high affinity 
calcium sites can be saturated over a range of 70 – 100 µM intracellular free 
calcium and once this calcium-dependant component determined by the tail domain 
is saturated, the channel gating behaviour is determined solely by the core domain 
(Wei et al., 1994). Additional to the high affinity sites in the BK channel, 
concentrations of calcium or other divalent cations in the 100 µM to 100 mM range, 
produce distinct effects on channel gating that have been attributed to non-selective, 
low affinity binding sites (Horrigan & Aldrich, 2002). Crystallographic structural 
studies have since indicate that the Ca2+ bowl is located within the RCK2 domain 
and may have evolved from a helix in the RCK2 domain. These studies have also 
suggested that Ca2+
 
 binding occurs at the assembly interface deep within the RCK1 
and RCK2 dimer (Yuan et al., 2010). The proposed structure of the BK channel 
calcium bowl is illustrated in the next section (see section 1.5 and Figure 1.10B). 
1.4.3.3 The gating ring theory - the S6-RCK1 linker 
In BK channels, it is proposed that the two RCK domains on each α-subunit create 
an octameric complex forming a gating ring similar to that described in bacterial 
MthK channels (Jiang et al., 2001; Jiang et al., 2002b). The gating domain is 
physically coupled to the pore by the S6-RCK1 linker and mechanically alters the 
conformation between the channel’s open and closed state (Figure 1.7A). Activation 
of the voltage-sensing domain in the BK channel will change the conformation of the 
channel to open the pore. This will decrease the length of the linker-gating ring
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Figure 1.7
Spring-based gating mechanism for BK channels
Figure 1.7. Spring-based gating mechanism for BK channels.  (A) The proposed 
gating mechanism of a voltage- and calcium- activated K+ channel. The addition of 
Ca2+ expands the gating ring, pulling on the linker that tethers the RCK1/RCK2 gating 
ring to the S6 domain, pulling the inner helices apart to open the pore (Jiang et al., 
2002). (B) In the drawing, the S6 gate and S4 voltage sensor from a single subunit are 
shown. The linker-gating ring complex is represented by an intracellular spring that is 
directly attached to the S6 gate. The charged S4 voltage sensor is indirectly 
connected to the S6 gate through a spring. (i) Depolarization moves the charge on the 
S4 voltage sensor outward, opening the S6 gate, (ii) Increasing the linker length would 
decrease the opening forces. (iii) Ca2+ opens the channel by turning the passive 
spring of the linker-gating ring complex into an active force-generating machine (Niu 
et al., 2004).
Jiang et al., 2002 Nature





S6-RCK1 linker S6-RCK1 linker
Ca2+ Ca2+
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complex (Figure 1.7Bi). In the absence of calcium and voltage, the linker-gating ring 
complex forms a passive spring (Figure 1.7Bii). The spring is not expected to be 
slack as small changes in length have been shown to dramatically change channel 
activity, presumably directly changing the ‘spring’ tension in this region. Binding of 
calcium expands the gating ring, pulling on the linker that tethers the RCK1 ring to 
the S6 domain and pulling the inner helices apart to open the pore (Jiang et al., 
2001; Dong et al., 2005) (Figure 1.7Biii). It is probable that the free energy from 
calcium binding to the channel is converted in to mechanical work changing the 
passive spring into a force-generating machine to open the pore (Yusifov et al., 
2008).  
This model couples both the voltage sensing ability of the channel and the calcium 
sensing domain through the S6 gate allowing both independent and synergistic 
activation of the channel by voltage and calcium, the properties synonymous with 
the BK channel. 
 
1.4.3.4 The RCK1-RCK2 linker 
The linker between the RCK domains, the RCK1-RCK2 linker (see Figure 1.3), has 
also been implicated in the gating kinetics of the BK channel. It varies in length from 
sea urchin to human by ~100 to 240 amino acids taking into account multiple splice 
variants generated in this region and may be of structural importance despite poor 
evolutionary conservation (Lee et al., 2009a). However, studies have predicted that 
the RCK1-RCK2 linker has no regular secondary structure (NORS). In crystallisation 
studies the RCK1–RCK2 linker could not be detected by electron density which was 
suggested as consistent with the region being unstructured (Wang & Sigworth, 
2009; Wu et al; 2010; Yuan et al., 2010). 
In a study examining the length of the RCK1-RCK2 linker it was found that linker 
length rather than the specific amino acid sequence of the linker was important for 
functionality of the channel. Shortening of the RCK1-RCK2 linker reduced channel 
activity possibly by increasing the strain on the gating machinery or altering the 
dynamics of the interface between the two RCK domains. Lengthening the RCK1-
RCK2 linker apparently did not have any effect on channel function. Hence it would 
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appear that the RCK1-RCK2 linker may play an important role in the dynamics of 
the interaction between the two RCK domains and the role they play on channel 
gating (Lee et al., 2009a). Interestingly, the crystal structure explains why length of 
the linker may be important; the end of RCK1 using crystal structural analysis is a 
long distance away from the beginning of RCK2 (this is illustrated later in Figure 
1.10) (Yuan et al., 2010). 
The RCK1-RCK2 linker is known to contain at least 3 sites of alternative splicing 
(Tseng-Crank et al., 1994). In the light of the linker length theory in gating kinetics, it 
would be interesting to examine how splice insertion of, for example the 58 amino 
acid STREX insert at splice site C2 might affect the gating mechanism. It is 
conceivable that evolutionary retained splice sites may enforce a structural change, 
perhaps creating secondary structure in this region that could change the gating 
properties of the channel, perhaps changing the assembly interface between the two 
RCK domains. A study looking at the effect of stretch activation of the BK channel 
containing the alternatively spliced STREX insert in the RCK1-RCK2 linker, 
demonstrated that mechanical forces generated by membrane stretch can be 
detected via the STREX motif, leading to an open conformation of the channel 
(Naruse et al., 2009) suggesting the possibility of some sort of interaction with the 
plasma membrane, but more importantly a possible role for the linker in controlling 
channel activity.  
 
1.4.3.5 The C-terminus, a necessary component? 
In the previous sections it has become clear that the C-terminus of the BK channel 
is important for normal channel function. Studies involving truncation of the entire C- 
terminus, three residues after the S6 transmembrane domain, show no evidence of 
channel tetramerization, cell surface expression or functional channels (Schmalhofer 
et al., 2005). It appears that there is a crucial component to the functioning core 
region of the BK channel that necessitates the inclusion of the S0-S8 region (amino 
acids 1-652 as described by (Schmalhofer et al., 2005)). When the tail region is 
functionally expressed as a separate domain and expressed in oocytes, patches 
that contain the S0-S8 core of the channel can be “cross-crammed” into these 
oocytes creating functional channels within minutes and suggesting that the C-
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terminal domain must be cytosolic (Meera et al., 1997). Experiments involving 
murine and Drosophila BK channels that have different affinities for calcium, also 
suggest that functional channels can be produced, even if the core and tail regions 
expressed are from different species (Wei et al., 1994). This is consistent with the 
proposed role of the RCK1 domain as part of a linker-gating ring that must be 
attached to the pore S6-linker to be able to transmit the energy necessary for 
channel opening (Schmalhofer et al., 2005). 
Controversially, it has been suggested that BK channels truncated at the base of the 
S6 domain can form functional channels and also retain their calcium-sensing ability 
(Piskorowski & Aldrich, 2002). It remains to be seen whether this finding can be 
replicated, as it may be that there was some endogenous expression of BK channel 
that may have rescued the truncated channel, or indeed if this finding does hold true 
then it is possible that perhaps calcium binding sites are not present solely in the C-
terminus but may also exist within the core region of the channel, perhaps masked 
by the normal folding of the protein and only revealed upon truncation, although this 
does seem very unlikely. 
 
1.5 The 3D structure of the BK channel 
 
So far I have described the topological aspects and functional domains of the BK 
channel with a little information on the structure of the inner pore based on studies 
from bacterial K+ channels (MacKinnon, 2004a). In the following section I would like 
to discuss some of the seminal structural studies that have aided our recent 
understanding of the BK channel. In the last year or so there has been three or four 
key studies that have defined the BK channel structure. Studies from Fred 
Sigworth’s lab using electron cryomicroscopy, demonstrated the first structural 
insight to the BK channel at a resolution of ~1.7-2.0 nm (Wang & Sigworth, 2009). 
These structural observations correlated well with studies that used disulphide 
cross-linking to identify the positions of the transmembrane domains in the BK 
channel (Liu et al., 2010). Subsequent to Fred Sigworth’s cryo-EM model, Roderick 
MacKinnon who won the Nobel prize for his work on the structure of ion channels, 
turned his attention to the BK channel describing the gating apparatus of the human
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Figure 1.8
Cryo-EM structure of the BK channel
Figure 1.8. Cryo-EM structure of the BK channel.  (A) Side view surface rendering of 
the membrane-subtracted BK channel map, obtained from 3,400 images of particles 
in large vesicles. Superimposed is the membrane density (mesh). The colour indicate 
the various predicted regions in accordance with comparisons with known crystal 
structures of Kv and MlotiK channels. For illustrative purposes dashed circles repre-
sent the probable position of S0-S1 linker and the RCK1-RCK2 linker with solid circles 
indicating the probable location of the identified domains. Scale bar illustrates size of 
the C-terminus and the approxiamate distance of the RCK1-RCK2 interface from the 
plasma membrane (B) Extracellular aspect of the membrane-restored reconstruction 
of BK. Protrusions are identified corresponding to the pore domain (red box), S2 
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BK channel at a much higher resolution of 3.0 Å (Yuan et al., 2010), with a parallel 
study from one of MacKinnon’s previous colleagues Youxing Jiang confirming the 
structural arrangement of the C-terminus also at 3.1 Å (Wu et al; 2010). 
Prior to Fred Sigworth’s model of BK (Wang & Sigworth, 2009), the only information 
on the BK channel structure was through indirect studies on homologous prokaryotic 
K+ channel structure through sequence alignment despite a very low sequence 
identity (<20%). Using a novel technique called electron cryomicroscopy (cryo-EM) 
(Frank, 2006) Wang & Sigworth expressed channels in lipid vesicles frozen in 
vitreous ice and imaged by electron microscope. They then summated images from 
around 8,400 individual protein particles, analysed them and created a 3D 
reconstruction of the BK channel at a resolution of 1.7-2.0 nm (Figure 1.8A). In their 
“membrane restored” cryo-EM map of the extracellular face of BK (Figure 1.8B) they 
identified protrusions corresponding to the turret region of the pore domain (red 
square), the S2 helix of the voltage sensor (green circle) which concurs with crystal 
structural analysis of both Kv1.2 and MlotiK1 X-ray structures (Long et al., 2005; 
Clayton et al., 2008) and a much larger protrusion not present in voltage gated K+
The position of the transmembrane domains of the BK channel has also recently 
been identified by Guoxia Liu et al, (Figure 1.9) using disulphide cross-linking to 
identify the proximities of cysteine substitutions in the extracellular flanks of the 
transmembrane domains. They have shown that the S0 domain is located outside of 
the S1-S4 bundle and is more closely associated with the S3 and S4 domains (see 
Figure 1.9) (Liu et al., 2010), which they identified as inconsistent with their previous 
inference that the extracellular end of the S0 domain is between the S2 and S3 
domains (Liu et al., 2008). Using the Kv1.1/Kv2.1 channel structure they 
superimposed the extracellular ends of the S0-S6 domains to illustrate the 
proximities of each transmembrane domain in the BK channel (Figure 1.9A). A side 
view of the voltage-gated K
 
channel structures at the periphery of the voltage sensing domain, the S0 domain 
with its extracellular N terminus of ~40 residues. They suggested that the S0 domain 
appeared to be in contact with the S2 and S3 domains, consistent with a recently 
revised cross linking study (Liu et al., 2008; Liu et al., 2010). 
+ channel illustrates the position of transmembrane 
domains in the membrane which would be a similar arrangement in the BK channel 
however with an additional S0 domain (Figure 1.9B). 
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Figure 1.9
The positions of the transmembrane domains in the BK channel
Figure 1.9. The positions of the transmembrane domains in the BK channel.  (A) 
Extracellular view of the Kv1.2/Kv2.1 channel crystal structure with superimposed 
labelled circles uniquely coloured for each BK α-subunit, representing the approxi-
mate locations of the extracellular ends of S0-S6. Circles are based on the extent of 
cross-linking between cysteine residues in the extracellular loop linking transmem-
brane domains. Adapted from Liu et al., 2010. (B) View of the model in A from the side 
of the membrane (colours are not comparable). The model represents a Kv1.2 
voltage-gated K+ channel that is proposed to be similar in structure to the core region 
of the BK channel (Wang & Sigworth., 2009). The side profile demonstrates how the 
transmembrane domains position in the membrane around the central pore region. 
Adapted from Yarovoy et al., 2006.
BK channel extracellular view
Liu et al, 2010.  J. Gen. Physiol.
K+ channel structure side view




The structure of the  BK channel intracellular C-terminus domain and proposed 
arrangement of the calcium bowl
Figure 1.10. The structure of the C-terminus Domain. (A) Secondary structure of the 
human BK C-terminus from the crystal structure in ligand bound state (50 mM 
calcium) illustrating RCK1 (in blue) and RCK2 (in red) with unresolved segments 
indicated by dashed lines. The position of the RCK1-RCK2 linked is indicated. The 
Ca2+ bowl is indicated by a green line with a Ca2+ ion illustrated by a yellow sphere. 
(B) Superposition of the Ca2+ bowl from the human BK C-terminus (green) and the 
Ca2+ binding site from the calpain-1 catalytic subunit (blue) that has been previously 









Yuan et al., 2010 Science
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To go back to the model of Wang and Sigworth, they were able to conclude that the 
pore and voltage sensing regions of the BK channel were similar to that seen in the 
crystal structures of the 6-TM voltage-gated K+
Building upon the Wang and Sigworth model, the recent study from Roderick 
Mackinnon’s lab described the crystal structure of the C-terminus of the BK channel 
by expressing residues 341-1056 in insect cells (Spodoptera Frugiperda), at much 
higher resolution of 3.0 Å (Yuan et al., 2010)(Figure 1.10) in 50 mM calcium (ligand 
bound). In their model Yuan et al, describe the tandem RCK domains folded tightly 
against one another forming a more extensive interface than their prokaryotic 
counterparts. As previously mentioned (see section 1.4.3.4) the inability to define 
the electron density for the long linker connecting RCK1 and RCK2 is consistent 
with this region being unstructured, but they identify that length would be important 
as the end of RCK1 is located a long distance from the beginning of RCK2 (Figure 
1.10A). Crucially it was suggested that the calcium bowl is not distal to the RCK2 
domain, but an integral structural element of it and located at the assembly interface 
between the RCK domains (Figure 1.10A & B) (Yuan et al., 2010). 
 channels (Long et al., 2005; Long et 
al., 2007). They then described the large C-terminal domain which composes the 
gating ring and the tail region which would contain the calcium bowl (Figure 1.8A) 
and suggested that the smaller second RCK domain (RCK2) in the BK channel can 
be seen in the lower mass of the gating ring, illustrated by the tapered channel 
structure (Figure 1.8A) (Wang & Sigworth, 2009). 
The second major structural study which came from Youxing Jiang’s lab extensively 
detailed the BK C-terminal structure at the assembly interface in a calcium free state 
(ligand un-bound) suggesting that calcium binding could trigger conformational 
changes at the assembly interface leading to channel activation. They also identified 
the three Ca2+
 
 binding sites in their model and by including the S6-RCK1 linker in 
the structural study were able to generate a model for the full channel by docking 
the C-terminal domain of the BK channel to the homologous crystal structure of a 





The proposed crystal structure of the BK channel
Figure 1.11. The proposed crystal structure of the BK channel.  A ribbon representa-
tion of the BK channel tetramer viewed from the side (Wu et al., 2010). The Kv1.2 
S1-S6 crystal structure (green) is docked atop of the BK gating ring with the RCK1 and 
RCK2 domains coloured yellow and magenta, respectively. The C-terminus was 
resolved in a ligand un-bound state (calcium free). All three Ca2+ binding sites are 











1.6 The dynamic regulation of BK channels 
 
The BK channel pore forming α-subunit is encoded only by a single gene (Slo, 
KCNMA1), forming a channel consisting of four α-subunits arranged around a 
central K+
 
 conducting pore. The α-subunit has high amino acid sequence identity 
(~98%) in mammals (Lu et al., 2006) unlike other voltage-gated ion channels that 
have a variety of isoforms arising from multiple genes. Functional diversity of the BK 
channel can be achieved by a combinatorial association with regulatory β-subunits, 
variation in the usage of alternative splicing within the KCNMA1 gene, the formation 
of heterotetrameric channels composed of multiple splice variant α-subunits and co-
translational as well as post-translational mechanisms. These additional 
mechanisms can influence channel activity through voltage sensitivity and calcium 
sensitivity, regulate the activation and deactivation rates that control cellular 
excitability and control trafficking of the channel protein to enable functional 
expression at the plasma membrane. 
1.6.1 Regulatory β- subunits 
The BK channel can achieve functional diversity through an association with 
auxiliary β-subunits (Brenner et al., 2000b; Orio et al., 2002; Lippiat et al., 2003). 
The β-subunit was first cloned from bovine smooth muscle (Knaus et al., 1994b; 
Knaus et al., 1994c; Knaus et al., 1994d) and subsequently named β1. Since then a 
family of four β-subunits have been identified each with a different tissue distribution 
and different effects on BK channel pharmacology and gating including the β2 
subunit (Bentrop et al., 2001), the β3 subunit (Xia et al., 2000) and the β4 subunit 
(Brenner et al., 2005). Moreover, β-subunits have also been implicated in trafficking 
of BK channels and expression at the cell surface (Toro et al., 2006; Kim et al., 
2007b). 
The β-subunits are membrane spanning proteins containing intracellular N- and C-
terminal domains with two transmembrane domains, separated by a large 
extracellular loop (Jiang et al., 1999)(Figure 1.3). The diversity required for tissue 
specific roles of the BK channel can in part be achieved by the tissue specific 
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expression of the regulatory β-subunits (Jiang et al., 1999). Interestingly, it appears 
that BK β-subunits have not been identified in Drosophila or C.elegans (Orio et al., 
2002), suggesting that their expression may represent an adaption evolved to 
regulate BK channels in different tissues, in more complex vertebrate organisms.  
In determining the region within the BK channel that is involved in β-subunit 
modulation, a Drosophila BK channel (dSlo) that is unresponsive to the β-subunit 
was studied with different chimeric regions of the human BK channel (hSlo) (Wallner 
et al., 1996). Human BK channels purified from smooth muscle have been seen to 
be tightly associated with an accessory β-subunit that dramatically increases open 
probability (β1). It was found that the 31 amino acids at the N-terminus of the human 
BK channel, which include the S0 transmembrane domain, when explanted into the 
Drosophila BK channel, were critical for β-subunit modulation in BK channels 
(Wallner et al., 1996). Therefore, it seems that the S0 domain of the pore-forming α-
subunit of the BK channel is important for facilitating the regulatory effects of β-
subunits (Wallner et al., 1996; Meera et al., 1997; Liu et al., 2008; Wu et al., 2009; 
Liu et al., 2010). The additional S0 domain in the BK channel may represent part of 
the evolutionary adaptation within the α-subunit for effective regulation of the 
channel by these regulatory domains.  
The β-subunits contribute greatly to the diverse phenotype associated with the BK 
channel through the control of calcium sensitivity, channel gating and pharmacology 
allowing the BK channel to play important physiological roles in different tissues with 
different β-subunit expression profiles around the body. Downregulation of the β1 
subunit, primarily expressed in smooth muscle, is associated with elevated blood 
pressure (Brenner et al., 2000a) and phasic contractions in bladder (Petkov et al., 
2001) with gain of function mutants suggested to be protective against diastolic 
hypertension (Fernandez-Fernandez et al., 2004). The β2 subunit selectively 
expressed in chromaffin cells and the brain, demonstrates fast ‘ball and chain’ type 
channel inactivation (Bentrop et al., 2001). The β3-subunit, structurally similar to β1 
and β2 and mainly expressed in testis, pancreas and spleen, also confers rapid 
inactivation (Xia et al., 2000). The β4 subunit is expressed predominantly in brain 
can effect BK channel regulation of neuronal excitability with dysfunction leading to 
temporal lobe seizures (Brenner et al., 2005). The differing functions and locations 
of the β-subunits, illustrate how they can finely tune the gating properties of the BK 
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channel and modulate the functional diversity required of the channel around the 
body. 
 
1.6.2 Alternative splicing – diversifying channel function 
Functional complexity within the mammalian genome can be achieved by a process 
of alternative splicing. When the human genome project had finished mapping the 
human genome, surprisingly they identified far fewer genes (~30,000) than the 
earlier molecular predictions (of over 100,000 genes) that were expected to 
contribute to the higher complexities of the human organism (Claverie, 2001; Venter 
et al., 2001). In fact by examining the number of genes, the human organism would 
appear to be only about five times as complex as a bacterium such as 
Pseudomonas aeruginosa (Claverie, 2001). With only about 1.5% of the human 
genome actually coding for functional proteins, non-coding “introns” that separate 
the coding sections called “exons” along with non-coding RNA and miscellaneously 
named “junk DNA”, make up the rest of the genome. However, alternative splicing 
accounts for the complexity required in the vertebrate genome. 
The DNA sequence is represented by primary RNA transcripts which are then 
processed to remove non-coding introns so that the coding sections (exons) can be 
spliced together for generation of mature RNA which will then be transcribed into a 
functional protein (Figure 1.12). Alternative splicing can modify proteins by including 
or excluding specific coding sections within the gene creating distinct protein 
products. Alternative splicing is seen in nearly all metazoan organisms as a means 
for producing functionally diverse polypeptides from a single gene (Lopez, 1998). 
The diversity that splicing can create is exemplified in Drosophila, whereby 
alternative splicing of one gene (DSCAM) can produce nearly three times the 
number of proteins as would be encoded by the entire fly-genome (Black, 2000). 
This illustrates how splicing can effectively increase the coding capacity of a gene 
creating wide ranging functional diversity. Alternative splicing can also dynamically 
regulate the on-off gene expression switch by the introduction of premature stop 
codons within spliced exons (Smith & Valcarcel, 2000). Computer algorithms have 
predicted that splicing occurs in the genome far higher than expected and it would
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Figure1.12
Overview of pre-mRNA alternative splicing
Figure 1.12. Overview of pre-mRNA splicing.  A gene contains numerous exons and 
introns. Exons are the coding regions of the genome and can be spliced together in 
different ways. Exons 1-4 may be included or excluded from the mature mRNA gener-
ating different products. Alternative splicing allows selection of particular exons to gen-
erate functional diversity within a protein. The different forms of the mRNA are called 
transcript variants, splice variants, or isoforms.
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appear that nearly every gene in the human genome may be spliced (Fodor & 
Aldrich, 2009). 
Alternative splicing of ion channels has an important role in generating functional 
diversity. To pose an evolutionary question as to the function of splicing, it would 
appear that evolutionary progress has favourably retained the splicing mechanism 
for generating protein diversity over the evolution of new paralogues of ion channels. 
This crucially allows cells to directly regulate channel properties on a fast timescale 
and in a more precise manor than would be possible if transcription of one gene 
needed to be repressed and transcription of another initiated (Copley, 2004). 
 
1.6.2.1 Alternative splicing in the BK channel 
Differential splicing of BK channel RNA transcripts represents a mechanism for 
generating diversity from the single gene (KCNMA1) that codes the channel. Distinct 
phenotypes can be regulated by alternative splicing of the channel such as auditory 
tuning (Rosenblatt et al., 1997; Beisel et al., 2007) and neuronal excitability (Tseng-
Crank et al., 1994). Indeed numerous alternatively spliced variants of the BK 
channel have been identified (Lagrutta et al., 1994; Xie & McCobb, 1998; Zarei et 
al., 2001; Erxleben et al., 2002b; Chen et al., 2005; Fodor & Aldrich, 2009) that 
control multiple aspects of channel function. Generally the KCNMA1 gene is highly 
conserved consisting of around 35 exons, 27 of which are constitutive with the 
remainder being alternatively regulated (Figure 1.13). The entire coding region of 
the BK channel spans about 750 kb of the human genome (Lu et al., 2006). 
Comparison of KCNMA1 cDNAs from a number of different vertebrate species 
suggest that there are up to 8 alternative sites of splicing that result in two or more 
changes of amino acid
In the BK channel alternative splicing has been demonstrated to play an important 
role in modifying channel function by altering calcium- and voltage- sensitivity
 sequence, along with additional species-unique splice 
variants (Tseng-Crank et al., 1994; Korovkina et al., 2001; Zarei et al., 2001; Zarei et 
al., 2004; Beisel et al., 2007). Some splice sites are found in the amino terminus 
(N1-N2) of the BK channel although the majority are located in the carboxy-terminus 
(C1-C5) (Tseng-Crank et al., 1994). 
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Figure 1.13
Intron-exon structure map of murine BK channel and alternative splice sites
Figure 1.13. Intron-exon structure map of murine BK channel and alternative splice 
sites.  (A) Topology of BK channel illustrating alternative splice sites in the N-terminus 
(N:1-2) and C-terminus (C:1-5). (B) Predicted intron-exon structure of mouse 
KCNMA1 gene. Constitutive exons are shown as open boxes and alternative spliced 
exons in splice site C2 are shaded grey. Exon 1 contains the initiator start methionine 
of MDALI.., Location of C-terminus splice sites are shown, numbered C1-5, N-terminal 
sites are shown, number N1-2. Expanded view across splice site C2 illustrates spliced 
exons for each of the five identified splice variants at this site. (Information summated 
from references: Tseng-Crank et al., 1994; Korovkina et al., 2001; Zarei et al., 2001; 
Chen et al., 2005; Beisel et al., 2006; Fodor & Aldrich, 2008). The approximate length 
of the genome is indicated.
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(Adelman et al., 1992; Lagrutta et al., 1994; Tseng-Crank et al., 1994; Saito et al., 
1997; Shipston et al., 1999; Ha et al., 2000), regulating protein phosphorylation 
(Tian et al., 2001; Tian et al., 2004) and other intracellular signalling cascades (Tian 
et al., 2001; Erxleben et al., 2002a) as well as controlling cell surface expression 
(Zarei et al., 2001; Kwon & Guggino, 2004; Zarei et al., 2004). 
 
1.6.2.2 The STREX splice variant 
In the BK channel, splice site C2 is located in the linker region between the RCK1 
and RCK2 domains of the intracellular C-terminus (Figure 1.3) and has been shown 
to have five distinct splice variants that can be inserted at this site, some of which 
influence the channel phenotype. The insertless variant, referred to as the ZERO 
variant, results from splicing of exon 19 to exon 23, an e20 variant has a 3 amino 
acid ‘IYF’ insert includes exon 20 between exon 19 and exon 23. The e21 variant 
has a 58 amino acid insert from inclusion of exon 21 between exon 19 and 23 and 
the e22 variant has a 29 amino acid insert from inclusion of exon 22 between exon 
19 and 23. The e23 variant skips exon 23 which results in splicing of exon 19 to 24 
leading to a frameshift and a truncated channel that is not expressed at the plasma 
membrane (Chen et al., 2005)(Figure 1.13). These splice variants can have a 
significant effect on the functional properties of the channel (Chen et al., 2005; 
Saleem et al., 2009). 
The e21 variant, highly conserved from human to zebrafish, encodes a cysteine-rich 
domain of 58 amino acids that confers an apparent increased Ca2+
The STREX insert has been previously shown to contain a PKA phosphorylation 
serine site (S636) that mediates channel inhibition (Tian et al., 2004) and a ‘CSC’ 
motif that confers hypoxic sensitivity to BK channels (McCartney et al., 2005). 
Therefore the STREX insert has already been shown to have an important role in 
 sensitivity to the 
BK channel and was first defined in 1997 (Saito et al., 1997). Subsequently, it was 
identified that the number of channels containing this 58 amino acid splice insert, 
relative to channels without an insert at the C2 site, could be modulated by the 
hypothalamic-pituitary-adrenal (HPA) stress axis (Xie & McCobb, 1998). They 
henceforth named this exon, the STRess axis-regulated EXon, or STREX.  
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tuning BK channel properties. However, the molecular basis for the apparent 
increased Ca2+
The tissue distribution of the STREX channel variant suggests that it is mostly 
prevalent in endocrine tissues such as the chromaffin cells of the adrenal gland, the 
pancreas and pituitary as well as the cerebellum, uterine smooth muscle, and 
prostate (Tseng-Crank et al., 1994; Ferrer et al., 1996; Saito et al., 1997; Xie & 
McCobb, 1998; Shipston et al., 1999; Chen et al., 2005; Zhu et al., 2005). It is 
largely absent from spinal cord tissue, the majority of smooth muscle cells and 
skeletal muscle. 
 sensitivity is unknown. The cysteine rich composition of STREX 
when included in the RCK1- RCK2 linker within the C-terminus of the BK channel, 
generates a cysteine rich domain (CRD) that incorporates the upstream haem-
binding domain (hbd) (see Figure 3.1), although the role of this domain is not known. 
STREX also introduces a series of basic residues to a region that already has an 
appreciable positive charge, although whether this region may also be a functional 
polybasic domain has also not been examined. Some of the additional features 
described that may underlie the mechanism that defines the STREX channel 
phenotype will be explored in this thesis. 
It is clear that extrinsic factors influence splicing of the BK channel gene at splice 
site C2. A hypophysectomy (ablation of the hypothalamus) was shown to trigger an 
abrupt decrease (by 50%) in the proportion of STREX channel variants in relation to 
insertless ZERO channels in adrenal chromaffin cells where the BK channel is 
thought to play an important role in cellular excitability (Xie & McCobb, 1998). This 
effect could be rescued by injection of ACTH, a stress hormone secreted from the 
pituitary under hypothalamic control, thus implicating the endocrine-stress axis in the 
regulation of STREX inclusion. However, in chronic stress models which would be 
predicted to have an opposing elevation in splice insertion of the STREX exon, a 
modest decrease (~25%) in the proportion of STREX channel variants has been 
observed in adrenal tissue (McCobb et al., 2003). In a more recent study of chronic 
stress, no significant change was observed in the relative number of STREX 
channel transcripts despite an observed increase in the total number of BK channel 
transcripts under stress conditions in adrenal chromaffin cells and a decrease in 
STREX was actually noted in the pituitary gland (Chatterjee et al., 2009). In another 
study, ablation of the pituitary gland shifted the firing properties of adrenal 
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chromaffin cells from a more STREX-like to a more ZERO-like phenotype (Lovell & 
McCobb, 2001) which would certainly implicate the HPA-axis in the splicing 
decisions of the BK channel gene. Intriguingly, both gonadal (sex) and adrenal 
(stress) hormones that respond to stress have been shown to regulate the splicing 
decision of the STREX exon, with glucocorticoids (stress hormones) negatively 
affecting inclusion of STREX and androgens (sex hormones) promoting STREX 
inclusion (Lai & McCobb, 2002) to act as a mechanism to fine-tune chromaffin cell 
excitability. Conversely, there is evidence for both positive and negative regulatory 
control of BK channel gene splicing by the stress hormone glucocorticoid (Lai & 
McCobb, 2002). These studies suggest that multiple steroid hormones 
(glucocorticoids and adrenal androgens) that are able to respond to elevation in 
stress levels can regulate STREX splicing (Lai & McCobb, 2002). 
The antitheism seen in some of the hormonal studies described, may relate to the 
age of the animal studied and the distinct possibility that splicing is more plastic 
earlier in life (Lai & McCobb, 2002). Certainly, developmental changes have been 
described across the brain during which the proportion of STREX channels is 
highest in the early embryonic stage and then undergoes significant developmental 
downregulation, relative to increasing total BK expression, during postnatal stages 
(MacDonald et al., 2006). This dynamic control of splicing decisions observed would 
be expected to have a significant role in the activity, plasticity and/or connectivity 
during neuronal development of the developing organism. 
Speculatively, the downregulation of STREX channel transcripts may relate to a 
specific down-scaling of cell excitability perhaps linked to passive coping 
mechanisms in the developing organism as it proceeds into postnatal life (McCobb 
et al., 2003). Whether splice regulation could contribute to coping mechanisms in 
response to stress in adult mammals would certainly be interesting to investigate. 
Alternative splicing is a powerful mechanism to directly regulate BK channels 
precisely, inferring wide ranging functional properties on a fast timescale. Splicing 
allows the channel to be specifically modulated for specific cell types, at different 
developmental stages and in response to different physiological inputs. 
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1.6.3  Post-translational modifications 
Proteins including ion channels are regulated by various post-translational 
modifications which tune protein function specific to the requirements of different cell 
types. They include lipid modifications such as palmitoylation and myristoylation 
(Resh, 2006a) and modulation by phosphorylation at serine, threonine or tyrosine 
residues (Levitan, 1994; Reinhart & Levitan, 1995; Shipston & Armstrong, 1996; Hall 
& Armstrong, 2000; Tian et al., 2004; Tian et al., 2008b; Zhou et al., 2010). 
 
1.6.3.1 Lipophilic modification of proteins 
The covalent addition of lipid groups to proteins was first described for brain myelin 
by Folch and Lees in 1951 (Folch & Lees, 1951). It wasn’t until nearly 30 years later 
that it was rediscovered that viral membrane glycoproteins contain covalently bound 
fatty acids (Schmidt et al., 1979; Schmidt & Schlesinger, 1979). Indeed it has taken 
several more decades to understand the wide ranging significance of lipophilic 
modifications to proteins. Several hundred proteins have since been identified with 
covalently bound lipid groups. The three most common types of lipids to be attached 
to proteins are the fatty acids, isoprenoids and glycosylphosphatidylinositol anchors. 
These lipophilic additions regulate protein interaction with the plasma membrane 
and other proteins, as well as facilitating signalling and protein trafficking (Resh, 
2006a). The addition of fatty acids to substrate proteins is a process called fatty 
acylation. The two most common forms of protein fatty acylation involve the covalent 
attachment of myristate (a 14-carbon saturated fatty acid) or palmitate (a 16-carbon 
saturated fatty acid). Myristoylation is a co-translational process and generally not 
reversible which occurs through amide linkages (N-acylation) to amino-terminal 
glycine residues. Palmitoylation, on the other hand, occurs by a post-translational 
mechanism through a thioester linkage (S-acylation) to specific cysteine residues. 
Palmitate, one of the most common fatty acid modifications, is unique in its ability to 





Palmitoylation involves the attachment of palmitate through a thioester linkage to the 
sulfhydryl group of a cysteine residue in a target protein. This will increase the 
hydrophobicity of the protein and can therefore increase membrane association. 
Palmitoylated proteins can be classified into five general classes. 1) transmembrane 
proteins S-acylated on cysteines at or near the transmembrane domain. 2) Ras 
proteins where prior prenylation of the cysteine residue within the C-terminal is 
required for S-palmitoylation. 3) Proteins S-palmitoylated at one or more cysteines 
near the N- or C-terminus. 4) Members of the Src family of tyrosine protein kinases 
with a consensus sequence for dual acylation and 5) proteins including Hedgehog 
and the G-protein (Gαs
The diverse effects of palmitoylation on the modified protein are beginning to be 
understood more than just simply functioning to increase hydrophobicity and thereby 
membrane association, but also to regulate and specify membrane interactions, 
influence sorting, direct localisation to specific regions in the membrane (eg. lipid 
rafts), influence protein signalling, regulate protein trafficking and alter the functional 
properties of the protein (Resh, 1999; Bijlmakers & Marsh, 2003; Resh, 2006a). To 
examine the effect of pharmacological inhibition of protein palmitoylation, 2-
bromopalmitate (2BP), a non-metabolizable palmitate analog is mainly used that 
blocks palmitate incorporation into proteins (Webb et al., 2000). The mechanism 
responsible for 2BP mediated inhibition of protein palmitoylation is not known. It is 
possible that it binds to a palmitoyl transferase forming an inhibitor:enzyme complex. 
Alternatively, transfer of 2BP to the target cysteine may occur although the 
increased hydrophilicity of the bromine atom would reduce binding of the modified 
protein to the lipid bilayer (Resh, 2006c). It could also alter the lipid metabolism 
reducing the concentration of intracellular palmitoyl CoA pools. Despite the unknown 
nature of its actions it is an effective tool for studying the role of palmitoylation. 
) subunit that contains palmitate covalently bound via an 
amide-linkage to an N- terminal cysteine residue (Resh, 1999, 2006a).  
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1.6.3.1.2 Palmitoyl Acyl Transferases 
The enzymes responsible for the covalent addition of palmitate to target proteins 
have been elusive for a long time. Initially, genetic screening helped to identify the 
transferase enzymes in yeast that were involved in palmitoylation (Bartels et al., 
1999). These enzymes, referred to as palmitoyl acyl transferases or PATs, have a 
common topology and motif, comprising several transmembrane domains and an 
Asp-His-His-Cys (DHHC)-cysteine rich domain (CRD), hereafter referred to as a 
DHHC domain. The DHHC domain has been identified as the active palmitoyl 
transferase, as disruption of this motif by mutagenesis abolishes PAT activity 
(Fukata et al., 2006). In mammalian genomes (human and mouse), 23 kinds of 
DHHC proteins are predicted (Fukata et al., 2004; Ohno et al., 2006). No DHHC 
domains have been identified in prokaryotes or archea, which coincides with the 
widespread occurrence of palmitoylation in eukaryotes and its apparent absence in 
prokaryotes (Mitchell et al., 2006). To identify the PATs for a particular substrate, a 
systematic evaluation of all 23 DHHC proteins would be required. The prevalence of 
various pathological conditions in human, associated with mutations in DHHC 
proteins such as schizophrenia, Huntington’s disease and X-linked mental 
retardation alongside various cancers make them attractive therapeutic targets of 
the future (Linder & Deschenes, 2007; Fukata & Fukata, 2010). The activity of 
palmitoylating enzymes (PATs) and de-palmitoylating enzymes called pamitoyl 
protein thioesterases (PPTs) are finely tuned and determine the palmitoylation 
status of the protein. In contrast to the large family of DHHC PATs, de-palmitoylating 
enzymes are limited and include acyl-protein thioesterase 1 (APT1), palmitoyl 
protein thioesterase 1 (PPT1) and PPT2 (Fukata & Fukata, 2010). 
 
1.6.3.1.3 Palmitoylation - A diverse role in modulating ion channels 
Recent studies have illustrated that ion channels can be reversibly modified by 
palmitoylation to regulate channel function, assembly, membrane targeting and 
steady state cell surface expression. Palmitoylation has been demonstrated to play 
a diverse role in the modulation of voltage sensing in the voltage-gated Kv1.1 
channel by protein-membrane interaction (Gubitosi-Klug et al., 2005) and the 
modulation of L-type Ca2+ channel (Chien et al., 1996) and N- P/Q-type Ca2+ 
48
channel (Hurley et al., 2000) which function through the regulatory influence of β2a 
subunit interaction. It has also been shown that palmitoylation has a wide role to 
play in channel trafficking such as in the regulation of cell surface stability and 
synaptic clustering of GABAA
Palmitoylation is an integral process that is crucial not only for simple protein 
trafficking to the plasma membrane. Its dynamic controllable and versatile aspects 
are reasons why it may have been evolutionarily favoured as a post translational 
modification to fine tune protein and cellular function. Palmitoylation has emerged 
over the past decade as an important and dynamic mechanism to control ion 
channel proteins.  
 receptor ligand-gated channels (Rathenberg et al., 
2004), trafficking of the AMPA receptor and NMDA receptor ligand-gated ion 
channels (Hayashi et al., 2005; Hayashi et al., 2009) and targeting of the P2X7 
receptor ATP-gated cationic channel to lipid microdomains, alongside additional 
roles in regulation of cell surface expression (Gonnord et al., 2009). Palmitoylation 
has been implicated in mediating ion channel internalization in voltage-gated Kv1.5 
ion channels (Jindal et al., 2008) and has even been shown to regulate other post 
translational modifications such as the phosphorylation status of the glutamate 
receptor (GluR6) ligand-gated ion channel (Pickering et al., 1995). Finally, another 
dimension in which palmitoylation has been demonstrated to play a significant role is 
in the structural assembly of sodium channels (Schmidt & Catterall, 1987) and the 
structural formation of aquaporin-4 channel arrays to mediate bidirectional water 
transport across the blood-brain interface (Suzuki et al., 2008). 
 
1.6.3.1.4 Palmitoylation and secondary membrane targeting motifs 
Whilst there is no clear consensus sequence for palmitoylation, the common 
denominator is often an additional membrane-targeting sequence in the vicinity of 
the target cysteines that consists of either a region positive charges, adjacent lipid 
anchors or transmembrane domains (Bijlmakers & Marsh, 2003; Dietrich & 
Ungermann, 2004). This would suggest that the local environment of the target 
sequence is probably quite important in controlling the availability of certain 
cysteines for palmitoylation. In theory a single palmitoyl group should be sufficient 
for membrane association (Resh, 2006b) frequently however additional signals are 
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involved. A two-signal hypothesis for membrane binding was initially proposed for 
Ras proteins (Hancock et al., 1990) which suggested that additional membrane 
binding signals for peripheral membrane proteins were required that may include the 
addition of lipid modifications such as myristoylation and prenylation or the presence 
of a polybasic domain. When palmitoylation is the second signal, the first signal may 
simply act as a targeting motif for interaction with the plasma membrane, whereby 
palmitoylation can occur and stabilize the association. 
 
1.6.4 Polybasic domains 
Clusters of hydrophobic and positively charged amino acids often precede and 
follow one or more palmitoylated cysteines. In G-protein signalling, the Gα subunit 
needs to be localised at the plasma membrane in order to couple to its effectors. 
Association of the Gα
Regions of positive charge in a protein can function as membrane-binding signals 
through an enhanced affinity for the negatively charged headgroups of the lipid 
membrane, via an electrostatic interaction. Potential partners for these basic 
domains are the monovalent acidic phosphatidylserine (PS) (one negative charge) 
or the less abundant and more negatively charged phosphoinositides such as PIP
 subunit with the plasma membrane is achieved through 
palmitoylation and as proposed by the two-signal hypothesis, a second targeting 
signal, which in this case is a cluster of basic residues (Crouthamel et al., 2008). 
Disruption of the polybasic domain decreases membrane association and 
interestingly, also abolishes palmitoylation of the protein (Crouthamel et al., 2008). 
Whether disruption of the polybasic domain abolishes targeting of the protein to the 
plasma membrane or whether the palmitoylation status was altered by the disruption 
of the surrounding basic environment is unknown. It is interesting to note that 
studies have suggested that multiple palmitoylated cysteine residues do actually 
decrease the relative importance of polybasic motifs (Crouthamel et al., 2008), 
suggesting that stability may be an important function of the polybasic domain in 
proteins palmitoylated at a single site. 
2 
(four negative charges) and PIP3. Additionally, these acidic lipids are more 
concentrated at the plasma membrane compared to intracellular membranes 
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(McLaughlin & Murray, 2005; Mulgrew-Nesbitt et al., 2006), thus providing a good 
mechanism for guiding basic clusters to the plasma membrane. 
The lipid composition of the plasma membrane largely comprises the zwitterionic, 
electrically neutral lipids of phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE), constituting ~60%, with the charged monovalent acidic lipid phosphatidylserine 
(PS) constituting ~25% of the inner leaflet of the plasma membrane (McLaughlin et 
al., 2002; Mulgrew-Nesbitt et al., 2006). Compared to other phospholipids, 
phosphoinositides are present in very low levels of ~1-2%. Yet, despite their low 
concentration, phosphoinositides play an important role in nearly all aspects of cell 
physiology (Lemmon, 2003; McLaughlin & Murray, 2005; Di Paolo & De Camilli, 
2006) and have a strong negative valency of -4 (McLaughlin et al., 2002). Hence the 
cytosolic-membrane interface carries an appreciable negative charge, especially in 
comparison to other intracellular membranes that have less charge. Generally, 
targeting of polybasic clusters to the plasma membrane is fairly non-specific, 
however there is evidence of specific electrostatic sequestering of the strongly 
negative-charged phosphoinositdes (PIP2 and PIP3). Therefore, it is plausible that a 
protein with a cluster of four or more basic residues (Mulgrew-Nesbitt et al., 2006) 
located at the membrane interface, would presumably be able to sequester a PIP2
The specific role of a polybasic domain in either targeting of lipidated regions of 
protein to the plasma membrane or facilitating lipidation of regions of protein for 
stable attachment to the plasma membrane is not well understood. It is possible that 
polybasic regions are necessary signals to perhaps orientate protein segments 
towards the plasma membrane for palmitoylation (Kosloff et al., 2002) because 
despite palmitoylation providing a strong anchor at the plasma membrane, it must 
first be targeted there to undergo this modification. Examples of proteins that are 
regulated by lipid and polybasic interaction with the plasma membrane include the 
PSD-95 and GAP-43 proteins (El-Husseini et al., 2000), Ras proteins (Hancock et 
al., 1989; Hancock et al., 1991; Laude & Prior, 2008), and G protein alpha subunits 
(Pedone & Hepler, 2007). Indeed polybasic targeting motifs alone have also been 
shown to be sufficient for membrane targeting, such as in the small GTPases Rit 
and KRas (Heo et al., 2006).  
 
lipid molecule.  
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1.6.4.1 The electrostatic switch 
Secondary signals necessary for palmitoylation can play an additional role in 
regulating cycles of de-palmitoylation and re-palmitoylation through myristol, 
farnesyl or electrostatic switches (Resh, 2006a). Electrostatic switches are 
physiological mechanisms that can function to disrupt positively charged polybasic 
regions, removing their functional significance. Phosphorylation could conceivably 
disrupt a polybasic domain by incorporation of a negatively charged phosphate 
group (Kim et al., 1994a). For example, phosphorylation of K-Ras within its C-
terminal polybasic region by PKC causes K-Ras to translocate from the plasma 
membrane to the mitochondria where it induces apoptosis (Bivona et al., 2006). This 
mechanism is known as an electrostatic switch, whereby the function of the basic 
domain can be switched on or off by phosphorylation, decreasing the net positive 
charge in the region. 
 
1.6.5 Phosphorylation 
Protein phosphorylation has been identified as a mechanism whereby functional 
diversity can be generated in BK channels through post-translational modification. 
The phosphorylation state of a protein is an equilibrium between opposing protein 
kinase and phosphoprotein phosphatase activities (White et al., 1991; Reinhart & 
Levitan, 1995). Several serine/threonine kinases have been shown to modulate BK 
channel activity, such as the cAMP dependant protein kinases (PKA) (Tian et al., 
2001; Tian et al., 2004), cGMP dependant protein kinases (PKG) (White et al., 2000; 
Zhou et al., 2000) and protein kinase C (PKC) (Reinhart & Levitan, 1995; Shipston & 
Armstrong, 1996; Zhou et al., 2010). Additionally, phosphatases can regulate the 
channel, such as, phosphoprotein phosphatase-1 (PP1) which has been implicated 
in modulating phosphorylation status (Reinhart & Levitan, 1995) and a 
calcium/calmodulin-dependant phosphatase has been shown to inhibit the channel 
(Loane et al., 2006). PKA activation of BK channel can also be controlled by 
opposing endogenous type 2A-like protein phosphatases (PP2A) (Tian et al., 1998; 
Tian & Shipston, 1998; Widmer et al., 2003). These interactions can play an 
important role in tissue function by 'tuning' the apparent calcium and/or voltage 
sensitivity of the BK channel (Chung et al., 1991; Schubert & Nelson, 2001).  
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Recent studies to come out of our lab have demonstrated that BK channels show 
functional heterogeneity in their response to protein kinase A (PKA) mediated 
phosphorylation. This heterogeneity is largely due to pre-mRNA splicing of the BK 
channel. PKA phosphorylation of a conserved serine phosphorylation motif S869 (or 
S927 numbered in STREX channels) in the C-terminus of the ZERO variant of the 
BK channel leads to channel activation (Tian et al., 2001; Tian et al., 2004). 
However, splice insertion of the STREX exon generates an additional PKA 
consensus motif (S636) that when phosphorylated, results in channel inhibition by 
PKA (Tian et al., 2001; Tian et al., 2004). In an elegant study examining the 
phosphorylation status of individual subunits that make up the functional channel, 
we determined that only 1 α-subunit within the BK channel tetramer is required to be 
phosphorylated by PKA at the S636 PKA-phosphorylation site, to lead to complete 
channel inhibition (Tian et al., 2004). This single subunit rule of phosphorylation at 
the additional STREX phosphorylation site presumably induces a major change in 
the functional channel to mediate this inhibitory effect. 
It is evident that protein kinases dynamically modulate the BK channel, largely by 
activating the channel via PKA and PKG and inhibiting the channel via PKC. 
Although recent studies have postulated multiple phosphorylation sites, suggesting 
the process may be more complex. Phosphorylation regulates the channel by 
shifting the voltage activation curve without effecting single channel conductance or 
voltage sensitivity. Alternative splicing is also able to switch channel activity in 
response to phosphorylation supporting data suggesting that it may be a more 
complex mechanism. Nevertheless, phosphorylation clearly plays an important role 
in tuning the BK channel in response to intracellular calcium and voltage sensitivity. 
 
1.7 Outlining the primary aims of the thesis 
   
Palmitoylation is increasingly emerging as a mechanism to regulate ion channels. It 
has recently been implicated in many diverse roles such as in the regulation of 
voltage sensing (Gubitosi-Klug et al., 2005), membrane trafficking (Hayashi et al., 
2005; Hayashi et al., 2009), channel assembly (Schmidt & Catterall, 1987) and 
protein phosphorylation (Pickering et al., 1995). The ability of palmitoylation to 
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regulate proteins post-translationally endows the cell with control over various 
aspects of protein function through rapid cycles of palmitoylation and de-
palmitoylation (Resh, 2006b).  
In the BK channel, alternative splicing of the STREX insert at the multiple splice site 
C2 within the C-terminus, introduces features typically associated with (a) 
membrane targeting domains and (b) regions that could be regulated by 
palmitoylation. 
Inclusion of STREX generates a cysteine rich region and a series of basic residues. 
Cysteine residues have been identified in many proteins as targets for post-
translational modifications such as palmitoylation (Resh, 1999). Palmitoylation 
increases the hydrophobicity of a protein, which in turn facilitates membrane 
association. As previously discussed, whilst there appears to be no clear consensus 
sequences for palmitoylation sites, they often appear to be located near to additional 
membrane-targeting sequences in the vicinity of the target cysteines, such as 
polybasic domains (Bijlmakers & Marsh, 2003; Dietrich & Ungermann, 2004). 
Indeed, polybasic domains may function independently as membrane targeting 
domains for the negatively charged inner leaflet of the plasma membrane 
(McLaughlin & Murray, 2005; Mulgrew-Nesbitt et al., 2006) or may be able to 
regulate the local environment within the protein to influence or regulate 
palmitoylation (Crouthamel et al., 2008). Therefore, the cysteine rich STREX insert 
would appear to have characteristics similar to regions in other proteins that have 
been previously identified as being palmitoylated and function as membrane 
targeting domains. 
Fundamentally, alternative splicing of the STREX insert alters the channel properties 
of the BK channel, increasing the calcium sensitivity of the channel and modulating 
the response of the channel to phosphorylation. Are these additional properties in 
STREX channels mediated by the cysteine rich domain and/or the putative 
polybasic domain generated by splicing of STREX? Does the STREX domain target 
an otherwise cytosolic C-terminus to the plasma membrane? Does palmitoylation 
regulate BK channel function? And, is it possible that other areas in the BK channel 
protein may be palmitoylated, outside of STREX? 
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In this thesis, I set out with the overall hypothesis that the BK channel is a 
palmitoylated protein and that palmitoylation controls channel function. I will 
investigate whether the STREX insert contains membrane targeting domains, 
whether this is reliant on palmitoylation and whether there are additional sites in the 




The focus of each chapter will involve determining: 
 
1. Firstly in Chapter 3, whether the STREX insert functions as a palmitoylation-
dependent membrane targeting domain and what the functional significance of this 
is. 
2. Secondly in Chapter 4, whether the series of polybasic residues generated when 
STREX is alternatively spliced into the C-terminus may function as a functional 
polybasic domain in controlling membrane targeting and/or influencing the 
palmitoylation status of the channel.  
3. And Finally in Chapter 5, I will examine the entire BK channel protein for 
additional sites that may be palmitoylated to determine if multiple sites act 
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‘In the discovery of secret things, and in the investigation of hidden 
causes, stronger reasons are obtained from sure experiments and 
demonstrated arguments than from probable conjectures and the 
opinions of philosophical speculators’ 
 
 









2.1 Molecular Biology Protocols 
 
2.1.1 Channel Constructs 
The generation of full-length murine ZERO and STREX channels with epitope-tags 
in pcDNA3 vectors are described in (Shipston et al., 1999). STREX channels have a 
58 amino acid insert at splice site C2 located in the intracellular linker between the 
two RCK domains, whereas the ZERO channel has no insert (Figure 2.1A).  C-
terminal tagged –GFP and –HA fusion proteins were made as described in (Chen et 
al., 2005). S0-S1 loop proteins were generated by PCR amplification from full length 
channel constructs using primers with overhanging Xhol and BamHI restriction sites 
and including a Kozak site to genetically enhance translation (Table 2.1). The PCR 
product was then restriction digested and subcloned in frame into a pEYFP-N1 
vector backbone. To generate N-terminal Flag- epitope tagged full-length STREX 
and ZERO channel constructs, a synthetic double-stranded Flag- oligonucleotide 
was blunt end ligated in frame with the initiator methionine (MDALI..) codon using 
forward and reverse oligonucleotides as described in (Chen et al., 2005)(Figure 
2.1B). 
 
2.1.2 Standard PCR conditions 
Standard polymerase chain reactions (PCR) to amplify selected pieces of DNA, 
were carried out in 50 µl reactions, containing 1 U of Taq DNA polymerase 
(Fermentas), 10x reaction buffer (Fermentas), 0.2 mM each of dATP, dCTP, dTTP, 
and dGTP (NE BioLabs), 1.5 mM MgCl2, and 125 ng of oligonucleotide sense and 
antisense primer. Reactions were generally run for 1 minute at 94 OC, through 25 
cycles using annealing temperatures appropriate to the primers’ calculated Tm using 
the Stratagene formula (see Equation 2.1), and 72 OC extension phases according 
to the length of the amplicon, approximately 1 minute per kb, followed by 7 minutes 
at 72 OC after the final cycle.        
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Figure 2.1
Schematic of channel constructs
Figure 2.1. Schematic of channel constructs.  (A) Topology of BK channel illustrating 
the full channel domain (light and dark grey) and C-terminal domain from the end of 
S6 (dark grey). (B) Schematic of expression constructs used in the study. Full length 
channels with C-terminal -HA tags and full length channels with N-terminal Flag- 
tagged (broken line illustrates constructs with or without Flag- tag) are illustrated 
(Flag-ZERO-HA and Flag-STREX-HA). C-terminal constructs (S6-COOH) represent 
the entire C-terminus from the end of the S6 transmembrane domain to the COOH 
end of the channel (S6:ZERO COOH-GFP and S6:STREX COOH-GFP). S0-S1 loop 
constructs only contain the intracellular loop between the S0 and S1 transmembrane 
domains (S0-S1 loop-YFP). The ZERO constructs have a dashed line which repre-











































Equation 2.1:  
TM =
81.5 + 0.41 (%GC) −  675
N − (%mismatch)
 
In equation 2.1, ‘N’ is the primer length as a number of base pairs. 
 
2.1.3 Site Directed Mutagenesis 
Site directed mutagenesis of a specific amino acid residue(s) was carried out using 
PCR in 50 µl reactions with the QuikChange XL Site-directed Mutagenesis Kit from 
Stratagene. The QuikChange method relies on linear amplification of template DNA 
by using high-fidelity DNA polymerase. Each reaction contained, 2.5 U/µl Pfu turbo 
polymerase, 1x reaction buffer, 3 µl Quiksolution (Stratagene), 0.2 mM each of 
dATP, dCTP, dTTP, and dGTP (NE BioLabs), 1.5 mM MgCl2, 10 ng template DNA, 
125 ng of oligonucleotide sense primer, 125 ng of oligonucleotide antisense primer, 
diluted in DEPC water. Reactions were generally run for 1 minute at 94 OC to 
denature the DNA template, then 18 cycles, using annealing temperatures 
appropriate to the primers’ calculated Tm, assessed using the formula from 
Stratagene (see Equation 2.1) and 72 OC extension phases according to the length 
of the amplicon (approximately 1 minute per kb), followed by 10 minutes at 72 OC 
after the final cycle. The PCR product then underwent a DpnI (10 U/µl) digestion to 
eliminate any parental methylated DNA template, for 1 hour at 37 O
 
C. 
2.1.4 Design of oligonucleotides for site directed mutagenesis 
When designing an oligonucleotide for site directed mutagenesis, a 17-20 base 
oligonucleotide with the mismatch located in the centre was sufficient for single base 
mutations (Table 2.1). This allows 8-10 perfectly matched nucleotides on either side 
of the mismatch. For mutations involving 2 or more mismatches, an oligonucleotide 
usually around 25 bases or longer was required to allow for 12-15 perfectly matched 
nucleotides on either side of the mismatch. Oligonucleotides were normally 
generated with between 40-60% G-C content, and with a higher G-C content at the
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Table 2.1 
Primers used for site directed mutagenesis in the BK channel
Table 2.1 Primers used for site directed mutagenesis in the BK channel. Numbering 
starts from initiator methionine MDALI.. in the murine BK channel (accession number 
NM_010610). Numbering after residue 632 includes the 58 amino acid STREX insert.
Mutation   Sequence 5' - 3'   
Xhol-Koz FWD 5’- CCG CTC GAG GGC CAC CAT GCG GAC GCT CAA GTA CCT G  -3’ 
BamHI REV 5’- GGT GGA TCC AAT CTG CCA GTC AGT GTC TG  -3’ 
C53A:C54A:C56A FWD 5’- CCT GTG GAC CGT TGC CTG CCA CGC CGG GGG CAA GAC G   -3’ 
  REV 5’- CGT CTT GCC CCC GGC GTG GCA GGC AAC GGT CCA CAG G   -3’ 
C53A FWD 5’- AAG TAC CTG TGG ACC GTT GCC TGC CAC TGC GGG GGC AAG ACG AA -3’ 
  REV 5’- TTC GTC TTG CCC CCG CAG TGG CAG GCA ACG GTC CAC AGG TAC TT  -3’ 
C54A FWD 5’- AAG TAC CTG TGG ACC GTT TGC GCC CAC TGC GGG GGC AAG ACG AAG  -3’ 
  REV 5’- CTT CGT CTT GCC CCC GCA GTG GGC GCA AAC GGT CCA CAG GTA CCT  -3’ 
C56A FWD 5’- CCG TTG CCG CCC ACG CCG GGG GCA AGA CGA AG   -3’ 
  REV 5’- CTT CGT CTT GCC CCC GGC GTG GGC GGC AAC GG   -3’ 
C53A:C54A FWD 5’- GTA CCT GTG GAC CGT TGC CGC CCA CTG CGG GGG CAA   -3’ 
  REV 5’- CTT GCC CCC GCA GTG GGC GGC AAC GGT CCA CAG GTA -3’ 
C612A:C615A FWD 5’- AGG GCG TTT TTT TAC GCC AAG GCC GCT CAT GAT GAC GTC ACA GAT CC  -3’ 
  REV 5’- GGA TCT GTG ACG TCA TCA TGA GCG GCC TTG GCG TAA AAA AAT GCC CT  -3’ 
C628A:C630A FWD 5’- AAA AGA ATT AAA AAA GCT GGC GCC AGG CGG CCC AAG ATG TCC  -3’ 
  REV 5’- GGA CAT CTT GGG CCG CCT GGC GCC AGC TTT TTT AAT TCT TTT -3’ 
K627E:R631E FWD 5’-  GAT CCC AAA AGA ATT AAA GAA TGT GGC TGC GAG CGG CCC AAG ATG   -3’ 
  REV 5’- CAT CTT GGG CCG CTC GCA GCC ACA TTC TTT AAT TCT TTT GGG ATC   -3’ 
K627A:R631A FWD 5’- GAT CCC AAA AGA ATT AAA GCA TGT GGC TGC GCG CGG CCC AAG ATG   -3’ 
  REV 5’- CAT CTT GGG CCG CGC GCA GCC ACA TGC TTT ATT TCT TTT GGG ATC   -3’ 
R640E:R642E FWD 5’- GAT GTC CAT CTA CAA GGA AAT GGA ACG AGC  ATG TTG TTT TG  -3’ 
  REV 5’- CAA AAC AAC ATG CTC GTT CCA TTT CCT TGT AGA TGG ACA TC  -3’ 
R640A:R642A FWD 5’- GAT GTC CAT CTA CAA GGC AAT GGC ACG AGC ATG TTG TTT TG -3’ 
  REV 5’- CAA AAC AAC ATG CTC GTG CCA TTG CCT TGT AGA TGG ACA TC  -3’ 
S636E FWD 5’- GCA GGC GGC CCA AGA TGG AAA TCT ACA AGA GAA TGA GAC G  -3’ 
  REV 5’- CGT CTC ATT CTC TTG TAG ATT TCC ATC TTG GGC CGC CTG C  -3’ 
S636A FWD 5’- GCA GGC GGC CCA AGA TGG CCA TCT ACA AGA GAA TGA GAC G -3’ 
  REV 5’- CGT CTC ATT CTC TTG TAG ATG GCC ATC TTG GGC CGC CTG C -3’ 
C645A:C646A FWD 5’- CAA GAG ATT GAG ACGAGC AGC TGC TTT TGA TTG CGG ACG TTC TG -3’ 
  REV 5’- CAG AAC GTC CGC AAT CAA AAG CAG CTG CTC GTC TCA TTC TCT TG -3’ 
C645A FWD 5’- GAG AAT GAG ACG AGC AGC TTG TTT TGA TTG CGG ACG -3’ 
  REV 5’- CCG CAA TCA AAA CAA GCT GCT CGT CTC ATT CTC TTG -3’ 
C646A FWD 5’- GAA TGA GAC GAG CAT GTG CTT TTG ATT GCG GAC G -3’ 
  REV 5’- CGT CCG CAA TCA AAA GCA CAT GCT CGT CTC ATT  -3’ 
C649A FWD 5’- GCA TGT TGT TTT GAT GCC GGA CGT TCT GAG CGT G  -3’ 
  REV 5’- CAC GCT CAG AAC GTC CGG CAT CAA AAC AAC ATG C -3’ 
C656A:C658A FWD 5’- TCT GAG CGT GAC GCC TCG GCC ATG TCA GGC   -3’ 
  REV 5’- GCC TGA CAT GGC CGA GGC GTC ACG CTC AGA   -3’ 
C684A FWD 5’- CTG TTA ATG ATG CCT CCA CCA GTT T -3’ 
  REV 5’- AAA CTG GTG GAG GCA TCA TTA ACA G -3’ 
S927E FWD 5’- GGG ATG TTA CGC CAG CCG GAG ATC ACA ACT GGG GTC AAC  -3’ 
  REV 5’- GTT GAC CCC AGT TGT GAT CTC CGG CTG GCG TAA CAT CCC  -3’ 
S927A FWD 5’- GAT GTT ACG CCA GCC GGC CAT CAC AAC TGG GGT CAA C -3’ 
  REV 5’- GTT GAC CCC AGT TGT GAT GGC CGG CTG GCG TAA CAT C -3’ 
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5’ prime end than the 3’ prime end. The TM or melting temperature of the 
oligonucleotide reflecting base content, was calculated using an equation from 
Eurofins MWG Operon (equation 2.2 & 2.3) and was designed to be close to 70 O
Equation 2.2:  
C, 
to coincide with the annealing temperatures of the polymerases used in the future 
PCR extension phase. Oligonucelotide sequences where ordered from Eurofins 
MWG Operon, Ebersberg, Germany. 
Sequences with 15 or less bases: 
TM [°C] = 2(nA + nT) + 4(nG + nC
Equation 2.3:  
)  
Sequences with more than 15 bases: 
TM [°C] = 69.3 + [41(nG + nC
Where, n = number of nucleotides of type X and, s = number of all nucleotides per 
sequence. The primer sequences designed for site directed mutagenesis carried out 
in this thesis are shown in Table 2.1. 
) / s – (650 / s)]  
 
 
2.1.5 Transformation of chemically competent E.coli 
Transformation of newly synthesized plasmid DNA was carried out using chemically 
competent XL10-Gold® ultracompetent E.coli cells (Stratagene). 100 µl aliquots 
were stored at -80 OC and subsequently thawed on ice. They were then further split 
into 50 µL aliquots. 10 ng of plasmid DNA was added and the mixture was 
incubated on ice for 20 minutes. Subsequently, cells were heat-shocked at 42 OC for 
45 seconds and 500 µL of LB medium was added. The mixture was incubated for 30 
minutes to 1 hour at 37 OC in a shaking incubator, at 200 rpm and then 200 µl of 
cells were plated onto selective agar containing the appropriate antibiotic and 




2.1.6 PCR screening of bacterial colonies 
Individual colonies grown on selective agar plates were picked using a sterile pipette 
tip, then dipped vigorously into a 50 µl PCR reaction tube containing primers specific 
to the region of interest. A standard PCR reaction amplified the region of interest, 
which could then be run out on an agarose gel. Those colonies that were shown by 
PCR screening to be the correct size (or if using double digest plasma DNA, if it 
contained the correct size of insert), were again picked from the same plate using a 
sterile pipette tip and inoculated into either 5 or 250 mls Luria Broth (LB) medium 
with the appropriate antibiotic. This was incubated overnight at 37 O
 
C in a shaking 
incubator, at 200 rpm, in order to set up either a mini- or maxi- prep culture 
respectively. 
2.1.7 Maxiprep alkaline lysis for plasmid DNA isolation 
Maxiprep isolation of plasmid DNA required the 250 ml bacterial culture described in 
section 2.1.6 to be pelleted at 5000 x g for 5 minutes at 4 O
 
C. The pellet was then 
homogeneously resuspended, harvested and lysed before clearing the bacterial 
lysate and precipitating the plasmid DNA using the QIAGEN Hispeed Plasmid Maxi 
Kit (QIAGEN) according to the manufacturer’s instructions. Briefly, plasmid DNA 
binds to anion-exchange resin under low-salt and pH conditions. RNA, proteins, 
dyes and low molecular weight impurities are removed by a medium-salt wash. 
Plasmid DNA is then eluted in a high-salt buffer concentrated and desalted by 
isopropanol precipitation. The DNA is then washed filtered and eluted in QIAGEN 
Buffer TE or water. 
2.1.8 Miniprep alkaline lysis for plasmid DNA isolation 
Miniprep isolation of plasmid DNA for advanced screening of mutants required that 
individual bacterial colonies were seeded, using a sterile pipette tip, into 5 ml of LB 
medium, and then incubated overnight at 37 OC in a shaking incubator, at 200 rpm. 
1.5 ml of each culture was transferred into a microcentrifuge tube, and centrifuged at 
12000 x g for 1 minute. The LB broth was then aspirated from the pellet, which after 
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resuspension, followed the manual procedure (lyse, bind, wash and elute) using the 
QIAprep Spin Miniprep Kit (QIAGEN) according to the manufacturer’s instructions. 
 
2.1.9 Quantitation of DNA 
A 1/100 dilution of the DNA sample in DEPC H2
Equation 2.4:  
0 was prepared and its absorbance 
at 260 nm and 280 nm measured using a UV spectrophotometer. Purity was 
assessed using the ratio of A260/A280 with an ideal ratio of 1.8 indicating pure 
dsDNA, whilst lower ratios were indicative of contamination with other nucleic acids 
or protein. To calculate the concentration where an OD260 of 1 indicates DNA at a 
concentration of 50 µg/ml, the formula was applied as shown in Equation 2.4; 
OD260 x 50µg/ml dilution factor = [DNA] (µg/ml) 
 
2.1.10 Preparation of DNA for sequencing 
DNA was sent for sequencing to Eurofins MWG Operon, Germany, as specified, in a 
total volume of 15 µl DEPC H2
 
O in 1.5 ml tubes. Purified plasmid DNA was sent at a 
concentration of 50-100 ng/µl as prepared previously (section 2.1.7 or 2.1.8). 
Primers were ordered from Eurofins MWG Operon for sequencing, or were sent at a 
concentration of 2 pmol/µl in a minimum volume of 15 µl (corresponding to an 
amount of 30 pmol). Sequencing covers an area of interest specific to the primers 
sent and not the whole plasmid. Sequencing results were analysed with vector NTI 
10.1.1 (Invitrogen) and Chromas Lite 2.0 (Technelysium Pty Ltd). 
2.1.11 Double Restriction Digest  
On confirmation of the correct mutated sequence of DNA, double restriction digests 
of the sequenced region into a new vector were made to assure a clean vector 
backbone without possible additional erroneous mutations that would not have been 
64
sequenced. Double restriction digests were prepared in 20 µl reactions, each 
containing 2-10 U  (1 U being the amount of enzyme required to completely digest 1 
µg substrate DNA in 60 minutes) of the respective restriction enzyme (NE BioLabs) 
in the appropriate buffer (NE BioLabs) diluted to 1x with DEPC water, and 0.2-1 µg 
of DNA sample. These reaction mixtures were then incubated at 37 O
 
C for 1 hour. 
2.1.12 DNA agarose gel electrophoresis & gel purification 
Gel Electrophoresis, to separate the DNA by molecular weight to confirm sizes of 
digested fragments using an electric field, was carried out using a 1% agarose (w/v) 
gel, prepared in 50 ml or 100 ml of 1xTBE buffer (45 mM Tris-base, 45 mM Boric 
acid, 2 mM EDTA, pH 8.0), depending on the number of samples. If the expected 
size of the DNA fragment was less than 300 bp, the percentage of agarose was 
increased up to 4% to increase band definition when imaging under UV 
transillumination. SYBR Safe DNA gel stain (Invitrogen Molecular Probes) was 
added at a X1 final concentration and mixed by swirling. The gel was then poured 
onto a plate to set. DNA samples were mixed with 5 µL loading dye (10x recipe for 
100 ml: 60% glycerol (v/v), 0.25% bromophenol blue (w/v), 33% 150 mM Tris (pH 
7.6) (v/v) in H2
 
0), loaded, and run for 20-30 minutes at 160 V using a Bio-Rad model 
200/2.0 power supply and Bio-Rad wide min-sub cell GT gel electrophoresis 
apparatus. The appropriate DNA fragments could then be cut out and purified from 
the agarose gel using Zymoclean gel DNA recovery kit that utilises fast spin column 
technology to yield high-quality purified DNA. 
2.1.13 Ligation of plasmid vector and insert DNA 
Ligation of the vector backbone and the newly generated site directed mutant insert 
was carried out using T4 DNA ligase (Fermentas). Ligation catalyzes the formation 
of a phosphodiester bond between juxtaposed 5’ phosphate and 3’ hydroxyl termini 
in duplex DNA. The ligation enzyme joins blunt end and cohesive end termini as well 
as repairing single stranded nicks in duplex DNA. Reaction conditions were as 
follows – T4 DNA Ligase 5 U (Fermentas), 1x T4 DNA Ligase Reaction Buffer [50 
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mM Tris-HCL (pH 7.5), 10 mM MgCl2
Equation 2.5: 
ng of vector x kb size of insert
kb size of insert
x molar ratio of 
insert
vector
=ng of insert 
, 10 mM dithiothreitol, 1 mM ATP, 25 ug/ml 
bovine serum albumin] (Fermentas). For vector:insert DNA ratios an equation (see 
equation 2.5) was used to find the optimum ratio for successful ligation. Generally a 
1:3 and 1:7 ratio (vector:insert) was used. 
This reaction was then carried out at 16 O
 
C overnight, before proceeding to 
transformation of chemically competent E.coli as in 2.1.5 and Maxiprep in 2.1.7.  
 
2.2 Mammalian cell culture protocols 
 
2.2.1 Cell lines 
The HEK 293 cell line, one of the most amenable and commonly used genetic 
expression systems in science, was used to transiently express cloned BK channels 
and splice variants of the BK channel. The HEK293 cell was initially derived from the 
human embryonic kidney (HEK) by Alex Van der Eb in the early 1970’s and 
subsequently transformed by adenovirus in work carried out by Frank Graham 
(Graham et al., 1977). Interestingly we call these “293” based on Graham’s habit of 
numbering his experiments – the original HEK293 cell clone was simply his 293rd 
experiment. HEK 293 cells do not endogenously express BK channels but do retain 
their protein kinase and phosphatase pathways (Thomas & Smart, 2005). 
Manipulation of the HEK293 cell allows the study of isolated proteins in over-
expression systems that hijack the cell’s synthetic protein machinery and force 
efficient translation of the transfected gene. Transfection of the BK 
 
channel 
construct into the HEK 293 cell line provides a means to characterise and study the 
alternative splice variants and site directed mutants, in isolation of endogenous BK 
channels whilst in their native state. 
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2.2.2 Standard cell culture passage protocol 
HEK 293 cells were used, over a passage range of 10-35 times. Cells were 
maintained in DMEM (Dulbecco’s Modified Eagle Medium, 41965) + L-glutamine 
(GIBCO®, Invitrogen) with 10% (v/v) FCS (Fetal Calf Serum) no antibiotic (GIBCO®, 
Invitrogen), in 25 cm2 flasks, at 37 0C in 95% (v/v) air, 5% (v/v) CO2, and passaged 
every 3-4 days at 70-90% confluency. The medium was removed and discarded, 
and cells washed using 5 ml of HBSS (Hanks Balanced Salt Solution) (GIBCO®, 
Invitrogen). This was removed, then 0.5 ml of Trypsin-EDTA X1, 25300 (GIBCO®, 
Invitrogen) was added and cells incubated at 37 OC for 1-2 minutes. The flask was 
gently tapped to detach cells, which were then resuspended in 1 ml of DMEM + 10% 
FCS by triturating up and down slowly using a sterile p1000 pipette. Once cells were 
fully resuspended, 13 ml of DMEM+10%FCS were added to each 0.5 ml of cell 
suspension. Cells were triturated and 5 ml was then transferred into a new sterile 25 
cm2
 
 tissue culture flask. 
2.2.3 Transfection of cells using Lipofectamine2000 
Cells were cultured on coverslips in sterile 6 well tissue culture plates in 2 ml DMEM 
+ L-glutamine with 10% (v/v) FCS (no antibiotic), at 37 OC, in 95% (v/v) air, 5% (v/v) 
CO2, until 40% confluent, normally after 24 hours. For each transfection reaction, 
1.5 µg DNA and 5 µl LipofectamineTM 2000 11668-019 (Invitrogen) were diluted 
separately in 100 µl DMEM + L-glutamine without serum, and incubated for 20 
minutes. Following this incubation, 200 µl of the DNA-lipofectamine2000 complex in 
DMEM was added directly into the culture medium in the well. Cells were 
subsequently incubated for 24-48 hours at 37 OC in 95% (v/v) air, 5% (v/v) CO2
 
, in 





2.3 Electrophysiology & Membrane potential assays 
 
2.3.1 Electrophysiology 
The true birth of electrophysiology can be attributed to Luigi Galvani whose 
prophetic understanding described the propagation of neuromuscular electrical 
excitability at the turn of the eighteenth century. Intriguingly, for an ion channel 
electrophysiologist such as myself, Galvani’s delicate work enabled him to first 
postulate the existence of water-filled channels which would penetrate the surface of 
muscle fibres to allow the spread of electrical excitability (Galvani, 1794; 
Verkhratsky et al., 2006), the first concept of the ion channel (Verkhratsky et al., 
2006). 
 
2.3.2 Electrophysiological Assays 
The electrophysiological techniques used were single-channel and macro-patch 
current recordings, performed in the inside-out configuration of the patch clamp 
technique, at room temperature (20-24 °C). Channel constructs were studied in 
isolated HEK 293 cells normally 24-48 hours after transient transfection as 
described in section 2.2.3. Glass coverslips were placed in a perfusion recording 
chamber attached to an inverted microscope (Nikon Diaphot, Japan). The cells and 
patch pipettes were observed using x40 phase contrast objective. Mechanical and 
hydraulic manipulators (Narishige International, Japan, model MHW-3) mounted on 
the microscope stage, provided the control of coarse and fine manipulation required 
for patch clamping of isolated cells. Channel activity was recorded using an 
Axopatch-200 patch clamp amplifier (Axon Instruments, USA), an AD converter in 
the interface board (Digidata 1200, Axon Instruments, USA) and a computer for 
display and analysis. Borosilicate glass capillaries GC150F-7.5 (Harvard Apparatus, 
Kent) were pulled and fire polished to resistances of 5-10MΩ each day and 
subsequently attached to the mechanical and hydraulic manipulator.  
All recordings were carried out in equimolar potassium gradients. The bath solution 
(intracellular) contained: 140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 30 mM glucose, 10 
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mM Hepes with free calcium [Ca2+]i buffered with 1 mM BAPTA, (pH 7.3). The 
appropriate free calcium concentration is as described in the figure legends. The 
pipette solution (extracellular) contained the same solute composition as the bath 
solution with a standard 0.1µM CaCl2
To determine the single channel conductance (in pS) of BK channels, single channel 
amplitude (i) was measured over a range of voltage potentials (v) (-80 mV to + 80 
mV) and plotted as a straight line. Conductance (G) was taken as the slope of the 
line as described by the Ohms law relationship as shown in equation 2.6; 
. Channel activity was determined in a range of 
extracellular calcium (0 – 10 µM) after being allowed to stabilize for 10 minutes after 
patch excision.  
Equation 2.6 
V= IR       or         R =  V
I




         and,        1
R 
= G 
Macropatch recordings were made to determine channel activity, excised inside-out 
patches were held at a -80mV holding potential and pulsed for 100ms over a voltage 
range from -120mV to +120mV in 20mV increments. Tail currents were measured 
after the pulse potential as the tail current is proportional to the channel open 
probability at the end of the preceding depolarisation (Islas & Sigworth, 1999). The 
tail currents were then normalised to the peak tail current which was expressed as 
100% when examined in high intracellular calcium (1 µM Ca2+), and plotted as 
G/GMAX versus the respective test potential. Each voltage step was stepped back to 
-80 mV and final values were expressed as a percentage, therefore these values 
reflect conductance (G), (each value was not divided by the -80 mV holding potential 
to give an absolute conductance value but because values were expressed as a 
percentage they yield the same results). The curves generated were then fitted to a 
Boltzmann equation using graphpad prism software using equation 2.6, whereby the 
voltage for half activation (V0.5MAX
Equation 2.6: 
Y = Bottom +
(Top − Bottom)
1 + exp �V50 − XSlope �
 
) could be determined.  
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To determine the voltage dependence of the channel, a logarithmic transformation 
to linearize the activating component of the normalised (G/GMAX
Equation 2.7: 
) curve plotted 
against the depolarised potentials of 0 mV to +120 mV was made using equation 
2.7. The voltage dependence was derived from the slope of the line. 
In((G/GMAX)/(1-G/GMAX
To define the activation and deactivation kinetics of the channels, activation curves 
were best fitted by a single exponential function (as shown in equation 2.7) from the 
beginning of channel activation to the peak plateau current and deactivation curves 
were fitted from the peak tail current to the baseline.  
)) 
Equation 2.7 




The standard exponential was fitted using the Clampfit software which is a basic 
function used to fit changes in current or voltage that are controlled by one or more 
first-order processes. The fit solves for the amplitude A, the time constant τ, and the 
constant y-offset C for each component i. The simplex method was used which uses 
the least squares, mean absolute, maximum likelyhood and minimax minimization 
method. 
By calculating the time constant (tau) at which the channel’s activating or 
deactivating kinetics reached (tau = 1-1/e), differences between the channel variants 
could be examined. All kinetic analysis was carried out using Clampfit v 10.0.1.10. 
Data acquisition and voltage protocols were controlled by pCLAMP9 software (Axon 
Instruments). All recordings were sampled at 10 kHz and filtered at 2 kHz. Single-
channel conductance measurements were derived by examining traces using 
WINEDR (Version 2.3.9, J. Dempster, University of Strathclyde, U.K.).  
 
70
2.3.3 Fluorescent Membrane Potential (FMP) assay 
Membrane potential assays were performed in transfected HEK293 cells using 
FLIPR® Membrane Potential Blue dye (Molecular Devices, Sunnyvale, California) 
as previously described (Saleem et al., 2009). Cells were seeded onto black clear 
bottom Poly-D-Lysine coated 96-well plates (Greiner Bio-One Ltd, Gloucestershire 
UK) 48 hours prior to experiments. The fluorescent membrane potential (FMP) blue 
dye (Molecular Devices) was prepared as described by the manufacturer’s 
instructions in normal saline solution containing in mM: 140 NaCl, 5 KCl, 2 CaCl2, 1 
MgCl2, 20 glucose, 10 HEPES, (pH 7.4). Once the cells reached 90-100% 
confluency the culture medium was removed and cells were incubated with the FMP 
dye for 30 minutes at 37 OC to allow dye loading into the cell membrane. Assays 
were performed at 22 O
A decrease in relative fluorescent units (RFU) reflects membrane hyperpolarisation 
(BK channel activation). Non-transfected HEK 293 cells elicited a depolarisation in 
response to the influx of calcium ions and some calcium driven activity, this was 
reported as an increase in fluorescence. Blocking of the BK channel by Paxilline, a 
selective inhibitor of BK channels (Knaus et al., 1994a), showed a response similar 
to untransfected HEK 293 cells with an increase in fluorescence. This indicated that 
the hyperpolarising decrease in fluorescence was indeed mediated by the 
transfected BK channel (Saleem et al., 2009). Data was analysed using SoftMax 
Pro, Microsoft excel and GraphPad Prism. Raw data was displayed over the time 
course to illustrate the response of transfected cells to ionomycin. Average data was 
obtained at the peak ionomycin-induced hyperpolarising response within each assay 
plate corresponding to the control channel (either STREX or ZERO) response (the 
peak response was recorded at either T=70 seconds or T=100 seconds as stated in 
the figure legends). To examine the isolated channel current, the untransfected HEK 
response in each assay plate could be subtracted from each transiently transfected 
C using a FlexStation® II (Molecular Devices) and channels 
activated by applying 1 µM of the calcium-ionophore, ionomycin (0.01% DMSO). 
The automated liquid-handling function of the Flexstation ® II administered 50 µl 
ionomycin (1 µM) to each individual well to a final volume of 250 µl, 16 seconds after 
the experiment began.  The fluorescence changes were read at high sensitivity for 
180 seconds at intervals of 1.52 seconds with excitation/emission wavelengths of 
530/565nm respectively.  
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channel variant and the peak value of the control STREX or ZERO channel 
response could then be normalised to 100% whereby mutant channels could be 
compared. Only assay plates that passed a ‘Z’ parameter statistical test (Zhang et 
al., 1999) that examines the reliability of the data well to well, were used in these 
studies (Saleem et al., 2009). 
 
 
2.4 Imaging protocols 
 
2.4.1 Fixing and mounting of cells 
Transiently transfected HEK 293 cells as described in section 2.2.3 were typically 
fixed 48 hours post transfection. The medium was aspirated and the cells washed 3 
times with 1 ml HBSS containing 2 mM CaCl2 and 1 mM MgCl2. The cells were then 
incubated in 1 ml 4% (w/v) paraformaldehyde in PBS (Phosphate Buffered Saline) 
for 15 minutes. The paraformaldehyde was aspirated and cells washed 3 times in 
HBSS containing 2 mM CaCl2 and 1 mM MgCl2, then quenched for 10 minutes in 1 
ml PBS containing 50 mM NH4Cl2, prepared freshly. After quenching, the cells were 
washed a further 3 times in HBSS containing 2 mM CaCl2 and 1 mM MgCl2. 
Coverslips were dipped in distilled H2O, drained briefly to remove excess H2
 
O, then 
mounted onto slides using Mowiol, a high quality anti-fade medium and left to dry 
overnight before imaging. 
2.4.2 Screening of fluorescently-labelled cells 
A Standard epi-fluorescent Nikon ECLIPSE TE200 microscope was used to screen 
the HEK 293 transfected fluorescently-labelled cells. Cells were examined under a 
100x/1.3 Planar Fluor lens. Cells where studied under white light to ascertain 
reasonable confluency in a randomly selected field of view, before switching to 
fluorescence. All cells in each field of view were recorded according to fluorescence 
in the cellular membrane, cytosol, nucleus or a combination of all three. These tally 
results could then be calculated as a percentage of the total cell count (small ‘n’) 
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which would reflect 1 experiment or larger ‘N’. Results could then be presented as 
mean percentage with the standard error about the mean. 
 
2.4.3 Confocal Imaging of fluorescently-labelled cells 
Confocal images were acquired with a Zeiss Axioscope confocal laser scanning 
microscope (LSM510) operating with a 25 mW argon laser tuned to lines at 458, 488 
and 514 nm.  Cells were examined with a Zeiss plan-apochromat 1.4 NA x63 oil 
immersion objective lens.  Images through single confocal planes were taken at the 
middle of the z-axis of the cell. To image eGFP (and Alexa 488 antibody), 488 nm 
excitation was used and emission was collected using a 500-530 nm band pass filter 
and for eYFP, 514 nm excitation and a 530 nm long pass filter was used.  The multi-
track function was used to image two or more fluorophores in the same cell in order 
to minimise cross-talk between fluorophores. Texas red (excitation 595-605 nm) was 
used to detect the Alexa fluor 594 antibody labeled Flag-tagged constructs with 
emission at 617 nm. 
 
2.4.4 Immunofluorescent cell surface labelling 
To study cell surface expression of BK channels, constructs were made with an 
extracellular N-terminal Flag- tag to record channel expression on the cell surface 
and with -HA tags on the C-terminus to study total BK expression inside the cell 
(constructs were made as described in section 2.1.1). 48-72 hours after transfection 
of Flag tag constructs, the medium was aspirated and the cells washed once with 
DMEM + L-glutamine +10% (v/v) FCS (no antibiotic) at room temperature. The Anti-
flag M2 mouse monoclonal antibody (Sigma) was diluted 1:100 in DMEM + L-
glutamine +10% (v/v) FCS. Cells were incubated for 2 hours on ice, to block channel 
endocytosis, with the primary antibody. The cells were then washed in DMEM + L-
glutamine +10% (v/v) FCS (no antibiotic) once. The secondary antibody, Alexa fluor 
594 conjugated anti-mouse IgG antibody (Invitrogen / Molecular Probes) was diluted 
1:1000 in DMEM + L-glutamine +10% (v/v) FCS. The cells were then incubated with 
the secondary antibody for 1hr on ice. Subsequently the cells were then fixed in 1ml 
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4% (w/v) paraformaldehyde in PBS, for 30 minutes at room temperature. The 
paraformaldehyde was aspirated and cells washed 3 times with PBS.  Coverslips 
could then be mounted by dipping in distilled H2O, drained briefly to remove excess 
H2O, then mounted onto slides using Mowiol, and left to dry overnight at room 
temperature in the dark, then stored at 4 O
 
C, before imaging. 
2.4.5 Immunofluorescent labelling 
Channel constructs labelled with a C-terminal -HA tag required permeabilisation for 
immuno-labelling. The protocol described in section 2.4.4 was followed until fixing of 
cells by paraformaldehyde at which point cells were washed 3 times with PBS 
before preceeding to the permeabilization of the cells. Cells were permeabilized with 
0.3% Triton X-100 in PBS for 10 minutes at room temperature, then washed three 
times in PBS. To block further permeabilization of cells a blocking solution of 
3%BSA in PBS and 0.05% Triton X-100 was incubated for 30 minutes. To label the 
HA tag, cells were incubated with an anti-HA rabbit polyclonal antibody (Zymed) 
(1:500) in the blocking solution as before. This was then left overnight at 4OC or 
incubated at room temperature for 1 hour. Cells were washed three times in PBS 
and then incubated with a secondary antibody Alexa 488 conjugated anti-Rabbit IgG 
(1:1000) in blocking solution, for 1 hour at room temperature. An additional wash in 
PBS three times preceeded two washes in distilled H2O before mounting of the 
coverslips. For mounting, coverslips were dipped in distilled H2O, drained briefly to 
remove excess H2O, then mounted onto slides using Mowiol, and left to dry 
overnight at room temperature in the dark, then stored at 4 O
  
C, before imaging. 
2.4.6 Quantification of Immunofluorescent labelling 
Confocal images were acquired on a Zeiss LSM510 laser scanning microscope, 
using a 63x oil Plan Apochromat (NA =1.4) objective lens, in multi-tracking mode. 
Quantification of Flag surface expression was done in two ways: 1) Using confocal 
microscopy, transfected cells were examined for total protein expression, identified 
by the intracellular C-terminal -HA tag that was labelled with the secondary antibody 
Alexa 488 (at wavelength ~520 nm) and counted. In the same field of view, cells 
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were then examined under a different fluorescent wavelength (~620 nm) to detect 
the extracellular Flag- tagged secondary antibody Alexa fluor 594, on channels that 
would only be on the surface of the cell. The gain intensity set to detect Flag- tagged 
channels on the control cells was used at the same intensity when examining 
mutant channel constructs so that comparative analysis by counting could be made. 
These values could then be expressed as a percentage of total channels transfected 
and subsequently as a percentage of control which is illustrated in the figures in this 
thesis. 2) Confocal images of random single cells or small clusters of cells taken at 
wavelengths to detect both Flag- and -HA were examined using Image J. 1.42q 
(Wayne Rasband. National Institutes of Health USA) software. Absolute measures 
could be made by highlighting a particular cell, switiching to greyscale and 
quantifying total fluorescent protein expression. A ratio of surface Flag- 
(extracellular) fluorescence to intracellular signal (-HA) was taken and normalised to 
the corresponding control group (100%) as indicated in the respective figure 
legends. In these experimental paradigms the data obtained for relative surface 
expression using the threshold method was quantitatively the same as using 
absolute ratio measures. 
 
 
2.5 Biochemical assays 
 
2.5.1 3
HEK 293 cells were transiently transfected in 12-well cluster dishes (≈3 × 10
H-palmitic acid incorporation 
6 cells 
per well) using Fugene HD transfection agent (Roche) in a 6:2 ratio to cDNA.  The 
intracellular C-terminal or full length constructs used are indicated in the respective 
figure legend and all contained a C-terminal –HA epitope tag. Forty-eight hours after 
transfection, cells were washed with pre-warmed (room temperature) PBS, then 1 
ml of fresh DMEM containing 10 mg/ml fatty acid-free BSA was added for 30 
minutes at 37 °C. Cells were incubated in DMEM/BSA containing 0.5-0.8 mCi/ml 3H-
palmitic acid (Perkin Elmer, USA) for 4 hours at 37 °C, and then the medium 
containing the free label was removed. Cells were then lysed in 150 mM NaCl, 50 
mM Tris-Cl, 1% Triton X-100 (pH 8.0), and channel fusion proteins were captured by 
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using magnetic microbeads coupled to the HA antibody (μMACS epitope tag 
isolation kits, Miltenyi Biotec) overnight at 4 °C. After washing columns with 150 mM 
NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris-Cl (pH 8.0), 
followed by washes with 50 mM Tris-Cl (pH 7.5) captured proteins were eluted in 
SDS/PAGE sample buffer [50 mM Tris-Cl (pH 6.8), 5 mM DTT, 1% SDS, 1 mM 
EDTA, 0.005% bromophenol blue, 10% glycerol] prewarmed to 95 °C. 
 
2.5.2 Western Blotting and 3
Duplicate samples were run on separate SDS-PAGE gels for subsequent Western 
Blotting to detect total –HA tagged channel construct and for fluorography of 
H detection 
3H-
palmitate incorporation. SDS-PAGE was used to separate proteins according to 
their electrophoretic mobility. SDS (sodium dodecyl sulphate), is an anionic 
detergent which denatures secondary and non-disulfide-linked tertiary structures 
and applies a negative charge to each protein in proportion to its mass. The SDS-
PAGE gel was run at 170 V for one hour to separate the proteins. Proteins were 
transferred to nitrocellulose membranes and probed with a polyclonal α-HA antibody 
(1:1,000; Zymed) with subsequent application of a secondary antibody conjugated to 
horseradish peroxidise (HRP) and detection by enhanced chemi-luminescene (ECL) 
using a GeneGnome imaging system. To detect 3H-palmitate incorporation the 
nitrocellulose membrane was dried, sprayed with En3
 
hance fluorographic spray 
(PerkinElmer–Cetus) and exposed to light-sensitive film at −80 °C by using a Kodak 
Biomax transcreen LE (Amersham) for 1-4 weeks at -80 °C. 
 
2.6 Prediction Algorithms 
 
2.6.1 CSS-palm - 
We exploited the published CSS-palm palmitoylation algorithm (Zhou et al., 2006; 
Ren et al., 2008) to predict cysteine residues within the entire coding sequence of 
palmitoylation prediction 
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the murine BK channel α-subunit as well as the STREX C-terminus alone. 
Palmitoylation prediction was set to the highest cutoff in the algorithm at 0.9. Scores 
indicate CSS-palm prediction; a higher number represents a higher probability, with 
a score above 1.0 demonstrating a strong prediction. Mutagenesis of key residues 
was also examined to determine the affect on palmitoylation status of the already 
identified palmitoylated residues. CSS-palm scores were determined with the 
published and recently revised CSS-palm v2.0 algorithm at http://bioinformatics.lcd-
ustc.org/css_palm/prediction.php
 
 by inputting the full-length coding sequence of the 
murine STREX channel, start methionine MDALI.., accession number: 
NM_010610.2 and AF156674 for STREX. 
2.6.2 BH search – membrane binding
A Basic Hydrophobicity (BH)-scale algorithm recently developed (Brzeska et al., 
2010) was used to identify potential membrane binding sites in less structured 
regions of proteins. It is a modified version of the EMBOSS Pepinfo program, 
designed to be more convenient for scoring basic residues and their interaction with 
the plasma membrane. The algorithm can be found at 
 prediction 
http://helixweb.nih.gov/bhsearch/. The program examines the hydrophilic nature of 
basic residues in a protein and their electrostatic interaction with the negatively 
charged plasma membrane. Using a scoring system, the program averages values 
in a previously determined and newly adapted Wimley and White hydrophobicity 
scale (Wimley & White, 1996) called the Basic Hydrophobicity (BH) scale. Each 
amino acid in a segment of a selected length, called the window size, is scored 
according to the scale and a value given to the amino acid in the middle of the 
window. To discriminate between segments from soluble proteins and membrane 
spanning sequences, a window length of 19 was determined to best identify 
membrane-spanning sequences. It was proposed that a larger window length of 19 
was more suitable because protein-spanning sequences passing through the interior 
of the protein are usually shorter than membrane spanning sequences (Kyte & 
Doolittle, 1982). Thus, for a window of 19, the first score, which is the average of the 
values for residues 1-19, is given to residue 10. The program then averages the 
values for residues 2-20 and gives that score to residue 11, continuing in this 
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manner until the end of the sequence with the last residue scored being 10 residues 
from the C terminus. Residues at the start or end of protein sequences are therefore 
not accurate scores. A threshold value of 0.6 was identified as the optimal 
parameter for identifying lipid-binding sites in proteins (Brzeska et al., 2010). 
 
 
2.7 Statistical analysis 
 
Data was analysed and presented using GraphPad Prism v4.03 (GraphPad 
Software, Inc). All statistical analysis was carried out using one-way Anova with 
tukey post-hoc test comparison test, with significant differences indicated by p 





2-Bromohexadecanoic Acid (2BP) - Sigma-Aldrich Co Ltd. Palmitate inhibitor. Made 
up as a fresh 100 mM stock in 100% ethanol and applied at a final concentration 
100µM. 
2-Hydroxytetradecanoic acid (2HM) – Sigma-Aldrich Co Ltd. Myristate inhibitor. 
Dissolved in DMSO. Used at a final concentration of 0.1-1 mM. 
Neomycin trisulfate salt hydrate – Sigma-Aldrich Co Ltd. Used to inhibit actions of 
PIP2. Soluble in H2O and made up as a 1 M stock stored at -4 0
Poly-L-Lysine Hydrochloride – Sigma-Aldrich Co Ltd. Used to inhibit actions of PIP
C. Used as a final 
concentration of 5 mM. 
2. 
Made up in PBS and sonicated for 10 minutes at stock concentration of 25 µg/ml, 
stored at -20 0C. Used at final concentration of 5 µg/ml. 
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PI(4,5)P2 – L-a-Phosphatidylinositiol-4,5-bisphophate (Brain, Porcine-Triammonium 
Salt) Avanti Polar Lipids, Inc. Made up in de-ionised H2O and sonicated on ice for 
10-30 minutes (to replicate conditions as in (Vaithianathan et al., 2008) and stored in 
-20 0
PI(4,5)P
C. Used as a final concentration of 10 µM. 
2 [diC16, synthetic] – Triphosphoinositide sodium salt, 1,2-Diacyl-sn-
glycero-3-phospho-(1-D-myo-inositol 4,5-bisphosphate) sodium salt - Sigma-Aldrich. 
Made up in de-ionised H2O and sonicated on ice for 10-30 minutes (to replicate 
conditions as in (Vaithianathan et al., 2008) and stored in -20 0
PIP
C. Used as a final 
concentration of 10 µM. 
2 (Phosphatidylinositol-4,5-Biphosphate) Monoclonal Antibody – Assay Designs. 
Made up in PBS at 40 µg/µl stock and stored in -20 0
8-CPT-cAMP - Merck-Calbiochem. PKA activator. Soluble in H
C. Used as a final 
concentration of 10-15 µg/µl injected directly into the bath. 
2O and stored at -20 
0
8-CPT-cGMP - Merck-Calbiochem. PKG activator. Soluble in DMSO and stored at -
20 
C. Used at final concentration of 0.1 mM, application for 10-30 minutes. 
0
Okadaic acid – Merck-Calbiochem. Inhibits protein phosphatases (PP1 & PP2) and 
some serine/threonine protein phosphatases. Soluble in ethanol made up as stock 
concentration of 1 mg/ml stored at -20 
C. Used at a final concentration of 0.1 mM application for 10-30 minutes. 
0
H89 – Assay Designs - PKA inhibitor. Soluble in DMSO stored at -20 
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3.1 Chapter 3 introduction 
 
3.1.1 The STREX splice variant of the BK channel 
The C-terminus of the BK channel, despite the presence of hydrophobic domains, is 
predicted to be a cytosolic component of the BK channel (Meera et al., 1997). In 
studies that used immunolabelling of the linking regions between the hydrophobic 
domains in the C-terminus under non-permeabilised conditions, the C-terminus was 
identified as cytosolic (Meera et al., 1997). This work supported evidence gathered 
from investigations examining core and tail domains expressed separately (Wei et 
al., 1994; Meera et al., 1997) and recent crystal structural analysis that has 
modelled the C-terminal domain as an entirely cytosolic component of the BK 
channel (Wang & Sigworth, 2009; Wu et al., 2010; Yuan et al., 2010). 
Alternative splicing within the BK channel C-terminus has been shown to 
dramatically change the properties of the channel. Insertion of the 58 amino acid 
STREX insert at the C2 splice site (Figure 3.1A), leftward shifts the calcium- and 
voltage- sensitivity of the channel (Saito et al., 1997; Shipston et al., 1999; Chen et 
al., 2005; Saleem et al., 2009) and generates an additional PKA phosphorylation 
site (S636) that results in channel inhibition (Tian et al., 2001; Tian et al., 2004). 
However, the molecular basis for the change in BK channel phenotype with STREX 
inclusion is unknown.  
Features contained within the sequence of the alternatively spliced STREX exon 
may help to identify the mechanisms that underlie the different channel properties 
associated with the STREX channel. The STREX insert, upon inspection, is a 
cysteine-rich domain, with 6 out of 58 amino acids being cysteine residues (Figure 
3.1B). Cysteine residues are known targets for post-translational lipid modifications, 
with palmitoylation being one of the most common forms. Palmitoylation can modify 
protein function by increasing the hydrophobicity of the target protein facilitating 
membrane targeting and adhesion (Resh, 1999). Using a prediction algorithm (Zhou 
et al., 2006; Ren et al., 2008) to determine potential palmitoylation sites in proteins, 
the STREX insert was identified as a target for palmitoylation (Table 3.1). 




Sequence alignment of the cysteine rich STREX insert 
A
Figure 3.1. Sequence alignment of cysteine rich STREX insert.  (A) Schematic illus-
trating the topology of the BK channel pore forming α-subunit. The STREX insert at 
the C2 site of splicing is located within the RCK1-RCK2 linker region, in the intracellu-
lar C-terminus. Inclusion of STREX introduces a cysteine rich domain (CRD) encom-
passing the haem-binding domain (hbd) and the STREX insert. Cysteine residues 
within the STREX insert are highlighted in grey, with all cysteine residues that make 
up the CRD numbered (from C612 – C684) and the PKA phosphorylation serine 
residue (highlighted by an asterisk, *). (B) Sequence alignment of the STREX insert 
illustrates the evolutionarily conserved cysteine residues highlighted in grey, across 


















C-terminal domains (Resh, 1999), such as in the ionotropic glutamate receptor 
GluR6 that contains two palmitoylation cysteine sites within in the C-terminus 
(Pickering et al., 1995). Membrane targeting domains often use combinations of 
palmitoylation and other lipid modifications or polybasic domains to carry out specific 
functions (Bijlmakers & Marsh, 2003; Dietrich & Ungermann, 2004). The local 
environment around a palmitoylation site often appears to be quite indicative of its 
ability to be palmitoylated and function as a membrane targeting domain. Therefore, 
the additional presence of a series of basic residues around the C2 splice site and 
STREX domain may well be characteristic of a palmitoylated functional membrane 
targeting region.  
One possible explanation for the dramatic shift in channel gating seen with splicing 
of the STREX insert is that STREX itself may act as a membrane targeting domain 
that may change the configuration of the channel through the process of 
palmitoylation. The C2 splice site is located in the linker (RCK1-RCK2 linker) that 
joins the two RCK domains that form the gating domain of the BK channel. The 
RCK1-RCK2 linker has recently been modelled on the periphery of the gating 
domain and hence does not appear to be buried within the channel structure (Yuan 
et al., 2010) (Figure 1.10). This suggests that it is possible that the linker region 
could freely interact with the plasma membrane. Additional studies have identified 
that the RCK1-RCK2 linker, which has poor evolutionary conservation across 
different species, is predicted to have no regular secondary structure (NORS) (Lee 
et al., 2009a) and in crystal structural studies of the channel, this region cannot be 
defined (Wang & Sigworth, 2009; Yuan et al., 2010). It has also been shown that the 
length of the RCK1-RCK2 linker rather than the specific amino acid sequence is 
more important in manifesting changes in channel activity (Lee et al., 2009a). 
Therefore the linker would appear not to be constrained by specific arrangements 
within the channel and may be able to adopt a conformational change upon splice 
inclusion of the STREX insert.  
The STREX insert also brings a previously identified phosphorylation site that has 
been implicated in the functional heterogeneity to PKA regulation seen in the BK 
channel. Specifically it was found that PKA phosphorylation at the S927 site, outside 
of STREX, activates the channel whereas inclusion of the STREX insert which 
contains an additional PKA phosphorylation site, S636, results in channel inhibition 
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(Tian et al., 2001; Tian et al., 2004). Phosphorylation therefore plays an important 
role in the properties attributed to the STREX channel by PKA regulation and may 
have additional roles influencing how the STREX domain operates in the channel. 
 
3.1.2 Working hypothesis 
In this chapter, the hypothesis that STREX is a membrane targeting domain 
independent of the N-terminal transmembrane domains and is controlled by 
palmitoylation will be tested. 
 
3.1.3 Aims to be addressed in this chapter 
3.1.3.1 Is STREX a membrane targeting domain? 
In order to examine whether STREX functions as a membrane targeting domain, the 
cellular location of C-terminal constructs generated without N-terminal 
transmembrane domains, with and without the STREX insert (see methods section 
2.1.1), was examined by a fluorescent imaging strategy. These fluorescent fusion 
proteins were expressed in HEK293 cells that are amenable expression systems for 
studying the BK channel which is not native to this cell line. It would be predicted 
that the insertless ‘ZERO’ C-terminal domain which has been largely cited as a 
cytosolic domain, would be present in the cytoplasm of the cell. Therefore if the 
STREX insert is able to function as a membrane targeting domain, then the ‘STREX’ 
C-terminal domain, which is the same as ZERO except for an additional 58 amino 
acid insert at splice site C2, would locate at the plasma membrane.  
 
3.1.3.2 Is membrane targeting of STREX palmitoylation-dependant? 
To study palmitoylation as a mechanism for targeting STREX to the plasma 
membrane a fourfold approach was made. Firstly, a prediction algorithm allowed 
identification of potential palmitoylation sites within the BK C-terminus. Secondly, a 
site directed mutagenesis strategy mutating key cysteine residues that are predicted 
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to be palmitoylated in STREX, allowed the location of fluorescently tagged C-
terminal constructs to be determined therefore identifying key residues involved in 
membrane targeting. Thirdly, by using pharmacological approaches to inhibit lipid 
modification the mechanism responsible for membrane association was identified. 
And fourthly, to directly assess palmitoylation of the STREX C-terminus, 
incorporation of radiolabelled 3
 
H-palmitate into C-terminal channel proteins identified 
the key cysteine residues in the C-terminus that are important for palmitoylation. 
3.1.3.3 What is the functional significance of palmitoylation? 
To examine the functional significance of palmitoylation, successful mutant cysteine 
residues identified in the imaging and radiolabelling assays were substituted into full 
length channels and screened using a membrane potential assay that can 
discriminate different channel phenotypes based on altered voltage- and calcium- 
sensitivity or changes in cell surface expression. Channels with differing responses 
dissected out by the membrane potential assay were then taken forward and 
examined by electrophysiological patch clamp techniques to isolate the kinetics of 
the mutant channels with relation to the wild-type STREX channel.  
 
3.1.3.4 Does phosphorylation regulate membrane targeting of STREX? 
To identify whether phosphorylation of the S636 site within the STREX insert that 
mediates channel inhibition by PKA is involved in the regulation of the membrane 
targeting properties of the STREX insert, a similar imaging strategy was used to 
examine cellular location of C-terminal STREX fluorescently tagged fusion protein 
by mutating the S636 phosphorylation site and introducing phospho-mimetic 






3.2.1 STREX as a membrane targeting domain 
To examine whether the STREX insert may act as a membrane targeting domain, 
an imaging approach was taken to examine where the C-terminal domain localises 
in HEK293 cells. C-terminal constructs of the insertless ZERO channel and the 
STREX channel, that is the same as ZERO except for an additional 58 amino acid 
insert, were created by subcloning the murine intracellular carboxyl (C-) terminus 
(from residue G328 to residue C1226) of the BK α-subunit. A fluorescent protein tag 
(GFP) was fused to carboxyl end of the C-terminal protein to allow detection of the 
expressed protein (see section 2.1.1 & Figure 2.1). Constructs were then expressed 
in mammalian HEK293 cells (Figure 3.2A).  
Expression of the insertless ZERO C-terminus construct (S6:ZERO), demonstrated 
a diffuse cytoplasmic presence (17%) and strong nuclear localisation (99%). There 
was no evidence of plasma membrane expression (N= 3, n= >500 cells counted) 
(Figure 3.2B, left panel). Conversely, expression of the STREX C-terminus construct 
(S6:STREX) resulted in robust plasma membrane expression, with 73% of all cells 
transfected showing clear fluorescence at the plasma membrane in the absence of 
transmembrane segments and a strong nuclear fluorescence in over 90% of all cells 
(N= >4 n= >1000 cells counted) (Figure 3.2B, centre panel).  
Therefore, alternative splicing of the STREX insert does influence the cellular 
location of the largely cytosolic/nuclear C-terminus and acts as a membrane 
targeting domain. 
 
3.2.2 STREX is a cysteine rich domain  
Alternative splicing of the STREX insert at splice site C2 generates a cysteine rich 
domain (CRD) (Figure 3.1A). Within the CRD 10 cysteine residues make up the 78 
amino acid residues in the region that incorporates the CRD (from C612 – F691)  
(Figure 3.1A). The CRD comprises the STREX insert and an upstream hame-
binding domain (hbd). Sequence alignment of the murine coding region of the CRD 
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suggests strong evolutionary conservation of cysteine residues across the 
vertebrate phyla, indicating that these residues may have structural or functional 
importance (Figure 3.1B).  
Cysteine residues can be modified by post-translational modifications such as 
palmitoylation which will enhance a protein’s ability to be targeted to the plasma 
membrane (Resh, 1999). Therefore it is possible that membrane targeting of the 
STREX domain may be mediated through palmitoylation of cysteine(s) residues 
within STREX.  
 
3.2.3 Cysteine residues in STREX are predicted to be palmitoylated 
To investigate whether the cysteine rich domain may promote targeting of the 
STREX insert to the plasma membrane via palmitoylation, a recently developed 
computer algorithm (CSS-Palm v2.0) (Zhou et al., 2006; Ren et al., 2008), was used 
to screen for potential sites of palmitoylation within the STREX C-terminus. 
The CSS-Palm algorithm predicts cysteine residues or cysteine motifs that may be 
palmitoylated. The algorithm is based on data from 263 experimentally verified 
palmitoylation sites from 109 distinct proteins (published prior to November 2006) 
which groups them into subsets based on sequence similarity and identifiable 
palmitoylation motifs. Each cysteine is given a final score for potential palmitoylation 
based on a defined similarity score. The higher the score of a cysteine residue 
within a sequence, the more confidence there is that the peptide may be 
palmitoylated above the high threshold cut off value of 0.9. A value above 2.0 
indicates a very high score as a potential palmitoylation site. The most recent 
version of the algorithm (CSS-palm v2.0) was used in this study. The CSS-palm 
v2.0 algorithm can be found at http://bioinformatics.lcd-ustc.org/css_palm. 
The murine STREX splice variant of the BK channel sequence (accession number 
NM_010610) spanning the intracellular C-terminus from the end of the S6 
transmembrane domain to the end of the intracellular carboxyl tail (G328 - C1226), 
was examined by inputting the amino acid sequence, in FASTA format, into the 





Predicted palmitoylation scores for cysteine residues in the intracellular C- 
terminus of the STREX splice variant of the BK channel
Table 3.1. Predicted palmitoylation scores for cysteine residues in the intracellular C- 
terminus of the STREX splice variant of the BK channel. (A) Scores indicate CSS-
palm prediction; a higher score represents higher probability. CSS-palm scores were 
determined with the published CSS-palm v2.0 at http://bioinformatics.lcd-
ustc.org/css_palm by inputing the protein sequence of the entire intracellular 
C-terminus of the STREX variant of the BK channel (starting at glycine residue G328 
and spanning until cysteine residue C1226). Highest scoring residues for palmitoyla-
tion are shown in grey. (B) Sequence diagram illustrating the position of cysteine 




645-646 649 656 658 684612 615 628 630
hbd
Cysteine position:
2.5 0.6 1.1 <0.5 <0.5 <0.5<0.5<0.50.80.7CSS-palm score:





Position Peptide CSS-palm v2.0 score 
422 ADACLIL 0.2 
430 NKYCADP 0.1 
485 DAICLAE 0.3 
498 AQSCLAQ 0.6 
554 PTVCELC 0.6 
557 CELCFVK 0.9 
612 FFYCKAC 0.7 
615 CKACHDD 0.8 
628 IKKCGCR 0.0 
630 KCGCRRP 0.1 
645 RRACCFD 2.5 
646 RACCFDC 0.6 
649 CFDCGRS 1.1 
656 ERDCSCM 0.2 
658 DCSCMSG 0.3 
684 VNDCSTS 0.3 
753 FHWCAPK 0.1 
780 VVVCIFG 0.3 
855 INLCDMC 0.8 
858 CDMCVIL 0.8 
878 DKECILA 0.4 
969 PFACGTA 0.2 
1033 RDRCRVA 0.2 
1053 DGGCYGD 0.3 




The algorithm calculated the predicted palmitoylation score for all cysteine residues 
in the C-terminus of the BK channel (Table 3.1A). Using a high threshold cut-off 
score (above 0.9), the two residues with the highest predicted scores were located 
within the STREX insert, C645 - CSS-Palm score 2.5 and C649 - CSS-Palm score 
1.1 (indicated by grey boxes) (Table 3.1A).  
Therefore the algorithm suggests that cysteine residues within the STREX insert 
may be palmitoylated which would enable the STREX domain to function as a 
membrane targeting domain. 
 
3.2.4 C645-C646 residues are important for STREX C-terminus association at 
the plasma membrane  
The S6:ZERO construct did not show evidence of plasma membrane association, 
therefore it would be assumed that if cysteine residues are important for localisation 
at the plasma membrane, then any cysteine residues outside of the STREX region 
would appear not to have a functional role in plasma membrane targeting of the C-
terminus. To examine the potential of cysteine residues within the STREX domain to 
anchor the C-terminus at the plasma membrane via palmitoylation, a site directed 
mutagenesis approach was taken by mutating cysteines to neutral alanine (A) 
residues. Cysteine residues within the identified CRD incorporating STREX were 
also examined. C-terminal constructs were designed with individual cysteine 
mutations and dual cysteine mutations and transfected into HEK293 cells to 
examine C-terminal association with the plasma membrane.  
The total plasma membrane expression of the S6:STREX -GFP fusion construct 
was normalised to 100% therefore allowing direct comparison of mutated cysteine 
constructs to S6:STREX (black bars) (Figure 3.2C). Mutation of cysteine residues in 
the N-terminal end of the CRD upstream of the STREX insert that includes cysteine 
residues within the hbd (C612A:C615A) and (C628A:C630A), had no effect on the 
association of the C-terminal fusion proteins at the plasma membrane 
(C612A:C615A, 97 ± 9 %, and C628A:C630A, 98 ± 5 % of S6:STREX. N= >4, n= 






Cysteine residues are important for targeting of the STREX C-terminus 
(S6:STREX) to the plasma membrane
Figure 3.2. Cysteine residues are important for targeting of the STREX C-terminus 
(S6:STREX) to the plasma membrane. (A) Schematic of C-terminal -GFP fusion 
constructs. (B) Representative single confocal images of C-terminal STREX 
(S6:STREX), dicysteine mutant (C645A:C646A) and the insertless C-terminal ZERO 
(S6:ZERO) construct, expressed in HEK293 cells. (Scale bars: 10 µm). (C) Summary 
bar graph of the respective C-terminal cysteine point mutation constructs expressed 
at the plasma membrane as a percentage of S6:STREX (where S6:STREX is 100%). 
































































































Within the STREX insert, mutation of C645A reduced plasma membrane expression 
to 46 ± 6 % with mutation of the adjacent cysteine residue, C646A, having a greater 
effect reducing plasma membrane expression to 12 ± 3 % (N= >4, n= >600 cells 
counted). The double mutant (C645A:C646A) almost completely abolished plasma 
membrane association of the C-terminal fusion proteins to 0.5 ± 0.3 % plasma 
membrane expression of S6:STREX (N= >4, n= >1600 cells counted) (Figure 3.2B, 
right panel). Subsequent cysteine residues in the C-terminal end of STREX had no 
significant effects in reducing association at the plasma membrane, (C649A 95 ± 
6%, C656A:C658A 97 ± 9 % and C684A 94 ± 9 % of S6:STREX. N= >4, n= >350 
cells counted).  
The data would suggest that the C645 or C646 cysteine residues must be crucial for 
targeting of the STREX C-terminal constructs to the plasma membrane. Therefore 
palmitoylation at these cysteine residues may be important for membrane targeting 
of the STREX insert.  
 
3.2.5 Palmitoylation controls the association of C-terminus constructs at the 
plasma membrane 
To identify whether palmitoylation does play an important role in association of the 
STREX C-terminus at the plasma membrane an inhibitor of palmitoylation, 2-
bromopalmitate (2-BP, 100 µM) was pre-incubated for various time periods in 
transiently transfected HEK293 cells (Fig 3.3). 2-bromopalmitate (2BP) is a non-
metabolizable palmitate analog that blocks palmitate incorporation into proteins 
(Webb et al., 2000).  Pre-incubation with 2-BP  for 6 hours had no significant effect 
on plasma membrane association of S6:STREX constructs (104 ± 7 %, N=>4, n= 
>500 cells counted), however longer incubation periods of 24 and 48 hours had a 
significant effect in nearly completely abolishing membrane association of the 
STREX C-terminus (Figure 3.3B, right panel & C). 24 hours incubation with 2-BP 
decreased the association of STREX at the plasma membrane to 21 ± 4 % whereas 
a longer incubation time of 48 hours essentially abolished plasma membrane 
expression to 1 ± 0.7 % (N= >4, n= >1000 cells counted). As a control for general 





Palmitoylation controls the association of C-terminus constructs at the plasma 
membrane
Figure 3.3. Palmitoylation controls the association of C-terminus constructs at the 
plasma membrane. (A) Schematic of the STREX C-terminal -GFP fusion construct. 
(B) Representative single confocal images of S6:STREX, and S6:STREX after 48hr 
incubation with palmitoyltransferase inhibitor 2BP (100 µM) (Scale bars: 10 µm). (C) 
Summary bar graph of the respective C-terminal construct localization at the plasma 
membrane after 6, 24 and 48 hours incubation with 2BP, expressed as a percentage 
of S6:STREX (where S6:STREX is 100%) and 24 hour incubation with myristate 
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hydroxymyristate (2-HM, 0.1-1 mM), was found to have no significant effect on C-
terminal association at the plasma membrane (97 ± 3 %, N=>4, n= >350 cells 
counted), (Figure 3.3C). The vehicle for 2-BP, 0.1% DMSO also had no effect on C-
terminal targeting to the plasma membrane (102 ± 3 %, N=>4, n= >350 cells 
counted).  
The data suggests that palmitoylation plays a key role in the STREX domain 
associating at the plasma membrane. The decreased expression seen at the 
plasma membrane with 48 hours pre-incubation of 2-BP was similar to the 
decreased expression seen with mutation in the double cysteine motif 
(C645A:C646A) in STREX. This would suggest that endogenous palmitoylation may 
regulate the C645:C646 motif in STREX, to promote the C-terminus of the STREX 
channel to associate with the plasma membrane independent of transmembrane 
domains.  
 
3.2.6 STREX channel activation driven by increased calcium is diminished in 
C645A:C646A mutant channels 
To examine the functional effect of palmitoylation, cysteine residues were mutated in 
full length STREX channels and examined in a membrane potential assay that has 
been previously used as a preliminary screen of recombinant BK channels (Saleem 
et al., 2009) with good correlation to patch clamp electrophysiology.  
The membrane potential assay is a high-throughput assay that uses voltage 
sensitive fluorescent reporter dyes (FLIPR-blue bis-oxonol dye, Molecular Devices) 
with rapid sensitivity to report ion channel activity to a stimulus. Using Ionomycin (1 
µM) to stimulate calcium entry into cells, the calcium sensitive component of the BK 
channel could be driven, activating the channels. Upon stimulation of the BK 
channel, potassium ion efflux would hyperpolarise the cell membrane which would 
result in a decrease in relative fluorescence as the FLIPR dye moves out of the cell 
membrane and is quenched by the extracellular medium. In un-transfected cells 
calcium entry would cause a depolarisation which resulted in an increase in relative 
fluorescence as the FLIPR dye moved into the cytoplasm of the cell. 
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Full length STREX channels, STREX channels with mutation of the C645A:C646A 
and ZERO channels were transiently transfected into HEK293 cells and seeded into 
96 well assay plates. Cells were loaded with FLIPR-blue dye (Molecular Devices) 
and the assay was then run in the Flexstation ® II during which cells were 
stimulated by 1 µM Ionomycin to activate the BK channel. Ionomycin was delivered 
by the automated liquid-handing function of the Flexstation ® II which administered 
50 µl of Ionomycin to a total well volume of 200 µl, 16 seconds after the  Flexstation 
® II began reading to allow a measure of baseline fluorescence. Changes in 
fluorescence were then measured over a time course of 180 seconds. 
Changes in absolute relative fluorescence could be detected (units = relative 
fluorescent units, RFU) and illustrated in a graph against time (seconds) or 
expressed as the isolated channel current by subtracting the control HEK response 
from the transiently transfected channel response within the assay plate. Using the 
full length STREX channel as a control response, the peak hyperpolarisation was 
normalised to 100% (at t=70 seconds) and channel variants and mutants could then 
be compared to the STREX channel. 
A representative trace illustrates the activation of the STREX channel (black circle) 
showing a decrease in fluorescence that peaks at around the 70 second time point 
corresponding to hyperpolarisation of the cells (Figure 3.4A). Un-transfected 
HEK293 cells (open circle) show an increase in fluorescence corresponding to 
depolarisation due to calcium influx (Figure 3.4A). Comparing the insertless ZERO 
(grey circles) channel to the more calcium sensitive STREX channel (black circles), 
the hyperpolarising response in the same assay is largely attenuated at t=70s to 42 
± 10% when compared to STREX at 100% (N= 3, n= >20). Mutation of the key 
dicysteine residues (C645A:C646A) identified as important for targeting the C-
terminus to the plasma membrane (inverted triangles) shows a reduced 
hyperpolarising response of 68.3 ± 4% when compared to STREX at 100% at t=70s 
(N= 3, n= >20) midway between the STREX and ZERO channel phenotype (Figure 
3.4B). The discrimination of STREX and ZERO correlate well with the calcium and 
voltage sensitivities previously identified (Saleem et al., 2009). 
The data suggests that the C645A:C646A mutant channel displays an intermediate 
phenotype between the increased calcium sensitive STREX channel and the less 





STREX activation driven by calcium influx is diminished in C645A:C646A 
mutant channels
Figure 3.4. STREX activation driven by calcium influx is diminished in C645A:C646A 
mutant channels. (A) Representative time course plots of mean change in relative 
fluorescence units (RFU) of the FLIPR-blue membrane potential dye in HEK293 cells 
expressing STREX (black circles, �), C645A:C646A (inverted triangles,  ), ZERO 
(grey circles,   ), and mock-transfected HEK293 (open circles, �),  in response to 
calcium influx induced by 1 µM Ionomycin. (B) Summary bar chart of the peak hyper-
polarisation at t=70s for each variant expressed as a percentage of the STREX 
response (where STREX is 100%). Data was determined at the maximum hyperpolar-
ising response in STREX (t=70s) in the time course plots in (A). All data are Means ± 
S.E.M (N=3, n= >30), * p<0.05, ** p<0.01, compared to STREX. ($) ZERO is not 
significantly different from C645A:C646A (ANOVA with tukey post hoc test).



















































mediates the different properties that STREX insertion confers to the channel. 
Whether the dicysteine mutant channel has decreased calcium sensitivity becoming 
more “ZERO-like” or whether channel conductance has changed by disruption of 
channel structure requires full electrophysiological investigation. The membrane 
potential assay cannot directly discriminate between shifts in the calcium or voltage 
sensitivity of the channel, changes in single channel amplitude, nor would it resolve 
absolute cell surface expression of functional channels at the plasma membrane. 
 
3.2.7 Single channel amplitude is unchanged in STREX, C645A:C646A and 
ZERO channels 
To investigate whether differences in single channel amplitude of the mutant 
C645A:C646A channels may mediate the attenuated response described in the 
membrane potential assay, it was necessary to examine isolated channels 
electrophysiologically. 
Single channel amplitude was measured at a range of membrane potentials (-80 mV 
to +80 mV) in excised inside-out patches in symmetrical potassium gradients (140 
mM [K+]i / 140 mM [K+]o) and 0.33 µM [Ca2+]i
This suggests that the differences in channel activity described in the membrane 
potential assay are not mediated by changes in single channel amplitude. 
 (Figure 3.5A). Single channel slope 
conductance of the STREX channel was 233 ± 2.5 pS. There was no significant 
difference in single channel slope conductance in the C645A:C646A mutant channel 
at 230 ± 2.5 pS and the insertless ZERO channel at 231 ± 2.5 pS. Single channel 
openings are shown at +40 mV for each channel variant in Figure 3.5B.  
  
3.2.8 C-terminal targeting to the plasma membrane mediates STREX channel 
properties 
To examine BK channel activation in mutant channels, macroscopic currents were 
recorded by inside-out patch clamp analysis in symmetrical potassium gradients 
(140 mM [K+]i / 140 mM [K+]o), as before, to examine the calcium- and 
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Figure 3.5
Single channel amplitude is unchanged in STREX, C645A:C646A mutant and 
insertless ZERO BK channels
Figure 3.5. Single channel amplitude is unchanged in STREX, C645A:C646A mutant 
and insertless ZERO BK channels. (A) Current voltage plot for STREX channels 
(closed circles, �) dicysteine mutant C645A:C646A channels (inverted triangles    ) 
and insertless ZERO channels (grey circles,   ), illustrating that single channel 
conductance is unaffected in 0.33 µM free Ca2+ and 140 mM equimolar potassium 
gradients (N=3). Single channel conductance derived from the slope of the line. The 
conductance of STREX is 233.7 ± 0.2 pS, C645A:C646A is 230.4 ± 0.2 pS and for 
ZERO was 231.0 ± 0.2 pS. SEM is shown within the symbols. (B) Representative 





















voltage- sensitivity in the channel (Figure 3.6). An equimolar potassium gradient was 
used to remove the chemical gradient, therefore isolating the electrical driving force 
of the channels. Representative macropatch currents illustrate the typical outward 
component of the BK channel response to a depolarising voltage step protocol (-120 
to +120 mV) from a holding potential of -80 mV (Figure 3.6A). Activation (G/GMAX) 
curves were obtained by plotting normalised tail current amplitudes versus the 
respective test potential. These curves were fitted to a Boltzmann equation whereby 
the voltage for half activation (V0.5MAX
Measurement of channel activity was made in 0.33 µM Ca
) could be determined (Figure 3.6B). Tail 
currents were examined because the amplitude of the tail current is proportional to 
the channel open probability at the end of the preceding depolarisation (Islas & 
Sigworth, 1999). Previous functional studies of the STREX splice variant have 
demonstrated a dramatic shift in the apparent calcium sensitivity of the STREX 
channel compared to the insertless ZERO variant (Saito et al., 1997; Shipston et al., 
1999; Chen et al., 2005). In particular the difference in half maximal voltage for 
activation is most apparent at sub-micromolar free calcium concentrations whereas 
above 1 µM free calcium the voltage for half maximal activation of STREX channels 
begin to converge with the ZERO channel. Therefore the STREX variant is more 
potently activated within the physiological calcium and voltage range than ZERO 
(Chen et al., 2005).  
2+ at the midpoint of the 
physiological range for STREX to allow discrimination of differences in channel 
activity. The half maximal voltage for activation of normalised (G/GMAX
This data would appear to suggest that the C645:C646 dicysteine residues in 
STREX that target the C-terminus to the plasma membrane may mediate part of the 
shift in the half maximal activation of the STREX splice variant of the BK channel in 
relation to the insertless ZERO channel. The shift in channel activity recorded in the
) curves was 
determined in relation to STREX (Figure 3.6C). The voltage for half maximal 
activation of the STREX channel was 34.9 ± 1.6 mV. The C645A:C646A mutation 
significantly rightward shifted the voltage for half activation by ~18 mV to 52.8 ± 2.5 
mV (p<0.001 compared to STREX. N=>3), with the insertless ZERO channel 
showing the largest rightward shift to 68.2 ± 3 mV (p<0.001 compared to STREX. 
N=>3), in accordance with previous studies (Saito et al., 1997; Shipston et al., 1999; 
Chen et al., 2005). 
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Figure 3.6
C645A:C646A mutation rightward shifts the V0.5MAX of the STREX channel 
towards the ZERO channel
Figure 3.6. C645A:C646A mutation rightward shifts the V0.5MAX  of the STREX channel 
towards the ZERO channel. (A) Representative traces showing outward currents at 
depolarized potentials from HEK293 cells expressing STREX (black circles, �), 
C645A:C646A (inverted triangles,   ), and ZERO (grey circles, �), from excised 
inside-out patch recordings in equimolar (140 mM) potassium gradients and 0.33 µM 
free Ca2+. Outward currents were elicited by 100 ms depolarising voltage steps from 
-120 to +120 mV in 20 mV increments from a holding potential of -80 mV. (Scale bars: 
1 nA / 25 ms) (B) G/GMAX conductance curves from tail currents. (C) Summary bar 
graph showing V0.5MAX for STREX, cysteine mutant C645A:C646A and ZERO chan-
nels. All data are Means ± S.E.M (n= >3), *** p<0.001, compared to STREX (ANOVA 
































The voltage dependence of the mutant C645A:C646A channel is un-affected
Figure 3.7. The voltage dependence of the mutant C645A:C646A channel is 
un-affected. A logarithmic transformation of the G/GMAX activation curves over depo-
larised potentials of 0 to +120 mV as described in the macropatch recordings in Figure 
3.6B. STREX (closed circles, � ), C645A:C646A (inverted triangles,  ), and ZERO 























dicysteine mutant channel using electrophysiology correlates well with the shift in 
the channel response described by the membrane potential assay. 
 
3.2.9 Voltage dependence is unchanged in mutant channels  
To determine whether the voltage sensitivity of the C645A:C646A mutant channels 
has changed when compared to STREX or ZERO channels, a logarithmic 
transformation to linearize the activating component of the normalised (G/GMAX
  
) 
curves in Figure 3.6B were plotted against the depolarised potentials from 0 mV to 
+120 mV (Figure 3.7). Disruption of the C645:C646 cysteine residues has no effect 
on the voltage dependence of the channels when compared to STREX and ZERO. 
Therefore the changes in activity described for the STREX C645A:C646A and 
ZERO channels appear not to be mediated by an altered voltage sensitivity of the 
channels.   
3.2.10 Palmitoylation of the C-terminus is abolished by mutation of the 
C645:C646 residues in the STREX 
To directly address whether the STREX channels are indeed palmitoylated and to 
investigate if mutation of the key cysteine residues within STREX (C645A:C646A) 
could disrupt the palmitoylation status of the channel, 3
Transfected –HA tagged C-terminal constructs expressed in HEK293 cells were 
incubated with DMEM/BSA containing 0.5mCi/ml 3H-palmitic acid for 4 hours at 37 
H-palmitate incorporation into 
C-terminal fusion proteins was examined in HEK293 cells (Figure 3.8).  
0C and then lysed to collect the channel fusion proteins. The recovered samples 
could then be separated by SDS/PAGE and probed with polyclonal HA antibodies. A 
duplicate membrane was dried and sprayed with En3hance fluorographic spray and 
exposed to a light sensitive film at -80 0
The representative fluorographs (Figure 3.8) show that the STREX C-terminal 
construct (S6:STREX) is robustly palmitoylated in HEK293 cells by endogenous 
C for 1-3 weeks to detect palmitate 
incorporation as described (see methods section, 2.5.1). 
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Figure 3.8
Palmitate incorporation into S6:STREX is abolished by mutation of cysteine 
residues C645A:C646A and is absent in ZERO channels 
Figure 3.8. Palmitate incorporation into S6:STREX is abolished by mutation of 
cysteine residues C645A:C646A and is absent in ZERO channels. Representative 
fluorographs (Upper) and Western blots (Lower) of S6:STREX-HA, double cysteine 
mutant C645A:C646A-HA, and S6:ZERO-HA, expressed in HEK293 cells. Constructs 
were labelled with 3H-palmitate for 4 hours and the respective constructs immunopre-
cipitated (IP) using α-HA magnetic microbeads, subjected to SDS-PAGE and probed 
by a polyclonal HA antibody and detected by fluorography. Ratios of palmitate detec-


































palmitoyl tranfererases. In the insertless ZERO C-terminal construct, there is no 
detectable 3H-palmitate incorporation suggesting that the STREX insert contains the 
only palmitoylation site within the entire C-terminus of the BK channel. 3
Regulation of the palmitoylation status at this site in the STREX insert may be 
influenced by the local environment or by other important motifs close to the 
palmitoylation site. In palmitoylated proteins it has been shown that the local 
environment adjacent to a palmitoylation site is important for stability at the plasma 
membrane (Bijlmakers & Marsh, 2003; Dietrich & Ungermann, 2004). Therefore, the 
PKA phosphorylation site just upstream of the STREX palmitoylation site could 
potentially influence palmitoylation and hence the conformation of the STREX 
channel. 
H-palmitate 
incorporation was also abolished in the C645A:C646A mutant, suggesting that these 
residues are the major site of palmitoylation within the STREX insert and within the 
C-terminus of the STREX splice variant of the BK channel (Fig 3.8). Western blot 
analysis showed that total protein expression was essentially unchanged in the 
assays (n=3). Therefore this data identifies a novel palmitoylation site within the 
STREX C-terminus of the BK channel, (C645:C646), that is regulated by 
endogenous palmitoylation. The data also supports the hypothesis that the STREX 
insert is important for targeting of the C-terminus to the plasma membrane through a 
mechanism of palmitoylation.  
 
3.2.11 The PKA phosphorylation motif in STREX mediates membrane 
targeting of the C-terminus 
It has been previously shown that BK channels are differentially regulated by PKA 
mediated phosphorylation. PKA activates ZERO channels at a conserved C-terminal 
phosphorylation site (S927), downstream of the splice site C2. Conversely splicing 
of the STREX insert generates an additional PKA consensus motif in STREX, S636, 
just upstream of the palmitoylation site (C645:C646), that results in channel 







Mutation of the S636 PKA phosphorylation site in STREX disrupts C-terminus 
association with the plasma membrane
Figure 3.9. Mutation of the S636 PKA phosphorylation site in STREX with a phospho-
mimetic residue disrupts C-terminus association with the plasma membrane. (A) 
Schematic of C-terminal -GFP fusion constructs. (B) Representative single cell confo-
cal images of C-terminal S6:STREX, S636E and S927E, in HEK293 cells (Scale bars: 
10 µm). (C) Summary bar graph of the respective mutant serine C-terminal constructs 
localization at the plasma membrane expressed as a percentage of S6:STREX 
(where S6:STREX is 100%). *** p<0.001 compared with S6:STREX (ANOVA with 
tukey post hoc test).






























































To determine whether palmitoylation and phosphorylation might together mediate a 
conformational change in STREX that controls the different channel properties in the 
channel through membrane targeting, phosphomimetic mutant constructs were 
created to examine membrane association of C-terminal domains. Substitution of 
the PKA consensus serine residue with a phosphomimetic glutamic acid (E) residue 
(S636E) in STREX, essentially abolished C-terminal localisation at the plasma 
membrane to 3.5 ± 1.7% in comparison to STREX at 100%. Substitution with a 
neutral alanine (A) residue also reduced plasma membrane association of C-
terminal constructs to 17.2 ± 7% (N= >4, n= >600 cells counted) (Figure 3.9C). To 
examine whether these effects were unique to phosphorylation at the PKA 
consensus site in STREX, the same mutations were made at the conserved PKA 
motif downstream of the C2 splice site (S927), which is the major site for PKA 
activation. Substitution of serine-927 with glutamic acid and alanine residues had no 
significant effect on STREX C-terminal association with the plasma membrane 
(S899E was 92.2 ± 5% of S6:STREX, S899A was 90.3 ± 2.9% of S6:STREX. N= 
>4, n= >500 cells counted), (Figure 3.9C). 
Therefore mimicking phosphorylation at the PKA motif in STREX (S636) decreases 
membrane targeting of the STREX C-terminus. However, to directly investigate PKA 
mediated regulation of C-terminal association at the plasma membrane, PKA was 
activated using a cell-permeable cAMP analogue 8-CPT-cAMP, to study the effect. 
 
3.2.12 PKA phosphorylation dissociates the STREX C-terminus from the 
plasma membrane 
In this set of experiments HEK293 cells expressing the STREX C-terminal construct 
were incubated with the membrane-permeable cAMP analogue 8-CPT-cAMP (0.1 
mM) for 10-30 minutes, to establish whether constructs at the plasma membrane 
could be dissociated by PKA phosphorylation. Pretreatment with 8-CPT-cAMP (0.1 
mM), significantly reduced membrane association of the STREX C-terminal 
constructs to 38 ± 3% when compared to STREX at 100% (N= >4, n= >350 cells 
counted) (Fig 3.10). The effect of cAMP could be abolished with PKA inhibitor H89 
(1 µM) (96 ± 5% of S6:STREX) (N= >4, n= >350 cells counted) (Fig 3.10). Okadaic 
acid (10 nM) a potent inhibitor of protein phosphatases 1 and 2A that has been 
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Figure 3.10
PKA phosphorylation of S6:STREX disrupts C-terminal association with the 
plasma membrane
Figure 3.10. PKA phosphorylation of S6:STREX disrupts C-terminal association with 
the plasma membrane.  Summary bar graph illustrating the effect of kinase activity on 
association of the S6:STREX -GFP tagged construct at the plasma membrane 
expressed as a percentage of S6:STREX (where S6:STREX is 100%). Ionomycin (1 
µM) and KCL (25 mM) were used as activators of the BK channel. Okadaic acid (10 
nM) inhibits phophatase activity which has also been shown to modulate BK channel 
activity. cAMP (0.1 mM) activates PKA-dependant phosphorylation and H89 (1 µM) is 
an inhibitor of PKA phosphorylation. cGMP (0.1 mM) activates PKG-dependant phos-
phorylation and PKC was activated with the phorbol ester PMA (100 nM) both in the 















































































shown to modulate the BK channel (White et al., 1991; Reinhart & Levitan, 1995; 
Loane et al., 2006) had no effect on membrane association of the C-terminal 
STREX constructs (96 ± 3%) and did not affect the cAMP response (32.1 ± 3%).  
To examine the effect of other protein kinases to exclude non-specific 
phosphorylation of BK channels at different sites, cells were activated by protein 
kinase G (PKG) or C (PKC) analogues that have been shown to modulate BK 
channel activity independent of STREX (White et al., 2000; Zhou et al., 2000). 
Activation of PKG with the cell permeant cGMP analogue 8-CPT-cGMP (0.1 mM) in 
the presence of okadaic acid had no effect of STREX localisation at the plasma 
membrane (103 ± 5%). Similarly, PKC activation with the phorbol ester PMA (100 
nM) in the presence of okadaic acid had no effect (102 ± 5%) (N= >4, n= >350 cells 
counted). Therefore PKG and PKC phosphorylation of BK channels does not affect 
membrane association of the STREX domain. 
As a further control for general activation of the BK channel and membrane 
association of the C-terminal constructs, ionomycin (a calcium ionophore) (1 µM) 
was used to elevate intracellular calcium and high KCL (25 mM) was used to 
depolarise the cell membrane. There was no significant effect on the plasma 
membrane localisation of STREX (ionomycin, 105.2 ± 14.7% and KCl, 93.8 ± 8.7%. 
N= >4, n= >350 cells counted) (Fig 3.10). 
Together, this data supports a model in which PKA phosphorylation of STREX 
results in dissociation of the STREX domain from the plasma membrane. This may 
represent the configurative changes that may underlie the dramatic changes in 





Here for the first time, the alternatively spliced STREX insert within the RCK1-RCK2 
C-terminal linker of the BK channel has been shown to function as a membrane 
targeting domain. This ability of STREX to associate with the plasma membrane is 
regulated by palmitoylation and may be modulated by phosphorylation. 
Palmitoylation may also contribute to the increased calcium sensitivity inherent to 
the STREX splice variant of the BK channel. Aspects of this work have been 
published in PNAS (see appendix #1; (Tian et al., 2008a)). 
 
3.3.1 STREX insert is a membrane targeting domain 
By determining the cellular location of fluorescently tagged C-terminal constructs of 
the BK channel, the ZERO C-terminal construct as expected for a cytosolic protein, 
was located diffusely in the cell’s cytoplasm, however, unexpectedly it was also 
found in the nucleus (this will be discussed later in chapter 4 section 4.3.7) when 
expressed in HEK293 cells. STREX C-terminal constructs, that have an additional 
58 amino acid insert within the RCK1-RCK2 linker, demonstrated strong plasma 
membrane expression in up to 73% of cells expressing the C-terminal fusion protein 
and also a strong nuclear expression. Identical results were seen in cells that 
endogenously express STREX channels including murine anterior pituitary 
corticotrophe (AtT20) cells, rat pheochromocytoma PC12 cells, and human 
insulinoma INS-1 cells (see appendix #1; (Tian et al., 2008a)). Therefore, alternative 
splicing of the STREX insert, which is dynamically regulated by stress hormones 
(Xie & McCobb, 1998), introduces a membrane targeting domain to the cytosolic C-
terminus of the BK channel. 
To examine the mechanism underlying membrane association of STREX, a strategy 
to mutate cysteine residues identified as potential sites for palmitoylation within the 
STREX cysteine rich domain (CRD) was used. Two evolutionary conserved cysteine 
residues C645:C646 were found to be important for the membrane targeting ability 
of STREX C-terminus constructs. Mutation of these cysteine residues decreased 
membrane association of STREX C-terminal constructs by ~99%, no other cysteine 
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residue in the CRD had any effect. Application of a palmitoylation inhibitor, 2-BP 
reduced membrane association of the STREX C-terminal constructs by ~99%, as 
seen with the double cysteine mutant. Interaction of the STREX domain with the 
plasma membrane was not disrupted by an inhibitor of myristoylation (2-HM) 
suggesting that the effect of palmitoylation is not mediated by the general properties 
of lipidation of proteins. 
 
3.3.2 Palmitoylation controls membrane association of STREX 
To directly address whether the STREX C-terminus is palmitoylated, a radiolabelled 
assay examining 3H-palmitate incorporation into C-terminal STREX, the insertless 
C-terminal ZERO and mutant cysteine C645A:C646A STREX C-terminal constructs 
was examined. The ZERO C-terminus was not palmitoylated suggesting that the 
insertless C-terminus does not have any additional palmitoylation sites. The STREX 
C-terminus was robustly palmitoylated and importantly, mutation of the identified 
cysteine residues, C645A:C646A, totally abolished palmitoylation within the STREX 
C-terminal construct. This suggests that the C645:C646 cysteine residues are the 
key palmitoylation sites within the STREX splice variant C-terminus of the BK 
channel.   
3H-palmitate incorporation was also studied in full length STREX channel constructs 
which were also robustly palmitoylated, however in full length channel constructs 
that did not have the 58 amino acid STREX insert, (ZERO channels), 3
 
H-palmitate 
incorporation was diminished but not abolished (see appendix #1; (Tian et al., 
2008a)). Hence the C645:C646 site in STREX is the major palmitoylation site in the 
BK C-terminus, however the channel may be palmitoylated at additional sites 
outside of the C-terminus (this will be discussed further in chapter 5). 
3.3.3 Palmitoylation functionally affects STREX channels 
So does palmitoylation have a functional role in the BK channel? To examine this, 
channels with mutation of the key cysteine residues identified as being palmitoylated 
were studied electrophysiologically. Double cysteine mutation in the STREX channel 
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rightward-shifted the voltage for half-maximal activation by ~33 mV, back towards 
the less calcium sensitive insertless ZERO channel phenotype. Therefore, it would 
appear that palmitoylation is able to regulate channel activity perhaps mediating the 
increased calcium sensitivity of the STREX channel over the ZERO channel. This 
suggests that the properties associated with STREX may be controlled by dynamic 
post-translational modification through palmitoylation of the STREX domain. 
Whether palmitoylation per se controls the changes in channel properties directly 
through the voltage or calcium sensor or whether the RCK1-RCK2 interaction with 
the plasma membrane mediates a shift in channel properties through a 
conformational change in the gating domain, is unknown.  
In additional experiments following on from this work it was demonstrated that 
inhibition of palmitoylation by 2-BP also rightward-shifted the voltage for half-
maximal activation of the STREX channel by ~15 mV (see appendix #1; (Tian et al., 
2008a)). The smaller shift in channel activity in comparison to that seen in the 
cysteine mutant channel could possibly be due to channels that are still 
palmitoylated, although the right-ward shift is consistent with a role for palmitoylation 
in contributing to STREX channel’s increased calcium sensitivity. 
 
3.3.4 Can STREX structurally interact with the plasma membrane? 
Upon alternative splicing of STREX at splice site C2, the STREX insert is located 
within the RCK1-RCK2 linker of the cytosolic C-terminal domain of the BK channel. 
Crystal structural studies described recently by the Sigworth, MacKinnon and Jiang 
labs have illustrated the RCK1-RCK2 linker as located peripherally to the channel’s 
gating domain (see Figure 1.10)(Wang & Sigworth, 2009; Wu et al., 2010; Yuan et 
al., 2010). Therefore the region appears not to be buried within the globular 
structure of the functioning RCK domains, but would potentially be able to interact 
with different regions of the cell including possibly the plasma membrane.  
Cryo-EM studies examining the BK channel structure in its lipid environment, 
suggest that the distance from the RCK1-RCK2 interface to the plasma membrane 
would be ~5 nm (see Figure 1.8)(Wang & Sigworth, 2009). Recent crystal structural 
analysis examining the tandem RCK domains within each C-terminal subunit of the 
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human BK channel, describe a long unstructured linker connecting RCK1 to RCK2. 
The end boundary of the RCK1 domain (in murine STREX channel) is defined at 
F610, based on the unstructured region in the channel sequence that links the two 
RCK domains (Yuan et al., 2010). This recent crystal structure builds upon 
comparative studies by the same group in 2001 which aligned the BK channel 
sequence to the crystal structure of prokaryotic K+ channels despite low sequence 
homology at less than 20% (Jiang et al., 2001). Studies have identified the boundary 
of the second RCK2 domain using alignment techniques against several bacterial K+
The RCK1-RCK2 linker region is predicted to have no regular secondary structure 
(NORS) (Lee et al., 2009a) so it is difficult to assess firstly, the structure the linker 
may adopt and secondly, what the linear length of the polymer would be. To identify 
whether the STREX domain would be capable of interaction with the plasma 
membrane, simple assumptions can be made to predict the potential length of the 
RCK1-RCK2 linker. 
 
channels and based on some of the preliminary work by Jiang et al, (in murine 
STREX channel) to start at H776 (Yusifov et al., 2008) which was confirmed by the 
recent BK crystal structure studies (Wu et al., 2010; Yuan et al., 2010). This means 
that the linker between the RCK domains (RCK1-RCK2 linker) is 166 amino acids in 
length (it would be 108 amino acids in length for the insertless ZERO channel 
linker). 
In the literature, a cited value for the average length of an amino acid within a 
polypeptide varies. Estimates examining protein folding and unfolding, cite a contour 
length of ~4 Å per amino acid (Carrion-Vazquez et al., 1999; Ainavarapu et al., 
2007). Using this value and for the purposes of the model assuming the RCK1-
RCK2 linker has very little secondary structure and conforms to a linear string, the 
length would be (166 amino acids x 4 Å) ~64 nm. Of course amino acid chains 
would not be expected to form linear strings and there would probably be some 
structural component within the linker. However, it is wholly feasible using these 
assumptions that the linker could reach the plasma membrane potentially by 
unravelling from whatever structure the linker may have or even if unstructured, it 
may be able to freely move within the cell cytoplasm to reach the plasma membrane 
which is 5 nm from the RCK1-RCK2 interface.  
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Alternatively, if we consider that the plasma membrane of a cell is ~10 nm in 
thickness and requires ~21 amino acids in an α-helical conformation to cross the 
lipid bilayer (Stryer, 1997), then by asking the question of what is the easiest way to 
get to the plasma membrane and back using simple α-helices, less than ~30 amino 
acids (5nm distance = 11 amino acids x2 = 22) is all that would be required. 
Although we do not know how the RCK1-RCK2 linker folds, it realistically could 
reach across the relatively small 5 nm distance to interact with the plasma 
membrane (Figure 3.11).  
Whether palmitoylation targets this region to the plasma membrane, or whether 
palmitoylation occurs at the plasma membrane, whereby the region may have been 
targeted through some other mechanism was examined in a follow up study recently 
published from our lab (Tian et al., 2010). In the study we were able to identify the 
enzymes responsible (DHHC’s) for palmitoylating the STREX palmitoylation site. 
The DHHC’s involved were mostly thought to be localised in the Golgi/ER (see 
appendix #3; (Tian et al., 2010)) and despite one of the DHHC’s involved being a 
membrane bound enzyme, it is possible that the STREX domain could be 
palmitoylated in the Golgi before export to the plasma membrane whereby the 
palmitoylated STREX RCK1-RCK2 linker can then target the plasma membrane. 
This proposes that palmitoylation itself may act as a membrane targeting signal. 
It is also unknown in the full length functional channel, in its native environment, 
whether the C-terminus would actually interact with the plasma membrane. A 
feasible experiment to test this could involve a protease digestion site at the S6-
RCK1 linker whereby the C-terminal, fluorescently tagged, could be removed from 
the transmembrane core and then examined for stable cell surface expression. 
 
Together, the data in this chapter suggests that the STREX domain can interact with 
the plasma membrane to contribute to the altered features inherent to the STREX 
channel. Future experiments could focus on the properties of membrane binding 
through palmitoylation by examining binding of recombinant proteins to liposomes.
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Figure 3.11
Model of RCK1-RCK2 linker interaction with the plasma membrane through the 
STREX domain
Figure 3.11. Model of RCK1-RCK2 linker interaction with the plasma membrane 
through the STREX domain. Model illustrating how palmitoylation may anchor the 
STREX domain at the plasma membrane. Distances of plasma membrane and 
distance from RCK1-RCK2 interface to the plasma membrane are shown (not to 
scale). The RCK1-RCK2 linker is 166 amino acids in length, predictions suggest a 
minimum of 30 amino acids are required to reach the plasma membrane and back 
using a simple structure. Palmitate residues that insert into the lipid membrane are 
illustrated in red at the dual cysteine C645-C646 palmitoylation site. The phosphoryla-




















3.3.5 Phosphorylation decreases membrane stability 
BK channels are differentially regulated by PKA mediated phosphorylation that leads 
to activation in ZERO channels, and inhibition in STREX channels. PKA regulation 
of channel inhibition in STREX channels was also found to conform to a single 
subunit rule (Tian et al., 2004). It is probable that the opposing inhibitory effects 
described with PKA phosphorylation in STREX are the result of major 
conformational rearrangements in the C-terminus of the BK channel. It has been 
shown that palmitoylation of STREX mediates membrane targeting and therefore 
this could be a mechanism whereby phosphorylation of a single subunit could result 
in channel inhibition by destabilisation of the STREX domain.  
The STREX phosphorylation site is just 9 amino acids upstream from the 
C645:C646 palmitoylation site in STREX. Mutation of S636 to a phosphomimetic 
(glutamic acid - E) residue in fluorescently tagged STREX C-terminal constructs 
resulted in a decreased membrane association of STREX by ~96%. Substitution 
with a neutral (alanine – A) residue at S636 also decreased membrane association 
of the C-terminal STREX construct by ~83%, suggesting that this area may be 
functionally important in regulating how the STREX domain interacts with the 
plasma membrane or it may be structurally important for stability of STREX at the 
plasma membrane. Using cAMP, to activate PKA-dependant phosphorylation of C-
terminal STREX constructs already at the plasma membrane, also decreased 
association by ~62%. This effect could not be mimicked by PKG or PKC analogues 
or protein phosphatase inhibitors, but importantly was blocked by a PKA inhibitor, 
H89.  
These studies using site directed mutagenesis to disrupt the STREX PKA-
phosphorylation site do not reveal the mechanism underlying phosphorylation and 
membrane association of the STREX domain. Additionally we do not understand the 
cycles of phosphorylation or dephosphorylation that may be involved in regulating 
channel trafficking and recycling from the membrane. Nor do we understand how 
phosphorylation may regulate palmitoylation at the site just immediately 
downstream, that is if palmitoylation is the key regulator of membrane association of 
the STREX domain. However, the data suggests that PKA-dependant 
phosphorylation in STREX can regulate destabilisation of the membrane association 
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of the STREX domain. Interestingly, the STREX phosphorylation site is located in a 
region of basic charge, the introduction of a strongly negative charge as a result of 
palmitoylation may be significant in disrupting the basic environment just upstream 
from the palmitoylation site. Basic domains as seen in STREX, have been shown to 
be important for palmitoylation, for example in G-protein signalling the Gα
The role of the basic domain and whether phosphorylation could potentially control 
membrane stability and palmitoylation within STREX will be discussed further in 
chapter 4. 
 subunit 
associates with the plasma membrane through palmitoylation. However, disruption 
of a region of basic residues close to the palmitoylation site decreases membrane 
association and abolishes palmitoylation of the protein (Crouthamel et al., 2008). 
Therefore, one of the major questions is whether this basic domain is important for 
palmitoylation or stability of STREX at the plasma membrane and does 
phosphorylation regulate this?  
 
3.3.6 How could membrane targeting of the RCK1-RCK2 change the 
properties of the BK channel 
A study examining the length of the RCK1-RCK2 linker suggests that the length 
rather than amino acid composition is more important in conferring mechanical 
constraints on the BK channel’s gating domain (Lee et al., 2009a). They suggest 
that changing the length of the linker could affect channel activity by increasing the 
strain on the gating machinery or by altering the dynamics of the interface between 
the RCK domains. If the RCK1-RCK2 linker were to act almost like a spring that 
could influence the gating domain of the channel, it is conceivable that STREX could 
induce a conformational change in the RCK1-RCK2 linker that might alter the 
interface between the RCK domains. In the crystal structure of the C-terminal 
domain, the calcium binding site is proposed to be located on the RCK assembly 
interface (Yuan et al., 2010) which is different to the much studied MthK channel 
where calcium binds on the flexible interface (see Figure 1.11). Therefore if 
structural changes or changes in tension are able to influence the assembly 
interface between the RCK domains where calcium binds in the BK channel, then 
these changes conceivably could also alter calcium binding or calcium affinity and 
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therefore change the characteristics of the insertless ZERO BK channel to those 
inherent to the STREX BK channel. If the RCK1-RCK2 linker is capable of 
interacting with the plasma membrane through the STREX domain, then it would 
certainly support the theory that STREX can mediate stretch sensitivity by 
modulating BK channel activity through interaction with the plasma membrane 
(Naruse et al., 2009).  
 
3.3.7 Challenges for the future 
Challenges for the future will be to examine (i) the functional relevance of 
palmitoylation in native cells (ii) what controls palmitoylation within the cell (iii) What 
palmitoyl acyl transferases (PATs) and or pamitoyl protein thioesterases (PPTs) are 
involved in controlling palmitoylation of the channel (iv) and how do the PATs and 
PPTs regulate the channel (v) could palmitoylation regulate other properties in the 
channel for example protein interaction of specific membrane targeting to specialist 
regions (vi) is the basic domain near to the palmitoylation site important – this will be 
addressed in chaper 4 (vii) are their additional palmitoylation sites in the BK channel 
– this will be addressed in chapter 5 (viii) were does palmitoylation of STREX occur 
and is this specific – partly addressed in (appendix #3; (Tian et al., 2010)) (ix) do 
extracellular signals regulate palmitoylation of STREX? 
 
 
3.3.8 In Summary 
This data reveals that the STREX splice variant of the BK channel is regulated by 
palmitoylation, controlling membrane targeting of the STREX domain. Palmitoylation 
and membrane targeting of the RCK1-RCK2 linker may be the mechanism 
responsible for the increased calcium sensitivity associated with STREX channels 
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The POLYBASIC DOMAIN 









4.1 Chapter 4 introduction 
 
4.1.1 Polybasic domains 
Palmitoylation sites appear to have no canonical consensus sequence that can 
identify a target cysteine residue(s) within a protein. Target cysteines are usually 
located near to transmembrane domains where they are able to interact with the 
plasma membrane (Bijlmakers & Marsh, 2003; Dietrich & Ungermann, 2004) or in 
intracellular domains close to additional membrane targeting sequences. Regions of 
basic charge or adjacent lipid anchors (Bijlmakers & Marsh, 2003; Dietrich & 
Ungermann, 2004) are often identified in the vicinity of palmitoylated cysteine 
residues located in intracellular domains.  
In STREX channels, the C645:C646 cysteine residues are palmitoylated within the 
STREX insert located in the C-terminus, as previously discussed (see chapter 3). 
Alternative splicing of the 58 amino acid STREX insert also introduces a series of 
basic charges to a region just upstream of the C645:C646 palmitoylation site. This 
region incorporates 11 basic amino acid residues out of a total of 21 amino acids in 
close proximity to the STREX channel palmitoylation site. It is possible that this 
series of basic residues upon splice insertion of STREX may form a functional 
polybasic domain (Figure 4.1). 
Polybasic domains are clusters of basic residues in proteins that can function as 
membrane targeting signals (Heo et al., 2006). They enhance a protein’s affinity for 
the negatively charged inner leaflet of the plasma membrane through an 
electrostatic mechanism whereby basic residues interact with acidic lipids. Indeed, it 
is well established that many proteins require non-specific electrostatic interactions 
for their activity and regulation (Mulgrew-Nesbitt et al., 2006). However, generally 
simple electrostatics are not enough to strongly associate proteins at the plasma 
membrane (Mulgrew-Nesbitt et al., 2006) and therefore many basic domains 
function in conjunction with additional hydrophobic regions within the same region of 
the protein (Ben-Tal et al., 1996). Polybasic domains are also considered to 
influence palmitoylation of peripheral proteins in stabilising membrane localisation, 




Sequence alignment of basic residues in the intracellular C-terminus of the 
STREX channel
A








Figure 4.1. Sequence alignment of basic residues in the intracellular C-terminus of the 
STREX channel.  (A) Schematic illustrating the topology of the BK channel pore form-
ing α-subunit. Splicing of the STREX insert is at splice site C2 within the RCK1-RCK2 
linker region, in the intracellular C-terminus. (B) Inclusion of STREX introduces a 
series of basic residues (+) (basic charge conservation highlighted by grey box) that 
form a putative polybasic domain (indicated by labelled black line). Sequence align-
ment of the region preceding and including the STREX insert (indicated by labelled 
black line) illustrates the highly conserved positively charged residues in the polybasic 
domain across vertebrates and the palmitoylated cysteine residues in STREX 
(indicated by black box outline). S636 PKA-phosphorylation site in STREX is indicated 
in yellow. Channel sequence of the mouse is numbered from MDALI start site 
(accession number NM_010610) and illustrated beginning at cysteine residue 612.
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The lipid membrane carries an appreciable negative charge in comparison to other 
intracellular membranes which have less charge (Stryer, 1997). Hence, polybasic 
clusters generally bind to the plasma membrane through non-specific electrostatic 
interactions, although there is evidence that they may also specifically sequester 
phosphoinositides that have greater negative valences (McLaughlin et al., 2002; 
Mulgrew-Nesbitt et al., 2006). The local environment around a palmitoylation site in 
many proteins appears to be important (Crouthamel et al., 2008) and therefore the 
question is whether this basic region might function as a polybasic domain that may 
influence membrane association or regulate the palmitoylation status of the 
C645:C646 site in STREX. 
Preliminary screening of the STREX channel using an algorithm to examine basic 
regions that may potentially interact with the plasma membrane (Brzeska et al., 
2010), identified the polybasic domain just upstream of the STREX palmitoylation 
site as a possible plasma membrane targeting motif (Figure 4.2).  
 
4.1.2 What would the functional role of a polybasic domain be in the STREX 
channel? 
Polybasic domains play a dual role in facilitating targeting and stabilization of 
lipidated regions of proteins to the plasma membrane. Disruption of these polybasic 
domains in regions with lipid modifications can often decrease membrane 
association of the protein (Crouthamel et al., 2008).  
In the previous chapter it was identified that phosphorylation within the STREX 
insert at serine-S636, could influence membrane association of the STREX C-
terminus. Phosphorylation at this serine has been previously identified as being 
important in mediating the STREX channel’s inhibitory effect on channel activity 
mediated by PKA phosphorylation (Tian et al., 2004). Using a site directed 
mutagenesis strategy, the introduction of a phosphomimetic residue with a 
negatively charged side chain (glutamic acid) appeared to decrease membrane 
association of the STREX C-terminus despite the region presumably still being 
capable of palmitoylation at the C645:C646 site. A reduced membrane association 
of the STREX C-terminus was also induced using a cAMP analogue to establish the 
effect of PKA phosphorylation. The presence of basic charges in the vicinity of the 
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phosphorylation site was postulated to be significant in exerting this effect (see 
section 3.3.6). It is possible that this basic region may have a potential role as a 
putative polybasic domain. The serine phosphorylation site, S636, is located in the 
mid-point of the identified polybasic domain (Figure 4.1) and phosphorylation would 
presumably introduce a strong negative charge that would disrupt the basic charge 
of this region. Therefore, it is important to establish the role of the polybasic domain 
in membrane targeting through palmitoylation of the STREX C-terminus and what 
the mechanism is that mediates membrane dissociation by PKA phosphorylation. 
 
4.1.3 Working Hypothesis 
In this chapter, the hypothesis that splicing of the STREX insert introduces a 
functional polybasic domain that may control the ability of palmitoylation to anchor 
STREX at the plasma membrane will be tested. 
 
4.1.4 Aims to be addressed in this chapter 
4.1.4.1 Is the polybasic domain a functional membrane association domain? 
In order to examine whether the polybasic domain identified just upstream of the 
STREX palmitoylation site is functional in controlling membrane association, firstly a 
basic-hydrophobic prediction algorithm was used to identify whether the putative 
polybasic domain was indicative of a membrane association domain. Secondly, by 
deliberately disrupting the polybasic domain, neutralising positive charges in the 
region with neutral amino acids or negatively charged amino acids for maximum 
disruption by site directed mutagenesis, membrane association of fluorescently 
tagged STREX C-terminal constructs was assessed by an imaging strategy.  
 
4.1.4.2 Does the polybasic domain influence channel properties? 
To examine the functional significance of the polybasic domain, mutated residues 
within the polybasic domain were screened in full length channels using a 
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membrane potential assay that can discriminate different channel phenotypes based 
on activation driven by calcium. Polybasic mutant channels were then examined 
more closely by electrophysiological patch clamp techniques to determine the 
calcium- and voltage- sensitivity of the mutant channels and isolate the differing 
kinetics in relation to the wild-type STREX channel.  
 
4.1.4.3 How is palmitoylation of the STREX C-terminal influenced by the   
polybasic domain?  
To determine whether disruption of the polybasic domain only affects membrane 
targeting of the STREX C-terminus or whether disruption of the local environment 
around the palmitoylation site may affect the palmitoylation status within STREX, 
incorporation of radiolabelled 3
 
H-palmitate into STREX C-terminal channel proteins 
was examined to identify palmitoylation at the C645:C646 site when the overall 
basic charge of the polybasic domain is disrupted.  
4.1.4.4 Does phosphorylation regulate the function of the polybasic domain? 
To examine whether phosphorylation may function as a physiological switch to 
control the overall basic charge of the polybasic domain, the PKA phosphorylation 
site was mutated in the STREX C-terminal constructs and examined to identify 
radiolabelled 3
 
H-palmitate incorporation to determine whether the palmitoylation of 
the C645:C646 site is modified. 
4.1.4.5 What does the polybasic domain interact with? 
Finally, to assess whether the polybasic domain has a specific lipid-binding partner 
such as PI(4,5)P2 in the plasma membrane or whether binding is non-specific, full 
length STREX channels were examined electrophysiologically to assess the effect 
of depletion of phosphoinositides on channel activity in accordance with 





4.2.1 The polybasic domain is an evolutionary conserved region 
Sequence alignment of the series of basic charged amino acids that make up the 
putative polybasic domain identified in the region upstream of the C645:C646 
palmitoylation site in STREX, suggests that these basic residues are largely 
evolutionary conserved across the vertebrate phyla (Figure 4.1B). Alternative 
splicing of the STREX insert at splice site C2, bring an additional 5 basic charges to 
a region immediately upstream that already contains 6 basic residues. This 
generates a series of 11 basic amino acid residues out of 21 (K623 – R642) in close 
proximity to form a cluster that could operate as a functional polybasic domain. In 
this polybasic domain evolutionary retention across vertebrates appears to favour 
conservation of basic charge rather than the specific amino acid, which is apparent 
when examining the alignment of the Murinae (mice and rat) amino acid sequence 
against all other vertebrates. The basic arginine residue (R631) in the Murinae 
genome is substituted for a basic Lysine (K) residue in the same position across 
other vertebrates. Therefore it would seem that the charged nature of this region, 
and not necessarily the amino acid sequence, may be of significant functional 
importance. 
 
4.2.2 Basic-Hydrophobicity analysis suggests that the polybasic domain 
could potentially interact with the plasma membrane 
To determine whether the polybasic domain identified in the C-terminus of the 
STREX splice variant of the BK channel would be able to function independently as 
a membrane interaction domain, a computer algorithm (Brzeska et al., 2010) that 
utilises basic and hydrophobic parameters was used to calculate potential 
membrane interaction sites within the C-terminus. 
Hydrophobicity scales are useful for determining regions of proteins that may 
penetrate into the plasma membrane, however many do not take into account the 
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effect of basic residues and their electrostatic interaction with negatively charged 
regions of the plasma membrane. A Basic Hydrophobicity (BH)-scale algorithm 
recently developed (Brzeska et al., 2010) identifies potential membrane binding sites 
in less structured regions of proteins. It takes into account the role of a hydrophilic 
basic residue’s electrostatic interaction with the negatively charged plasma 
membrane, as well as the significance of hydrophobic residues in membrane 
attachment. Using a scoring system, the program averages values in a previously 
determined and newly adapted Wimley and White hydrophobicity scale (Wimley & 
White, 1996) called the Basic Hydrophobicity (BH) scale.  Each amino acid in a 
segment of a selected length, called the window size, is scored according to the 
scale and a value given to the amino acid in the middle of the window. To 
discriminate between segments from soluble proteins and membrane spanning 
sequences, a window length of 19 was determined to best identify membrane-
spanning sequences. It was proposed that a larger window length of 19 was more 
suitable because protein-spanning sequences passing through the interior of the 
protein are usually shorter than membrane spanning sequences (Kyte & Doolittle, 
1982). A threshold value of 0.6 (dashed line) (Figure 4.2) was identified as the 
optimal parameter for identifying lipid-binding sites in proteins (Brzeska et al., 2010).  
The mouse STREX splice variant of the BK channel sequence (accession number 
NM_010610) spanning the intracellular C-terminus from the end of the S6 
transmembrane domain (beginning at glycine residue 328, ..GNRKK..) to the end of 
the intracellular carboxyl tail (ending at cysteine residue 1226, ..VEDEC), was 
examined using the BH algorithm. Inputting the STREX C-terminus channel 
sequence (S6:STREX), the identified polybasic domain exceeded the probability 
threshold of 0.6 for a potential membrane interaction site, with maximum values 
recorded between residues 626-646 (Figure 4.2A) with a peak score of 1.05. The 
STREX insert is highlighted by a grey box in all respective algorithm plots illustrated 
in Figure 4.2. The insertless ZERO channel C-terminus sequence (S6:ZERO) that 
does not have the 58 amino acid STREX insert at splice site C2 and was previously 
shown not to associate with the plasma membrane in an imaging assay (see 
chapter 3, Figure 3.2) did not exceed the threshold for interaction with the plasma 
membrane despite 6 remaining basic residues (Figure 4.2D). This suggests that 
according to the algorithm, inclusion of the STREX insert is crucial for association of
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Figure 4.2 
Basic Hydrophobicity profiles of the STREX C-terminus with mutations in the 
putative polybasic domain
Figure 4.2. Basic Hydrophobicity profiles of the STREX C-terminus with mutations in 
the putative polybasic domain. (A) The C-terminus of the BK channel containing a 
STREX insert (indicated by grey box) contains a predicted membrane binding site in 
the identified polybasic domain (peak residues 633-635). (B) Mutation of positive 
residues to negative in the region immediately upstream of STREX (K627E:R631E). 
(C) Mutation of positive residues to negative in the region inside the STREX insert 
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this region with the plasma membrane via a polybasic domain and that greater than 
6 basic residues are required to generate a region with a strong enough membrane 
binding energy to form a functional polybasic domain. By disrupting the polybasic 
domain, the importance of a series of basic residues for plasma membrane 
interaction was assessed using a site-directed mutagenesis strategy. Firstly, to 
neutralise the influence of positive charge in the polybasic domain, a neutral alanine 
(A) amino acid residue was substituted for basic residues in two independent 
regions of the polybasic domain inside and outside of the STREX insert. Secondly, 
to maximally disrupt the influence of the polybasic domain, negatively charged 
glutamic acid (E) amino acid residues were substituted for basic residues in the 
same two independent regions of the polybasic domain. 
Mutation of the polybasic domain followed a two-fold approach firstly, targeting the 
basic region immediately upstream of the STREX insert by identifying K627 and 
R631 as potential key residues close to the centre of this region that would disrupt 
the polybasic domain and then secondly, targeting the downstream basic region 
inside STREX, identifying R640 and R642 as potential key residues that would 
disrupt the centre of this region of basic charge and therefore the influence the role 
of the polybasic domain.  
Disruption of the polybasic domain by inserting negatively charged glutamic acid (E) 
residues at K627E:R631E, immediately upstream of the STREX insert (Figure 4.2B) 
and at R640E:R642E, within the STREX insert (Figure 4.2C) decreased the BH 
probability score for potential plasma membrane interaction to 0.63 and 0.84 
respectively. Neutralising basic residues in the polybasic domain did not have such 
a profound influence on disrupting membrane interaction (probability score: 
K627A:R631A 0.82, R640A:R642A 0.91), suggesting that substitution with negative 
residues has the most significant effect in disrupting the ability of the polybasic 
domain to associate with the plasma membrane. 
The palmitoylation deficient C-terminus of the STREX channel (C645A:C646A) 
which has previously been shown to decrease targeting of the C-terminus to the 
plasma membrane (see chapter 3, Figure 3.2), did not affect the BH probability 
score of 1.05 for plasma membrane interaction seen with the wild-type STREX 
channel C-terminal sequence (data not shown). 
126
This data suggests that the polybasic domain may act independently of 
palmitoylation as a plasma membrane targeting motif through a conserved series of 
basic charges.  
 
4.2.3 The polybasic domain is important for associating the STREX C-
terminus at the plasma membrane 
Previously, the STREX insert was identified as a plasma membrane targeting 
domain for the C-terminus of the BK channel (see chapter 3). Identification and 
removal of a key palmitoylation motif in the STREX insert, abolished membrane 
targeting of fluorescently labelled STREX C-terminal fusion proteins (Figure 3.2). 
Considering that the polybasic domain may be able to act independently of 
palmitoylation to associate with the plasma membrane, the role of the polybasic 
domain in membrane association was examined using a similar imaging strategy 
(Figure 4.3).  
Fluorescently labelled STREX C-terminal constructs were developed as previously 
described (see section 2.1.1 & Figure 2.1) using the carboxyl terminus without N-
terminal or transmembrane domains of the BK α-subunit and attaching a green 
fluorescent protein tag to the carboxyl end of the fusion protein (Figure 4.3A). 
Expression of the STREX C-terminus construct (S6:STREX) resulted in robust 
plasma membrane expression (Figure 4.3B, upper left panel), with 60% of cells 
transfected showing fluorescence at the plasma membrane in the absence of 
transmembrane segments (n=650 cells counted) in HEK293 cells. Total plasma 
membrane expression in S6:STREX was normalised to 100% allowing comparison 
of mutated constructs to STREX (Figure 4.3C). The S6:STREX construct also 
showed strong expression in the nucleus with 91% of cells transfected also showing 
nuclear localisation.  
Using site directed mutagenesis to neutralise or disrupt the function of the polybasic 
domain, the affect on localisation at the plasma membrane could be examined. 
Mutation of the basic region immediately upstream of the STREX insert to neutral 
alanine (A) residues (K627A:R631A) and negative glutamic acid (E) residues 
(K627E:R631E), abolished membrane targeting to 26.5% and 6.3% respectively (n= 




The polybasic domain is important for targeting of the STREX C-terminus to 
the plasma membrane 
A
Figure 4.3. The polybasic domain is important for targeting of the STREX C-terminus 
to the plasma membrane. (A) Schematic of C-terminal -GFP fusion construct with 
mutation sites indicated relative to STREX. (B) Representative single cell confocal 
images of C-terminal STREX (S6:STREX) and C-terminal STREX polybasic mutants 
K627A:R631A, K627E:R631E, R640A:R642A and R640E:R642E, expressed in 
HEK293 cells. (Scale bars: 10 µM). (C) Summary bar graph of the respective 
C-terminal construct localization at the plasma membrane expressed as a percentage 
of S6:STREX (where STREX is 100%). *** p<0.001 compared with STREX (ANOVA 















































































appearing to be targeted to the nucleus (99% and 100% respectively).  Mutation of 
the basic region inside the STREX insert to negative glutamic acid (E) residues 
(R640E:R642E), also abolished membrane targeting to 3.3%, with targeting directly 
to the nucleus (100%) (n= 1031 cells counted). Surprisingly, when the same 
approach was taken to neutralise the basic region inside the STREX insert with 
alanine (A) residues (R640A:R642A) fluorescence at the plasma membrane actually 
increased to 160% when compared to S6:STREX (n=760 cells counted) (Figure 
4.3C). Nuclear localisation was also almost totally abolished in the (R640A:R642A) 
mutant, with only 11.5% of cells showing fluorescence in the nucleus compared to 
91% in the S6:STREX control construct. 
 
4.2.4 The polybasic domain is functionally important to the STREX channel 
The functional effect of disruption of the polybasic domain in the normal full length 
STREX channel was first examined using a membrane potential assay (Saleem et 
al., 2009). As before, mutated channels were transiently transfected into HEK293 
cells and seeded into 96 well assay plates. The FLIPR-blue dye (Molecular Devices) 
was administered to the cells to allow the dye to load into the cell membrane. The 
assay was then run in the Flexstation ® II during which cells were stimulated by 1 
µM Ionomycin, a calcium ionophore, to activate the BK channel. Changes in 
fluorescence were then measured over a time course of 180 seconds. 
Using the full length STREX channel as a control response, the peak 
hyperpolarisation was taken at t=100s and these values could then be expressed as 
the isolated channel current by subtracting the control HEK response from the 
transiently transfected channel response within the assay plate and then normalised 
to 100%. All polybasic mutants could then be compared to the STREX channel 
phenotype (Figure 4.4). A representative trace illustrates the raw data for the 
different channel responses to activation driven by calcium influx in the polybasic 
mutant channels with respect to the STREX channel response and the un-
transfected HEK293 response (Figure 4.4A). Disruption of the polybasic domain by 
introducing negatively charged amino acids to both previously identified basic 
regions (K627E:R631E & R640E:R642E) significantly attenuated channel activation 




STREX channel activation driven by calcium influx is diminished when the 
polybasic domain is disrupted
A
Figure 4.4. STREX channel activation driven by calcium influx is diminished when the 
polybasic domain is disrupted. (A) Representative time course plots of mean change 
in relative fluorescence units (RFU) of the FLIPR-blue membrane potential dye in 
HEK293 cells expressing STREX (closed circles,     ),  K627E:R631E (upright trian-
gles,   ),  R640E:R642E (inverted triangles,   ), and mock-transfected HEK293 (open 
circles,    ),  in response to calcium influx induced by 1 µM Ionomycin. (B) Summary 
bar chart of the membrane potential change for each construct expressed as a 
percentage of the maximal hyperpolarisation with the untransfected HEK293 
response subtracted and STREX expressed as 100%. Data was determined at the 
maximum hyperpolarising response in BK-STREX (t=100s) in the time course plots in 
(A). All data are Means ± S.E.M (N=4, n=48), * p<0.05, ** p<0.01, compared to STREX 
(ANOVA with tukey post hoc test).

































































STREX (Figure 4.4B). This data suggests that the channel’s sensitivity to increased 
intracellular calcium has significantly decreased in polybasic mutant channels. 
Mutation of the polybasic domain by substituting neutral alanine (A) residues for 
basic charge did not have any statistically significant effect on the ionomycin- 
induced hyperpolarising response of the channel (K627A:R631A, 94.2 ± 2.8 and 
R640A:R642A, 106.1 ± 3.9, n = >25) (Figure 4.4B). 
 
4.2.5 Single channel amplitude does not mediate changes in channel activity 
with mutation of the polybasic domain 
The membrane potential assay described in the previous section, examines the 
general ionomycin-induced hyperpolarising responses of the BK channel and 
various mutants by driving activation of the channel in a well of transfected HEK293 
cells. However, the assay cannot discriminate between the calcium- or voltage- 
sensitivity of the channel, nor can it assess changes in single channel amplitude and 
it cannot indicate changes in cell surface expression of functional channels at the 
plasma membrane. Therefore, to investigate the properties of the mutant channels 
that may mediate the altered sensitivities described in the membrane potential 
assay, it was necessary to examine isolated channels electrophysiologically. 
To determine the single channel amplitude of STREX and investigate whether a 
decrease in single channel amplitude might mediate the decreased sensitivity of the 
polybasic mutants as described in the membrane potential assay, measurements 
were made at a range of voltage potentials (-80 mV to +80 mV) in equimolar (140 
mM) potassium gradients. Channels were examined at 0.33 µM [Ca2+] in excised 
inside-out patches (Figure 4.5). The slope conductance of the STREX channel was 
244 +/- 4.4 pS. There was no significant difference in single channel slope 
conductance across the polybasic mutants in comparison to STREX under these 
recording conditions (Figure 4.5A). Mean single channel amplitude under the same 
conditions and examined at +40 mV (Figure 4.5B) was as follows; STREX 10.4 ± 
0.2, K627A:R631A 10.1 ± 0.34, K627E:R631E 9.9 ± 0.3, R640A:R642A 10.3 ± 0.2, 
& R640E:R642E 10.9 ± 0.03 (n=3). This suggests that changes in the sensitivity of 
the polybasic mutant channels described in the membrane potential assay are not 
mediated by changes in single channel amplitude. 
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Figure 4.5
Single channel amplitude is not affected by disruption of polybasic domain 
A
Figure 4.5. Single channel amplitude is not affected by disruption of polybasic domain. 
(A) Current voltage plot for STREX channels and STREX channels with mutations in 
the polybasic domain. Recordings were made in excised inside-out patches in equi-
molar 140 mM K+ gradients, 0.33 µM free Ca2+ and at +40 mV. STREX (closed circles, 
�), K627A:R631A (squares, � ), K627E:R631E (upright triangles,    ), R640A:R642A 
(diamonds,    ), and R640:R642 E (inverted triangles,    ) (N=3) Single channel 
conductance was derived from the slope of the line.(B) Representative single channel 
recordings of excised inside-out patches recorded in same conditions as before and 

















4.2.6 STREX channel activity can be modulated by the polybasic domain 
To investigate if disruption of the polybasic domain might have an effect on channel 
activity, macroscopic BK currents were recorded in equimolar potassium gradients 
by inside-out patch clamp analysis (Figure 4.6). Representative currents illustrate 
the typical outward component of the BK response to a depolarising voltage step 
protocol (-120 to +120 mV) from a holding potential of -80 mV (Figure 4.6A).  
Activation (G/GMAX) curves, as before, were obtained by plotting tail current 
amplitude against test potential and fitting to a Boltzmann equation allowing 
determination of the voltage for half activation (V0.5MAX)(Figure 4.6B). Previous 
functional studies of the STREX splice variant of the BK channel have demonstrated 
a dramatic shift in the apparent calcium sensitivity of the STREX channel compared 
to the insertless ZERO variant (Saito et al., 1997; Shipston et al., 1999; Chen et al., 
2005). The STREX channel is more calcium sensitive over a range of 0 to 1.0 µM 
Ca2+ whereby beyond 1 µM Ca2+ it becomes difficult to distinguish the sensitivity of 
STREX from ZERO, as the calcium binding sites in the channel become saturated 
(Chen et al., 2005). All further analysis of the STREX channel and the polybasic 
mutants were therefore carried out in 0.33 µM Ca2+
Measurement of channel activity in 0.33 µM Ca
 where the apparent calcium 
sensitivity is much greater than the insertless ZERO channel.  
2+ meant that mutational disruption of 
the polybasic domain could be directly compared to wild type STREX channel 
activity. The half maximal voltage for activation of normalised (G/GMAX
Mutation of the basic region with negative residues immediately upstream of the 
STREX insert to disrupt the polybasic domain (K627E:R631E), caused a significant 
(~ +30 mV) rightward shift in the half maximal voltage for activation of the channel to 
71.9 ± 7.8 mV, with channels beginning to activate at -20 mV. Substitution of neutral 
residues in this region (K627A:R631A) had no significant effect, (54.3 ± 10.5), 
although there was a trend to a rightward shift in channel activity (see Figure 4.6B & 
C), perhaps suggesting that neutral substitution of basic residues may not fully 
disrupt the polybasic domain but may begin to decrease the influence of the charged 
domain.  Disruption of the downstream basic region inside STREX with negative
) curves was 
determined for each polybasic mutant in relation to STREX (Figure 4.6C). The 
voltage for half activation of the STREX channel was 40.6 ± 2.5 mV (n=8).  
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Figure 4.6
Disruption of the polybasic domain shifts the activation of STREX channels
Figure 4.6. Disruption of the polybasic domain shifts the activation of STREX chan-
nels. (A) Representative traces showing outward currents at depolarized potentials 
from HEK293 cells expressing STREX (closed circles,  �), K627A:R631A (squares,   
� ), K627E:R631E (upright triangles,  ), R640A:R642A (diamonds,   ) and 
R640E:R642E (inverted triangles,    ) from excised inside-out patch recordings in equi-
molar (140 mM) K+ gradients and 0.33 µM free Ca2+. Outward currents were elicited 
by 100 ms depolarising voltage steps from -120 to +120 mV in 20 mV increments from 
a holding potential of -80 mV. (Scale bars: 1 nA / 25 ms) (B) G/GMAX conductance 
curves showing STREX channel activity over a range of voltage potentials and 
variants with mutations in the polybasic domain.  (C) Summary bar graph showing 
V0.5MAX of the STREX channel and each polybasic mutant expressed in HEK293 cells. 
All data are Means ± S.E.M (n=3-7), ** p<0.01, compared to STREX (ANOVA with 
































residues (R640E:R642E), did not have a significant functional effect on half maximal 
voltage for activation, (56.4 ± 3.4  mV). Again this was an intermediate rightward 
shift (of ~ +16 mV) between STREX and the K627E:R631E channel mutant 
suggesting that perhaps only partial disruption of the polybasic domain occurs by 
mutating this downstream region of the polybasic domain (Figure 4.6B & C). 
Interestingly, mutation of the same downstream basic region inside STREX with 
neutral alanine (A) residues, (R640A:R642A), caused a large leftward shift (of ~ -35 
mV) in the channel activation, with the channel activating at much more negative 
potentials close to -60 mV. The half maximal voltage for activation of the channel 
R640A:R642A was 4.4 ± 7.1 mV (Figure 4.6B & C), which suggests that the 
mechanism that mediates this effect may be different to mutations made in the 
region immediately upstream of the STREX insert and different to mutation in the 
same region with negatively charged residues.  
 
4.2.7 Voltage dependence is unchanged in polybasic mutant channels  
Disruption of the polybasic domain is functionally significant to channel activity 
(Figure 4.6), but what is not clear is whether the voltage sensitivity has changed or 
whether the calcium sensitivity of the channel has been changed.  
To determine whether the voltage sensitivity of the polybasic mutant channels has 
changed in relation to the wild type STREX channel, a logarithmic transformation to 
linearize the activating component of the normalised (G/GMAX
To further analyse the inherent voltage sensing properties of the polybasic mutant 
channels, the voltage sensing component of channel activation was isolated by 
examining channels in an extracellular solution containing zero calcium (<10 nM 
Ca
) curves in Figure 4.6B 
was plotted against the depolarised potentials of 0 mV to +120 mV (Figure 4.7). 
Disruption of the polybasic domain has little or no effect on voltage dependence of 
the channels when compared to STREX. Therefore, disruption of the polybasic 
domain does not alter the voltage dependence of the mutated polybasic channels.  
2+) (Figure 4.8). As described before, normalised (G/GMAX) curves were 
constructed by measuring tail currents, this time in zero calcium (Figure 4.8A). The 
half maximal voltage for activation of normalised (G/GMAX) curves was again 
determined for each polybasic mutant in relation to STREX (Figure 4.8B). The
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Figure 4.7
The voltage dependence of STREX channel activation is not affected by 
disruption of the polybasic domain
Figure 4.7. The voltage dependence of STREX channel activation is not affected by 
disruption of the polybasic domain. A logarithmic transformation of the G/GMAX activa-
tion curves over depolarised potentials of 0 to +120 mV as described in the macro-
patch recordings in Figure 4.6B. STREX (closed circles, � ), K627A:R631A (squares, 
� ), K627E:R631E (upright triangles,  ), R640A:R642A (diamonds,  ), and 
R640E:R642E (inverted triangles,   ), illustrate that mutation of the polybasic domain 
does not significantly affect the voltage sensitivity of the channels. The voltage 

























STREX channel activity in polybasic mutant channels is not shifted in zero 
calcium
Fig 4.8 STREX channel activity in polybasic mutant channels is not shifted in zero 
calcium. (A) G/GMAX conductance curves of STREX channel activation over a range 
of transmembrane voltage potentials (-120 to +120 mV) from excised inside-out mac-
ropatch recordings in in equimolar (140 mM) K+ gradients and zero calcium (<10 nM) 
and variants with mutations in the polybasic domain.  STREX (closed circles,    ), 
K627A:R631A (squares,    ),  K627E:R631E (upright triangles,    ), R640A:R642A 
(diamonds,   ), and  R640E:R642E (inverted triangles,    ). (C) Summary bar graph 
showing V0.5MAX of the STREX channel and each polybasic mutant expressed in 




















































voltage for half activation of the STREX channel this time was 119.3 ± 5.0 mV. 
However, neutral or negative mutation of the polybasic domain in the region 
upstream of the STREX insert or in the region within the STREX insert had no 
significant effect on the half maximal voltage for activation of the channel. The 
voltage for half maximal activation of the polybasic mutant channels were as follows; 
K627A:R631A, 130 ± 3.7 mV; K627E:R631E, 138 ± 7.5 mV; R640A:R642A, 148.9 ± 
12.0 mV and R640E:R642E, 130.9 ± 3.7 mV. Therefore it is possible to conclude 
that any changes seen in the activity of the polybasic mutant channels in relation to 
wild type STREX must be due to the effects on the calcium sensitive component of 
the STREX splice variant of the BK channel. 
 
4.2.8 Mutation of polybasic domain affects the activation and deactivation 
kinetics of the STREX channel  
It has been previously described that the STREX channel has considerably slower 
deactivating kinetics when compared to the ZERO channel (Chen et al., 2005). In 
0.33 µM Ca2+
The representative macroscopic currents examined previously (Figure 4.6A) 
comparing STREX with channels that had mutations in their polybasic domain, 
demonstrated visible shifts in channel kinetics. To define the activation kinetics of 
the various polybasic mutants, activation curves were best fitted by a single 
exponential function from the beginning of channel activation to the peak plateau 
current. By plotting tau (tau = 1-1/e) the activation kinetics of the channel and 
various mutant channels could be examined (Figure 4.9).  
 it was shown that channel activity was rightward shifted in polybasic 
mutants that had negatively charged residues substituted in the basic region. The 
rightward shift in channel activity is moving towards the ZERO channel phenotype 
and so it is plausible to hypothesize that the activation and deactivation kinetics in 
the polybasic mutants may also shift towards a more ZERO-like channel phenotype, 
therefore this was studied next. 
The STREX channel showed a half activation time constant of 19.6 ± 3.01 ms (n=7) 
at +60 mV in 0.33 µM Ca2+ and equimolar (140 mM) potassium gradients (Figure 
4.9A & C). The only mutant that showed significantly faster activation kinetics than
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Figure 4.9
STREX channel activation rates in polybasic mutants
Figure 4.9. STREX channel activation rates in polybasic mutants. Recordings are from 
excised inside-out patch recordings in equimolar (140 mM) K+ gradients and 0.33 µM 
Ca2+ in HEK293 cells. (A) Data recorded shows a depolarising voltage pulse from a 
holding potential of -80 mV to the indicated voltages in STREX (closed circles, � ), 
K627E:R631E (upright triangles,    ), R640A:R642A (diamonds,   ). (B) A typical exam-
ple of the activating kinetics of STREX (black) and the R640A:R642A (grey) mutant 
upon a voltage pulse to +60 mV and expressed relative to the plateau current as 
100%. (C) Summary bar graph showing the time constant for activation of STREX and 
the mutated polybasic channels. All data are Means ± S.E.M (n=3-7), * p<0.05, com-


























































STREX was R640A:R642A with a time constant of 4.16 ± 0.71 ms (n=3). A 
representative trace shows the activating kinetic of a STREX channel (black) in 
Figure 4.9B, in which the R640A:R642A (grey) mutant is overlain to illustrate the 
differences in activation rates of the two channel constructs. The other polybasic 
mutant channels did not show any statistically significant change in channel 
activation (Figure 4.9C). To define the deactivating kinetics of the various polybasic 
mutants, deactivation curves were fitted in the same way by a standard exponential 
function from the peak tail current to the baseline. By deriving the time constant the 
deactivation kinetics of the channel and various polybasic mutant channels could be 
compared (Figure 4.10). 
The STREX channel showed a tau of 10.22 ± 1.64 ms (n=7) at +120 mV in 0.33 µM 
Ca2+ and equimolar (140 mM) potassium gradients (Figure 4.10A & C). This time the 
K627E:R631E mutant channel which has previously been shown to disrupt the 
polybasic domain causing a significant rightward shift in channel activity and V0.5MAX
It is clear from the evidence presented so far, that the polybasic domain does play a 
functional role in mediating the channel properties that give the STREX splice 
variant of the BK channel its phenotype. Disruption of the polybasic domain with 
negatively charged amino acids thought to oppose the influence of the large basic 
charge inherent to the domain, rightward shifts the activity of the channel back 
towards the insertless ZERO BK channel without affecting single channel amplitude. 
Disruption of the polybasic domain was also shown to increase deactivating kinetics 
of the channel, typical of what would be expected of a channel that behaves more 
like the ZERO channel. However what has been suggested is that these effects are 
most likely to be mediated through a calcium sensitive component of the channel, 
since voltage dependence of activation was unchanged and no differences could be 
seen between the mutant channels in zero calcium. Surprisingly, mutation of the 
basic region inside STREX with neutral residues suggested that the channel was
, 
had a tau value that was significantly faster at 3.9 ± 0.6 ms at +120 mV. A 
representative trace illustrates the different kinetics in deactivation between STREX 
(black) and K627E:R631E (grey), the mutant is overlain to illustrate the difference in 
deactivation rates of the two channel constructs (Figure 4.10B).  The other polybasic 




STREX channel deactivation rates in polybasic mutants
Figure 4.10. STREX channel deactivation rates in polybasic mutants. Tail currents 
were measured from excised inside-out patch recordings in equimolar (140 mM) K+ 
gradients and 0.33 µM Ca2+ in HEK293 cells. (A) Data recorded following 100 ms 
voltage pulses to the indicated voltages and repolarisation to a holding potential of -80 
mV in STREX (closed circles, � ), K627E:R631E (upright triangles,    ), R640A:R642A 
(diamonds, o). (B) A typical example of the deactivating tail current kinetics of STREX 
(black) and the K627E:R631E (grey) mutant channel following a 100ms voltage pulse 
from +120mV to -80mV and expressed relative to the peak tail current as 100%. (C) 
Summary bar graph showing the time constant for deactivation of STREX and the 
mutated polybasic channels. All data are Means ± S.E.M (n=3-7), * p<0.05, compared 

























































activated more than STREX, illustrated by increased activity over the voltage range 
examined and faster activating kinetics. As with the other mutants this was not 
mediated through altered voltage dependence or changes in single channel 
amplitude. 
 
4.2.9 Does the polybasic domain work alone? 
It is interesting to speculate on how the polybasic domain may exert its control on 
the STREX channel. In the previous chapter, palmitoylation was shown to play an 
important role in membrane targeting of the intracellular C-terminus of the STREX 
BK channel. Many palmitoylated proteins have been shown to operate alongside 
other additional signalling mechanisms such as a polybasic domain (Bijlmakers & 
Marsh, 2003; Dietrich & Ungermann, 2004). Therefore, it is important to ascertain 
whether the polybasic domain in STREX does operate independently of the 
palmitoylation motif as suggested by the membrane association prediction algorithm 
(Figure 4.2). Does this polybasic domain act alongside palmitoylation as a 
requirement for stability at the plasma membrane? Or does the polybasic domain 
influence the palmitoylation status of the STREX channel? 
Using the CSS-palm algorithm that was used to predict the key cysteine residues 
involved in palmitoylation of the STREX channel, disruption of the polybasic domain 
was examined in relation to predictive scores for palmitoylation of cysteine residues 
in the STREX palmitoylation motif, C645, C646 and C649 (Table 4.1). The algorithm 
predicted that the CSS-palm score for palmitoylation of C645 (the cysteine with the 
highest predicted palmitoylation score in BK) would be very slightly lowered when 
mutations were made in the nearby polybasic domain. STREX 2.48 versus 
K627A:R631A 2.38, K627E:R631E 2.42 and R640E:R640E 2.39 (Table 4.1). 
Interestingly the R640A:R642A mutant that was more active than the STREX 
channel and showed increased presence at the plasma membrane when expressed 
as a C-terminal protein in imaging assays, actually showed an increased probability 
score for palmitoylation at 2.70 (Table 4.1). This analysis suggests that it is possible 
that the polybasic domain may be involved in regulating the palmitoylation status of 
the STREX palmitoylation motif and membrane targeting of the domain. Therefore it 
was important to directly examine the palmitoylation status of the intracellular C-
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Table 4.1
Disruption of the polybasic domain by introduction of negative and neutral 
charges changes predicted palmitoylation scores for the STREX palmitoylation 
site C645:C646
Table 4.1. Disruption of the polybasic domain by introduction of negative and neutral 
charges changes predicted palmitoylation scores for the STREX palmitoylation site 
C645:C646. Scores indicate CSS-palm prediction; a higher score represents higher 
probability. CSS-palm scores were determined with the published CSS-palm v2.0 at 
http://bioinformatics.lcd-ustc.org/css_palm by inputing the protein sequence of the 
entire intracellular C-terminus of the STREX variant of the BK channel (starting at 
glycine residue G328 and spanning until cysteine residue C1226) and then polybasic 
mutant sequences. Negative substitution generally lowers the score however, neutral 
substitution at the R640A:R642A site unexpectantly increases the predicted palmiot-
ylation score.
645 RRACCFD 2.484 
646 RACCFDC 0.571 
649 CFDCGRS 1.083 
 645 RRACCFD 2.422 
646 RACCFDC 0.56 
649 CFDCGRS 0.905 
 645 RRACCFD 2.375 
646 RACCFDC 0.726 
649 CFDCGRS 1.048 
 645 ERACCFD 2.391 
646 RACCFDC 0.167 
649 CFDCGRS 0.429 
 645 ARACCFD 2.703 
646 RACCFDC 0.417 
649 CFDCGRS 0.81 
 







terminus of the channel with mutations in the polybasic domain in order to ascertain 
the role of the polybasic domain in palmitoylation of STREX channels. 
 
4.2.10 The polybasic domain regulates the palmitoylation status of the 
C645:C646 site in the STREX channel 
To address whether disruption of the polybasic domain would affect the 
palmitoylation status of the STREX C-terminus as previously described (see 
Chapter 3), radiolabeled 3H-palmitate incorporation into C-terminus fusion proteins 
were examined in HEK293 cells (Figure 4.11). The representative fluorographs 
show that in the polybasic mutants K627A:R631A, K627E:R631E and 
R640E:R640E, 3H-palmitate incorporation was essentially abolished, suggesting 
that the polybasic domain must play an important role in regulating the 
palmitoylation status of the C645A:C646A palmitoylation motif. Interestingly, the 
R640A:R642A C-terminal mutant showed an increased level of palmitoylation 
suggesting that neutral substitution of basic residues with alanine (A) residues close 
to the identified palmitoylation motif can increase palmitoylation status of the C-
terminal constructs. This finding was very much unexpected however it may explain 
the differences seen with this mutant channel in previous experiments. Western blot 
analysis showed that total protein expression was unchanged in the assays and 
data was quantified by expressing detectable levels of 3
 
H-palmitate over detectable 
levels of protein expression and then comparing to STREX as 100% (n=3). 
Quantification showed that there was a 300% increase in palmitoylation of C-
terminus constructs when the channel was mutated at R640A:R642A and that the 
K627A:R631A mutation could reduce (to 10%) but not abolish palmitoylation of the 
C-terminus constructs.  
4.2.11 Phosphorylation within the polybasic domain destabilises the basic 
region abolishing palmitoylation 
If disruption of the polybasic domain by neutralisation of basic charge or introduction 
of two negatively charged amino acid residues can abolish palmitoylation then it was 





Palmitoylation of STREX is modulated by the polybasic domain
Figure 4.11. Palmitoylation of STREX is modulated by the polybasic domain. (A) Rep-
resentative fluorographs (upper) and western blots (lower) of -HA tagged C-terminal 
S6:STREX-HA, and polybasic mutant C-terminal channels K627A:R631A-HA, 
K627E:R631E-HA, R640A:R642A-HA, R640E:R642E-HA expressed in HEK293 cells. 
Constructs were labelled with 3H-palmitate for 4 hours and immunoprecipitated (IP) by 
using α-HA magnetic microbeads and detected by fluorography. (B) Quantative data 
of detectable levels of palmitoylation expressed as a ratio in comparison to total 
protein expression and relative to S6:STREX as 100%. (N=3) ** p<0.01, compared to 































































































































Palmitate incorporation into S6:STREX is abolished by mutation of PKA phos-
phorylation site S636
Figure 4.12. Palmitate incorporation into S6:STREX is abolished by mutation of PKA 
phophorylation site S636. Representative fluorographs of S6:STREX-HA, phosphomi-
metic S3363E-HA, and phosphonull S363A-HA, expressed in HEK293 cells. Con-
structs were labelled with 3H-palmitate for 4 hours and the respective constructs 
immunoprecipitated (IP) using α-HA magnetic microbeads, subjected to SDS-PAGE 























2 negative charges, within STREX and the middle of the basic domain may also 
have the same affect. In chapter 3, phosphorylation at the PKA phosphorylation site 
within STREX, S636, was shown to disrupt the STREX C-terminal construct’s 
association at the plasma membrane (see Figure 3.9). Therefore radiolabeled 3
 
H-
palmitate incorporation into C-terminal fusion proteins that had phosphonull alanine 
(A) mutations and phosphomimetic glutamic acid (E) mutations at the PKA 
phosphorylation site were examined in HEK293 cells (Figure 4.12). The 
representative fluorographs demonstrate that mutation of the PKA phosphorylation 
site with either a negatively charged glutamic acid amino acid to mimic 
phosphorylation or a neutral amino acid which would remove the phosphorylation 
site, totally abolished palmitoylation in the STREX C-terminus. Whilst introduction of 
a negative glutamic acid residue abolished palmitoylation as would be predicted, 
neutral substitution also had the same effect suggesting that maybe the 
phosphorylation motif is important in the region for effective palmitoylation. 
4.2.12 Does the polybasic domain target PI(4,5)P2
Polybasic domains facilitate interactions with the negatively charged plasma 
membrane through electrostatic interactions. Many proteins such as Src, K-Ras, and 
MARCKS, with basic domains bind non-specifically to the overall negatively charged 
inner leaflet of the plasma membrane that is composed of the charged monovalent 
acidic lipid phosphatidylserine (~25%) that has one negative charge (McLaughlin et 
al., 2002; Mulgrew-Nesbitt et al., 2006). However, there is also strong evidence that 
other proteins such as small guanosine triphosphatases (GTPases), with a cluster of 
four or more basic residues can laterally sequester phosphoinositides in the plasma 
membrane such as PI(4,5)P
 in the plasma membrane?  
2
To test whether the polybasic domain in STREX is anchored to the plasma 
membrane by binding to PI(4,5)P
 which has a stronger negative valency of four negative 
charges (McLaughlin & Murray, 2005; Heo et al., 2006).  
2, the strategy was to examine the role of PI(4,5)P2
Recently studies have demonstrated that PI(4,5)P
 
in the plasma membrane and its effect on channel function (Figure 4.13). 
2, independent of PI(4,5)P2 
metabolites and downstream signalling can activate BK channels (Vaithianathan et 
al., 2008). Therefore to replicate these findings and determine the effect of PI(4,5)P2 
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on the channel and the role that the polybasic domain might play in affecting 
channel activity, PI(4,5)P2 (Avanti Polar Lipids, Inc) was added directly to the 
intracellular face of excised patches in the inside-out configuration (Figure 4.13A). 
All subsequent patches were examined in equimolar potassium gradients (140 mM) 
and 0.33 µM Ca2+. However, PI(4,5)P2 did not appear to have any effect on channel 
activity or single channel amplitude in the conditions examined (Figure 4.13A,E & F). 
PI(4,5)P2 was made up as described in the methods section (see section 2.7) and 
applied as described by Vaithianathan et al. It is interesting that in their methods 
Vaithianathan et al, report sonicating the PI(4,5)P2 (although sourced from a 
different company – Sigma-Aldrich) in a working stock solution for 30 minutes on ice 
(Vaithianathan et al., 2008). However, Avanti polar lipids, the leading suppliers in 
lipid compounds, specifically highlight that PI(4,5)P2 is more difficult to work with 
than more conventional lipids and recommend caution when sonicating the 
PI(4,5)P2 vesicles as PI(4,5)P2 will break down more easily than conventional lipids 
(Avanti Polar Lipids, Inc). Following on from this advice I also tried to apply 
PI(4,5)P2 dissolved in de-ionised H2O without sonication, but again did not see any 
change in channel activity (data not shown). Repeating the same experiment but 
with PI(4,5)P2
In their study, the BK channel variant used would not have the STREX insert, 
therefore I also examined the affect of PI(4,5)P
 from Sigma-Aldrich and sonicating for 30 minutes on ice also did not 
have any effect on channel activity (data not shown). 
2 upon the ZERO insertless variant of 
the BK channel but again did not see any change in channel activity (data not 
shown). Therefore under the conditions used in this thesis the effect of PI(4,5)P2 
reported by Vaithianathan et al could not be replicated. The reason for this 
discrepancy is not clear, however, this may perhaps be a secondary effect of 
prolonged sonication and destruction of PI(4,5)P2
Alternatively, if PI(4,5)P
.  
2 was to have specific role in anchoring the STREX domain 
linker at the plasma membrane via the polybasic domain, then depletion of PI(4,5)P2 
should have a measurable effect on channel activity (Figure 4.13B). In the same 
study, Vaithianathan et al, reported that PI(4,5)P2 monoclonal antibodies applied to 
the cytosolic side of the plasma membrane decreased NPo (channel activity) in BK 
channels to <35% of channels that had been previously activated by lipid kinases 
(activated by Mg-ATP) in the absence of protein phosphatases (Okadaic acid) to 
increase PI(4,5)P2 levels in the patch. This was carried out after a 30 minute
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Figure 4.13. Phosphoinositides do not modulate the BK channel. STREX channel 
activity from an excised inside-out patches in equimolar (140 mM) K+ gradients and 
0.1 µM Ca2+. (A) Bath application of 10 µM PI(4,5)P2 sonicated for 30 minutes prior 
to application. (B) Bath application of PI(4,5)P2 monoclonal antibody (10 µg/µl). (C) 
Wash in of Neomycin (5 mM). (D) Wash in of Poly-L-lysine (5 µg/µl). Control record-
ings after 10 minutes stabilization and the time course shown after drug application is 
2 minutes post-drug, with washout recordings shown after 5 minutes. (E) Bar graph 
illustrates absolute single channel amplitude at +40 mV. (F) Bar graph illustrates chan-
nel activity (I/i) expressed as a percentage of control. All data are Means ± S.E.M (n > 




































































































rundown period during which they propose that PI(4,5)P2 would become depleted 
and lead to BK channel rundown (Vaithianathan et al., 2008). The time course for 
application of anti-PI(4,5)P2 to shift activation in HCN channels has been reported 
as t1/2 ~3.6 minutes in oocytes (Pian et al., 2006) and an almost instant effect of anti-
PI(4,5)P2 has been described, over a period of several seconds, in deactivating the 
PI(4,5)P2 modulated Kir2.1 channel in oocytes (Xie et al., 2008). However, cytosolic 
application of the PI(4,5)P2
The third approach taken was to use neomycin, an aminoglycoside polycation that is 
reported to bind specifically to PI(4,5)P
 -antibody (10 µg/µl) in the same recording conditions 
described previously, had no observable effect on channel activity or single channel 
conductance in HEK293 cells (Figure 4.13B,E & F), even after 10 minutes of bath 
application (n=3).  
2 sequestering it and therefore an indicator of 
a channel’s affinity for PI(4,5)P2 (Schulze et al., 2003). Neomycin is a positively 
charged compound that blocks PI(4,5)P2 based on an electrostatic mechanism. In 
STREX channels it had differing effects on channel activity and single channel 
amplitude (Figure 4.13C). Upon application of neomycin (5 mM) via wash in, single 
channel amplitude decreased from 10 to 4.8 pA within 1 minute of application and 
channel activity also significantly decreased (Figure 4.13E & F). Channel activity 
either remained low or was completely eliminated after ~3 minutes incubation with 
neomycin, however this effect could be washed out after 5 minutes. These effects 
seen with neomycin look more like a classic pore block than a reduction in PI(4,5)P2 
modulation of the channel. Indeed neomycin has been shown in other channels to 
block slowly inactivating Ca2+ channels (Suarez-Kurtz & Reuben, 1987) and inward 
Ca2+ current (Gustin & Hennessey, 1988). Previous studies on native BK channels 
also identified neomycin specifically as a potent “fast” blocker from the cytoplasmic 
side of the channel that may compete for the K+ ion binding inside the pore (Nomura 
et al., 1990). Therefore neomycin is not a good indicator of PI(4,5)P2 modulation of 
the BK channel as it has additional effects in channel pore block. Care should be 
taken when using this compound to identify PI(4,5)P2
Finally, poly-L-lysine is another polycation agent used in multiple studies to 
sequester PI(4,5)P
 modulation of ion channels. 
2. Therefore, to examine the role of PI(4,5)P2 using another 
agent, poly-L-lysine (5 µg/µl) was applied to inside-out patches in equimolar 
potassium gradients (140 mM) and 0.33 µM Ca2+ at +40 mV, as before. 
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Interestingly, initial application of poly-L-lysine had a different effect to that described 
of neomycin. Poly-L-lysine decreased channel activity to ~20% without a change in 
single channel amplitude for several minutes after application (Figure 4.13D,E & F). 
However, after 3-4 minutes single channel conductance also decreased (from 9.9 ± 
0.2 to 3.4 ± 0.5 pA at +40 mV – data not shown). Unlike neomycin, the effects of 
poly-L-lysine could not be reversed as quickly taking more than 10 minutes wash out 
and in 2 out of 4 experiments could not be washed back to control levels at all. 
Therefore unlike the “fast” blocking properties of neomycin, poly-L-lysine appears 
initially to have characteristics of a “slow” channel block such as that seen with the 
classic BK channel blocker TEA, which reduces single channel open probability 
without affecting single channel amplitude (Wangemann & Takeuchi, 1993). Poly-L-
lysine may operate by decreasing the surface potential around the entrance to the 
internal vestibule of the channel pore. The BK channel, unlike other K+ conducting 
channels has two negative rings at the entrance to the channel pore (See Figure 
1.6)(Brelidze et al., 2003). The strong positive charge of poly-L-lysine may decrease 
the negative surface potential that lines the inner vestibule of the cytoplasmic side of 
the BK channel pore which is thought to increase the pool of available K+
These polycations that are used non-specifically to sequester PI(4,5)P
 ions and 
contribute to the unique large conductance properties of the BK channel. However, 
ultimately poly-L-lysine decreases channel conductance possibly through a similar 
mechanism of binding within the channel vestibule. Indeed previous studies have 
demonstrated that poly-L-lysine does decrease both channel activity and 
conductance of BK channels in tracheal myocytes (Oshiro et al., 2000) however in 
these recording conditions, channel activity decreases initially with a latent decrease 
in single channel amplitude after several minutes.  
2 may have 
additional actions in channel block. Whilst such observations have not been 
recorded in voltage-gated K+ channels this may be due to the different structure of 
the pore region in comparison to the much larger BK channel pore (see chapter 1, 
section 1.4.2). It certainly highlights the importance of understanding the potential 
additional actions drugs may have and certainly in the case of the BK channel these 
polycations appear to occlude the ion-conducting pathway at a site within the pore 
possibly close to where the narrow K+ selective region begins. 
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4.3 Discussion  
 
Alternative splicing of the STREX insert at the C2 splice site located in the linker 
between the two RCK domains, introduces a series of basic charged residues, just 
upstream of the key palmitoylation site, which is functional in controlling association 
of the STREX C-terminus at the plasma membrane, via palmitoylation.  
 
4.3.1 The polybasic domain is a functional membrane targeting domain 
By identifying, using basic-hydrophobic analysis, that the polybasic domain just 
upstream of the key palmitoylation site in STREX could potentially form a membrane 
targeting domain, a site directed mutagenesis strategy was taken to disrupt the 
influence of the overall basic charge. 
A series of eleven basic residues that comprise the polybasic domain largely show 
strong evolutionary conservation across vertebrates suggesting a positive selection 
pressure may have retained this region as an important component of the STREX 
channel. Site directed mutation of the basic charge, separately in two regions within 
the polybasic domain - one inside STREX and one outside of STREX, demonstrated 
that membrane association of fluorescently tagged STREX C-terminal constructs 
could be influenced by the polybasic domain. By taking this approach to examine 
the two regions within the polybasic domain the data suggests that it is probable that 
the entire polybasic domain is necessary to maintain a strong basic environment for 
association with the negatively charged plasma membrane.  
 
4.3.2 Disruption of the polybasic domain shifts STREX channel properties 
towards the ZERO channel phenotype 
Polybasic mutant channels were initially examined by a membrane potential assay 
to discriminate differences in channel properties driven by calcium influx. It was 
apparent that mutagenesis of basic residues with negative charges to disrupt the 
basic region had the maximal effect in significantly shifting the polybasic mutant
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channel’s response to calcium influx. In the same manor imaging studies also 
highlighted a decreased localisation of the polybasic mutant C-terminal constructs at 
the plasma membrane. It is possible that this decreased membrane targeting may 
underlie the shift in channel activity that was described by the membrane potential 
assay. In electrophysiological studies to assess voltage- and calcium- sensing 
properties of the polybasic mutant channels, mutation with negative residues in the 
region outside of STREX (K627E:R631E) shifted the voltage for half maximal 
activation by ~ +31 mV and also slowed the time constant for channel deactivation. 
This rightward shift in channel activity of the STREX (K627E:R631E) channel to 
more positive potentials, appears to reflect a shift towards the insertless ZERO 
channel phenotype which is shifted by a similar proportion (ZERO shift was ~ +34 
mV see Figure 3.6). Despite the K627E:R631E mutation almost appearing to 
resemble the ZERO channel phenotype, substitution of negative residues in the 
region within STREX (R640E:R642E) only shifted the voltage for half maximal 
activation by ~ +16 mV. This was not statistically significant, but did however follow 
the general trend of shifting towards the ZERO channel phenotype. Together it 
appears that the region just upstream of the STREX insert may be more important in 
influencing channel activity. However, this does not rule out that there may be 
additional sites that may also determine gating/Ca2+
As would be predicted the K627A:R631A mutant channel activity was only 
marginally rightward shifted when compared to the larger shift induced by mutation 
with negative charges. Substitution with alanine residues would be expected to 
decrease the effect of basic charge with a neutral charge and would not necessarily 
disrupt the overall basic charge of the polybasic domain. To test if this assumption 
would be correct, an experiment could be designed to mutate all of the basic 
residues in the polybasic domain to alanine residues which might be expected to 
mimic the negative residue substitutions that disrupt the polybasic domain, as it 
would no longer be present in the channel. Interestingly, opposed to the other 
polybasic mutations made in the channel, the R640A:R402A mutant channel 
showed a dramatic leftward shift in STREX channel activity by ~ -35 mV, with the 
channel activating at more negative potentials of -60 mV and with a significantly 
faster time constant for the channel’s activating kinetics. It is unknown what may 
mediate this effect but it will be discussed in the next section. The single channel 
 sensitivity in STREX channels 
not related to the polybasic domain.  
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amplitude and voltage dependence of all these mutant channels was unchanged 
suggesting that the calcium- sensitive component of the channel must be modified in 
STREX channels with a non-functional polybasic domain. From this data it is 
apparent that the functional polybasic domain is important in conferring additional 
calcium- sensitivity to the STREX channel over the ZERO channel. The polybasic 
domain has been shown to influence membrane association of the C-terminus and 
so it is possible that the polybasic domain may be important in controlling membrane 
targeting of the RCK1-RCK2 linker by controlling palmitoylation of the STREX 
C645:C646 site. 
 
4.3.3 The polybasic domain controls palmitoylation of the STREX C645:C646 
site 
Palmitoylated cysteines are often located in the vicinity of additional lipid anchors or 
regions rich in basic residues (Bijlmakers & Marsh, 2003; Dietrich & Ungermann, 
2004). The presence of a polybasic domain would presumably significantly enhance 
the overall membrane binding energy of a palmitoylated domain through 
electrostatic interactions (Resh, 1994). In addition, palmitoylation of proteins by 
DHHC’s require that the palmitoylated domain is located close to either the plasma 
or intercellular membranes where the DHHC enzymes are located (Fukata et al., 
2006). Therefore the local environment surrounding a palmitoylation site is 
potentially important for stability at the membrane. In theory, if the polybasic domain 
is important for palmitoylation then disruption of the polybasic domain could 
destabilize the palmitoylation status of the nearby C645:C646 site leading to 
decreased membrane association of the STREX C-terminus, as seen in the imaging 
assays (Figure 4.3). By examining the effect of disrupting the polybasic domain 
using the palmitoylation prediction algorithm, the predictive scores for the 
palmitoylation site in STREX were found to be decreased. Although the 
palmitoylation prediction scores only decreased by a small amount, this may 
indicate that disruption of the polybasic sequence could potentially affect the 
palmitoylation status of the nearby site. Therefore to directly assess how the 
polybasic domain might influence palmitoylation, radiolabelled 3H-palmitate 
incorporation into the STREX C-terminal constructs with neutral and negative 
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substitutions in the polybasic domain was tested using a biochemical assay. 
Substitution of basic residues by negatively charged residues almost totally 
abolished palmitoylation suggesting that the polybasic domain must be important for 
palmitoylation of the STREX domain. In the case of the alanine substitution within 
the STREX basic region (R640A:R642A), as predicted by the palmitoylation 
prediction algorithm, there was a dramatic increase in palmitoylation.  
The mechanism underlying how the R640A:R642A mutant might increase the 
palmitoylation status of the STREX C-terminal constructs is unknown, however this 
may explain the mechanism behind the dramatic leftward shift in channel activity 
previously described. Alanine mutation at this site may change the structural 
conformation of the region allowing greater accessibility to the target cysteine 
residues for palmitoylation in all four subunits of the functional channel. Alternatively, 
mutation in this region may even be important for palmitoylation of the adjacent 
cysteine residue, C649, which in the wild-type STREX channel is predicted to be 
palmitoylated, although in HEK293 cells under normal conditions, was found not to 
be the case. What is clear from this data is that the surrounding environment around 
a target palmitoylation site is important and can regulate the palmitoylation status of 
the protein. 
In a recently published follow-up study from our lab, we showed that overexpression 
of DHHCs that endogenously control STREX palmitoylation, can also palmitoylate 
the cysteine residue (C649) immediately downstream of the C645:C646 site. This 
demonstrates that palmitoylation is able to target this residue under different 
conditions and that potentially this residue could be targeted as a result of structural 
adaptations that allow greater accessibility (see appendix #3; (Tian et al., 2010)). 
 
4.3.4 The polybasic domain’s non specific interaction with the plasma 
membrane 
The electrostatic partner of the polybasic domain in STREX is unknown. However, 
the evidence suggests that PI(4,5)P2 is not the target for the polybasic domain as 
there was no apparent change in channel properties, as seen in the mutated 
polybasic domains in mutant channels, with the addition of PI(4,5)P2 or the addition 
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of the PI(4,5)P2 monoclonal antibody that would block the actions of PI(4,5)P2
4.3.5 Control of membrane targeting by phosphorylation – an electrostatic 
switch 
 in the 
channel recordings. Polybasic domains have been identified to associate with the 
plasma membrane through general electrostatic interactions with the cytosolic-
membrane interface which has an appreciable negative charge in contrast to other 
intracellular membranes that have less charge (McLaughlin et al., 2002; Mulgrew-
Nesbitt et al., 2006). Therefore it is more likely that the polybasic domain in the 
RCK1-RCK2 linker located just upstream from the key palmitoylation site in STREX 
probably interacts with the negatively charged plasma membrane via a non-specific 
interaction. A potential partner for the polybasic domain would be the negatively 
charged monovalent acidic phosphatidylserine (PS) that constitutes ~25% of the 
inner leaflet of the plasma membrane (McLaughlin et al., 2002; Mulgrew-Nesbitt et 
al., 2006).  
In chapter 3, phosphorylation at the PKA phosphorylation site within STREX, S636, 
was shown to disrupt the STREX C-terminal construct’s association at the plasma 
membrane. Phosphorylation of a serine residue introduces a phosphoryl group that 
adds two negative charges to a modified protein (Kim et al., 1994a; Stryer, 1997). It 
was hypothesized that insertion of a negative charge into a largely basic region 
would be of functional significance if the basic domain was functionally important, as 
has been shown in this chapter. In the STREX membrane targeting sequence 
shown below, the PKA phosphorylated serine (shown in bold) is located close to the 
midpoint of the polybasic domain (all basic residues in the polybasic domain are 
defined by (+) charges). 
STREX membrane targeting sequence: 
(++ I ++ CGC ++ P + MSIY ++ M ++) 
The introduction of 2 negative charges would, in the same way as shown by the 
mutagenesis studies, disrupt the series of basic charge weakening the electrostatic 
interaction and decreasing membrane association, but through a physiological 
mechanism. Therefore the question is, does phosphorylation act as a physiological 
mechanism to disrupt C-terminal targeting at the plasma membrane? 
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The polybasic domain in STREX contains 6 arginine residues and 5 lysine residues 
and no acidic residues and therefore has a charge of about +13 at a neutral pH (pH 
~7) (Kim et al., 1994a; Kim et al., 1994b). Phosphorylation at the STREX S636 PKA 
phosphorylation site would be expected to switch the overall net charge of the 
region to +11, but crucially, it would theoretically break the large polybasic domain 
into two smaller basic regions with a net charge of between +5 & +6 and +2 & +3. 
These smaller basic regions on their own are perhaps not strong enough to secure 
membrane binding or to stabilise the environment for efficient palmitoylation of the 
STREX domain. In Figure 4.12 it was demonstrated that mutation of the S636 
phosphorylation site did abolish 3
The dynamic interaction between phosphorylation and palmitoylation was expanded 
in published work from our lab where it was found that phosphorylation of the 
STREX domain by PKA which leads to channel inhibition is conditional on the 
STREX domain being palmitoylated leading to subsequent dissociation from the 
plasma membrane (see appendix #1; (Tian et al., 2008a)).  
H-palmitate incorporation into STREX C-terminal 
constructs. This suggests that phosphorylation disrupts the stability of the polybasic 
region surrounding the palmitoylation site thereby decreasing efficient palmitoylation 
of STREX. Therefore, this physiological mechanism of regulation proposes that 
reversible membrane binding could be achieved by phosphorylation at the S636 site 
in STREX. This implies that phosphorylation could act as an ‘electrostatic switch’ 
regulating the stability of membrane association of the STREX membrane targeting 
domain, in native cells. 
 
Together this data suggests that membrane targeting of the STREX domain is 
important for mediating the properties of the STREX channel and that 
phosphorylation can mediate dissociation of the STREX membrane targeting 
domain by destabilising the functional polybasic domain and disrupting the stability 
of palmitoylation at the nearby site. 
 
4.3.6 The structure of the polybasic domain and STREX insert 
The RCK1-RCK2 linker has been described as an unstructured region (Lee et al., 





The STREX channel membrane targeting domain
Figure 4.14. The STREX channel membrane targeting domain. (A) Model illustrating 
the membrane targeting domain in the RCK1-RCK2 intracellular linker of the STREX 
channel comprising of the polybasic domain and palmitoylation site. (B) Magnified 
region of the membrane targeting domain as shown by broken red box in A. Palmitate 
residues are illustrated in red and basic charged residues are illustrated by (+). The 
STREX insert is highlighted by a solid black underline but only the first 19 residues are 
shown for diagramatic purposes. The membrane targeting domain forms a flat interac-
tion domain that tethers the RCK1-RCK2 linker to the plasma membrane. The PKA 
phosphorylation site that can destabilize membrane association is indicated by a 
yellow box.
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implications are there for the structure of this linker upon alternative splicing of the 
STREX insert. The palmitoylation site in STREX would presumably penetrate the 
lipid membrane tethering the region to the membrane. The structure of polybasic 
domains that are implicated in electrostatic association with the plasma membrane 
are generally described as being flat, a property that can distinguish polybasic 
membrane targeting domains from those that target the nucleus and bind DNA 
which tend to have significant curvature (Honig & Nicholls, 1995; Mulgrew-Nesbitt et 
al., 2006). Therefore it is possible that the membrane targeting domain is a linear 
structure composed of a polybasic domain electrostatically attracted to the 
negatively charge lipid membrane and with an anchoring palmitoylation site that 
penetrates the lipid bilayer at the C-terminal end (Figure 4.14). This would impose 
structure on the RCK1-RCK2 linker by incorporating both elements into a membrane 
targeting domain. As discussed before (see section 3.3.5) the linker potentially 
would be long enough to reach the plasma membrane and stabilise association of 
the membrane targeting domain which appears to require both elements of 
palmitoylation and the polybasic domain (Figure 4.14). 
It is clear that these structural differences imposed on the RCK1-RCK2 linker with 
insertion of the alternatively spliced STREX insert, contribute to the increased 
calcium sensitivity inherent to the STREX channel when compare to insertless 
ZERO channel and this may be reflected in a conformational change in the RCK 
interface and calcium binding site as discussed previously (see section 3.3.5). 
 
4.3.7 A polybasic domain as a nuclear localisation signal? 
In the imaging assays that examined the fluorescently tagged C-terminal constructs 
with and without the STREX insert along with the various mutations both in this 
chapter and in chapter 3, the STREX C-terminal constructs localised at the plasma 
membrane (~60-70 %), however in ~91% of all cells there was strong nuclear 
localisation. Disruption of the polybasic domain, as with mutation of the key 
palmitoylation residues in the previous chapter (see Figure 3.2), diminished 
membrane association of the STREX C-terminal constructs which appeared to be 
then targeted directly to the nucleus. The insertless ZERO C-terminal constructs 
also appeared in the nucleus as well as having a diffuse presence in the cytosol. 
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This would not be expected for a cytosolic domain and may be indicative of a 
nuclear localisation signal present in the C-terminus. 
Classical nuclear localisation signals are characterised by short stretches of basic 
amino acids (Pouton et al., 2007). The simian virus 40 large T-antigen has a single 
cluster of basic residues (PKKKRKV) (Kalderon et al., 1984), whereas 
nucleoplasmin requires two clusters of essentially basic regions 
(KRPAATKKAGQAKKKK) (Robbins et al., 1991) and the oncoprotein c-Myc has a 
fairly unique sequence of only three basic residues (PAAKRVKLD) (Dang & Lee, 
1988). In the STREX channel, the polybasic sequence is as follows, 
(KRIKKCGCRRPKMSIYKRMRR) and could therefore potentially function as a 
nuclear localisation signal perhaps similar to the bipartite nature of the nuclear 
localisation signal inherent to the nucleoplasmin protein. However, what was most 
interesting and perhaps increasingly supportive of this theory was that double 
alanine mutations of basic residues in the STREX segment of the polybasic domain 
(R640A:R642A) completely abolished all nuclear localisation of the STREX C-
terminal constructs (see Figure 4.3B). This implies that a nuclear localisation signal 
may have been disrupted. Whilst this does not fully explain why the insertless ZERO 
constructs that would only have 6 of the 11 basic amino acids in the polybasic 
domain is also able to localise at the nucleus, although ZERO C-terminal constructs 
also show a diffuse cytoplasmic presence not apparent in with STREX C-terminal 
constructs, it may reflect the importance of the sequence composition of a nuclear 
localisation signal which may still be functional in the ZERO C-terminus. The 
importance of the composition of neutral, basic and acidic amino acids within the 
sequence of a nuclear localisation signal has been demonstrated by mutagenesis 
studies in c-Myc (Makkerh et al., 1996). Indeed
Therefore whether the polybasic domain in STREX would be capable of functioning 
as a nuclear localisation signal with the presence of a palmitoylation site just 
downstream is unknown and even if palmitoylation was blocked in STREX, could 
then the C-terminus even locate at the nucleus? The ZERO channel, that does not 
 it has been shown that polybasic 
clusters functioning as nuclear localisation signals can be prevented by hydrophobic 
amino acids (Heo et al., 2006) and presumably this would also be true to some 
extent for lipid additions such as palmitoylation just immediately downstream of the 
polybasic domain in STREX.  
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contain the STREX insert, has six basic residues without a nearby hydrophobic 
palmitoylation site and therefore could potentially function as a nuclear localisation 
signal if the C-terminus was able to operate as an independent domain. In fact 
recent evidence has suggested that the C-terminus of the Slo3 channel can be 
expressed in a variety of tissues, including brain, as a fragment that may regulate 
both the Slo3 and Slo1 channel (Wrighton & Lippiat, 2010). Therefore it is plausible 
that the C-terminus of the BK channel could be independently functional and could 
specifically target the nucleus, but to what effect? In another study that examined 
the role of a C-terminal proteolytic fragment that is part of the CaV1.2 channel, it 
showed that it could act as a transcription factor that autoregulates CaV
It remains to be seen whether these observations of the C-terminal domain of the 
BK channel are functionally significant or just an artefact of overexpression. 
1.2 
transcription in cardiac myocytes (Schroder et al., 2009). Therefore, whether the C-
terminus of the BK channel, in native cells, can be expressed as an independent 
domain either as a whole fragment or a partial fragment is unknown. Indeed, 
whether it would able target the nucleus to be of functional relevance would require 
further investigation.  
 
4.3.8 Challenges for the future 
Challenges for the future will be to examine (i) the degree of regulation by 
phosphorylation of the palmitoylated membrane targeting domain in native cells (ii) 
by what mechanism is palmitoylation of STREX increased by mutation of residues in 
the local vicinity (iii) is the polybasic domain a nuclear localisation signal and if so 
could the C-terminus have a functional role within the nucleus (iv) to define the 
structure of the RCK1-RCK2 linker with and without STREX (v) what effect STREX 





4.3.9 In Summary 
Together this data demonstrates that the polybasic domain in the STREX channel is 
an important component of a functional membrane targeting domain. The polybasic 
domain comprises an important basic region surrounding the target palmitoylation 
site in STREX that controls the stability of palmitoylation and therefore membrane 
association. Tethering of the RCK1-RCK2 linker, upon alternative splicing of the 
STREX insert, to the plasma membrane configures the STREX channel to have a 
greater calcium sensitivity presumably by mediating structural adaptations in the 
gating domain or calcium binding site and regulates PKA mediated channel 






















5.1 Chapter 5 introduction 
 
5.1.1 Additional palmitoylation sites in the BK channel 
Previously, the alternatively spliced STREX insert within the C-terminus of the BK 
channel was identified to contain a single di-cysteine palmitoylation site (see chapter 
3). C-terminal constructs that lack the STREX insert (ZERO) were not palmitoylated 
suggesting that there are no additional palmitoylation sites within the C-terminus of 
the BK channel. Palmitoylation of the STREX C645:C646 site was shown to control 
membrane targeting of the STREX domain which regulates the channel’s increased 
calcium sensitivity over the ZERO channel phenotype and mediates channel 
inhibition by PKA phosphorylation. However, additional studies on full length 
channels lacking the STREX insert indicated that the channel could still be 
palmitoylated at a site that must exist outside of the C-terminus. 
 
Palmitoylation has been shown to occur at two independent sites within the same 
protein and can also mediate two completely unrelated mechanisms in the target 
protein. AMPA receptor subunits GluR1-GluR4 are palmitoylated at two distinct 
sites, one is located at the N-terminal transmembrane domain 2 and the second is 
located in the C-terminal domain. Increased palmitoylation at the transmembrane 
domain site increases accumulation of the receptor in the Golgi, however when 
palmitoylation is increased at the C-terminal site, it inhibits interaction with the 4.1N 
protein which stabilizes cell surface expression (Hayashi et al., 2005), suggesting a 
dynamic role for palmitoylation in the regulation of trafficking and recycling of AMPA 
receptor subunits in neurons. 
 
Palmitoylation has been shown to have multiple roles in controlling protein function 
in different ion channels including: the modulation of voltage-gated Kv1.1 channels 
(Gubitosi-Klug et al., 2005) and the L-, N-, and P/Q-type Ca2+ channels (Chien et al., 
1996). Palmitoylation also plays an important role in regulating phosphorylation in 
BK channels (Tian et al., 2008a) and in the glutamate receptor (GluR6) ligand-gated 
ion channel (Pickering et al., 1995); as well as regulating cell surface stability of 
GABAA receptor ligand-gated channels (Rathenberg et al., 2004), targeting to lipid 
microdomains of the P2X7 receptor ATP-gated cationic channel (Gonnord et al., 
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2009) and channel internalisation of voltage-gated Kv1.5 ion channels (Jindal et al., 
2008). Additionally, palmitoylation can control structural assembly of sodium 
channels (Schmidt & Catterall, 1987) and the structural formation of aquaporin-4 
channels (Suzuki et al., 2008). 
 
Therefore the role of palmitoylation in ion channels and other proteins can be 
multifaceted in the control of distinct protein functions. Multiple palmitoylation sites 
within a protein may indeed have distinct roles in channel function or may regulate a 
single mechanism through palmitoylation and de-palmitoylation at distinct sites.  
 
In a proteomic screen for palmitoylated proteins in the adult rat brain (Kang et al., 
2008) the BK channel was identified to be a palmitoylated protein. In the brain, 
generally the ZERO channel variant would be expressed as STREX channels have 
been shown to be expressed in low levels (MacDonald et al., 2006). Therefore it is 
possible that a palmitoylation site exists outside of the STREX insert. Moreover, 
using a protein prediction algorithm (CSS-palm) an additional potential 
palmitoylation site was identified in the intracellular linker that links the S0 and S1 
transmembrane domains (S0-S1 linker) (Figure 5.1). 
 
 
5.1.2 Working hypothesis 
In this chapter, the hypothesis is that there are additional palmitoylation sites in the 
BK channel that may be functionally distinct from the previously identified STREX 
palmitoylation site.   
 
 
5.1.3 Aims to be addressed in this chapter 
5.1.3.1 Are there additional palmitoylation sites in the BK channel and do they 
target the plasma membrane? 
In order to identify additional palmitoylation sites in the BK channel, potential 
cysteine residues predicted using the CSS-Palm algorithm were investigated using a
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Figure 5.1 









Figure 5.1. Sequence alignment of conserved cysteine residues in the S0-S1 linker of 
the BK channel.  (A) Schematic illustrating the topology of the BK channel pore form-
ing α-subunit. Highlighted is the S0-S1 linker (dash lines) and the C2 splice site (black 
triangle). (B) Sequence alignment indicates evolutionary conserved cysteine residues 
in the intracellular linker between transmembrane domain S0 and S1 (indicated in 
grey), across vertebrates and Drosophila and C.Elegans. Channel sequence of the 
mouse is numbered from MDALI start site (accession number AF156674) and illus-
trated beginning at glycine residue 35 (the S0-S1 linker includes residue 44-114).
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    mouse    GGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNG 
    human    GGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNG 
   monkey    GGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNG 
      rat    GGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNG 
   rabbit    GGLFIILLWRTLKYLWTVCCHCGGKAKEAQKINNG 
  chicken    GGLFIILLWRTLKYLWTVCCHCGVKNKEAQKINGG 
zebrafish    GGLFIILLWRTLKYLWTVCCHCNIKNKEAQKVNNP 
  xenopus    GGLFIILVWRTFKYLWTVCCHCGGKNKEAQKVVNV 
Drosphila   AGLLVVLLWRAFA---FVCC-----RKEPDLGPND  




site directed mutagenesis study and examining 3
 
H-palmitate incorporation into full 
length channel constructs. To determine whether a palmitoylation site is functional in 
membrane targeting, short protein fragments containing the palmitoylation site were 
created fused with fluorescent tags. These fusion proteins were transfected into 
HEK293 cells to determine membrane expression and used to examine the effect of 
mutagenesis of the palmitoylation site on cellular location which was then clarified 
with pharmacological treatment to abolish palmitoylation the mechanism involved. 
 
5.1.3.2 What is the function of an additional palmitoylation site in BK 
channels? 
To examine the functional effect of the palmitoylation site within the S0-S1 linker, 
ZERO channels were screened using a membrane potential assay that can 
discriminate different channel phenotypes based on altered calcium- and voltage- 
sensitivity or changes in cell surface expression.  Channel variants with mutations in 
the identified palmitoylation site that showed different responses in the membrane 
potential assay were then examined by electrophysiological patch clamp techniques 
to determine any changes in calcium- and voltage- sensitivity. Mutant channels that 
demonstrated no difference in channel properties were then N-terminally tagged and 
immunofluorescently labelled extracellularly to ascertain any changes in cell 
membrane expression relative to total protein expression by confocal microscopy 
and biochemical analysis.  
 
 
5.1.3.3 Are palmitoylation sites functionally linked within a protein? 
It is important to identify whether palmitoylation can occur at two separate 
palmitoylation domains within the same channel protein and whether they can be 
independently regulated. Therefore to determine whether the two palmitoylation 
sites that are present in the STREX splice variant of the BK channel, can function 
independently, STREX channels containing the intact C645:C646 palmitoylation site 
were examined with mutation of the secondary palmitoylation site. This identified 
whether the STREX palmitoylation site could influence palmitoylation at the second 




5.2.1 A palmitoylation site in the S0-S1 linker of the BK channel 
To investigate whether there might be additional palmitoylation sites in the BK 
channel, the ZERO channel sequence was examined using the Clustering and 
Scoring Strategy Palmitoylation algorithm (CSS-palm). The murine BK channel 
sequence, accession number: AF156674 (incorporating start site MDALI to the end 
of the intracellular carboxyl tail ending at cysteine residue 1226, VEDEC) was input 
into the algorithm. Deletion of the STREX insert diminished all palmitoylation in C-
terminal constructs (see Figure 3.8) suggesting that only cysteine residues that 
scored highly outside of the C-terminus could be potential palmitoylation sites. The 
CSS-palm algorithm predicted a region with high probability that could act as a 
palmitoylation domain, located in the S0-S1 intracellular linker. In the S0-S1 linker 
three cysteine residues C53, C54 and C56 (numbered starting from MDALI) were 
identified that scored highly with values of 1.54, 1.48, 0.92 respectively (Table 5.1). 
Therefore, this region in the S0-S1 linker could represent a palmitoylation site that 
would be present in all BK channel variants (Figure 5.1A). 
Sequence alignment of the three cysteine residues in the S0-S1 linker (C53, C54 & 
C56) indicate strong evolutionary conservation across vertebrates with conservation 
of a double cysteine motif (C53 & C54) extending across Drosophila and C. 
Elegans. Therefore, it would appear that these cysteine residues may be functionally 
important to the BK channel (Figure 5.1B). 
 
5.2.2 BK channels are palmitoylated at the S0-S1 linker 
To investigate if the C53, C54, C56 cysteine residues are palmitoylated in vivo 
within the S0-S1 linker of the full length ZERO channel, 3H-palmitate incorporation 
was examined in HEK293 cells. Mutation of the identified cysteine residues in the 
S0-S1 linker would indicate which residues are important for palmitoylation of the 
ZERO channel. The representative fluorograph (Figure 5.2 upper) illustrating 
radiolabelled 3H-palmitate incorporation into full length ZERO channels show that
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Table 5.1
Predicted palmitoylation scores for cysteine residues in the ZERO channel
Table 5.1. Predicted palmitoylation scores for cysteine residues in the ZERO channel. 
Scores indicate CSS-palm prediction; a higher score represents higher probability. 
CSS-palm scores were determined with the published CSS-palm v2.0 at 
http://bioinformatics.lcd-ustc.org/css_palm by inputing the protein sequence of the 
entire ZERO BK channel (starting at MDALI and spanning the whole C-terminus to 
cysteine residue C1226; accession number: AF156674) Predicted palmitoylated 
cysteine residues in intracellular domains excluding the C terminus are highlighted in 
grey. * cysteine score at end of peptide is not reliable.
 
Position Peptide CSS-palm v2.0 score Location 
14 EVPCDSR 1.34 extracellular N-terminus 
53 WTVCCHC 1.54 intracellular S0-S1 loop 
54 TVCCHCG 1.48 intracellular S0-S1 loop 
56 CCHCGGK 0.92 intracellular S0-S1 loop 
141 IESCQNF 1.10 extracellular S1-S2 loop 
557 CELCFVK 0.87 intracellular C-terminus 
800 CDMCVIL 0.82 intracellular C-terminus 





BK channels are palmitoylated in the intracellular S0-S1 linker 
Figure 5.2. BK channels are palmitoylated in the intracellular S0-S1 linker. (A) Repre-
sentative fluorographs (upper) and western blots (lower) of full-length ZERO-HA chan-
nels and ZERO channels with mutation of key cysteine residues in the S0-S1 linker, 
expressed in HEK293 cells. Constructs were labelled with 3H-palmitate for 4 hours 
and immunoprecipitated (IP) by using α-HA magnetic microbeads and detected by 
fluorography. Ratios (normalised to the wild-type ZERO channel) of 3H-palmitate 






































triple mutation of the identified cysteine residues to alanine (C53A:C54A:C56A) 
within the S0-S1 linker can completely abolish palmitoylation in the ZERO channel. 
Individual point mutation of the cysteine residues that make up the palmitoylation 
motif decreased the level of 3H-palmitate incorporation by ~ 30-50% in the C53A, 
C53A:C54A and C56A mutant channels but did not affect palmitoylation in the C54A 
mutant channel. This suggests that the triple cysteine residues are a key constituent 
of the S0-S1 linker palmitoylation motif. Western blot analysis confirmed that total 
protein expression between the single double and triple mutants was largely 
unchanged in the assays (Figure 5.2 lower); hence the palmitoylation fluorographs 
reflect the degree of 3
This data suggests that channels with mutated residues at the C53A:C54A:C56A 
site in the S0-S1 linker, are not palmitoylated and therefore can be described as de-
palmitoylated channels. 
H-palmitate incorporation into the full length channel 
constructs (Figure 5.2).  
 
5.2.3 The S0-S1 targets the plasma membrane which is diminished by 
mutation of the C53:54:56A site 
To examine whether this newly identified palmitoylation motif in the S0-S1 linker 
may be able to interact with the plasma membrane in same manner as the 
palmitoylated STREX domain (see chapter 3, Figure 3.2), fusion proteins containing 
only the S0-S1 linker were created. The S0-S1 linker constructs incorporated the 
intracellular linker between the two transmembrane domains, S0 and S1, beginning 
at residue R44 and ending at residue R114 expressed in a fluorescently labelled 
pEYFP-N1 vector (see section 2.1.1 & Figure 2.1) (Figure 5.3A). The aim was to 
identify whether this motif could interact with the plasma membrane and what the 
functional contribution of each cysteine residue was within the palmitoylation motif. 
Transient expression of the S0-S1 linker fusion protein in HEK293 cells, resulted in 
robust expression at the plasma membrane, with 68% of cell transfected (n=850) 
showing strong fluorescence at the plasma membrane. Most constructs had strong 
intracellular expression with diffuse or punctuate fluorescence in the cytoplasm of 
97% of cells (n=850) (Figure 5.3B). A site directed mutagenesis approach was used 




Palmitoylation targets the S0-S1 linker to the plasma membrane
C
Figure 5.3. Palmitoylation targets the S0-S1 linker to the plasma membrane. (A) Sche-
matic of the S0-S1 linker-YFP fusion construct. (B) Representative single cell confocal 
images of the S0-S1 linker, S0-S1 C53A:C54A:C56A, and the S0-S1 linker incubated 
with an inhibitor of palmitoylation 2BP (100 µM) for 24 hours, expressed in HEK293 
cells. (Scale bars: 10 µm). (C) Summary bar graph of the respective mutations of three 
cysteine residues in relation to localization at the plasma membrane expressed as a 
percentage of S0-S1 (where S0-S1 is normalised to 100%). (For all S0-S1 linker 
constructs, N>3, n>330 cells analysed) ** p<0.01 *** p<0.001 compared to S0-S1 
(ANOVA with Tukey post hoc test).
S0-S1-YFP S0-S1-YFP + 2BPS0-S1 C53A:C54A:C56A
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identify the functional contribution of each cysteine residue in membrane 
association. Mutation of individual cysteine residues by point mutation to a neutral 
alanine (A) residue resulted in decreased expression at the plasma membrane. All 
mutant channels are expressed in relation to the wild-type S0-S1 linker construct at 
the plasma membrane which was normalised to 100%. Mutation of C53A resulted in 
a significant decrease to 30.8 ± 1.8% of wild-type S0-S1, associating at plasma 
membrane, C54A showed a smaller decrease with 63.9 ± 9.1% of wild-type S0-S1, 
at the plasma membrane and C56A showed the greatest decrease of the single 
point mutations with 24.6 ± 2.4% of wild-type S0-S1, at the plasma membrane. This 
suggested that each residue is important for the association of the S0-S1 linker at 
the plasma membrane. Mutagenesis of the double cysteine residues that are placed 
side by side (C53A:C54A), the same configuration as the palmitoylation motif in 
STREX (C645A:C646A), was also examined to identify if this may be a consensus 
sequence typical of a palmitoylation site in the BK channel. The C53A:C54A 
mutation in the S0-S1 linker resulted in a decrease of 27.9 ± 5.8% of wild-type S0-
S1 at the plasma membrane, suggesting that the mutation could still not fully abolish 
association with the plasma membrane. The next step was to mutate all three 
cysteine residues in a triple mutation, C53A:C54A:C56A which resulted in the lowest 
expression at the plasma membrane with 12.7 ± 5.8 % of wild-type S0-S1 appearing 
to associate at the plasma membrane (for all S0-S1 linker constructs, n > 330 cells 
counted) (Figure 5.3B&C).  
The S0-S1 fusion proteins showed very little nuclear localisation but in constructs 
that were not present at the plasma membrane they showed strong fluorescence in 
what appeared to be intracellular organelles encapsulating the nucleus, reminiscent 
of ER or Golgi localisation. However because the S0-S1 linker studied was only a 
protein fragment and would probably not reflect the full length channel, this was not 
examined any further.   
To investigate the effect of inhibition of palmitoylation on the short S0-S1 linker 
constructs, cells were incubated with the palmitoylation inhibitor 2-bromopalmitate 
(2-BP) which decreased the association of the S0-S1 linker at the plasma 
membrane similar to the double and triple cysteine mutant to 21 ± 2.1% of wild-type 
control S0-S1, at the plasma membrane (Figure 5.3B&C). This suggests that the S0-
S1 linker motif does associate with the plasma membrane through palmitoylation.  
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Together this data suggests that the triple cysteine motif identified in the S0-S1 
linker is a novel palmitoylation motif found within all BK channels.  
 
5.2.4 Palmitoylation of the S0-S1 linker is functionally important to the BK 
channel 
To investigate the functional effect of the S0-S1 linker palmitoylation motif in the 
ZERO channel, mutated full length channels were transiently transfected into 
HEK293 cells and examined as previously described by a membrane potential 
assay (Saleem et al., 2009)(see section 2.3.3). As before, mutated channels were 
transiently transfected into HEK293 cells and seeded into 96 well assay plates. The 
FLIPR-blue dye (Molecular Devices) was administered to the cells to allow the dye 
to load into the cell membrane. The assay was then run in the Flexstation ® II during 
which cells were stimulated by 1 µM Ionomycin, a calcium ionophore, to activate the 
BK channel by calcium influx. Changes in fluorescence were then measured over a 
time course of 180 seconds. 
The ZERO channel was measured as the control hyperpolarising response to 
channel activation by calcium influx (ionomycin 1 µM). The peak value in these 
assays was taken at t=70s and these values could then be expressed as the 
isolated channel current by subtracting the control HEK response from the 
transiently transfected channel response within the assay plate and then normalised 
to 100%. Therefore channels with mutations in the S0-S1 linker could be expressed 
according to the ZERO channel response (Figure 5.4). A representative trace 
illustrating the raw data of the ZERO channel, the S0-S1 mutant channels and un-
transfected HEK293 response to ionomycin is shown in (Figure 5.4A).  
Mutation of the triple (C53A:C54A:C56A) cysteine residues within the identified 
palmitoylation motif in the S0-S1 linker significantly attenuated the hyperpolarising 
response of the channels to 39.0 ± 5.5 % of wild-type ZERO (n= >15) (Figure 
5.4A&B). The functional effect of point mutations in the individual and double 
cysteine residues in the S0-S1 linker was not statistically significantly shifted with 
respect to the ZERO channel response (Figure 5.4B). Mutation of individual cysteine 
residues shifted the apparent response to, C53A 96.2 ± 10.7%, C54A 86.0 ± 14.8% 





Activation of BK channels by calcium influx is attenuated in S0-S1 mutant 
channels
Figure 5.4. Activation of BK channels by calcium influx is attenuated in S0-S1 mutant
channels. (A) Representative time course plots of mean change in relative fluores-
cence units (RFU) of the FLIPR-blue membrane potential dye in HEK293 cells 
expressing ZERO (grey circles, �), ZERO C53A:C54A (inverted triangles,   ), ZERO 
C53A:C54A:C56A (diamonds,   ), and mock-transfected HEK293 (open circles, �),  in 
response to calcium influx induced by 1 µM Ionomycin. (B) Summary bar chart of the 
membrane potential change for each construct expressed as a percentage of the 
maximal hyperpolarisation with HEK293 subtraction elicited in HEK293 cells express-
ing in the ZERO (grey) variant (where ZERO  is 100%). Data was determined at the 
maximum hyperpolarising response in the wild-type ZERO channel (t=70s) in the time 
course plots in (A). All data are Means ± S.E.M (N=3, n>24), *** p<0.001, compared to 




















































































data suggests that there was a significant decrease in the response to ionomycin of 
the ZERO C53A:C54A:C56A mutant channels relative to the wild-type ZERO 
channels; therefore the triple cysteine motif must be functionally important to the BK 
channel.  
 
5.2.5 Single channel amplitude is not affected in de-palmitoylated BK 
channels 
The membrane potential assay cannot discriminate between: shifts in the 
calcium/voltage sensitivity of the channel; altered channel conductance; or changes 
in expression of functional channels at the plasma membrane. As the 
C53A:C54A:C56A mutant channel showed the greatest change in membrane 
potential, palmitoylation incorporation and in the imaging assays, the functional 
impact of the ZERO C53A:C54A:C56A mutant channel was compared to that of the 
wild type ZERO variant channel hereafter. 
 
To investigate the properties of the C53A:C54A:C56A mutant channels that may 
mediate the attenuated response to ionomycin in the membrane potential assay, 
isolated channels were examined electrophysiologically. To determine whether the 
reduction in the sensitivity to ionomycin might be mediated by a reduced single 
channel amplitude, the triple cysteine mutant (C53A:C54A:C56A) channel was 
examined relative to the wild type ZERO channel over a range of membrane 
potentials (Figure 5.5). Measurements were made at a range of voltage potentials (-
80 mV to +80 mV) in equimolar (140 mM) potassium gradients and at 1 µM [Ca2+
 
] in 
excised inside-out patches (Figure 5.5). Single channel slope conductance in 
excised inside-out patches was unchanged between ZERO and ZERO 
C53A:C54A:C56A channels (ZERO, 231 ± 3.9 pS and ZERO C53A:C54A:C56A, 
227 ± 5.4 pS) (Figure 5.5A). Representative recordings at +40 mV and -40 mV 
illustrate the mean single channel amplitude (Figure 5.5B), these were as follows; 
ZERO 10.7 ± 0.1 & -10.4 ± 0.1 pA and, ZERO C53A:C54A:C56A 10.7 ± 0.3 & -10.7 





Single channel amplitude is not changed in de-palmitoylated BK channels
Figure 5.5. Single channel amplitude is not changed in de-palmitoylated BK channels. 
(A) Current voltage plot for ZERO channels (grey circles, �) and triple cysteine mutant 
C53A:C54A:C56A channels (diamonds,   ), illustrating that single channel conduct-
ance in 1 µM free Ca2+ and equimolar (140 mM) potassium gradients (N=3). Single 
channel conductance derived from the slope of the line. The conductance of the 
ZERO channel is 231.2 ± 3.9 pS and the triple cysteine C53A:C54A:C56A mutant 
channel is 227.1 ± 5.4 pS. (B) Representative single channel recordings of excised 


























Therefore the attenuated response to ionomycin in the membrane potential assay of 
the C53A:C54A:C56A mutant channels cannot be mediated by a reduction in single 
channel amplitude relative to the wild-type ZERO channel. 
 
5.2.6 S0-S1 palmitoylation has no effect on intrinsic channel activity  
Macropatch recordings were carried out over a physiological range of intracellular 
calcium (0.33 to 10 µM [Ca2+]i) to determine the calcium- and voltage- sensitivity of 
the mutant channels. Recordings were made as described previously in equimolar 
(140 mM) potassium gradients by inside-out patch clamp analysis (Figure 5.6). 
Representative currents illustrate the typical outward component of the ZERO 
variant of the BK channel and mutant channel currents in response to a depolarising 
voltage step protocol (-120 to +120 mV) from a holding potential of -80 mV (Figure 
5.6A). Activation (G/GMAX) curves were obtained by plotting normalised tail current 
amplitudes versus the respective test potential. These curves were fitted to a 
Boltzmann equation whereby the voltage for half activation (V0.5MAX) could be 
determined. In 1 µM free calcium, the mid-point of the physiological calcium range 
for activation of the ZERO channel, the voltage for half activation of ZERO was 11.1 
± 9.2 mV. The triple cysteine mutant C53A:C54A:C56A channel showed no 
significant difference in the half maximal voltage for activation of the channel (12.5 ± 
5.7 mV) when compared to the wild-type ZERO channel (Figure 5.6B). The V0.5MAX
 
 
across the calcium range of 0.33 – 10 µM free calcium for ZERO and the 
C53A:C54A:C56A mutant channel was not significantly different suggesting that the 
calcium sensitivity of the channel is unchanged with mutation of the S0-S1 
palmitoylation site (Figure 5.6C). 
To examine the voltage sensitivity of the C53A:C54A:C56A mutant channel relative 
to the wild-type ZERO channel, a logarithmic transformation to linearize the 
activating component of the normalised (G/GMAX) curves in Figure 5.6B were plotted 
against the depolarised potentials of 0 mV to +120 mV (Figure 5.7). This data 
showed that the voltage dependence of the ZERO C53A:C54A:C56A channel was 
not significantly changed from wild-type ZERO channels. These data suggest that 
neither changes in single channel conductance nor channel calcium- and voltage- 





Calcium sensitivity is un-affected in de-palmitoylated channels 
Figure 5.6. Calcium sensitivity is un-affected in de-palmitoylated channels.  (A) Repre-
sentative macropatch recordings traces showing BK currents in response to a depo-
larising voltage step protocol (-120mV to +120mV) from a holding potential of -80mV 
from excised inside-out patch recordings in equimolar potassium gradients and 1 µM 
free Ca2+ (Scale bars: 1 nA / 25 ms) (B) G/GMAX conductance curves show no change 
in channel activation at 1 µM free Ca2+ between ZERO (grey circles,  ) and ZERO 
C53A:C54A:C56A (diamonds,  ). (C) Summary bar graph illustrates no significant 
changes in V0.5MAX across the physiological calcium range 0.33 µM – 10 µM free Ca2+. 































The voltage dependence of the ZERO C53A:C54A:C56A channel is 
unchanged
Figure 5.7. The voltage dependence of the ZERO C53A:C54A:C56A channel is 
unchanged. A logarithmic transformation of the G/GMAX activation curves over depolar-
ised potentials 0 - 120 mV as described in Figure 5.6B. ZERO (grey circles,  ), and 

























Number of functional ZERO C53A:C54A:C56A channels appears reduced in 
membrane patches when compared to wild-type ZERO channels
Figure 5.8. Number of functional ZERO C53A:C54A:C56A channels appears reduced 
in membrane patches when compared to wild-type ZERO channels. Bar graph illus-
trating the average number of functional channels in membrane patches assessed by 
determining total conductance (I) divided by single channel amplitude (i) to inidcated 
NPo in macropatch recordings and indicated as number of channels in single channel 
recordings. ZERO C53:C54A:C56A N=26, ZERO N=12. Data represents Means ± 












C53A:C54A:C56A mutant channels observed in the membrane potential assays. 
However, during patch clamp analysis there appeared to be fewer of the ZERO 
C53A:C54A:C56A mutant channels at the plasma membrane (ZERO 
C53A:C54A:C56A channels were reduced by ~70%, n=26) when compared to wild-
type ZERO channels (n=12) (Figure 5.8). 
 
Therefore, we examined cell surface expression of the ZERO channel and the 
mutant (ZERO C53A:C54A:C56A) channel by using quantitative 
immunofluorescence. 
 
5.2.7 Palmitoylation is an important determinant of BK channel cell surface 
expression.  
To determine whether the triple cysteine C53A:C54A:C56A mutant channel might 
disrupt the normal expression of channels at the plasma membrane, channel 
constructs were created with extracellular N- terminal FLAG- tag epitopes that 
enabled detection on the extracellular surface of HEK293 cells. Constructs also had 
C- terminal -HA tag epitopes to determine total protein expression. In non- 
permeabilised cells, the extracellular N-terminal Flag- tagged channels were labelled 
with a primary antibody (Anti-flag M2 mouse monoclonal antibody) and then 
fluorescently labelled with a secondary antibody (Alexa fluor 594 conjugated anti-
mouse IgG antibody) to measure Flag- tagged channels that would represent 
channels that were only present on the cell surface. After permeabilisation the –HA 
tag was labelled with a primary antibody (anti-HA rabbit polyclonal antibody) and 
subsequently fluorescently labelled with a secondary antibody (Alexa 488 
conjugated anti-Rabbit IgG) to detect cells that efficiently expressed all transfected –
HA tag channel protein. In a field of view, cells were counted by confocal 
microscopy initially at wavelength GFP-Green-488 nm to detect cells that were 
efficiently transfected with –HA tagged channel protein and labelled by the 
respective secondary antibody. In the same field of view cells were then counted at 
the TexasRed-594 nm wavelength to detect the number of channels that showed 
efficient expression of the FLAG- tagged antibody that indicates channels expressed 
at the cell surface prior to permeabilisation (Figure 5.9).   
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Figure 5.9
Palmitoylation of the S0-S1 linker regulates cell surface expression of BK 
channels
Figure 5.9. Palmitoylation of the S0-S1 linker regulates cell surface expression of BK 
channels. (A) Representative confocal images of HEK293 cells expressing Flag-
ZERO-HA (top panels), and Flag-ZERO C53A:C54A:C56A-HA (bottom panels). The 
extracellular Flag- epitope was labelled (red) under non-permeabilised conditions (cell 
surface) with the C terminal –HA epitope tag (green) labelled following cell permeabili-
sation. Flag- and –HA labelling from the same cell are then overlaid (merge). Scale 
bars are 10 µM. (B) Percentage of cells expressing channel constructs at the plasma 
membrane as a percentage of ZERO normailsed to 100%. (C) Quantification of greys-
cale fluorescence for channels at the plasma membrane as a percentage of ZERO 
normalised to 100%. Data are Means ± S.E.M (n >3). *** p < 0.01, ANOVA with post 




















































Representative confocal images show the wild type ZERO channel (top panels) of 
cell surface expression of Flag- tagged channel protein in RED (cell surface), the 
permeabilised cells subsequently labelled for -HA in GREEN (permeabilised) and 
Flag- and –HA labelling from the same cell are then shown in overlaid images 
(merge) (Figure 5.9A). The S0-S1 linker palmitoylation deficient channel, ZERO 
C53A:C54A:C56A, (bottom panel) shows significantly reduced cell surface 
expression of Flag- tagged channel protein in RED in this field of view (cell surface), 
but permeabilised cells subsequently labelled for -HA in GREEN illustrate normal 
expression of channel protein (permeabilised). An overlain image shows no 
evidence of surface expression (merge) (Figure 5.9A).  
Flag-ZERO-HA channels showed robust Flag- tag expression at the cell surface in 
60% of permeabilised transfected cells. With the ZERO channel expression at the 
plasma membrane normalised to 100%, the ZERO C53A:C54A:C56A mutant 
channel showed a reduced Flag- tag expression to ~68% of total transfected cells at 
the cell surface, identified by cell counting at a set level of microscope intensity (see 
methods 2.4.6) (Figure 5.9B). By using quantitative immunofluorescent analysis, 
using Image-J software (see methods 2.4.6), to examine N-terminal Flag- tagged 
ZERO C53A:C54A:C56A mutant channels, a more significant decrease in cell 
surface expression of ~55% in relation to the ZERO channel was observed (Figure 
5.9C). Therefore, this data suggests that mutation of the S0-S1 palmitoylation site in 
ZERO channels decreases cell surface expression. 
The N-terminal S0-S1 linker palmitoylation site (C53:C54:C56) is an independent 
motif upstream of the previously identified palmitoylation site in the STREX insert 
located in the intracellular C-terminus (C645:C646) (see chapter 3, Figure 3.1). It 
would not be expected that these two distal palmitoylation sites in the STREX splice 
variant of the BK channel would be structurally linked and therefore it would be 
predicted that the C53:C54:C56 S0-S1 palmitoylation site would still be 
palmitoylated in the STREX channel independent of the C645:C646 STREX 
palmitoylation site and therefore would still regulate cell surface expression of the 
STREX channel.  
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Figure 5.10
Disruption of the S0-S1 palmitoylation motif in the STREX channel reduces
palmitoylation 
Figure 5.10. Disruption of the S0-S1 palmitoylation motif in the STREX channel 
reduces palmitoylation. (A) Representative fluorographs (upper) and western blots 
(lower) of full-length STREX-HA channels, STREX C53A:C54A:C56A-HA, ZERO-HA 
and ZERO C53A:C54A:C56A-HA channels expressed in HEK293 cells. Constructs 
were labelled with 3H-palmitate for 4 hours and immunoprecipitated (IP) by using α-HA 
magnetic microbeads and detected by fluorography. Ratios are shown demonstrating 







































ratio:      1.0          0.6          1.0           0.0
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5.2.8 STREX channels are still palmitoylated when the S0-S1 linker 
palmitoylation motif is mutated 
To examine the palmitoylation status of the STREX channel in channels that have 
mutations in the S0-S1 linker palmitoylation site (STREX C53A:C54A:C56A), 3H-
palmitate incorporation into full length STREX and mutant BK channel proteins was 
examined in HEK293 cells (Figure 5.10). The representative fluorograph (upper 
panel, lane 1&2) illustrates that triple mutation of the identified S0-S1 palmitoylation 
motif can reduce 3
Therefore mutation of the S0-S1 linker palmitoylation motif reduces the total 
palmitoylation status of the STREX channel but does not abolish it suggesting that 
palmitoylation must still occur at the STREX palmitoylation site. 
H-palmitate incorporation into the STREX C53A:C54A:C56A 
channels by ~40% (Figure 5.10). The same mutation in the ZERO channel (upper 
panel, lane 3&4) completely abolished palmitoylation suggesting that in STREX the 
C645:C646 site can still be palmitoylated. The western blot analysis (lower panel) in 
this particular experiment shows that protein expression between the STREX 
channel variants was not equivalent however the C53A:C54A:C56A mutations do 
not compromise STREX expression in other assays (Figure 5.10) 
 
5.2.9 S0-S1 palmitoylation is functionally important in STREX channels that 
are also palmitoylated within STREX  
To investigate the functional effect of the S0-S1 palmitoylation motif in STREX 
channels, mutated channels STREX C53A:C54A:C56A were examined using the 
membrane potential assay as previously described (Saleem et al., 2009)(see 
section 2.3.3). 
The STREX channel was measured as the control hyperpolarising response to 
channel activation by calcium influx (ionomycin 1 µM). The peak value in these 
assays was taken at t=70s and these values could then be expressed as the 
isolated channel current by subtracting the control HEK response from the 
transiently transfected channel response within the assay plate and then normalised 
to 100%. Therefore STREX channels with mutations in the S0-S1 linker could be 
expressed according to the wild-type STREX channel response (Figure 5.11). A
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Figure 5.11. Disruption of the S0-S1 linker palmitoylation site in STREX splice variant
channels also attenuates the ionomycin driven channel activation. (A) Representative 
time course plots of mean change in relative fluorescence units (RFU) of the FLIPR-
blue membrane potential dye in HEK293 cells expressing STREX (black circles, �), 
STREX C53A:C54A:C56A (upright triangles,    ), and mock-transfected HEK293 (open 
circles, �),  in response to calcium influx induced by 1 µM Ionomycin. (B) Summary 
bar chart of the membrane potential change for each construct expressed as a 
percentage of the maximal hyperpolarisation with HEK293 subtraction elicited in 
HEK293 cells expressing in the STREX (black) variant (where STREX  is 100%). Data 
was determined at the maximum hyperpolarising response in the wild-type STRE 
channel (t=70s) in the time course plots in (A). All data are Means ± S.E.M (N=3, 




Disruption of the S0-S1 linker palmitoylation site in STREX splice variant
channels also attenuates the ionomycin driven channel activation








































representative trace illustrating the raw data of the STREX channel, the S0-S1 
mutant channel (STREX C53A:C54A:C56A) and un-transfected HEK293 response 
to ionomycin is shown in (Figure 5.11A).  
The mutated STREX C53A:C54A:C56A channel hyperpolarising response to 
ionomycin was significantly attenuated to 73.0 ± 4.6 % of wild-type STREX (n= >21) 
(Figure 5.11B). Therefore mutation of the S0-S1 linker palmitoylation motif in 
STREX is functionally significant and has a similar effect as observed in the ZERO 
channel in reducing the apparent channel response to increased intracellular 
calcium. 
 
5.2.10 Palmitoylation of the S0-S1 linker controls cell surface expression of 
STREX channels 
Therefore to determine whether the S0-S1 linker palmitoylation site also controls cell 
surface expression of the STREX splice variant of the BK channel, N-terminal Flag- 
tag and C-terminal –HA tag constructs were created for both wild type STREX and 
the S0-S1 linker palmitoylation deficient STREX C53A:C54A:C56A channel, to 
examine plasma membrane expression in HEK293 cells (Figure 5.12) as previously 
described.   
Representative confocal images show the wild type STREX channel (top panels) of 
cell surface expression of Flag- tagged channel protein in RED (cell surface), the 
permeabilised cells subsequently labelled for -HA in GREEN (permeabilised) and 
Flag- and –HA labelling from the same cell are then shown in overlaid images 
(merge) (Figure 5.12A). The S0-S1 linker palmitoylation deficient channel, STREX 
C53A:C54A:C56A, (bottom panel) shows significantly reduced cell surface 
expression of Flag- tagged channel protein in RED in this field of view (cell surface), 
but permeabilised cells subsequently labelled for -HA in GREEN illustrate normal 
expression of channel protein (permeabilised). An overlain image shows no 
evidence of surface expression (merge) (Figure 5.12A).  
Flag-STREX-HA channels showed robust Flag- tag expression at the cell surface in 
80% of permeabilised transfected cells. With the STREX channel expression at the 
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Figure 5.12
The S0-S1 palmitoylation motif also controls cell surface expression of STREX 
channels
Figure 5.12. The S0-S1 palmitoylation motif also controls cell surface expression of 
STREX channels. (A) Representative confocal images of HEK293 cells expressing 
Flag-STREX-HA (top panels), and Flag- STREX C53A:C54A:C56A -HA (bottom 
panels). The extracellular Flag-epitope was labelled (red) under non-permeabilised 
conditions (cell surface) with the C-terminal –HA epitope tag (green) labelled following 
cell permeabilisation. Flag- and –HA labelling from the same cell are then overlaid 
(merge). Scale bars are 10 µm. (B) Percentage of cells expressing channel constructs 
at the plasma membrane as a percentage of STREX normailsed to 100%. (C) Quanti-
fication of greyscale fluorescence for channels at the plasma membrane as a percent-
age of STREX normalised to 100%. Data are Means ± S.E.M (n >3). *** p < 0.01, 


















































plasma membrane normalised to 100%, the S0-S1 linker palmitoylation deficient 
STREX C53A:C54A:C56A channel showed a reduced Flag- tag expression to ~67% 
of total transfected cells at the cell surface, identified by cell counting at a set level of 
microscope intensity (see methods 2.4.6) (Figure 5.12B). By using quantitative 
immunofluorescent analysis of N-terminal Flag- tagged STREX C53A:C54A:C56A 
mutant channels showed a greater decrease in cell surface expression to ~45% was 
seen in relation to the wild-type STREX channel (see methods 2.4.6) (Figure 5.12C). 
Therefore, mutation of the S0-S1 palmitoylation site in STREX channels that contain 
an intact palmitoylation site in the C-terminus also decreases cell surface 
expression. This data suggests that the S0-S1 linker palmitoylation site acts 
independently of the C645:C646 palmitoylation site in STREX to control cell surface 
expression of the STREX splice variant of the BK channel.  
 
Together this data presents a novel mechanism whereby a palmitoylation motif 





Here, a palmitoylation site has been identified that is present in all functionally 
expressed BK channels, located in the N-terminal intracellular S0-S1 linker. 
Palmitoylation at this site plays a critical role in the control of cell surface expression 
of BK channels. Aspects of this work have been published in the Journal of 
Biological Chemistry (see appendix #4; (Jeffries et al., 2010a)). 
 
5.3.1 BK channels are palmitoylated in the S0-S1 linker  
Using a palmitoylation prediction algorithm to examine the entire BK channel 
sequence, a series of cysteine residues in the S0-S1 linker were identified as a 
potential palmitoylation site. The identified three cysteine residues (C53:C54:C56) 
were found to be conserved across vertebrates and largely conserved in Drosophila 
and C.Elegans, suggesting evolutionary retention of a functionally important region. 
Mutation of the three cysteine residues (C53A:C54A:C56A) completely abolished 
radiolabelled 3
 
H-palmitate incorporation into full length channels, therefore 
identifying this site as a single palmitoylation site in the ZERO variant of the BK 
channel. Palmitoylation of the S0-S1 linker was found to target the linker region to 
the plasma membrane, with mutation of all three cysteine residues decreasing 
membrane targeting to ~13% of the control S0-S1 linker. Incubation with a 
palmitoylation inhibitor 2BP also decreased membrane targeting to a similar degree 
to ~21% of the control S0-S1 linker. These short constructs were largely located in 
the cytoplasm when not tethered to the plasma membrane as would be predicted for 
an intracellular linker. This demonstrates that the S0-S1 linker is palmitoylated and 
can target to the plasma membrane. 
5.3.2 Palmitoylation at the S0-S1 linker controls cells surface expression but 
not channel activity 
To examine the functional significance of de-palmitoylated BK channels, channels 
with mutations in the S0-S1 linker palmitoylation site were examined by a membrane 
potential assay that can discriminate differences in channel properties or a change 
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in the expression of functional channels at the cell surface. Mutation of the triple 
(C53A:C54A:C56A) cysteine residues within the identified palmitoylation site 
significantly attenuated channel activation driven by ionomycin in mutant channels 
by ~60% when compared to the wild-type ZERO channel. Mutations in single or 
double residues did not have any significant effect. This apparent reduction in 
activation by ionomycin was not mediated by changes in single channel 
conductance, voltage dependence of the channel nor was it due to changes in 
calcium sensitivity. However, during electrophysiological patch clamp analysis 
decreased numbers of the palmitoylation deficient channels were noted in the 
membrane patches examined. As the membrane potential assay cannot 
discriminate between shifts in the calcium/voltage sensitivity of the channel; altered 
channel conductance, nor changes in expression of functional channels at the 
plasma membrane, the cell surface expression of the mutant channels were 
examined. 
Mutation of the S0-S1 linker palmitoylation site significantly reduced cell surface 
expression to ~45% of wild-type ZERO channels using quantitative 
immunofluorescence despite total protein expression being unaffected. To 
investigate whether palmitoylation of the S0-S1 linker controls cell surface 
expression of channels that are also palmitoylated at the distinct C-terminal 
alternatively spliced STREX insert, STREX channels were examined with mutations 
in the S0-S1 linker. A similar decrease in cell surface expression of STREX 
channels with mutations in the S0-S1 linker palmitoylation site to ~45% of wild-type 
STREX channels when expressed as 100% using quantitative immunoflourescence. 
Therefore palmitoylation of the S0-S1 linker appears to be distinct and can function 
independently as a modulator of cell surface expression even if additional 
palmitoylation sites are expressed in splice variants of the BK channel. 
 
 
5.3.3 The importance of palmitoylation at the S0-S1 linker  
As protein palmitoylation is a highly dynamic and reversible process palmitoylation 
would have the ability to regulate surface expression and therefore cellular 
excitability on a fast timescale. In proteomic screens, BK channels have been 
identified as being palmitoylated in the adult rat brain (Kang et al., 2008), a tissue in 
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which the major channel variant is the ZERO channel with STREX channels 
expressed at relatively low levels (MacDonald et al., 2006). Therefore palmitoylation 
of the S0-S1 linker in the ZERO channel variant may be an important determinant of 
cell surface expression in neurons as a mechanism to regulate cellular excitability. 
Regulation of cell surface expression of BK channels has been shown to be 
modified in ageing coronary arteries (Marijic et al., 2001), in smooth muscle cells of 
the uterus during pregnancy (Song et al., 1999), colonic epithelia in response to 
aldosterone (Sorensen et al., 2008) and during malignant glioma tumor cell 
proliferation (Weaver et al., 2004). While multiple mechanisms may control steady 
state surface expression, palmitoylation may be an important additional mechanism 
for regulation of BK channel expression at the plasma membrane, in the control of a 
wide range of physiological functions. 
 
5.3.4 How might palmitoylation of the S0-S1 linker control cell surface 
expression? 
How palmitoylation may interplay with other trafficking signals, including those that 
we have recently identified in the RCK1-RCK2 linker of the BK channel (see 
appendix #2; (Chen et al., 2010)) is currently unknown, however palmitoylation of 
the S0-S1 linker could modulate cell surface expression of the BK channel by 
dynamic regulation of any of the multiple processes involved in the trafficking 
pathway to the plasma membrane. Palmitoylation may play a role in (i) facilitating 
export from the ER (ii) stabilisation at the plasma membrane (iii) decreased retrieval 
from the plasma membrane effectively increasing membrane expression or (iv) may 
control recycling of channels.  
The S0-S1 linker region has been shown previously to be important for controlling 
cell surface expression. A human splice variant of the BK channel which inserts a 44 
amino acid sequence in the S0-S1 intracellular linker just downstream of the 
C53:C54:C56 palmitoylation site (mk44), introduces a motif for endoproteolytic 
digestion and a site for N-myristoylation site that results in trapping of the channel in 
the ER (Korovkina et al., 2001). Endoproteolytic cleavage of this site allows the S0 
transmembrane domain to traffic independently of the rest of the channel. Whilst 
another splice variant in the human BK channel within the S0-S1 linker called SV1, 
193
has also been implicated in ER retention. The SV1 splice variant introduces 33 
amino acids to the end of the S0-S1 linker that includes an ER retention-retrieval 
motif, CVLF (Zarei et al., 2004).  
Indeed the S0 region is also important for regulation by β-subunits (Wallner et al., 
1996; Meera et al., 1997; Lippiat et al., 2003; Liu et al., 2008; Wu et al., 2009; Liu et 
al., 2010). Recent structural studies examining intra-α subunit di-sulfide cross-linking 
has demonstrated that the S0 transmembrane domain is located outside of the 
voltage sensing S1-S4 domains (Liu et al., 2010) and can form a major contact with 
the transmembrane domain 2 (TM2) of regulatory β1 (Liu et al., 2010) and β4 (Wu et 
al., 2009) subunits. Co-expression studies suggest a role for β-subunits in 
controlling BK channel cell surface expression and β1- and β2- subunits have been 
shown to regulate cell surface expression (Toro et al., 2006; Zarei et al., 2007). 
Therefore, increasing evidence supports an important role for the S0-S1 region in 
the control of BK channel cell surface expression. 
 
5.3.5 The local environment is important for palmitoylation 
As previously mentioned there is no consensus sequence for a potential 
palmitoylated cysteine motif, however, what is becoming more and more apparent is 
that the local environment surrounding a palmitoylated cysteine residue is important. 
Palmitoylated residues have been described to be located close to (i) regions of 
basic charge, as described for the STREX palmitoylation site (see chapter 4) and 
evident in some Ras proteins and G-proteins (Heo et al., 2006; Crouthamel et al., 
2008) (ii) additional lipid modifications such as myristic acid or prenyl groups as 
seen in Src family kinases and Gα subunits (Bijlmakers & Marsh, 2003; Dietrich & 
Ungermann, 2004) and (iii) located near to transmembrane domains where they are 
able to interact with the plasma membrane (Bijlmakers & Marsh, 2003; Dietrich & 
Ungermann, 2004) as is the case with the S0-S1 linker palmitoylation site.  
Indeed the S0-S1 palm site does not appear to have additional lipid modifications 
nearby although it does require palmitoylation of 3 cysteine residues to create a 
functional motif. Whilst the S0-S1 linker also does not have any nearby polybasic 
regions it is situated within 10 amino acids of the S0 transmembrane domain and 
therefore close to a membrane targeting sequence fulfilling the theory that the 
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palmitoylated site must be able to interact with the plasma membrane through 
additional signals or sequences nearby. Whether the local environment is crucial for 
(i) the ability of target cysteines to be palmitoylated, (ii) in locating the region to the 
plasma membrane which is rich in palmitoylating enzymes or (iii) to mediate stability 
of palmitoylated cysteines once associated with the membrane, is unknown.  
In the STREX domain, PKA phosphorylation of a serine close to the site of 
palmitoylation was shown to regulate membrane interaction of the C-terminus (see 
sections 3.2.1.1 & 4.2.1.1). However, PKA phosphorylation of a downstream tandem 
serine motif in the S0-S1 linker, shown to be phosphorylated in vivo (Yan et al., 
2008), by using phosphomimetic or phosphonull mutations had no effect on S0-S1 
linker interaction with the plasma membrane suggesting that not all palmitoylated 
regions can be controlled in the same way. 
 
5.3.6 The role of distinct palmitoylation sites in proteins 
Together the data illustrates that the BK channel may express two functionally 
distinct palmitoylation-dependant membrane interaction domains: the C-terminal 
alternatively spliced STREX insert and the constitutively expressed site in the S0-S1 
linker. Palmitoylation at two independent sites has been described in other proteins 
that can mediate two completely unrelated mechanistic controls in the target protein. 
AMPA ligand-gated cation channels are palmitoylated at two distinct sites, one 
controlled by a Golgi specific PAT (Keller et al., 2004) which promotes accumulation 
in the Golgi and decreased cell surface expression (Hayashi et al., 2005) and a 
second that appears to be involved in activity dependant internalisation from the 
plasma membrane (Hayashi et al., 2005). The distinct functional effects of 
palmitoylation at the STREX site in influencing channel properties and in the S0-S1 
linker in controlling cell surface expression, suggest that palmitoylation at these sites 
may be independently regulated. 
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5.3.7 Challenges for the future 
Challenges for the future will be to examine (i) Are there extrinsic factors that 
regulate palmitoylation (ii) over what timescale does palmitate turnover occur (iii) the 
role of palmitoylation in trafficking to or from the plasma membrane (iv) regulation of 
palmitoylation within the cell. 
 
5.3.7.1 Are there extrinsic factors that regulate palmitoylation?  
One of the major questions to be addressed in the future is how is palmitoylation 
regulated? It has been suggested that extrinsic factors can regulate palmitoylation. 
Glutamate treatment has been shown to regulate de-palmitoylation of the AMPA 
receptor in neurons (Hayashi et al., 2009) and palmitate cycling in the PSD-95 
protein is increased by calcium influx through NMDA receptors (El-Husseini Ael et 
al., 2002). Therefore, whether there may be other physiological mechanisms that 
can regulate the palmitoylation status, particularly in the BK channel in control of cell 
surface expression which would be crucial for regulation of cellular excitability, 
remains unknown. 
 
5.3.7.2 On what timescale does palmitate turnover occur?  
The timescale during which a protein can remain palmitoylated at the plasma 
membrane is variable. In the BK channel the length of time the channel could be 
palmitoylated could influence long term expression at the plasma membrane (as 
discussed in this chapter) or functional regulation by calcium and/or phosphorylation 
(see chapter 3) as previously described. Studies in other proteins to determine the 
half-life of palmitate in Ras proteins report 20 minutes for N-Ras (Magee et al., 
1987) and 2 hours for H-Ras (Lu & Hofmann, 1995; Baker et al., 2003) suggesting a 
fast turnover rate that may regulate cycles of palmitoylation therefore maintaining 
subcellular distribution of the protein for further specific trafficking to plasma 
membrane. This reversible nature of palmitoylation allows proteins to shuttle 
between the plasma membrane and intracellular compartments or relocalise when 
required in the cell. However, there is also evidence of many proteins such as 
SNAP25 that do appear to be stably palmitoylated (Kang et al., 2004). Whether the 
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palmitoylation status of the BK channel at the two independent sites is cyclic or 
stable is again unknown. 
 
5.3.7.3 The palmitoylation membrane trafficking pathway - from Golgi to 
membrane and back? 
It remains to be elucidated at which step in the trafficking pathway the S0-S1 linker 
within the BK channel is palmitoylated. The role of the enzymes (DHHC’s) that 
control palmitoylation of ion channels is not well known. They can be promiscuous in 
their ability to palmitoylate target proteins. For example, DHHC-3 is localised in 
Golgi (Keller et al., 2004), DHHC-17 has been identified in several vesicular 
structures including sorting/recycling and endosomal structures (Huang et al., 2004) 
and DHHC-5 -20 and -21 are found at the plasma membrane (Ohno et al., 2006), 
although generally their localisation is poorly understood (see appendix # 3; (Tian et 
al., 2010)). The four potential S0-S1 palmitoylation sites that would be present in the 
tetrameric channel could be palmitoylated or de-palmitoylated at any stage 
promoting trafficking, stabilisation or recycling at the plasma membrane. Indeed 
palmitoylation could be responsible for specific targeting or localisation to 
microdomains, such as lipid rafts, within the plasma membrane and therefore 
mediating the functional characteristics of specific domains within the cell. In 
trafficking between intracellular compartments, palmitoylation has been shown to be 
important for regulating ER export of yeast chitin synthase (Chs3) (Lam et al., 2006) 
whilst inhibition of protein palmitoylation has been shown to prevent efficient 
transport of the opioid receptor to the plasma membrane (Petaja-Repo et al., 2006). 
Therefore, it is plausible to envisage a highly regulated process of palmitoylation 
and de-palmitoylation through a series of docking sites from Golgi or ER, via 
transport proteins or secretory vesicles, to the membrane. The role of palmitoylation 
in membrane targeting is well described and therefore, events of palmitoylation 
could target the proteins to the membrane of transport structures, with de-
palmitoylation releasing it to traffick onwards to the next transport structure towards 
the plasma membrane. Hence de-palmitoylated channels may become stunted in 
the intracellular machinery leading to decreased cell surface expression as seen 
with the S0-S1 mutant palmitoylation deficient BK channel (Figure 5.13). In the small 
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Figure 5.13
The BK channel palmitoylation membrane trafficking pathway - from Golgi to 
membrane and back?
Figure 5.13. The palmitoylation membrane trafficking pathway - from Golgi to mem-
brane and back? Model of a cell showing the functional machinery responsible for 
building of the protein channel, trafficking to the plasma membrane and recycling of 
channels off the channel membrane. Several proposed sites where palmitoylation 
could occur are marked with numbers and indicate sites as follows: #1 Palmitoylation 
at Golgi could target BK to plasma membrane, #2 or de-palmitoylation may release BK 
from Golgi membrane were it is re-palmitoylated in transport vesicle, #3 Palmitoylation 
could stabilise BK at plasma membrane, #4 De-palmitoylation could allow internalised 
recycling of BK off the membrane, #5 Palmitoylation targets BK back to membrane 
















S0-S1 linker-YFP protein fragments, inhibition of palmitoylation by 2-BP or site 
directed mutagenesis confined the S0-S1 linker to structures reminiscent of Golgi or 
ER (Figure 5.3B), suggesting that maybe these small proteins never left the Golgi 
apparatus. However, the location of the small S0-S1 linker proteins would probably 
not reflect trafficking of the full length channel. Additionally, palmitoylation could also 
play a role in stability of the channel at the plasma membrane with de-palmitoylation 
releasing the channel to be internalised to a storage structure such as an endosome 
ready for speedy trafficking to the plasma membrane when required or even 
targeting for degradation to a lysosome. De-palmitoylated BK channels could 
therefore be internalised faster, decreasing the number of channels on the cell 
surface. These questions remain to be addressed in future studies.  
 
5.3.8 In summary 
This data reveals that the S0-S1 linker contains a constitutively expressed 
palmitoylation site that regulates cell surface expression of BK channels 



















6.1 General discussion 
 
6.1.1 Aims of the thesis  
In this thesis the primary aims were to identify (i) whether the cysteine rich STREX 
insert functions as a membrane targeting domain through palmitoylation of key 
cysteine residues (ii) whether a series of basic residues introduced upon splicing of 
the STREX insert can control the ability of palmitoylation to anchor STREX at the 
plasma membrane and (iii) whether there are additional palmitoylation sites in the 
BK channel that may be functionally distinct from the STREX palmitoylation site.   
 
6.1.2 STREX is a membrane targeting domain controlled by palmitoylation 
The STREX domain functions as a membrane targeting domain controlled by 
palmitoylation. Disruption of a key palmitoylation site in the STREX domain shifts the 
increased calcium-sensitivity of the STREX channel back towards the less calcium-
sensitive ZERO (insertless) channel phenotype. Palmitoylation of STREX is 
regulated by a polybasic domain which in turn is controlled by PKA-mediated 
phosphorylation, acting as an electrostatic switch. 
These findings that membrane targeting of STREX could mediate increased 
calcium-sensitivity in BK channels suggest that the channel phenotype could be 
regulated dynamically by control of the polybasic domain through phosphorylation 
which would influence the palmitoylation status and thereby the membrane targeting 
properties of the STREX domain. This has implications on cellular excitability. The 
STREX channel can respond more quickly than the ZERO channel to elevations in 
local levels of calcium. This increased sensitivity could then be switched off in order 
that the channel adopts a less sensitive phenotype when required, by disrupting the 
stability of the membrane association via palmitoylation of the STREX domain. 
Whether there may be other mechanisms to regulate the palmitoylation status of 
STREX and therefore mediating the properties of the channel is unknown. 
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6.1.2.1 Is palmitoylation the key to mediating the increased calcium sensitivity 
of STREX channels? 
Palmitoylation of the STREX splice variant of the BK channel was abolished by 
mutation of a dual cysteine site in the STREX domain. Mutation of this palmitoylation 
site shifted channel activity to more depolarised potentials towards the activation 
range for the insertless ZERO channel variant. Whilst imaging assays revealed that 
membrane association was diminished in the de-palmitoylated STREX C-terminal 
constructs. Together this data argues that membrane targeting of the STREX 
domain to the plasma membrane confers increased calcium sensitivity to the 
STREX channel. 
How does membrane targeting of STREX mediate these properties? Membrane 
targeting of the RCK1-RCK2 linker via the STREX insert may induce a 
conformational or structural rearrangement which increases the calcium sensitivity 
of the gating apparatus in the BK channel. An increased channel activity could be 
mediated by (a) increased tension on the channel pore facilitating channel opening 
or (b) by increasing accessibility of calcium at the calcium binding sites within the C-
terminal domain. It is possible that a conformational change may involve altering the 
dynamics at the assembly interface between the two RCK domains, particularly 
considering recent crystal structural analysis that has shown the calcium bowl to be 
located at the assembly interface (Wang & Sigworth, 2009; Wu et al., 2010; Yuan et 
al., 2010). A structural rearrangement of the assembly interface induced by 
membrane targeting of STREX could facilitate increased calcium accessibility to the 
calcium bowl therefore increasing the apparent calcium sensitivity of the channel. 
Indeed studies that have looked at the length of the RCK1-RCK2 linker have 
suggested that this region may indeed be important for mediating the dynamics of 
the RCK interface (Lee et al., 2009a). By dissociating the STREX membrane 
targeting domain from the plasma membrane, the structural conformation 
presumably would be lost, whether it be tension on the pore or accessibility of 
calcium to modulate the gating domain, and the channel would resume a ZERO-like 
conformation (see Figure 6.1).  
Structural analysis would be required to examine this hypothesis. Future studies 
could examine the crystal structure of the C-terminus of the ZERO and STREX 
channel in the presence of calcium, to identify whether the structural conformation of
202
Figure 6.1. Working model of palmitoylation of BK channels. Globular model (2 subu-
nit domains shown) based on the crystal structural studies from Yuan et al., 2010 and 
Wu et al., 2010. (BOX 1) The constitutively expressed S0-S1 linker palmitoylation site 
can interact with the plasma membrane controlling cell surface expression of BK 
channels. (BOX 2) Palmitoylation of the STREX membrane targeting domain may 
induce a structural change in the RCK1-RCK2 interface making the high affinity 
calcium binding site more accessible increasing the channel sensitivity to calcium. 
Destabilisation of the STREX membrane targeting domain releases the RCK gating 
domain to return to its normal conformation (see left side of diagram) resulting in 
decreased channel sensitivity to calcium, hence the STREX channel reverts back to 













Figure 6.1. Working model of palmitoylation of BK channels
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the RCK gating domains and the assembly interface or even the position of the 
calcium binding sites has been altered in the STREX splice variant. Perhaps a more 
accessible study might be to label the calcium bowl and/or RCK interface with a 
probe and by using high powered fluorescence-resonance energy transfer (FRET) 
microscopy (Duncan et al., 2004), quantitatively study conformational changes in the 
RCK1-RCK2 interface of the STREX C-terminus of the BK channel. Although such 
studies would have limitations governed by the size of the probes currently 
available, with developing technology it is not inconceivable that in the future, 
probes may be made available that will be small enough so they don’t affect the 
structure of the protein being studied.  
 
6.1.2.2 Does phosphorylation within the polybasic domain act as an 
electrostatic switch controlling membrane targeting of the STREX 
domain? 
Whilst palmitoylation of a cysteine residue cannot be precisely predicted, many 
palmitoylation sites require either (i) additional lipophilic modifications (ii) a polybasic 
domain (iii) or to be close to transmembrane domains (Bijlmakers & Marsh, 2003; 
Dietrich & Ungermann, 2004). The polybasic domain just upstream from the 
palmitoylation site in STREX was shown to control palmitoylation of STREX 
influencing membrane association of the C-terminus. Mutations in the polybasic 
domain suggest that this region may be important to stabilise palmitoylation at this 
site rather than to specifically target the region to the membrane. Mutation of the 
basic residues inside STREX to alanine (R640A:R642A), increased palmitoylation. 
By contrast all negative substitutions decreased palmitoylation, suggesting that 
perhaps the structure within this region or accessibility of the cysteine motif may be 
reliant upon a favourable local environment. 
PKA-mediated phosphorylation of STREX has been previously shown to inhibit 
channel activity (Tian et al., 2001; Tian et al., 2004). Interestingly, phosphorylation in 
STREX was shown to disassociate the STREX C-terminal constructs from the 
plasma membrane through abolishing palmitoylation of the STREX domain. 
Phosphorylation of STREX presumably destabilises the association of the STREX 
C-terminal constructs at the plasma membrane by breaking up the polybasic 
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domain. Phosphorylation of STREX therefore is a physiological mechanism that 
functions as an electrostatic switch to control membrane association of STREX by 
palmitoylation. The PKA-mediated inhibition of STREX channels (Tian et al., 2001; 
Tian et al., 2004) could therefore represent a shift from a more calcium sensitive 
phenotype that is inherent in STREX channels, to a less calcium sensitive 
phenotype, i.e. a ZERO-like phenotype, that is identified as channel inhibition. 
Electrophysiological studies examining PKA-regulation of STREX channels in zero 
calcium would eliminate the calcium sensitive component of the channel and could 
therefore determine whether PKA-mediated inhibition still occurs in STREX 
channels not activated by calcium, although low channel activity in zero calcium may 
make this a difficult experiment to carry out. However, such an experiment would be 
able to describe whether PKA-mediated inhibition in STREX channels results in a 
shift from a high to low calcium sensitive phenotype. 
Modulation of the STREX membrane targeting domain could therefore be a 
mechanism for regulating cellular excitability on a fast and dynamic timescale. 
Alternative splicing of STREX is under hormonal control and will produce a channel 
with increased sensitivity to calcium; this effectively increases repolarisation and 
therefore allows faster excitation of cells, if required. However, splicing would take 
time due to the synthesis and trafficking of new channels to the plasma membrane. 
A more dynamic control of STREX channel properties would be if palmitoylation of 
the STREX insert could be hormonally regulated. For example if de-palmitoylation 
was controlled by extrinsic factors, then the membrane association of the STREX 
channel could be destabilised leading to a less calcium sensitive ZERO-like 
channel. Alternatively, and perhaps even more dynamic, intracellular regulation by 
phosphorylation of the STREX domain could destabilise STREX at plasma 
membrane which will inhibit or shift channel activity to the less calcium sensitive 
phenotype, therefore changing cellular excitability on a timescale of seconds-
minutes. 
Crucially it will be important to determine in the full length STREX channel whether 
the RCK1-RCK2 linker does interact with the plasma membrane through 
palmitoylation of the STREX domain under physiological conditions. The structure of 
the RCK1-RCK2 linker cannot presently be defined due to its predicted unstructured 
composition; therefore whether STREX, which may generate structure in this region, 
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would allow crystallisation of this region would be interesting to study. Another 
important avenue to explore would be the palmitoyl acyl transferases (DHHC’s) 
involved in regulating palmitoylation of STREX and also the palmitoyl protein 
thioesterases (PPT) involved in de-palmitoylating STREX and where these 
processes occur in the cell and over what timescale. Additionally, the interaction 
between phosphorylation and palmitoylation could represent a general phenomenon 
present in other ion channels or proteins as a mechanism to regulate the effects of 
protein lipidation. Many of the techniques used in this study could be applied to 
potential palmitoylation sites in other ion channels that have yet to be explored. 
 
6.1.3 Palmitoylation in the S0-S1 linker of the BK channel regulates cell 
surface expression 
Through screening and mutagenesis studies an additional palmitoylation site was 
identified, located in the S0-S1 linker. Palmitoylation at the S0-S1 linker was shown 
to regulate cell surface expression, without affecting the calcium- or voltage- sensing 
properties of the channel. 
 
6.1.3.1 How does palmitoylation of the S0-S1 linker regulate cell surface 
expression?  
The S0-S1 palmitoylation site differs from the STREX palmitoylation site in that it 
does not have an adjacent polybasic domain nor does disruption of a nearby 
phosphorylation site disrupt palmitoylation at this site. The S0-S1 site is in the 
vicinity of a transmembrane domain and therefore located close to the plasma 
membrane, whereby palmitoylation can occur (see Figure 6.1). 
How palmitoylation may interplay with other trafficking motifs located within the BK 
channel is unknown. The processes, both intrinsic and extrinsic, that regulate 
palmitoylation will need to studied to understand how palmitoylation and de-
palmitoylation may regulate cell surface expression of BK channels. It would be 
interesting to study the mechanism of how surface expression is modulated by 
palmitoylation. Live cell imaging of fluorescently labelled channels at the cell surface 
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under conditions were they would be expected to be palmitoylated compared to 
subsequent application of a palmitoylation inhibitor, may reveal where in the 
trafficking pathway is palmitoylation of BK channels most important. Does 
palmitoylation regulate forward trafficking meaning that de-palmitoylated channels 
find it difficult to reach the plasma membrane or does it regulate surface stability 
whereby de-palmitoylation prompts faster internalisation? Little is known about the 
mechanisms involved in BK channel delivery and retrieval from the plasma 
membrane and the role of palmitoylation may play in these processes remains to be 
discovered. 
The regulation of BK channels on the cell membrane is crucial to defining the 
excitability of a cell. Palmitoylation may be an important mechanism whereby a cell 
can dynamically control cell surface expression of BK channels and therefore 
regulate cellular processes. 
 
6.1.3.2 Two distinct palmitoylation sites with different functional properties 
One of the key findings of this work is that two palmitoylation sites in one protein can 
be independently regulated to control two distinct functions within the channel 
protein (Figure 6.1). These findings will be interesting for the study of other proteins 
that may also be palmitoylated at multiple sites. Further studies examining 
specifically the palmitoylating enzymes responsible for cycles of palmitoylation and 
de-palmitoylation will also be important to identify location of these palmitoylation 
sites in the cell and how they may control the various channel functions and cellular 
physiology. 
 
6.1.4 Final overview 
This is the first evidence for palmitoylation of the BK channel. Palmitoylation of the 
BK channel has been shown to occur at two distinct sites, one in STREX and one in 
the constitutively expressed S0-S1 linker, which are functionally diverse but operate 
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Large conductance calcium- and voltage-gated potassium (BK)
channels are important regulators of physiological homeostasis
and their function is potently modulated by protein kinase A (PKA)
phosphorylation. PKA regulates the channel through phosphory-
lation of residues within the intracellular C terminus of the pore-
forming -subunits. However, the molecular mechanism(s) by
which phosphorylation of the -subunit effects changes in channel
activity are unknown. Inhibition of BK channels by PKA depends on
phosphorylation of only a single -subunit in the channel tetramer
containing an alternatively spliced insert (STREX) suggesting that
phosphorylation results in major conformational rearrangements
of the C terminus. Here, we define the mechanism of PKA inhibition
of BK channels and demonstrate that this regulation is conditional
on the palmitoylation status of the channel. We show that the
cytosolic C terminus of the STREX BK channel uniquely interacts
with the plasma membrane via palmitoylation of evolutionarily
conserved cysteine residues in the STREX insert. PKA phosphory-
lation of the serine residue immediately upstream of the conserved
palmitoylated cysteine residues within STREX dissociates the C
terminus from the plasma membrane, inhibiting STREX channel
activity. Abolition of STREX palmitoylation by site-directed mu-
tagenesis or pharmacological inhibition of palmitoyl transferases
prevents PKA-mediated inhibition of BK channels. Thus, palmitoyl-
ation gates BK channel regulation by PKA phosphorylation. Pal-
mitoylation and phosphorylation are both dynamically regulated;
thus, cross-talk between these 2 major posttranslational signaling
cascades provides a mechanism for conditional regulation of BK
channels. Interplay of these distinct signaling cascades has impor-
tant implications for the dynamic regulation of BK channels and
physiological homeostasis.
KCNMA1  acylation  protein kinase A  maxi-K
Large conductance calcium- and voltage-gated potassium (BK)channels are potently regulated by protein phosphorylation (1)
and are important determinants of neuronal, cardiovascular, en-
docrine, and epithelial function where channel dysfunction may
lead to major disorders such as hypertension (2, 3), ataxia (4),
epilepsy (5, 6), and incontinence (7). BK channels are potently
regulated by phosphorylation, and several putative phosphorylation
motifs on the pore-forming -subunit have been identified (8–12).
However, as for other potassium channels, the molecular basis
through which phosphorylation of the -subunit effects changes in
BK channel activity is essentially unknown.
BK channel pore-forming -subunits are encoded by a single
gene, KCNMA1 (13), and native BK channels show functional
heterogeneity in their response to protein kinase A (PKA)-
mediated phosphorylation. This diversity results, in large part, from
the extensive alternative pre-mRNA splicing of the pore-forming
-subunits (10, 12). Previous studies have demonstrated that PKA
phosphorylation of a conserved C-terminal phosphorylation motif.
RQPS899 results in BK channel activation (9, 10, 14). Inclusion of
the stress regulated exon (STREX) (15) in the intracellular C
terminus generates an additional PKA consensus motif (serine
residue 3 of the STREX insert, S3) that results in channel inhibition
by PKA (10, 14). PKA inhibition of STREX follows a single-subunit
rule, whereby only 1 -subunit within the BK channel tetramer is
required to be phosphorylated by PKA on S3 for inhibition to be
conferred (14). Thus, phosphorylation of a single STREX -sub-
unit probably induces major conformational rearrangements in the
BK channel C terminus to mediate channel inhibition.
The STREX insert is cysteine-rich (6 of 58 aa) that, when
included into the BK channel -subunit C terminus, generates a
cysteine-rich domain (CRD) in the intracellular linker between the
2 regulator of conductance (RCK) domains (Fig. 1A). In many
proteins, including other voltage- and ligand-gated ion channels
(16–21), cysteine residues are common targets for protein palmi-
toylation, the covalent attachment of a palmitate lipid to a cysteine
residue via a thioester bond. Palmitoylation can exert diverse effects
on protein function including allowing cytosolic protein domains to
anchor to the plasma membrane (22–24).
We thus hypothesized that palmitoylation of the STREX insert
might target the C-terminal domain of the BK channel to the
plasma membrane independently of the N-terminal transmem-
brane domains. Furthermore, this suggested a mechanism by which
phosphorylation of a single STREX subunit could result in channel
inhibition—through regulation of STREX domain interaction with
the plasma membrane. To test these hypotheses, we exploited an
integrated imaging, electrophysiological, and biochemical ap-
proach. We demonstrate that PKA-inhibition of BK channels
results from dissociation of the STREX domain from the plasma
membrane. Importantly, palmitoylation of STREX provides a
conditional gate for regulation of BK channel activity by PKA
phosphorylation.
Results and Discussion
STREX Insert Is a Membrane-Anchoring Domain of the Cytosolic C
Terminus of the BK Channel. To address whether the cysteine-rich
STREX domain is a membrane-anchoring module we developed
an imaging assay to screen the ability of the STREX insert, and its
cognate cysteine residues, to anchor the STREX C terminus to the
plasma membrane in the absence of the N-terminal transmembrane
domains of the -subunit. We generated fluorescent GFP fusion
constructs of the entire BK channel C terminus (Fig. 1B) as well as
constructs that encompass the CRD as fluorescent fusions with
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flanking mCer- and/or YFP fusion proteins to mimic the STREX
linker region between the RCK domains (Fig. 1C).
Expression of STREX C-terminal (Fig. 1B) or CRD constructs
(Fig. 1C) resulted in robust plasma membrane expression of the
fusion proteins in HEK293 cells in the absence of full-length BK
channels or transmembrane segments. Identical results were also
obtained in cells that endogenously express STREX variant chan-
nels including murine anterior pituitary corticotrope (AtT20) cells,
rat pheochromocytoma PC12 cells, and human insulinoma INS-1
cells (data not shown). In contrast, in all these systems, expression
of C-terminal, or CRD, fusion proteins that lack the STREX insert
(ZERO constructs), but that are otherwise identical to the STREX
constructs, did not localize to the membrane (Fig. 1 B–D). Coex-
pression of an HA-tagged STREX C terminus (STREX*) res-
cued the ZERO C-terminal GFP fusion protein localization to
the plasma membrane (Fig. 1B Lower Right). Thus, a STREX
subunit within a heteromeric assembly is sufficient to localize the
BK channel C terminus at the plasma membrane. These data
demonstrate that STREX acts as a membrane-targeting/anchoring
domain and that the key plasma membrane localization motifs must
reside within the CRD domain.
To determine whether the cysteine residues within the CRD
control membrane localization of the STREX C terminus, we
mutated cysteine residues to alanine in both the C-terminal and
CRD STREX constructs. Mutation of residue C13 to alanine alone
almost abolished membrane targeting in both fusion proteins (Fig.
1D), and mutation of its upstream vicinal cysteine residue (C12)
significantly reduced membrane localization. The double-mutant
C12:13A abolished membrane targeting of both fusion proteins
(Fig. 1 B–D). In contrast, mutation of any of the other cysteine
residues within the CRD had no significant effect on membrane
localization (Fig. 1 B–D).
Palmitoylation of STREX Is Required for Membrane Targeting of the
C Terminus. Using the CSS-palm palmitoylation algorithm (25), we
predicted that 4 of the 6 cysteine residues within the STREX insert
might be palmitoylated (Fig. 1A and Table S1), with cysteine
residues 12 and 13 in STREX having the highest CSS-palm scores.
Because mutation of C12 and C13 abolished membrane targeting
of the STREX C terminus, this data suggests that palmitoylation of
these residues controls STREX C terminus association with the
plasma membrane. These STREX cysteine residues are highly
evolutionarily conserved in vertebrates (Fig. 1A).
To directly address whether BK channels are in fact palmitoy-
lated in vivo, we assayed 3H-palmitate incorporation into full-length
channels, and the CRD construct, expressed in HEK293 cells. Both
full-length ZERO and STREX channels were robustly palmitoy-
lated in HEK293 cells by endogenous palmitoyl transferases (Fig.
Fig. 1. STREX targets BK channel C termi-
nus to the plasma membrane. (A) Schematic
illustrating the topology of the BK channel
pore forming -subunit. The STREX insert is
located in the linker between the 2 predicted
regulator of K conductance (RCK) domains
in the intracellular C terminus. Inclusion of
STREX generates a CRD encompassing the
heme-binding domain (hbd) and STREX. Se-
quence alignment indicates evolutionarily
conserved cysteine residues in the STREX in-
sert predicted to be palmitoylated by the
CSS-palm algorithm (shaded) and the PKA
phosphorylation site serine S3 (indicated by
the asterisk). Cysteine residues are numbered
in the CRD as follows: STREX residues num-
bered from the first STREX residue (K) and
upstream cysteines labeled by letters. (B and C)
Schematic of C-terminal GFP fusion (B) and
CRD domain (C) fused between CFP and YFP
constructs and representative single confocal
section images of STREX, STREX cysteine mu-
tants C12:13A and C23:25A, and the ZERO
variant (STREX insert excluded) expression in
HEK293 cells. In B Lower Right, the C-
terminal ZERO–GFP fusion construct was co-
transfected with a modified C-terminal
STREX construct (STREX*) in which the GFP
tag of STREX was replaced with an HA
epitope. (Scale bars: 5 m.) (D) Summary bar
chart of the respective C-terminal (f) or CRD
() construct localization at the plasma
membrane expressed as a percentage of the
respective STREX expression. Data are
means  SEM, N  12, n  350 for each
construct. **, P  0.01 compared with respec-
tive STREX construct (ANOVA with Student–
Neuman–Keuls post hoc test).







2A). Importantly, the STREX CRD construct is robustly palmi-
toylated, and 3H-palmitate incorporation was essentially abolished
in the C12:13A mutant, suggesting that these residues are the major
sites of palmitoylation within the CRD (Fig. 2A). As an alternative
biochemical approach to confirm endogenous palmitoylation of
STREX channels on cysteine residues, we also exploited a cysteine-
accessibility assay (26) after treatment of STREX channels with 1
M neutral hydroxylamine (ha). Ha cleaves the thioester bond
between endogenous palmitate and cysteine residues, allowing
previously palmitoylated cysteine residues to become accessible to
the sulfydryl-specific reagent biotin-BMCC (Fig. 2B). Functionally,
pretreatment of HEK293 cells with the palmitoyl transferase in-
hibitor 2-bromopalmitate [2-BP (27)] also abolished membrane
targeting of the STREX C terminus and CRD fusion proteins in the
imaging assays (Fig. 2C) as for the palmitoylation-deficient
C12:13A mutant. As a control for general effects on posttransla-
tional lipid modification, the myristoylation inhibitor 2-hydroxy-
myristate had no significant effect on C-terminal or CRD targeting
in these assays (Fig. 2C), and the vehicle (0.1% DMSO) was also
without effect (data not shown). Thus, although the 3H-palmitate-
incorporation assays and CSS-palm predictions reveal that cysteine
residues common to both the full-length ZERO and STREX
channels may be palmitoylated, only the C12 and C13 residues are
functionally important for membrane localization of the STREX C
terminus at the plasma membrane. Taken together, these data
support the hypothesis that the key determinant of STREX domain
association with the plasma membrane results from palmitoylation
of the STREX insert.
PKA Phosphorylation Dissociates the STREX C Terminus from the
Plasma Membrane. PKA inhibition of STREX channels results from
phosphorylation of serine residue 3 within the STREX insert (10,
14) that is just upstream of the site of palmitoylation (C12:13). We
reasoned that phosphorylation of S3, which would introduce a
negative charge into an otherwise basic region immediately up-
stream of C12:13, might result in destabilization of the STREX
domain with the plasma membrane leading to significant structural
rearrangements and thus channel inhibition. We took 3 approaches
to test this idea. First, we generated the STREX PKA phospho-
mimetic S3E by mutating STREX S3 to glutamic acid. The S3E
mutation abolished STREX C-terminal or CRD construct local-
ization at the plasma membrane (Fig. 3 A and C). The serine-to-
aspartate mutation (S3D, data not shown) also significantly re-
duced membrane expression, suggesting that both the S3E and S3D
mutants largely mimic PKA phosphorylation of S3. In contrast,
phosphomimetic mutation of S899 in the downstream C terminus,
which is the major site for PKA activation (9, 10, 14), had no
significant effect on STREX C terminus association with the
plasma membrane (Fig. 3 A and C). However, the phosphomimetic
mutations do not allow us to distinguish between a plasma mem-
brane trafficking defect and a reduced association of the C-terminal
domains once at the plasma membrane. Thus, in the second series
of experiments, we acutely treated HEK293 cells, expressing the
wild-type STREX C-terminal or CRD constructs at the plasma
membrane, with the membrane-permeable cAMP analogue
8-CPT-cAMP to establish whether constructs resident at the
plasma membrane could be dissociated by PKA phosphorylation.
Pretreatment of cells with 0.1 mM 8CPT-cAMP, in the presence or
absence of 10 nM okadaic acid, significantly reduced membrane
association of the STREX constructs (Fig. 3B). Importantly,
cAMP-induced dissociation was abolished by pretreatment with the
cell-permeable PKA inhibitor H89. In contrast, activation of pro-
tein kinase G (PKG) or C (PKC) had no effect on STREX
localization at the plasma membrane (Fig. 3D). In addition, neither
acute (3% O2), hypoxia (Fig. 3D), which also regulates BK
channels through the STREX insert (28), nor ionomycin-induced
calcium elevation or KCl-induced depolarization (Fig. S1) had any
significant effect on the plasma membrane localization of STREX.
These data support a model in which PKA phosphorylation of
STREX results in dissociation of the STREX domain from the
plasma membrane.
Palmitoylation Gates BK Channel Regulation by PKA. If this model
were correct, we would predict that PKA inhibition of STREX BK
channels would be lost in channels that are not palmitoylated. To
test this hypothesis, we examined the regulation of wild-type
STREX channels and the STREX palmitoylation-deficient mutant
C12:13A in electrophysiological assays. STREX channels are ro-
bustly inhibited by endogenous PKA closely associated with the
channel upon exposure of the intracellular face of the patch to
cAMP (Fig. 3 E and G). The effect of cAMP is abolished by the
PKA inhibitor PKI5-24, but not by inhibitors of PKG, PKC, or
CaMKII (Fig. S2) and is mimicked by application of exogenous
catalytic subunit of PKA (PKAc) (Fig. 3G). Although full-length
C12:13A channels are robustly expressed at the plasma membrane
(Fig. 3 F and H), suggesting the full-length C12:13A mutant is not
itself trafficking deficient, cAMP or PKAc fail to inhibit this
mutant. Furthermore, the inhibitory effect of cAMP on wild-type
STREX channels was abolished in cells pretreated overnight with
the inhibitor of palmitoylation, 2-BP (Fig. 3G). The C12:13A
mutation, and inhibition of STREX channel palmitoylation by
2-BP, which both dissociate the C terminus from the plasma
membrane (Fig. 2C), resulted in a right shift in the half-maximal
voltage for activation (Fig. S3a). Reduced basal activity per se is not
responsible for the loss of cAMP-mediated inhibition because
cAMP potently inhibited STREX channels recorded under con-
ditions to match the shift in V0.5 resulting from the C12:13A
Fig. 2. Palmitoylation of STREX required for membrane localization. (A)
Representative fluorographs (Upper) and Western blots (Lower) of full-length
STREX-HA and ZERO-HA channels (Left) and the wild-type STREX and mutant
C12:13A CRD-YFP constructs (Right) expressed in HEK293 cells. Constructs
were labeled with 3H-palmitate for 4 h and the respective constructs immu-
noprecipitated (IP) by using -HA or -GFP magnetic microbeads respectively
and detected by fluorography. (B) Representative blots from a cysteine-
accessibility assay after IP and treatment of STREX channels with 1 M neutral
hydroxylamine to cleave endogenous palmitate thioester bonds to cysteine
residues. Accessible cysteines were probed by using biotin-BMCC (Upper) with
total protein probed by -HA (Lower). (C) Summary imaging data of STREX
and C12:13A C terminus (f) or CRD () as in Fig. 1 B–D and the effect of 24-h
pretreatment of cells with the palmitoyltransferase inhibitor 2-bromopalmi-
tate (2-BP, 100 M) or the myristoylation inhibitor 2-hydroxymyristate (2-HM,
0.1–1 mM). Data are means  SEM, N  14, n  950 for each construct/
treatment. **, P  0.01 compared with respective STREX construct (ANOVA
with Student–Neuman–Keuls post hoc test).
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mutation (e.g., at 20 mV in 0.1 M free calcium, inhibition was
67  7% of control, n  12).
Palmitoylation appears to specifically gate PKA-mediated inhi-
bition of STREX channels because the palmitoylation status of
STREX does not alter its intrinsic hypoxia sensitivity (28) (Fig. 3 G
and H) or the regulation by PKG-dependent phosphorylation (Fig.
S3b). Moreover, inhibition of palmitoylation by 2-BP does not
modulate PKA-dependent activation of the ZERO splice variant
(Fig. S3c) that depends on phosphorylation of a PKA consensus
motif (S899) outwith the STREX insert.
Furthermore, the model proposed for palmitoylation-dependent
gating of PKA inhibition of STREX would be expected to adhere
to a ‘‘same-subunit’’ rule based on the previous demonstration that
only a single subunit of STREX needs to be phosphorylated at S3
for channel inhibition (14). The same-subunit model would predict
that PKA inhibition, as a result of phosphorylation of STREX at S3,
would occur only if the same subunit is also palmitoylated at C12:13.
By using a TEA-pore mutation strategy (Y334V) to determine
channel subunit stoichiometry (14), cotransfection of subunits that
could be palmitoylated but not phosphorylated (constructs with
S3A mutation) together with subunits that could be phosphorylated
but not palmitoylated (constructs with C12:13A mutation) revealed
that cAMP was unable to inhibit channel activity (mean change in
activity was 4  10%, n  12). In contrast, introduction of even a
single subunit that could be both phosphorylated and palmitoylated
(i.e., a wild-type STREX subunit) with subunits that could be
palmitoylated but not phosphorylated (S3A constructs) resulted in
robust channel inhibition by cAMP (inhibition was 71  6%, n 
8). These data demonstrate that palmitoylation of the same subunit
in which the channel is phosphorylated is required for PKA-
mediated inhibition.
To examine whether palmitoylation gates native STREX channel
regulation, we examined the regulation of BK channels in mouse
anterior pituitary corticotrope (AtT20) cells. STREX variant chan-
nels are robustly expressed in this system and are potently inhibited
by cAMP-dependent protein phosphorylation (29). cAMP potently
inhibited the outward paxilline-sensitive (BK) current in these cells
(Fig. 4). Pretreatment of AtT20 cells with 2-BP abolished cAMP-
mediated inhibition of the BK current in the whole-cell configura-
tion (Fig. 4). Similar data were obtained in perforated-patch
recordings: 8-CPT-cAMP-mediated inhibition of the paxilline-
sensitive current in 2-BP-treated cells was only 7  8% (n  4) of
that observed by 8-CPT-cAMP in vehicle-treated controls.
BK channels are remarkable in the range of physiological pro-
cesses they control, their functional heterogeneity as a result of
alternative splicing of the single gene encoding the pore-forming
-subunits, and their extensive regulation by reversible protein
phosphorylation. Our data reveal the molecular basis for PKA-
mediated inhibition of BK channels through the regulation of
STREX domain interaction with the plasma membrane. Palmi-
toylation of the STREX domain uniquely allows the large intra-
cellular C terminus of the STREX splice variant to associate with
the plasma membrane and, importantly, gates the regulation of
STREX channels by PKA. Critically, this regulation depends on the
site of palmitoylation being adjacent to the site of phosphorylation
in the same subunit polypeptide. Importantly, STREX channel
activation by PKG-mediated phosphorylation was not affected by
palmitoylation status. Furthermore, PKA-activation of ZERO
Fig. 3. PKA phosphorylation of STREX dissociates STREX from plasma membrane. (A) Representative single confocal sections from HEK293 cells expressing
wild-type STREX C-terminal constructs and the corresponding STREX and C-terminal PKA phosphorylation site phosphomimetic constructs S3E and S899E. (Scale
bars: 5 m.) (B) Effect of cell-permeable cAMP analogue 8-CPT-cAMP (0.1 mM, 10–30 min) on STREX C terminus (f) or CRD () membrane localization in the
presence or absence of 10 nM okadaic acid or the PKA inhibitor H89 (1 M). (C) Summary of S3E and S899E construct expression at the plasma membrane (na,
S899 site not present in CRD construct). (D) Effect of acute hypoxia (3% O2), PKG activation with the cell-permeable cGMP analogue 8-CPT-cGMP (0.1 mM in
the presence of 10 nM okadaic acid) or PKC activation with the phorbol ester PMA (100 nM in the presence of 10 nM okadaic acid) on construct localization at
the plasma membrane. Data are means  SEM, N  4, n  350. (E and F) Representative single-channel traces and diary plots of single-channel mean open
probability (Po) from isolated inside-out patches of HEK293 cells expressing full-length STREX (E) or C12:13A (F) channels before and 10 min after exposure to
cAMP. Single channels were assayed in physiological K gradients exposed to 0.2 M free calcium and 2 mM Mg-ATP. (G and H) Inhibition of STREX (G) or C12:13A
(H) channel Po by cAMP (0.1–1.0 mM) in the presence or absence of the PKA inhibitor PKI5-24 (0.45 M) or 24-h cell pretreatment with 100 M 2-BP; application
of catalytic subunit of PKAc (300 nM) or exposure to acute hypoxia (3%O2). Data are means  SEM, n  5–14 for each treatment. **, P  0.01 compared with
respective control (ANOVA with Student–Neuman–Keuls post hoc test).







channels was not affected by inhibitors of protein palmitoylation.
PKA and PKG activation of BK channels is independent of the
STREX insert and is thought to be mediated by consensus phos-
phorylation sites in the more distal C terminus (8–10, 12, 14).
Importantly, these sites are not juxtaposed to predicted sites of
palmitoylation, further supporting our model in which the cross-talk
between PKA inhibition and palmitoylation status of STREX
depends on both PKA phosphorylation and palmitoylation being in
close proximity on the same subunit in the tetramer, thus obeying
the single-subunit rule of PKA inhibition (14).
To what extent may such cross-talk between these major, dy-
namically regulated, lipid and phosphorylation signaling pathways
occur in other ion channels? Protein phosphorylation is a funda-
mental mechanism to control ion channel function, and increasing
evidence suggests that multiple ion channels are also regulated by
palmitoylation (16–21). We would predict that phosphorylation–
palmitoylation cross-talk is likely to occur when sites of palmitoyl-
ation are flanked by sites of serine/threonine phosphorylation. In
support of this, our pilot sequence analysis reveals (M.J.S. and
I.C.M.R., unpublished work) that in several ion channels reported
or predicted to be palmitoylated, the sites of palmitoylation are
frequently flanked by putative sites for serine/threonine phosphor-
ylation (M.J.S. and I.C.M.R., unpublished work). For example, in
ligand-gated GluR6 receptors, the identified sites of palmitoylation
are flanked by potential PKC phosphorylation sites, and it has been
reported that palmitoylation modifies PKC-mediated phosphory-
lation of GluR6 receptors (20). Thus, cross-talk between these
major posttranslational regulatory pathways, at the level of a single
ion channel polypeptide as reported here for BK channels, is likely
to be of much broader significance to conditionally regulate a
variety of other ion channels.
Although our data reveal that native BK channels are regulated
by this palmitoylation–PKA phosphorylation cross-talk, significant
challenges for the future will be to examine: (i) physiologically
relevant signaling pathways that dynamically regulate BK channel
palmitoylation and (ii) the functional relevance of this cross-talk on
cellular and systems physiology. For example, PKA inhibition of BK
channels is important for the control of stress hormone secretion in
AtT20 pituitary corticotrope cells, and inhibitors of secretion can
prevent PKA-mediated regulation of BK channels in this system
(29). However, because palmitoylation also controls multiple levels
of hormone secretion, including components of the secretory
apparatus per se, a major goal for the future will be to develop tools
to dissect the relative importance of palmitoylation cross-talk at the
level of BK channels compared with other palmitoylation-
dependent pathways in native systems.
Palmitoylation, like protein phosphorylation, is a dynamically
regulated mechanism (22, 23, 30). Thus, elucidation of signaling
pathways that control ion channel palmitoylation, together with
examination of cross-talk with phosphorylation signaling pathways
as reported here, will provide important insights into the role of
these distinct signaling pathways in the control of BK, and other ion
channel function and their role in physiological homeostasis.
Materials and Methods
Channel Constructs. The generation of full-length murine ZERO and STREX
channel epitope-tagged as well as TEA-pore mutant (Y334V) constructs have
been described (14, 31). C-terminal GFP constructs, the respective CRD con-
structs, and site-directed mutants were generated and sequence-verified as
described in SI Methods.
Cell Lines, Transfection, and Treatments. HEK293 cells and mouse anterior pituitary
corticotrope AtT20 D16:16. HEK293 cells and mouse anterior pituitary corticotrope
AtT20 D16:16 (passage 18–32) were subcultured essentially as described (10, 14,
29). Cells were transiently transfected by using Lipofectamine 2000 (Invitrogen)
or Fugene-HD.
Cell treatments: The palmitoylation inhibitor 2-bromopalmitate (2-BP; Sigma) was
madeasafresh100mMstock inDMSOandappliedatafinalconcentrationof100
M overnight. For the myristoylation inhibitor 2-hydroxmyristate (2-HM; Sigma)
fresh stock solutions were made either complexed to BSA, or dissolved in DMSO
as for 2-BP, and applied at 0.1–1 mM final concentration in each well. For acute
imaging assays, cells were incubated for 1 h in DMEM containing 15 mM Hepes
and 0.25% BSA (pH 7.4) at 37 °C before incubation for 10–30 min with fresh
medium containing the respective drug treatment before rapid fixing. For acute
hypoxia,mediumwascontinuouslybubbledwithnitrogengas (O2 levelare3%,
equivalent to 25 mmHg) and during fixation.
Imaging Assays. Cells were fixed with 4% paraformaldehyde, mounted in
Mowiol, and analyzed under epifluorescence by using an inverted Nikon Eclipse
2000 microscope with a 100 oil objective lens. Confocal images were acquired
on a Zeiss LSM510 laser scanning microscope with a 63 oil Plan Apochromat
(N.A.  1.4) objective lens, in multitracking mode to minimize channel cross-talk.
Membrane expression was quantified by using the LSM browser or Volocity
software as described in SI Methods. Data are shown as mean  SEM for N
independent experiments where n  minimum total number of cells analyzed
across experiments for each construct.
Palmitoylation Prediction and Palmitoylation Assays. CSS-palm prediction. We
exploited the published CSS-palm palmitoylation algorithm (25) to predict cys-
teine residues within the entire coding sequence of the murine STREX BK channel
-subunit as well as the STREX insert alone (see Table S1). Sequences were
analyzed with both the published CSS-palm v1.0 algorithm as well as the recently
refined CSS-palm v2.0 web interface. In both cases palmitoylation prediction was
initially set to the highest cutoff in both algorithms.
3H palmitic acid incorporation. HEK293 cells were transiently transfected in 6-well
cluster dishes (3  106 cells per well) with full-length STREX-HA, ZERO-HA
channels or the STREX CRD-YFP and CRD-C12:13A-YFP constructs, respectively.
Forty-eight hours after transfection, cells were washed, and 1 mL of fresh DMEM
containing 10 mg/ml fatty acid-free BSA was added for 30 min at 37 °C. Cells were
incubated in DMEM/BSA containing 0.8 mCi/ml 3H-palmitic acid for 4 h at 37 °C,
and then the medium containing the free label was removed. Cells were lysed in
150 mM NaCl, 50 mM Tris-Cl, 1% Triton X-100 (pH 8.0), and channel fusion
proteins were captured by using magnetic microbeads coupled to HA/GFP anti-
body (MACS epitope tag isolation kits, Miltenyi Biotec). After washing columns
with150mMNaCl,1%NonidetP-40,0.5%deoxycholate,0.1%SDS,50mMTris-Cl
(pH 8.0), followed by washes with 50 mM Tris-Cl (pH 7.5) captured proteins were
eluted in SDS/PAGE sample buffer [50 mM Tris-Cl (pH 6.8), 5 mM DTT, 1% SDS, 1
mM EDTA, 0.005% bromophenol blue, 10% glycerol] prewarmed to 95 °C. The
recovered samples were separated by SDS/PAGE, transferred to nitrocellulose
membranes, and probed with either a monoclonal GFP antibody (1:3,000; Clon-
tech) or polyclonal HA antibody (1:1,000; Zymed). A duplicate membrane was
dried, sprayed with En3hance fluorographic spray (PerkinElmer–Cetus) and ex-
posed to light-sensitive film at 80 °C by using a Kodak Biomax transcreen LE
(Amersham).
Cysteine-accessibility assays. Cysteine-accessibility assays were performed essen-
tially as described by Drisdel (26). Cells were lysed at 4 °C in buffer containing 150
Fig. 4. Palmitoylation gates PKA inhibition of BK channels in native cells. (A
and B) Representative whole-cell outward current traces from mouse anterior
pituitary corticotrope (AtT20) cells pretreated with vehicle (0.01% DMSO) (A)
or 2-BP (24 h, 100 M) (B) before (control) or 10 min after intracellular dialysis
with 0.1 mM cAMP or extracellular application of a 1 M concentration of the
BK channel inhibitor paxilline. Cells were voltage clamped at 50 mV in
physiological potassium gradients and traces shown recorded during voltage
steps to 40 mV for 100 ms. (C) Mean current density (pA/pF) of paxilline-
sensitive current from vehicle- and 2-BP-treated AtT20 cells determined 90 ms
into the pulse at 40 mV. (D) Percentage inhibition of paxilline-sensitive
current (Ipax) by cAMP in vehicle- and 2-BP-treated cells. Data are means 
SEM, n  9 for each treatment. **, P  0.01 compared with cAMP inhibition
in vehicle control (ANOVA with Student–Neuman–Keuls post hoc test).
21010  www.pnas.orgcgidoi10.1073pnas.0806700106 Tian et al.
mM NaCl, 50 mM Hepes (pH 7.5), 1.5 mM MgCl2, 1 mM EDTA, and 1% Triton-X-
100 containing 25–50 mM N-ethylmaleimide (NEM) to block reactive cysteines.
Cell lysates were spun, supernatants precleared with protein-G beads (Sigma),
and incubated overnight at 4 °C with mouse monoclonal -HA antibody. Immu-
nopurified channels were rapidly washed 3 times in lysis buffer without NEM and
treated with 1 M ha (ha) (pH 7.4) for 1 h or 1 M TrisHCl (pH 7.4) as a control
(ha). After washing, beads were exposed to the sulfydryl-specific biotinylating
reagent biotin-BMCC (10 M; Pierce) for 2 h at room temperature. Labeled
proteins were run on SDS/PAGE, transferred to PVDF membrane, and probed
with streptavidin-conjugated horseradish peroxidase (HRP) and detected by ECL.
Electrophysiological Assays. HEK293 cells. Single-channel current recordings were
performedinthe inside-outconfigurationof thepatch-clamptechnique,at room
temperature (20–24 °C). The pipette solution (extracellular) contained 140 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 2 mM MgCl2, 20 mM glucose, 10 mM Hepes (pH 7.4).
The bath solution (intracellular) contained 140 mM KCl, 5 mM NaCl, 2 mM MgCl2,
1 mM BAPTA, 30 mM glucose, 10 mM Hepes, 1 mM ATP (pH 7.3) with free calcium
[Ca2]i buffered to 0.2 M, unless indicated otherwise. Channel activity was
determined during 60-s depolarizations to 40 mV. Data acquisition and voltage
protocolswerecontrolledbyanAxopatch200BamplifierandpCLAMP9software
(Axon Instruments). All recordings were sampled at 10 kHz and filtered at 2 kHz.
Channel activity was allowed to stabilize for at least 10 min after patch excision
before addition of drugs. Catalytic subunit of PKAc was from Promega. The
8-CPT-cGMP, 8-CPT-cAMP, KT5823, chelerythrine chloride, KN-62, and PKI5-24
were from Calbiochem.
Single-channel open probability (Po) was derived either from single-channel
analysis using pSTAT (Axon Instruments) or WINEDR (Version 2.3.9, J. Dempster,
University of Strathclyde, U.K.). To determine the mean percentage change in
channel activity after a treatment, mean Po or N*Po was measured immediately
before and 10 min after the respective drug application. The effect of cAMP
and/or PKAc on channel activity was typically maximal by 5 min and remained
stable over the next 10–30 min after application to inside-out patches. The effect
of PKA-mediated phosphorylation was abolished in the absence of Mg-ATP and
could be reversed upon application of the catalytic subunit of protein phospha-
tase 2A (data not shown).
Mouse anterior pituitary corticotrope (AtT20) cells. Whole-cell currents were
recording in the conventional whole-cell recording mode of the patch-clamp
technique. The bath solution (extracellular) contained 140 mM NaCl, 5 mM KCl,
2 mM MgCl2, 1 mM CaCl2, 10 mM Hepes, and 20 mM glucose (pH 7.4) with or
without 0.002 tetrodotoxin. The patch pipette (intracellular) contained 140 mM
KCl, 2 mM MgCl2, 10 mM Hepes, 30 mM glucose, 1 mM BAPTA, and 1 mM ATP (pH
7.4) with intracellular free calcium ([Ca2]i) buffered to 200 nM. Perforated-patch
recordingswereconductedbyusingamphotericin inthepatchpipette.Cellswere
voltage clamped at 50 mV and depolarized to the respective potentials for 100
ms with leak subtraction applied by using a P/4 protocol and series resistance
compensation of 50%. Steady-state outward current was determined 90 ms
into the pulse and was stable for 30 min under these conditions.
Statistical Analysis. All data are presented as means  SEM with N  number of
independentexperimentsandnnumberof individualcellsanalyzedin imaging
assays.DatawereanalyzedbyANOVAwithposthocStudent–Neuman–Keuls test
with significance set at P  0.01.
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Trafficking of the pore-forming -subunits of large conduct-
ance calcium- and voltage-activated potassium (BK) channels to
the cell surface represents an important regulatory step in con-
trolling BK channel function. Here, we identify multiple traf-
ficking signals within the intracellular RCK1-RCK2 linker of the
cytosolic C terminus of the channel that are required for effi-
cient cell surface expression of the channel. In particular, an
acidic cluster-like motif was essential for channel exit from the
endoplasmic reticulum and subsequent cell surface expression.
This motif could be transplanted onto a heterologous nonchan-
nel protein to enhance cell surface expression by accelerating
endoplasmic reticulum export. Importantly, we identified a
human alternatively spliced BK channel variant, hSlo579–664,
in which these trafficking signals are excluded because of in-
frame exon skipping. The hSlo579–664 variant is expressed in
multiple human tissues and cannot form functional channels at
the cell surface even though it retains the putative RCKdomains
anddownstreamtraffickingsignals.Functionally, thehSlo579–664
variant acts as a dominant negative subunit to suppress cell sur-
face expression of BK channels. Thus alternative splicing of the
intracellular RCK1-RCK2 linker plays a critical role in deter-
mining cell surface expression of BK channels by controlling the
inclusion/exclusion of multiple trafficking motifs.
Large conductance calcium- and voltage-activated potas-
sium (BK)2 channels are widely expressed in mammalian cells
where they play an important role in a diverse range of physio-
logical processes ranging from the control of blood flow (1, 2)
to the control of neuronal excitability and neurotransmitter
release (3, 4). Indeed, a number of disorders, including hyper-
tension (1, 2), epilepsy (5), incontinence (6), and sexual dys-
function (7) may result from perturbations of BK channel func-
tion. Correct cellular targeting of BK channels is an important
regulatory mechanism, and changes in cell surface expression
of these channels have been associated with different physio-
logical demands, for example during pregnancy (8), with aging
in coronary arteries (9), and with aldosterone-induced potas-
sium secretion from the gut (10).
BK channels assemble as tetramers of pore-forming -
subunits, encoded by a single gene that undergoes extensive
pre-mRNA splicing and can form complexes with a family of
regulatory -subunits (11). Increasing evidence suggests that
alternative splicing at the N or C termini of BK channel -sub-
units is a major determinant of BK channel cell surface expres-
sion. For example, inclusion of the alternatively spliced SV1
insert at the intracellular N terminus results in expression of an
endoplasmic reticulum (ER) retention motif, CVLF, that pre-
vents efficient export of the channel from the ER (12). In addi-
tion, the N-terminal mk44 variant (13) is endoproteolytically
cleaved, resulting in plasma membrane localization of the N
terminus of the mk44 variant and intracellular retention of the
remaining cleaved pore-forming C terminus. Alternative splic-
ing of the very C terminus of -subunits is also a major deter-
minant of cell surface expression, although the regulatory
mechanisms are poorly understood (14). Alternative splicing
that results in premature truncation of the BK channel -sub-
unit C terminus also results in intracellular retention of the
channel as exemplified by the murine e23 (15) and rabbit
rbSlo2 (16) as a result of a loss of putative C-terminal ER export
signals as well as the RCK2 domain (15, 16).
Recent data also suggest that the intracellular C-terminal
linker between the two predicted regulator of potassium con-
ductance domains (see Fig. 1a, RCK1 and RCK2) is also an
important determinant of BK channel surface expression. First,
a rat splice variant SVcyt that has an 80-amino acid in-frame
deletion of the linker region is poorly expressed at the cell sur-
face (17). Second, deletion of 30 amino acids in the linker
regions produces nonfunctional channels that lack significant
cell surface expression (18). However, the mechanism(s) re-
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sponsible for the trafficking defect in these linker deletion
mutants are not known.
In this report, we identify multiple trafficking motifs within
the intracellular RCK1-RCK2 linker that control cell surface
expression of BK channel -subunits expressed in mam-
malian cells. Importantly, we reveal an acidic cluster-like motif
(DDXXDXXXI) that is critical for cell surface expression of the
channel that can be transplanted to a heterologous nonchannel
protein to enhance membrane expression. Furthermore, we
have isolated a widely expressed human BK channel splice
variant (hSlo579–664), in which the exons encoding these
trafficking motifs are excluded. Exclusion of these exons
results in an in-frame 86-amino acid deletion that encodes a
channel that is a dominant negative of cell surface expres-
sion. Taken together, our data reveal that alternative splicing
of the RCK1-RCK2 linker region, resulting in inclusion/ex-
clusion of multiple trafficking motifs, is an important deter-
minant of BK channel cell surface expression.
EXPERIMENTAL PROCEDURES
Cloning of the hSlo579–664 Variant, Channel Mutagenesis,
and GABABR1a Constructs—Ahuman tissue rapid scan cDNA
pool (Origene) was screened for splice variants by PCR-ampli-
fying a region between exons 15 and 25 (see Fig. 1a) of the
human BK channel -subunit with the forward and reverse
primer pairs: 5-TTgCCAACCTCTTCTCC-3 and 5-gTgCT-
TgAgCTCATGggTAAT-3, respectively. PCR amplicons were
cloned into the pCRII-TOPOvector (Invitrogen). To generate
full-length BK channel -subunit cDNAs, the novel variant
hSlo579–664 amplicon from pCRII-TOPO was subcloned
into the murine BK channel -subunit with an N-terminal
FLAG tag and/or a C-terminal HA or eYFP tag described pre-
viously (15, 19–21). Site-directed mutations were generated
using the QuikChange site-directed mutagenesis kit (Strat-
agene) using standard procedures. All of the amino acid num-
bering is based on the human BK channel-subunit (hSlo) with
start methionine at MDALI (accession number AAD31173).
GABABR1a receptor plasmids with N-terminal extracellular
HA-GABABR1a and HA-GABABR1a-ASRR plasmids were kind
gifts from Prof. Lily Jan (University of California at San Fran-
cisco) (22). To engineer the DDXXDXXXI sequence at the C
terminus of both constructs, we PCR-amplified the C terminus
with forward (5-TTTgCCAAggAggAACCAAAg-3) and
reverse (5-CTCTAgATCAAATTCTTTTgggATCTgTgA-
CgTCATCCTTgTAAAgCA-3) primers. The reverse primer
encodes a DDXXDXXXI sequence, and the resultant PCR
ampliconswere ligated into theGABABR1a plasmids usingClaI
and XbaI restriction sites. All of the sequences were confirmed
by automated sequencing on both strands (MWG-Biotech).
Quantitative Real Time-PCR TaqManTM Assay—Quantita-
tive analysis of the human BK channel variant transcripts was
performed using a TaqManTM assay (15). The probes and
primer sets of total hSlo and hSlo579–664 were designed with
Primer Express v1.2. TaqManTM probes, labeled at the 5 end
with 6-carboxyfluorescein and at the 3 end with 6-carboxytet-
ramethylrhodamine were synthesized by ABI (Applied Biosys-
tems). The following TaqManTM assays were used to screen
cDNAs from human tissues: for total hSlo: forward, 5-gTC-
TCAAATgAAATgTACACAgAATATCTCT-3; reverse, 5-




3; and probe, 5-CCAACCgAgAgAgCCggCATgA-3. The effi-
ciency, correlation coefficient (R2), and limit of detection for
each TaqManTM assay were: for total hSlo: 2.03, 0.97, and 0.3
fg of cDNA; and for hSlo579–664: 2.02, 0.99, and 0.3 fg of
cDNA. All of the data were analyzed using ABI Prism 7000 SDS
software version 1.0 (Applied Biosystems). Transcript expres-
sion was determined from standard curves generated using
dilutions of the respective splice variant plasmidDNA, and var-
iant expression is given as a percentage of total BK channel
transcripts in each tissue.
HEK293 Cell Culture and Immunofluorescence—HEK293
cells weremaintained and transfected as described (15, 21). Cell
surface labeling of the N-terminal FLAG epitope of BK chan-
nels in nonpermeabilized HEK293 cells was performed (15)
using mouse monoclonal anti-FLAG M2 antibody (50 g/ml
Sigma) and Alexa-594-conjugated anti-mouse rabbit IgG
(Molecular Probes). The cells were subsequently fixed in 4%
paraformaldehyde for 30 min, permeabilized with 0.3% Triton
X-100 for 10 min, and blocked with phosphate-buffered saline
containing 3% bovine serum albumin plus 0.05% Triton X-100
for 30 min. The intracellular C-terminal HA epitope tag was
detected using 0.5 g/ml anti-HA polyclonal rabbit antibody
(Zymed Laboratories Inc.) and Alexa-488-conjugated anti-rab-
bit chicken IgG (Molecular Probes), and the cells weremounted
using Mowiol.
Confocal images were acquired on a Zeiss LSM510 laser
scanning microscope using a 63 oil Plan Apochromat (NA 
1.4) objective lens in multi-tracking mode to minimize channel
cross-talk and analyzed as described (19). FLAG surface expres-
sion was quantified in twoways: (i) using a thresholdmethod to
detect the total number of all transfected cells that displayed
FLAG surface expression in each group and (ii) using absolute
measures based on ratios of surface FLAG (extracellular) fluo-
rescence to intracellular signal (eYFP orHA as appropriate) in a
random subset of all cells analyzed using Image J. The datawere
then normalized to the corresponding control group (100%) as
indicated in the respective figure legend. In these experimental
paradigms the data obtained for relative surface expression
using the threshold method were quantitatively the same as
using the absolute ratio measure, therefore these data were
pooled. In Fig. 2b 90% of all of the transfected cells display
surface expression of the respective e22 and zero variants;
however, we could not detect surface expression of the
hSlo579–664 variant in any cell examined. The same
approach was used for the HA-tagged GABABR1a receptor
constructs except that distinct fluorescent second antibod-
ies directed against the N-terminal HA tag were used in non-
permeabilized and permeabilized conditions.
To assay co-localization of the channelswith the ER,HEK293
cells were co-transfected with the HA-tagged channels and the
pdsRed-ER (Clontech) vector. The HA tag was detected as
above, and confocal images taken at Nyquist sampling rates
were collected and analyzed as described previously (23). The
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images were deconvolved using Huygens software (Scientific
Volume Imaging) and analyzed using ImageJ (National Insti-
tutes of Health) to obtain the Pearson’s correlation coefficient.
Coefficients range from 1 to 1. A value of 1 indicates a com-
plete positive correlation between the two channels, whereas
1 stands for a negative correlation.
Immunoprecipitation and Western Blotting—Immunopre-
cipitation (IP) and Western blotting were performed as previ-
ously described (15). HEK293 cells were solubilized at 4 °C in
lysis buffer (NLB) containing 150 mMNaCl, 50 mMHEPES, pH
7.5, 1.5 mMMgCl2, 10 mM sodium pyrophosphate, 20 mMNaF,
1mM EDTA, 5mM EGTA, 10% (v/v) glycerol, 1% Triton X-100,
and complete protease inhibitor mixture (Roche Applied Sci-
ence). After preclearing, the channels were immunoprecipi-
tated with anti-HA (rabbit polyclonal; Zymed Laboratories
Inc.) or anti-FLAG M2 monoclonal mouse antibody (Sigma).
Negative control IPs included: (i) IP of mock transfected cells;
(ii) IP from cells transfected with channels without the cognate
epitope tag; (iii) beads alone; or (iv) irrelevant IP antibody.
Bound complexeswere separated through a 10%SDS-PAGEgel
and electroblotted to polyvinylidene difluoride membrane and
probed for theHAor FLAG tag using rabbit polyclonal anti-HA
(Zymed Laboratories Inc.), 0.5 g/ml, or mouse monoclonal
anti-FLAG M2 (Sigma), 20 g/ml. The blots were incubated
with horseradish peroxidase-conjugated anti-rabbit IgG/or
anti-mouse IgG secondary antibody (1/5000 dilution; Sigma)
for 1 h at room temperature. The signals were detected using
ECL.
Cell Surface Biotinylation Assay—Plasmids expressing HA-
or eYFP-tagged BK channels were transiently transfected into
HEK293 cells with Exgen 500 (Fermentas). 48 h post-transfec-
tion, the cellswerewashed three timeswithHanks’ buffered salt
solution and then incubated on ice for 2 h in the presence of 5
g/ml of Sulfo-NHS-LC-biotin (Pierce). After three washes in
ice-cold 100 mM glycine in Hanks’ buffered salt solution, the
cells were lysed in NLB lysis buffer with protease inhibitor mix-
ture (Roche Applied Science). Biotinylated cell lysates were
incubated with streptavidin-immobilized beads (Pierce) over-
night at 4 °C, washed three times with cold Hanks’ buffered salt
solution, and washed once with water. The biotinylated mem-
brane BK channel proteins were removed from the beads by
incubating at 45 °C for 15 min in 2 Laemmli protein sample
buffer, separated by SDS-PAGE, and detected with anti-HA or
green fluorescent protein antibody usingWestern blot. Parallel
control biotinylation assays were conducted with: (i) mock
transfected cells, (ii) cells immunoprecipitated with streptavi-
din beads in the absence of biotin incubation, and (iii) immu-
noprecipitation with an irrelevant antibody.
Fluorescent Membrane Potential Assay—The membrane
potential assays were performed in transfected HEK293 cells
using FLIPR membrane potential blue dye (Molecular
Devices, Sunnyvale, CA) essentially as described (24).
Briefly, the cells were plated in black-walled, clear-bottomed
96-well plates and loaded with dye for 30 min at 37 °C. The
assays were performed at 22 °C using a FlexStation II sys-
tem (Molecular Devices), and the channels were activated by
applying 1 M of the calcium ionophore, ionomycin, 16 s
after the experiment began. The fluorescence changes were
read at high sensitivity at 180 s at intervals of 1.52 s with
excitation/emission wavelengths of 530/565 nm, respec-
tively. A decrease in relative fluorescent units, with respect
FIGURE 1. Cloning and tissue mRNA expression of a human BK channel splice variant, hSlo579 – 664, with an in-frame 86-amino acid deletion in the
RCK1-RCK2 linker region. a, schematic illustrating the topology of a BK channel -subunit with an extracellular N terminus and a large intracellular C terminus.
Exon (numbered open boxes) structure for the hSlo zero variant (with no alternatively spliced inserts in this region) and the hSlo579 – 664 variant are shown. The
representative agarose gel illustrates multiple amplicons generated by the forward (fwd) and reverse (rev) primers in human colon cDNA. The upper and lower
arrows indicate the human hSlo zero and hSlo579 – 664 variants, respectively, with the corresponding amino acid sequence. hSlo579 – 664 results from an
86-amino acid in-frame deletion; thus the rest of the intracellular C terminus including RCK2, the calcium bowl, and other essential trafficking motifs for cell
surface expression are retained. b, hSlo579 – 664 variant mRNA levels expressed as percentages of total BK channel mRNA transcripts in selected human tissues
determined using TaqManTM analysis. All of the data are the means 	 S.E., n  3/tissue region. MW, molecular mass.
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tomock transfected HEK293 cells, reflects membrane hyper-
polarization (BK channel activation).
BK channel activation was fully blocked by 1–10 M pax-
illine (not shown; see Ref. 23). The data were analyzed with
SoftMax Pro and exported to Igor Pro, Microsoft Excel,
and/or Prism for further analysis. To compare between
mutants, the relative fluorescent units were determined 70 s
into the assay. The response of each channel mutant was
then normalized to the hyperpolarization response of the
zero channel (100%).
Statistics—Statistical analysis was performed using Igor Pro
v6.0 using a one-wayANOVAwith aDunnett’s post hoc test for
significance between groups at p  0.05.
FIGURE 2. Lack of cell surface expression of the hSlo579 – 664 variant.
a, representative confocal images of HEK293 cells expressing FLAG-
hSlo579 – 664-HA (top panels), FLAG-e22-HA (middle panels), or FLAG-ze-
ro-HA (bottom panels). The extracellular FLAG epitope was labeled (red)
under nonpermeabilized conditions (cell surface) with the C-terminal HA
epitope tag (green) labeled following cell permeabilization. FLAG and
HA labeling from the same cell are then overlaid (Merge). The FLAG-
e22-HA construct is a splice variant with an alternatively spliced exon
(exon 22) included between exons 19 and 23. The scale bars are 2 m.
b, quantification of surface expression expressed as a percentage of the
total number of transfected cells with detectable cell surface (FLAG)
expression for experiments as performed in a. The data are the means 	
S.E. from a minimum of three independent experiments with 600 cells
analyzed/group. **, p  0.01, ANOVA with post hoc Dunnett’s test com-
pared with FLAG-zero-HA construct.
FIGURE 3. The hSlo579 – 664 variant is a dominant negative of cell sur-
face expression. a, Western blot of total cell lysates from the FLAG-
hSlo579 – 664-HA and FLAG-zero-HA variants expressed in HEK293 cells.
b, representative blots from co-immunoprecipitation (IP) experiments
from HEK293 cells co-expressing the zero-HA variant with either the FLAG-
hSlo579 – 664 or FLAG-e22 variants. Left panel, channels were immunopre-
cipitated with mouse anti-FLAG M2 antibody, and blots were probed with
rabbit anti-HA antibody. Right panel, channels were immunoprecipitated
with rabbit anti-HA antibody and probed with mouse anti-FLAG M2 anti-
body. c, zero-HA subunits were co-expressed with either FLAG-hSlo579–664-
eYFP, FLAG-e22-eYFP, or FLAG-zero-eYFP channels in HEK293 cells, and cell
surface (FLAG) expression was quantified. d, FLAG-zero-eYFP subunits were
co-expressed with either hSlo579 – 664-HA, e22-HA or zero-HA channels in
HEK293 cells. In c and d, the data are the cell surface FLAG staining values
expressed as percentages of control (surface FLAG-zero-eYFP levels when
co-expressed with the zero-HA construct) under nonpermeabilized condi-
tions. e, representative Western blots of HA or green fluorescent protein
immunoreactivity from cell surface biotinylation assays of HEK293 cells
expressing the indicated constructs and corresponding whole cell lysates. All
data are the means 	 S.E. from a minimum of six independent experiments
with 700 cells analyzed/group in c and d and three independent experi-
ments in a, b, and e. **, p  0.01, ANOVA with post hoc Dunnett’s test com-
pared with other groups.
Trafficking Signals in the BK Channel RCK1-RCK2 Linker
23268 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285 • NUMBER 30 • JULY 23, 2010
 at E
dinburgh U











Cloning of a Human BK Channel Splice Variant with an
86-Amino Acid Deletion in the RCK1-RCK2 Linker,
hSlo579–664—We isolated a human BK channel splice variant,
hSlo579–664, from human colon tissue cDNAs using reverse
transcription-PCR primers to amplify the region spanning
exons 15–25 (Fig. 1a) that encompasses the C-terminal region
of the predicted RCK1 domain and the unstructured (NORS)
RCK1-RCK2 linker (18). Using these primers, multiple sized
amplicons were generated that encoded for previously identi-
fied splice variants at sites of splicing C1 and C2, including the
human zero variant that lacks inserts at these sites (Fig. 1a).
From the amplicons we identified a significantly smaller sized
product than the insertless zero variant that results from skip-
ping three exons, producing a deletion of 86 amino acids
between isoleucine 579 and arginine 664. The exclusion of
exons 18, 19, and 23 results in splicing from exons 16 to 24,
leading to an in-frame deletion with the splice variant retaining
the more C-terminal RCK2 domain (25), the “calcium bowl”
required for calcium sensitivity of the channels, aswell asC-ter-
minal ER export signals (16).We have named this splice variant
hSlo579–664 (based on amino acid numbering system for hSlo
variant starting atMDALI, accession numberAAD31173). This
variant represents the human ortholog of the previously
described rat splice variant SVcyt (17). To quantify the expres-
sion of mRNAs encoding the hSlo579–664 splice variant in dif-
ferent human tissues, we designed and carried out TaqManTM
real time quantitative PCR assays. Total BK channel transcripts
(normalized to -actin) were highest in prostate, brain, muscle,
and uterus and lowest in heart, thyroid, plasma blood cell,
and bone marrow (data not shown). In most tissues, the pro-
portion of total BK transcripts that expressed the new vari-
ant, hSlo579–664, was less than
10% (Fig. 1b). The proportional
expression of the new variant
hSlo579–664, was highest in those
tissues, such as heart, thyroid,
plasma blood cell, and fetal liver,
which express the lowest total BK
channel transcript levels.
hSlo579–664 Is a Dominant Neg-
ative of Cell Surface Expression—
Fusion of green fluorescent protein
to the C terminus of the rat SVcyt
homolog resulted in trapping of the
SVcyt variant into the cytoplasm of
mammalian cells with no detectable
current (17). In addition, recent
data suggest that deletion of 30
amino acids in the RCK1-RCK2
linker results in nonfunctional
channels (18). To address whether
the hSlo579–664 splice variant
could be expressed at the cell sur-
face and form functional channels,
we took two approaches.
First, we asked whether single
channel/macropatch BK currents
were detectable in HEK293 cells expressing the hSlo579–664
variant using both untagged constructs as well as channels with
an N-terminal FLAG epitope and a C-terminal HA epitope. No
identifiable BK channel currents were observed in either 39 cell
attached patches or 29 excised inside out patches exposed over
the potential range 	100 mV and with 100 M free calcium.
In contrast, using the zero variant under identical conditions,
we observed multiple channels in 55% of patches in cell-at-
tached or excised patch configurations (data not shown). A
similar lack of functional expression was also observed in fluo-
rescent membrane potential assays (e.g. see Fig. 8).
Second, to determine whether the hSlo579–664 was
expressed at the cell surface, we transfected the FLAG-
hSlo579–664-HA construct in HEK293 cells (Fig. 2). In non-
permeabilized cells, the extracellular N-terminal FLAG tag
could not be detected in immunofluorescence assays in any cell
(n 1500 cells analyzed), suggesting that the channel could not
insert into the plasma membrane (Fig. 2). In contrast, in the
same experiments two distinct splice variants (FLAG-e22-HA
and FLAG-zero-HA variants (15)) showed robust FLAG tag
expression at the cell surface in 90% of nonpermeabilized,
transfected cells (Fig. 2). To confirm that the lack of FLAG
epitope detection with the FLAG-hSlo579–664-HA variant
was not due to a lack of protein expression, we analyzed expres-
sion of the HA epitope tag in the same cells under permeabi-
lized conditions (Fig. 2a). The hSlo579–664 variant displayed
robust expression in both immunocytochemical (Fig. 2a) and
Western blot (Fig. 3a) assays. Indeed, total cellular protein lev-
els of the hSlo579–664 construct were not significantly differ-
ent from that observedwith zero constructs, suggesting that the
lack of cell surface expression does not result from decreased
synthesis and/or increased degradation of the hSlo579–664
FIGURE 4. Exon 18 and exon 19, but not exon 23, are essential for BK channel cell surface expression.
a, in-frame deletion mutants of exons 18, 19, and 23 that are excluded in the hSlo579 – 664 trafficking-
deficient variant were expressed in HEK293 cells. Constructs contained an N-terminal extracellular FLAG
tag and a C-terminal HA tag. Cell surface expression was assayed in imaging experiments under nonper-
meabilized conditions by probing for the FLAG tag as in Fig. 3. The data are expressed as percentages of
control FLAG-zero-HA cell surface expression. b, inset, representative Western blots of HA immunoreac-
tivity from cell surface biotinylation assays of HEK293 cells expressing the zero or e18 
 e19 constructs
and corresponding whole cell lysates. All of the data are the means 	 S.E. from a minimum of three
independent experiments with 650 cells analyzed/group. **, p  0.01, ANOVA with post hoc Dunnett’s
test compared with all other groups.
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variant (Fig. 3a). As expected from the 86-amino acid deletion,
the hSlo579–664 variant was detectable as an 110-kDa
immunoreactive band in Western blots (Fig. 3a). Probing for
the hSlo579–664 variant in intact HEK293 cells revealed that
the hSlo579–664 variant was retained in intracellular struc-
tureswithin the cytoplasm.Although a functional role for intra-
cellular BK channels has been reported, for example in mito-
chondria (26), the hSlo579–664 variant did not co-localize with
mitochondrial markers (data not shown) in HEK293 cells but
was extensively trapped in the ER (Figs. 5 and 6). Taken
together, these data suggest that a homomeric hSlo579–664
variant is trafficking-deficient, is trapped intracellularly, and is
thus unable to form functional channels at the plasma
membrane.
Because BK channels exist as tetramers, the hSlo579–664
variant may be able to assemble with other BK channel splice
variant -subunits. To test this idea, we first performed recip-
rocal co-immunoprecipitation assays by expressing a FLAG-
tagged hSlo579–664 variant with HA-tagged zero subunits
(Fig. 3b). Co-expression of the FLAG-hSlo579–664 variantwith
the zero-HA variant resulted in robust, reciprocal co-immuno-
precipitation of both variants (Fig. 3b). Similar co-immunopre-
cipitation was observed using the e22 splice variant (Fig. 3b),
which also shows robust cell surface expression (Fig. 2), or
between hSlo579–664-HA and FLAG-zero (not shown). Thus
hSlo579–664 can heteromultimerize with other BK channel
-subunits, suggesting that channel assembly per se is not
compromised.
We next asked whether cell surface expression of the
hSlo579–664 variant may be rescued upon co-expression with
cell surface trafficking competent -subunits. We thus
expressed a FLAG-hSlo579–664-eYFP variant with the
zero-HA construct to allow simultaneous monitoring of
expression of both constructs in the same cell while assaying for
the external FLAG epitope tag (Fig. 3c) in nonpermeabilized
cell surface assays. However, no significant rescue of the
hSlo579–664 variant was observed. As controls, the co-expres-
sion of zero-HA had no effect on either FLAG-e22-eYFP or
FLAG-zero-eYFP surface expression (Fig. 3c). This was con-
firmed in cell surface biotinylation assays (Fig. 3e).
Because other BK channel -subunit splice variants may act
as dominant negative regulators of cell surface expression (15,
27), we thus askedwhether the hSlo579–664 variant could con-
trol cell surface expression of other variants. Using a FLAG-
tagged zero-eYFP construct (FLAG-zero-eYFP) co-expressed
with the hSlo579–664-HA, zero-HA, or e22-HA variants
allowed us to assay cells in which both constructs were co-
expressed while independently assaying for cell surface expres-
sion using the FLAG epitope. Co-expression of FLAG-zero-
eYFP and hSlo579–664-HA constructs resulted in a significant
reduction (60%) of cell surface expression of FLAG-zero-
eYFP (Fig. 3d). The effect of hSlo579–664-HAwas not due to an
overexpression artifact because co-expression of FLAG-zero-
eYFPwith e22-HAwaswithout effect on FLAG-zero-eYFP sur-
face expression.
Identical data were obtained in cells co-expressing FLAG-
zero channels lacking the eYFP tag with hSlo579–664-HA; sur-
face FLAG expression in the presence of hSlo579–664-HA was
37.6 	 4.2% of FLAG-zero, whereas co-expression with
e22-HA resulted in FLAG surface expression that was 95.0 	
5.6% of FLAG-zero channels. The residual cell surface expres-
sion of FLAG-zero channels in these immunofluorescence
assays when co-expressedwith hSlo579–664most likely results
from formation of homomultimers of FLAG-zero at the cell
surface because in both imaging and cell surface biotinylation
assays (Fig. 3e), we could not detect hSlo579–664 at the cell
surface. As hSlo579–664 and zero channels express at similar
levels in HEK293 cells (Fig. 3a); this may indicate that the effi-
ciency of heteromultimerization is compromisedwhen channel
subunits incorporate the hSlo579–664 variant.
The dominant negative effects of hSlo579–664 data were
recapitulated with biochemical assays of cell surface biotinyla-
tion (Fig. 3e). No significant surface expression could be
detected of either zero-HA or FLAG-hSlo579–664-eYFP in
cells expressing both constructs supporting the dominant neg-
ative role of hSlo579–664. In contrast, robust surface expres-
sion of both FLAG-e22-eYFP and zero-HA could be detected in
cells co-expressing these constructs (Fig. 3e). These data sug-
gest that the hSlo579–664 variant acts as a dominant negative
of cell surface expression.
Exons 18 and 19, but Not Exon 23, Are Essential for Cell Sur-
face Expression—Because the hSlo579–664 variant could het-
eromultimerize with other BK channel -subunits and act as a
dominant negative of cell surface expression, we hypothesized
that the mechanism underlying the trafficking defect was not a
result of incorrect channel assembly, because of the 86-amino
acid deletion, but rather arose from the deletion of essential,
discrete trafficking signals within the RCK-RCK2 linker upon
exclusion of exons 18, 19, and 23 in the hSlo579–664 variant.
As a first step to test this idea, we assayed the contribution of
the individual exons 18, 19, and 23, which are excluded in the
hSlo579–664 variant, to cell surface expression by determining
FIGURE 5. An acidic cluster-like motif in exon 19 is essential for cell surface expression. a, ClustalW sequence alignment of exons 18 and exon 19 from
human (Homo sapiens, accession number AAD31173), mouse (Mus musculus, accession number AAL69971), chicken (Gallus gallus, accession number
NP_989555), turtle (Trachemys scripta, accession number AAC41281), worm (Caenorhabditis elegans, accession number NP_001024259), and fly (Drosophila
melanogaster, accession number NP_524486). The exons form the extreme C terminus of the computationally predicted RCK1 domain and the start of the
unstructured RCK1-RCK2 linker. Three putative trafficking/sorting motifs predicted in this region are shown with only the acidic DDXXDXXXI motif fully
conserved across phyla. Amino acid numbering is based on the amino acid sequence of the human sequence AAD31173 that starts with MDALI. b, represen-
tative confocal sections from HEK293 cells transfected with the DDXXDXXXI mutants (D617A/D618A and I625A) and zero channels with the N-terminal epitope
labeled under nonpermeabilized conditions and the intracellular C-terminal HA tag under permeabilized conditions. The scale bars are 2 m. c, summary bar
chart of cell surface FLAG expression of trafficking/sorting motif mutants in which amino acids within the proposed motifs are mutated to alanine. Cell surface
expression is expressed as a percentage of the FLAG-zero-HA construct using FLAG surface expression in nonpermeabilized assays as in Fig. 2. d, representative
Western blots of HA immunoreactivity from cell surface biotinylation assays of HEK293 cells expressing the corresponding constructs and whole cell lysates.
e, summary bar chart of cell surface biotinylation data as in d. All of the data are the means 	 S.E. from a minimum of three independent experiments with 720
cells analyzed/group in c. **, p  0.01, ANOVA with post hoc Dunnett’s test compared with the zero channel.
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whether cell surface expression of the hSlo579–664 variant
could be rescued by the reinsertion of single or double exons in
combination (Fig. 4).We thus generated a number of chimaeras
in which one or two exons were ligated in-frame between exons
16 and 24 in the hSlo579–664 variant. Inclusion of exons 18, 19,
or 23 alone (constructs e18, e19, or e23) did not rescue any cell
surface expression of the hSlo579–664 variant. Similarly, inclu-
sion of exon 19 with exon 23 (e19 
 e23) or exon 18 with exon
23 (e18 
 e23) did not rescue cell surface expression of the
hSlo579–664 variant. In contrast, inclusion of both exons 18
and 19 (e18 
 e19) partially rescued cell surface expression in
both quantitative immunofluorescence assays (Fig. 4a) as well
cell surface biotinylation assays (Fig. 4b). These data suggest
that: (i) exon 23 is not essential per se for cell surface expression;
(ii) the length of the amino acid insertion per se is not important
for cell surface expression; and (iii) exons 18 and 19 are required
for cell surface expression, and thus their exclusion is likely to
result in loss of putative trafficking signals.
AnAcidicClusterMotif in the RCK1-RCK2Linker Is Required
for Cell Surface Expression—To further refine our analysis, we
aligned exons 18 and 19 from the zero variants of BK channel
orthologs from man to flies (Fig. 5a). This revealed the high
conservation of this region that spans the veryC terminus of the
computationally predicted RCK1 domain and the start of the
unstructured (NORS) RCK1-RCK2 linker region (18).
Examination of the amino acid sequence encoded by exons
18, 19, and 23 (Fig. 5a) revealed three regions that may act as
putative traffickingmotifs: (i) The junction of exon 16 and exon
18 encodes a putative TGN-endosome trafficking signal in ver-
tebrate BK channels (EXXXLI) similar to the consensus
(D/E)XXXL(L/I). However, (D/E)XXXL(L/I) motifs show con-
siderable degeneracy (28) with an RXXXLL signal exploited in
the Glut4 transporter (29) and an EXXXLI motif in AQP4 (30).
(ii) Exon 19 encodes a putative acidic cluster signal DDXXD
that is important for trafficking of a number of potassium chan-
nels (22, 31–34). In addition, the acidic cluster may also form
part of aDXXLL-likemotif (DXXXI) that is predicted (using the
PredictProtein server; data not shown) to form a short-helical
structure. Intriguingly, such a short -helical region is com-
monly observed in other ER exit signals with little primary
sequence homology (16, 35) and is predicted to play an impor-
tant role in the more C-terminal ER exit signal in BK channels
(16). Furthermore, this short -helical region represents the
only computationally predicted structured region in the other-
wise unstructured NORS (no regular secondary structure)
RCK1-RCK2 linker (18) conserved from man to flies. (iii) The
very 5 start of exon 23 encodes another putative acidic motif
(EDE) that is conserved in vertebrates.
We took a site-directedmutagenesis approach using the zero
variant to examine the contribution of these putative trafficking
signals in BK channel cell surface expression (Fig. 5, b and c).
Mutation of Glu576 or of Leu580 and Ile581 to alanine to disrupt
the EXXXLI motif at the exon 16-exon 18 junction, as well as
alanine mutation of the EDE motif in exon 23, significantly
reduced cell surface labeling of the zero variant in imaging
assays but did not abolish it (Fig. 5c). Furthermore, a combina-
tion of mutations at both sites did not abolish cell surface label-
ing, because expressionwas still 20.1	 4.2% of the zero variant.
FIGURE 6. Trafficking-deficient BK channel mutants are trapped in the
ER. a, representative single confocal sections from permeabilized cells
co-transfected with the corresponding HA-tagged BK channel site-di-
rected mutant (construct, green) and the endoplasmic reticulum marker
expression plasmid pdsRed-ER (ER, red). The merged images are shown in
the right-hand panels. b, summary bar graph of Pearson’s correlation coef-
ficient for quantitative co-localization of the respective HA-tagged chan-
nels with the pdsRed-ER marker (a value of 1.0 would indicate complete
co-localization). *, p  0.05, ANOVA with post hoc Dunnett’s test com-
pared with the zero channel.
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In contrast, mutation of the DDXXDXXXI motif (D617A/
D618A or I625A constructs) completely abolished cell surface
labeling in imaging assays as with the hSlo579–664 variant (Fig.
5, b and c). To confirm the lack of cell surface expression in
these mutants, we also performed cell surface biotinylation
assays (Fig. 5, d and e). Mutation of the DDXXDXXXI motif
(D617A/D618A mutant) again abolished cell surface expres-
sion as for the hSlo579–664 splice variant. In contrast, muta-
tion of the EXXXLI or EDE motifs (E576A or E634A/D635A/
E636A, respectively) significantly reduced but did not abolish
cell surface expression of the channel (Fig. 5, d and e). However,
because mutation of the EDE motif alone significantly reduced
surface expression, this would suggest that the inability to fully
rescue surface expression with the e18
 e19 construct in Fig. 4
is a result of the loss of the EDE sequence within exon 23 in the
e18 
 e19 construct. Mutation of the DDXXDXXXI motif also
completely abolished cell surface labeling in the e18
 e19 con-
struct, further confirming the essential requirement for this
sequence (not shown).
The mutant channels were now predominantly ER-localized
as determined by co-localization assays (Fig. 6, a and b). We
determined the Pearson’s correlation coefficient in quantitative
immunofluorescence imaging assays with the channel con-
structs upon co-expression with the ER marker pdsRed-ER
(Clontech). For the zero variant the coefficient was 0.59	 0.05,
which was significantly (ANOVA, post hoc Dunnett’s test p 
0.01) increased with the hSlo579–664 variant as well as the
D617A/D618A and I625A mutants (Fig. 6b), demonstrating
trapping of these mutants in the ER.
Because the DDXXDXXXI acidic-like motif plays a domi-
nant role in determining cell surface expression, we thus
asked whether this motif could function as a transplantable
trafficking signal. We exploited the GABABR1a receptor (a
nonchannel subunit of the G-protein-coupled receptor for
the -aminobutyric acid neuro-
transmitter), which is normally
retained in the ER by a RXRR-de-
pendent ER retrieval and retention
mechanism to examine whether
the DDXXDXXXI motif could
enhance cell surface expression of
the receptor as for acidic traffick-
ing motifs identified in other
potassium channels (22). We engi-
neered the DDXXDXXXI motif
onto the intracellular C terminus
of the GABABR1a receptor and
monitored cell surface to intracel-
lular expression by probing for the
extracellular N-terminal HA tag
under nonpermeablized and per-
meabilized conditions using quan-
titative immunofluorescence (Fig.
7). In agreement with previous
studies (22), the DDXXDXXXI
motif could not rescue surface
expression of the wild type
GABABR1a receptor (Fig. 7b).
However, in GABABR1a receptors with an arginine to ala-
nine point mutation in its ER retention/retrieval RXRRmotif
(ASRR mutant), surface expression of the GABABR1a recep-
tor was now detectable. Importantly, surface expression was
significantly enhanced (almost 2-fold) by transplanting the
DDXXDXXXI motif from the BK channel. Thus the DDXX-
DXXXI sequence cannot override the ER retention/retrieval
signal but can accelerate ER export in the absence of the
RXRR motif as demonstrated for other acidic ER export sig-
nals from inwardly rectifying potassium channels (22). To
verify that the D617A/D618A and I625A mutations resulted
in a significant reduction of functional BK channel expres-
sion at the plasma membrane, we exploited a membrane
potential assay (24) to interrogate BK channel activation in
response to ionomycin-induced (1 M) calcium influx in
HEK293 cells using the voltage-sensitive dye FLIPR blue
(Molecular Devices). In response to ionomycin HEK293
cells, expressing the functional zero channel variant elicited
a robust hyperpolarization compared with mock transfected
HEK293 cells (Fig. 8a). No significant hyperpolarization in
membrane potential was observed in cells expressing
hSlo579–664 (Fig. 8). Membrane hyperpolarization was sig-
nificantly attenuated (to less than 40% of zero) in cells
expressing either the D617A/D618A or the I625A mutant in
line with the reduced membrane expression in imaging
assays. The residual hyperpolarization with both mutants
suggests that low numbers of D617A/D618A and I625A
channels may reach the cell surface and that this level is
below the limit of detection in our cell surface labeling
assays. Taken together, these data reveal that the acidic clus-
ter-like motif in exon 19 represents a transplantable traffick-
ing motif that plays a critical role in controlling cell surface
expression of BK channels.
FIGURE 7. Acidic cluster sequence (DDXXDXXXI) is a transplantable ER export motif. a, re-
presentative single confocal sections from HEK293 cells expressing the GABABR1a receptor with
(GABABR1a(ASRR)
DDXXDXXXI) and without (GABABR1a(ASRR)) the DDXXDXXXI motif engineered onto the
C terminus. The N-terminal (extracellular) HA epitope tag was labeled under nonpermeabilized (left pan-
els, red) and permeabilized (middle panels, green) conditions in the same cell with the merged images
shown in the right-hand panels. The GABABR1a receptor contained an arginine to alanine mutation (ASRR)
compared with the wild type GABABR1a receptor. The scale bars are 2 m. b, summary bar graph of
quantitative surface/intracellular HA expression normalized to the ratio for the GABABR1a(ASRR) express-
ing cells (100%). **, p  0.01, ANOVA with post hoc Dunnett’s test compared with the zero channel (n 
16 –19/group).
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We have identified three distinct motifs within the intracel-
lular RCK1-RCK2 linker of BK channels that control their cell
surface expression. In particular, an acidic cluster-like motif,
DDXXDXXXI, is critical for cell surface expression and is highly
conserved from flies to man. This acidic motif can be trans-
planted to nonchannel proteins to accelerate ER export but
cannot override pre-existing ER retention signals, as described
for other acidic motifs (22). Importantly, alternative splicing of
a human BK channel splice variant hSlo579–664 that excludes
the exons encoding this motif results in a trafficking-deficient
BK channel that acts as a dominant negative for cell surface
expression.
TheDDXXDXXXImotifmay comprise both an acidic cluster
motif as well as a degenerate DXXLL motif. Indeed in worms
and flies, a DXXLI motif is retained, whereas the third position
is an arginine in vertebrates. Thus, although the motif does not
share sequence conservation with other trafficking motifs, it is
intriguing that the DXXXI motif is predicted to form a short
-helix at the very beginning of the predicted linker region that
otherwise lacks a regular secondary structure (18). A short
-helical structure is a feature commonly associated with ER
export signals that do not show sequence homology (16, 35) as
suggested for the more C-terminal ER export sequence in BK
channels (16). Acidic cluster motifs are also commonly used as
ER export signals, including in other potassium channels (22,
31, 33, 34). These features also appear crucial for cell surface
expression of BK channels. In contrast, the EDE acidic cluster in
exon 23 is not essential for surface expression, but mutagenesis
does significantly reduce it. Similar acidic clusters have been
reported in other transmembrane proteins including inwardly
rectifying and TASK3 potassium channels (22, 31, 33, 34). The
EXXXLI motif is most likely a member of the (D/E)XXXL(L/I)
sorting motif that shows considerable degeneracy; in fact, in
AQP4 channels an EXXXLI motif is essential for correct traf-
ficking (30).
The demonstration here of exclusion of the ER export
DDXXDXXXI acidic motif by alternative splicing in the
intracellular C-terminal linker of BK channels nicely con-
trasts with the inclusion of an hydrophobic (CVLF) ER reten-
tion signal through alternative splicing of the N-terminal
intracellular S0-S1 loopofBKchannels (12).Taken together, these
data strongly support the hypothesis that alternative splicing plays
a major role in controlling cell surface expression of ion channels
and that this can be achieved in the same channel by diametrically
opposite mechanisms: through either exclusion or inclusion of
cognate traffickingmotifs.
Why do BK channels have multiple trafficking motifs whose
inclusion can be controlled by alternative splicing? Because BK
channels have pleitropic functions in virtually all tissues of the
body, it is likely that multiple trafficking and sorting signals are
required to allow the correct surface expression and subcellular
localization of BK channels relevant to the target tissue of inter-
est. Furthermore, increasing evidence suggests that cell surface
expression of BK channels is dynamically regulated, both
through signals that may regulate splicing and through post-
translational modifications and assembly with distinct regula-
tory -subunits. Thus these multiple mechanisms are likely
coordinated to expose or mask the correct complement of traf-
ficking and sorting signals to allow appropriate distribution of
BK channels within distinct cell types. Indeed, alternative splic-
ing of the rat SVcyt ortholog of hSlo579–664 is dynamically
regulated in corporeal tissue in models of diabetes (17).
Whether the dominant negative function of hSlo579–664 is phys-
iologically relevant in this or other model systems remains to
be explored. Clearly the inclusion (13, 27) or exclusion (as
observed with the hSlo579–664 variant here) of trafficking
motifs through alternative splicing most likely represents a
fundamental mechanism for controlling BK channel cell sur-
FIGURE 8. Acidic cluster sequence (DDXXDXXXI) is required for efficient
functional channel expression. a, time course plots of change in relative
fluorescence units (r.f.u) of the FLIPR blue membrane potential dye in
HEK293 cells expressing zero (E), hSlo579 – 664 (ƒ), D617A/D618A (‚),
I625A (f), or mock transfected HEK293 cells () in response to calcium
influx induced by 1 M ionomycin. A decrease in fluorescence relative to
the HEK293 cell response indicates a net hyperpolarization of the mem-
brane potential resulting from activation of BK channels. b, summary bar
chart of the membrane potential change for each construct in a expressed
as a percentage of the maximal hyperpolarization elicited in HEK293 cells
expressing the zero variant (100%). The data were determined at t  70 s
in the time course plots in a. All of the data are the means 	 S.E. (n 
9 –12). **, p  0.01, ANOVA with post hoc Dunnett’s test compared with
the zero channel response.
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face expression under a variety of physiological and patho-
physiological conditions.
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Multiple Palmitoyltransferases Are Required for
Palmitoylation-dependent Regulation of Large Conductance
Calcium- and Voltage-activated Potassium Channels*
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Palmitoylation is emerging as an important and dynamic reg-
ulator of ion channel function; however, the specificity with
which the large family of acyl palmitoyltransferases (zinc finger
Asp-His-His-Cys type-containing acyl palmitoyltransferase
(DHHCs)) control channel palmitoylation is poorly understood.
We have previously demonstrated that the alternatively spliced
stress-regulated exon (STREX) variant of the intracellular
C-terminal domain of the large conductance calcium- and volt-
age-activated potassium (BK) channels is palmitoylated and tar-
gets the STREX domain to the plasmamembrane. Using a com-
bined imaging, biochemical, and functional approach coupled
with loss-of-function (small interfering RNA knockdown of
endogenous DHHCs) and gain-of-function (overexpression of
recombinant DHHCs) assays, we demonstrate that multiple
DHHCs control palmitoylation of the C terminus of STREX
channels, the association of the STREX domain with the plasma
membrane, and functional channel regulation. Cysteine resi-
dues 12 and 13 within the STREX insert were the only endog-
enously palmitoylated residues in the entire C terminus of the
STREX channel. Palmitoylation of this dicysteine motif was
controlled by DHHCs 3, 5, 7, 9, and 17, although DHHC17
showed the greatest specificity for this site upon overexpression
of the cognate DHHC. DHHCs that palmitoylated the channel
also co-assembled with the channel in co-immunoprecipitation
experiments, and knockdown of any of these DHHCs blocked
regulation of the channel by protein kinase A-dependent phos-
phorylation. Taken together our data reveal that a subset of
DHHCs controls STREX palmitoylation and function and sug-
gest that DHHC17 may preferentially target cysteine-rich
domains. Finally, our approach may prove useful in elucidating
the specificity ofDHHCpalmitoylation of intracellular domains
of other ion channels and transmembrane proteins.
S-Palmitoylation, the reversible addition of 16-carbon satu-
rated palmitic acid to intracellular cysteine residues through a
labile thioester linkage (1–5), is emerging as an important
dynamic and potent determinant of ion channel function.
Palmitoylation controls cell surface expression and regulation
of many ligand-gated ion channels, including -amino-3-hy-
droxyl-5-methyl-4-isoxazole-propionate (6), N-methyl-D-as-
partate (7), Kainate (8), P2X7 (9), and-aminobutyric acid, type
A (10–12). Palmitoylation also controls the function of voltage-
gated calcium (13–15), sodium (16), and potassium (17–19) as
well as other channels such asAQP4 (20). For example, inKv1.1
potassium channels palmitoylation controls voltage dependence
(18), and in the stress-regulated exon (STREX)3 splice variant of
large conductance calcium- and voltage-activated potassium (BK)
channels, palmitoylation determines channel regulation by pro-
tein phosphorylation (19). However, although functional insights
into ion channel regulation by protein palmitoylation are begin-
ning to emerge, the control of channel palmitoylation is poorly
understood, as for other palmitoylated proteins (21).
Protein palmitoylation is controlled by the balance of palmi-
toyl acyltransferases and palmitoyl thioesterases (1–5). Re-
cently the zinc finger DHHC (Asp-His-His-Cys) type-contain-
ing protein family has emerged as a large family of palmitoyl
acyltransferases with 23 members in the mouse and human
genomes (22, 23). Previous studies have implicated the rela-
tively promiscuous palmitoyltransferase DHHC3 (also known
as Golgi-specific DHHC zinc finger protein, GODZ) in palmi-
toylating some ligand-gated ion channels (6, 7, 10, 12). How-
ever, the role of DHHC3 or other DHHCs in controlling palmi-
toylation of other ion channels, including BK channels, is not
known. Furthermore, whether different DHHCs display speci-
ficity for palmitoylating individual ion channels has not been
examined systematically. Elucidation of such DHHC-substrate
relationships would provide significant insight into both the
functional role of ion channel palmitoylation and the specificity
of DHHCs for diverse target proteins.
We have previously demonstrated that a dicysteine motif
(Cys12-Cys13) within the alternatively spliced STREX insert of
the intracellular C terminus of BK channels (see Fig. 1) is pal-
mitoylated and targets the C terminus to the plasmamembrane
in the absence of the transmembrane domains (19). In this
manuscript, we have thus asked which DHHCs are responsible
for palmitoylation of the STREXdomain of the BK channel.We
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took advantage of the robust endogenous palmitoylation of
STREX channels in human embryonic kidney 293 (HEK293)
cells as an assay system to systematically exploit both loss and
gain of function approaches, through siRNA-mediated knock-
down of endogenous DHHCs and overexpression of murine
recombinant DHHCs, respectively, to interrogate the role of
individual DHHCs in controlling STREX palmitoylation. In
initial assays we exploited an imaging screen based on the
palmitoylation-dependent plasma membrane localization of
the intracellular STREX domain of the BK channel in HEK293
cells (19). Our data represent the first systematic analysis of the
contribution of individual DHHCs in controlling palmitoyla-
tion of a voltage-gated ion channel. These studies reveal that
multiple endogenousDHHCs control palmitoylation of STREX
and that DHHC17 has the highest selectivity for the STREX
Cys12-Cys13 motif. Furthermore, we demonstrate that the
DHHCs that regulate STREX palmitoylation can also assemble
as a complex with the channel and determine the regulation of
STREX channels by protein kinase A (PKA) phosphorylation.
EXPERIMENTAL PROCEDURES
Channel Constructs—The generation of full-length, C-termi-
nal, and CRD epitope-tagged constructs of the STREX and
ZERO variants of the murine BK channel has been described
(19). All mutagenesis was performed using QuikChange
mutagenesis (Stratagene) with constructs fully sequenced on
both strands to verify sequence integrity.
Cell Culture, Transfection, and RNA Extraction—HEK293
cells were maintained in DMEM containing 10% fetal calf
serum in a humidified atmosphere of 95% air, 5% CO2 at 37 °C.
The cells were passaged every 3–7 days using 0.25% trypsin in
Hanks’ buffered salt solution containing 0.1% EDTA. For RNA
extraction or biochemical studies, the cells were grown in 24- or
6-well plates, respectively. For electrophysiological or imaging
assays, the cells were plated on glass coverslips within 6-well
plates. Twenty-four hours prior to the experiment, the cells
were washed, and medium was replaced with DMEM contain-
ing ITS serum replacement (Sigma). The cells were transiently
transfected at 40–60% confluence using Lipofectamine 2000
(Invitrogen) or FuGENE-HD (Roche Applied Science). For
RNA interference, siRNAs were predesigned and supplied by
Qiagen. The knockdown of DHHCs was performed in HEK293
cells by using two siRNAs (10–20 nM of each siRNA) for each
gene. siRNA transfection was performed using HiperFect (Qia-
gen), essentially as described by the manufacturer. The respec-
tive cDNA was transfected 30 min after the completion of
siRNA transfection. RNA extraction was carried out 48–72 h
post-siRNA transfection using a High Pure RNA isolation kit
(Roche Applied Science) according to the manufacturer’s proto-
cols. In all of the imaging and biochemical assays siRNA knock-
down of DHHCs was monitored in parallel in each independent
experiment. Independent experiments were conducted a mini-
mum of three times in triplicate. The palmitoylation inhibitor
2-bromopalmitate (Sigma) was made as a fresh 100 mM stock in
Me2SO and applied at a final concentration of 100 M overnight.
Quantitative Real Time PCR—cDNA was synthesized from
the total mRNA of each DHHC knockdown sample using a
Transcriptor High Fidelity cDNA synthesis kit (Roche Applied
Science) as described by the manufacturer. The efficiency of
knockdown of eachDHHCat themRNA level was analyzed using
SYBR Green JumpStart Taq Ready Mix (Sigma) in a 25-l total
volume reaction on an ABIPrism 7000 real time PCR machine.
Approximately 50–75 ng of cDNA was used per reaction with
primersat0.2Mfinal concentrations.The internal referencecon-
trol was endogenous -actin detected using Qiagen primer set
AT01680476. All of the reactions were performed in triplicate.
Cyclingconditionswere50 °C for2min, 95 °C for10min, followed
by 40 cycles of 95 °C for 15 s, and then 60 °C for 1 min. All of the
primers were previously validated with efficiencies calculated to
be within 0.1 of the control using the equation e  10(1/slope)  1.
The percentage of mRNA remaining was calculated using the
equation %mRNA remaining  2Ct  100.
Imaging—Briefly, the cells were plated on glass coverslips,
transfected as above, and fixed 48 h after transfection except for
experiments in Fig. 4 where cells were fixed 24 h post-transfec-
tion. The cells were first washed twice with PBS (Invitrogen)
and then fixedwith ice-cold 4%paraformaldehyde in PBS for 15
min at room temperature. The cells were washed three times
with ice-cold PBS and quenched with 50 mM NH4Cl in PBS for
10 min. The cells were washed three times in ice-cold PBS
before mounting on microscope slides using Mowiol. The cells
were initially analyzed under epifluorescence using an inverted
Nikon Eclipse 2000microscope using a 100 oil objective lens.
High power confocal images were acquired on a Zeiss LSM510
laser scanning microscope, using a 63 oil Plan Apochromat
(NA  1.4) objective lens, in multi-tracking mode to minimize
channel cross-talk. For each independent cell transfection,
three or four coverslips/6-well cluster plate were analyzed for
each construct. For each coverslip three to five random fields of
view were analyzed to determine the number of transfected
cells with plasma membrane localization of the respective
fusion protein. The average percentage of transfected cells from
each well was then determined for each independent transfec-
tion (experiment) and normalized to the corresponding wild
type STREX control (membrane expression was typically
observed in  95% of transfected wild type STREX fusion pro-
teins). The majority of experiments were performed blind. In
addition, a random subset of cells was also analyzed by quanti-
fying the relative peripheral membrane expression compared
with the “intracellular” (cytoplasm nucleus) expression using
ImageJ. The ratio of membrane/intracellular fluorescence was
determined and normalized to control treated cells assayed in
the same experiment under identical conditions. There was no
qualitative difference between these approaches. As such all of
the data are expressed as percentages of the respective control
means  S.E. for N independent experiments, where n  min-
imum total number of cells analyzed across experiments for
each construct/treatment.
Palmitoylation Assays, Pulldowns, and Western Blotting—
CSS-palm prediction was performed using the published CSS-
palm v2.0 palmitoylation algorithm (24).
[3H]Palmitic Acid Incorporation—HEK293 cells were tran-
siently transfected in 6-well cluster dishes ( 3 106 cells/well)
with the HA-tagged constructs as indicated in the respective
figure legends. Forty-eight hours post-transfection, the cells
were washed, and 1 ml of fresh DMEM containing 10 mg/ml
DHHC Palmitoylation of BK Channels
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fatty acid free bovine serum albumin was added for 30 min at
37 °C. The cells were incubated in DMEM/bovine serum albu-
min containing 0.5mCi/ml [3H]palmitic acid (PerkinElmer Life
Sciences) for 4 h at 37 °C, and then the medium containing the
free label was removed. The cells were lysed in 150mMNaCl, 50
mM Tris-Cl, 1% Triton X-100, pH 8.0, and centrifuged, and
channel fusion proteins were captured using magnetic
microbeads coupled to HA/GFP antibody (MACSTM epitope
tag isolation kits; Miltenyi Biotech). After washing columns
with 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1%
SDS, 50 mM Tris-Cl, pH 8.0, followed by washes with 50 mM
Tris-Cl, pH 7.5, the captured proteins were eluted in SDS-
PAGE sample buffer (50 mM Tris-Cl, pH 6.8, 5 mM dithiothre-
itol, 1% SDS, 1 mM EDTA, 0.005% bromphenol blue, 10% glyc-
erol) prewarmed to 95 °C. The recovered samples were
separated by SDS-PAGE, transferred to nitrocellulose mem-
branes, and probed with either a monoclonal GFP antibody
(Clontech; 1:3000) or polyclonal HA antibody (Zymed Labora-
tories Inc.; 1:1000). A duplicate membrane was dried and
exposed to light-sensitive film at80 °C using a Kodak Biomax
transcreen LE (Amersham Biosciences). Co-immunoprecipita-
tion experiments were performed essentially as described using
the magnetic microbeads and antibodies as above.
Electrophysiological Assays—Single channel current record-
ings were performed in the inside-out configuration of the
patch clamp technique at room temperature (20–24 °C). The
pipette solution (extracellular) contained 140 mM NaCl, 5 mM
KCl, 1 mM CaCl2, 2 mM MgCl2, 20 mM glucose, 10 mM HEPES,
pH7.4. The bath solution (intracellular) contained 140mMKCl,
5 mM NaCl, 2 mM MgCl2, 1 mM 1,2-bis(o-aminophe-
noxy)ethane-N,N,N	,N	-tetraacetic acid, 30mMglucose, 10mM
HEPES, 1 mM ATP, pH 7.3, with free calcium [Ca2]i buffered
to 0.1 M, unless indicated otherwise. Channel activity was
determined during 60-s depolarizations to 40 mV. Data
acquisition and voltage protocols were controlled by an Axo-
patch 200B amplifier and pCLAMP9 software (Axon Instru-
ments Inc., Foster City, CA). All of the recordingswere sampled
at 10 kHz and filtered at 2 kHz. Channel activity was allowed to
stabilize for at least 10min after patch excision before the addi-
tion of drugs. The catalytic subunit of PKA (PKAc) was from
Promega (Madison, WI). Single-channel open probability (Po)
was derived from single-channel analysis using WINEDR (ver-
sion 2.3.9; Dempster, J., University of Strathclyde, Strathclyde,
UK). To determine the mean percentage of change in channel
activity after a treatment, mean Po or N*Po was measured
immediately before and 10 min after the respective drug appli-
cation. The effect of cAMP and/or PKAc on channel activity
was typically maximal by 5 min and remained stable over the
next 10–30 min following application to inside-out patches.
The effect of PKA-mediated phosphorylation was abolished in
the absence ofMg-ATP and prevented using the PKA inhibitor
PKI5–24 (data not shown and see Refs. 19 and 25–27).
Statistical Analysis—All of the data are presented as the
means  S.E. with N  number of independent experiments
and n  number of individual cells analyzed in imaging assays.
The data were analyzed by analysis of variance with post-hoc
Dunnett’s test or using a nonparametric Kruskal-Wallis test as
appropriate with the significance set at p 
 0.05.
RESULTS
Cysteine Residues within STREX Are the Only Endogenously
Palmitoylated Residues in the Entire C Terminus of BK
Channels—Expression of the entire intracellular C-terminal
domain of the STREX splice variant of the murine BK channel
as a HA- or GFP epitope-tagged construct (STREX-Cterm; Fig.
1a) in HEK293 cells resulted in robust palmitoylation (Fig. 1b)
by endogenous palmitoyltransferases (DHHCs) and expression
at the plasma membrane in the absence of the transmembrane
domains (Fig. 1, c and d). We have previously demonstrated
that the di-cysteine motif at amino acid positions 12 and 13
within the STREX insert is essential for this membrane local-
ization and can be conferred by expression of the cysteine-rich
domain (CRD) alone, which includes STREX and the immedi-
ately upstream heme-binding domain (19). In accordance with
this, mutation of both cysteines to alanine (C12A/C13A) abol-
ished palmitoylation of STREX-Cterm by endogenous DHHCs
(Fig. 1b) as well as plasma membrane localization (Fig. 1d). In
the C12A/C13A palmitoylation-deficient mutants, the fusion
protein was robustly expressed as for wild type (Fig. 1b) but
displayed a largely nuclear and/or cytoplasmic cellular distribu-
tion (Fig. 1c). Plasma membrane localization of the STREX C
terminus, or CRD, was also abolished by preincubation of cells
with the palmitoylation inhibitor 2-bromopalmitate (28, 29)
(Fig. 1d). Furthermore, expression of the ZERO variant C ter-
minus (ZERO-Cterm) that is identical to STREX-Cterm except
with the exclusion of the STREX insert (19, 25, 27), was not
palmitoylated by endogenous DHHCs inHEK293 cells and dis-
played a largely cytoplasmic distribution (Fig. 1, b and c). Taken
together, these data demonstrate that the only cysteine residues
within the entire C terminus of the STREX variant of the BK
channel that are endogenously palmitoylated in HEK293 cells
are cysteine residues 12 and 13 within the STREX insert.
Multiple Endogenous DHHCs Control Membrane Expression
of the STREXDomain—In an attempt to addresswhichDHHCs
regulate palmitoylation of the STREX insert, we first examined
the mRNA expression of endogenous DHHCs in our HEK293
cells. Using quantitative real time PCR (qRT-PCR) revealed
expression of all 23 humanDHHCs at themRNA level (Fig. 2, a
and b). In HEK293 cells DHHC4 mRNA was expressed at the
highest level with most other DHHCmRNAs expressed at lev-
els between 5 and 20% of DHHC4.
Based on this mRNA expression profile, we exploited multi-
ple siRNAs against each DHHC isoform to allow us to screen
the effect of knocking down DHHC isoforms on membrane
localization of the STREX domain. For themajority of DHHCs,
we could reliably achieve 80% knockdown (i.e. 
20% mRNA
remaining) of mRNA as determined by qRT-PCR, using two
siRNAs/DHHC (Fig. 1c). In a few cases (e.g. DHHC 11 and 19),
even using multiple distinct siRNA combinations, we were
unable to achieve mRNA knockdown above 50%. Because anti-
bodies are not available to reliably detectmostDHHC isoforms,
wewere unable tomonitor DHHCprotein levels. Thus tomon-
itor for knockdown efficiency in this system, we transfected
siRNA against GFP to knock down expression of the STREX-
Cterm-GFP fusion protein. Under our transfection conditions,
typically 75% of all cells express the transfected fusion con-
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struct. In the presence of GFP siRNA, less than 2% of all cells
displayed significant GFP expression, indicating that the effi-
ciency of GFP knockdown was 97%.
By exploiting this siRNA screen in conjunction with
expression of the CRD-YFP construct (to maximize signal/
noise ratio), we first assayed the contribution of individual
DHHCs to regulate the plasma membrane expression of the
CRD-YFP construct in imaging assays. Individual knock-
down of DHHCs 3, 5, 7, 9, and 17, but none of the other
DHHCs in which high efficiency knockdown could be
achieved resulted in a significant reduction in plasma mem-
brane expression of the CRD-YFP fusion protein in HEK293
cells compared with the control (scrambled siRNA) alone
(Fig. 2d), implicating these DHHCs in STREX palmitoyla-
tion. However, combinatorial knockdown of these DHHCs
did not result in additive effects beyond those seen with the
largest decrease in membrane expression of the CRD-YFP
fusion protein with siRNA against DHHC9 (data not shown).
Combinatorial knockdown was limited by the reduced effi-
ciency of knockdown using multiple siRNAs and was limited
by total siRNA concentrations 100 nM being toxic to cells.
In contrast, inhibition of palmitoyltransferase activity using
FIGURE 1. Endogenous palmitoylation of the BK channel C terminus in HEK293 cells is only conferred by cysteine residues 12 and 13 in the alternatively
spliced STREX insert. a, schematic illustrating a single pore-forming -subunit of the STREX splice variant of the BK channel. The STREX splice insert is localized in the
intracellular linker between the two regulator of potassium conductance (RCK) domains. The STREX insert together with the upstream heme-binding domain
represent the CRD of the linker. Amino acid numbering of the STREX insert starts with the first lysine residue, and cysteine residues 12 and 13 are predicted to be
palmitoylated. b, fluorograph (upper panel) and corresponding Western blot (lower panel) of HA-tagged C-terminal constructs of the BK channel expressed in HEK293
cells. The cells were labeled with [3H]palmitate (3H-palm) for 4 h, and the constructs were immunoprecipitated using anti-HA magnetic microbeads. c, representative
single confocal sections and schematics of GFP C-terminal or YFP CRD constructs expressed in HEK293 cells. The scale bars are 5 m. d, quantification of construct
expression at the plasma membrane expressed as percentages of the membrane expression of the respective STREX-Cterm or CRD fusion protein. Cells treated with
the palmitoyltransferase inhibitor 2-bromopalmitate (2BP) were exposed to 100 M overnight. The data are the means  S.E. where N  5 and n  400 for each
construct/condition. **, p 
 0.01, compared with respective STREX construct by analysis of variance with post-hoc Dunnett’s test.
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2-bromopalmitate reduced membrane expression of the
CRD-YFP fusion protein to 
10% of control (Fig. 1d).
Knockdown of DHHCs 3, 5, 7, 9, and 17 also significantly
reduced plasma membrane expression of the STREX-Cterm-
GFP fusion protein by50% (Fig. 3, a and b) comparedwith the
scrambled siRNA control. To test whether siRNA knockdown
of DHHCs 3, 5, 7, 9, and 17 in fact regulated palmitoylation
status of the STREX domain, we assayed [3H]palmitate incor-
poration into the STREX-Ctermconstruct. Importantly, siRNA
knockdown of these DHHCs also significantly reduced but did
not completely abolish palmitoylation of the STREX-Cterm
fusion protein (Fig. 3, c and d). Similar reductions in bothmem-
brane expression and palmitoylation were observed when each
individual DHHC was knocked down by siRNA. One possible
explanation is that knockdown of any one of theseDHHCs results
in a compensatory reduction in expression of a common DHHC.
For example, does knockdown of DHHC 3, 5, 7, or 9 also give a
reduced DHHC17 expression? However, at least at the mRNA
level, we sawno significant down-regulation of a commonDHHC
mRNAuponknockingdown individualDHHCs (datanot shown).
Taken together these data suggest that the endogenousDHHCs 3,
5, 7, 9, and 17 are important determinants of the palmitoylation
status of the STREX domain.
DHHC Overexpression Enhances Membrane Expression of
the STREX C Terminus—If endogenous DHHCs 3, 5, 7, 9, and
17 control palmitoylation of the STREX domain, we hypothe-
sized that overexpression of these DHHCs should enhance
plasma membrane localization of the STREX C terminus. We
thus co-expressed the STREX-Cterm-GFP construct with HA-
tagged murine DHHCs (22) and examined the plasma mem-
brane localization of STREX-Cterm-GFP in HEK-293 cells co-
expressing both fusion proteins. To facilitate analysis we
co-expressed constructs and imaged expression 24 h after
expression. Under these conditions STREX-Cterm-GFP mem-
brane localization is typically 25% (Fig. 4a) of that seen under
normal conditions when imaging is performed 48 h after trans-
fection as in Figs. 1 and 3. Under these conditions, overexpres-
sion of DHHCs 3, 5, 7, 9, and 17 significantly increased (more
than 2-fold) plasma membrane localization of the STREX-
Cterm fusion protein (Fig. 4b). This stimulatory effect was not
observed in the presence of the palmitoyltransferase inhibitor
2-bromopalmitate (data not shown).
In contrast, overexpression of DHHCs identified in our
siRNA screen because not being involved in endogenous palmi-
toylation of the STREX domain, including those such as
DHHCs 11, 19, and 24 in which siRNA knockdown was 
70%,
had no significant effect on STREX-Cterm-GFP expression at
the plasma membrane (Fig. 4c). Furthermore, co-expression of
the catalytically inactive palmitoyltransferase mutants DHHS3
or DHHS7 (22) had no effect on membrane expression, dem-
onstrating that the palmitoyltransferase activity of the DHHCs
is required rather than an effect via a possible chaperone func-
tion (Fig. 4c). To verify that the effect of DHHC overexpression
was dependent upon palmitoylation of the STREX domain
itself, we analyzed the effect of DHHCs 3, 5, 7, 9, and 17 on the
C12A/C13Amutant of the STREX-Cterm fusion protein that is
an absolute requirement for palmitoylation by endogenous
DHHCs and expression at the plasma membrane (Fig. 1, b–d).
Under these conditions membrane expression of the C12A/
C13A fusion alone is almost undetectable (Fig. 4d). Surpris-
ingly, overexpression of DHHCs 3, 5, 7, or 9 also significantly
enhancedmembrane expression of theC12A/C13A fusion pro-
tein to levels that in fact approached that observed upon co-
expression with the wild-type STREX-Cterm-GFP (Fig. 4d). In
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FIGURE 2. Multiple endogenous DHHCs control membrane localization of
the STREX domain. a, representative agarose gel of Sybr-safe-stained PCR
amplicons from real time qRT-PCR assays of DHHCs expressed in HEK293 cells
(note numbering according to human DHHC convention, thus no DHHC10). Mw,
molecular weight marker. b, relative mRNA expression of each DHHC expressed
as a percentage of DHHC4. c, efficiency of siRNA-mediated knockdown of each
DHHC using two independent siRNAs/DHHC. mRNA levels were quantified by
qRT-PCR, and the mRNA expression remaining, following siRNA-mediated
knockdown of the cognate DHHC, was expressed as a percentage of the respec-
tive control mRNA level for each DHHC. qRT-PCR assays were performed in par-
allel with the imaging assays in d. d, effect of DHHC knockdown on membrane
expression of the CRD-YFP construct expressed in HEK293 cells. The data are
expressed as the percentage of change in membrane expression compared with
the CRD-YFP construct in the presence of the scrambled siRNA. The data are the
means  S.E. where N  3 and n  350 for each siRNA knockdown. **, p 
 0.01,
compared with CRD-YFP construct with scrambled siRNA by nonparametric
Kruskal Wallis test with post-hoc test.
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increase membrane expression of the C12A/C13A mutant,
expression was still significantly lower (
40%) than that seen
with the STREX-Cterm alone. These data imply that DHHC 17
is likely the most selective DHHC for palmitoylation of cys-
teines 12 and 13 in the STREX domain but also suggest that
additional palmitoylation sites can be engaged by overexpres-
sion of DHHCs to control membrane expression of the C ter-
minus of the STREX BK channel.
Intriguingly, the cysteine residue (Cys16) immediately down-
stream of cysteines 12 and 13 within the STREX domain is also
predicted to be palmitoylated using the CSS-PALM v2.0 algo-
rithm (24). To address whether Cys16 may be a target for over-
expressed DHHCs, we made the triple mutant C12A/C13A/
C16A, in which all three cysteines are mutated to alanine. The
construct was robustly expressed in HEK293 cells but failed to be
located at the plasma membrane as predicted (Fig. 4e). However,
co-expression of any DHHC now failed to enhance plasmamem-
brane localization of the C12A/C13A/C16A construct (Fig. 4e).
Taken together, these data suggest thatDHHC17 ismost selective
for cysteines 12 and 13within STREX but that exogenous overex-
pression of DHHCs 3, 5, 7, or 9 can also regulate palmitoylation
status andmembrane localization via Cys16.
DHHCs Co-immunoprecipitate with STREX BK Channels—
Previous studies have suggested that a number of palmitoylated
proteins can assemble with their
cognate DHHCs (2, 12, 21, 30).
Because multiple DHHCs are able
to control the palmitoylation status
of the STREX domain, we asked
whether DHHCs may be able to
assemble in a complex with the
full-length BK channel. In these
studies full-length STREX chan-
nels with a C-terminal GFP fusion
were co-expressed with HA-
tagged DHHCs in HEK293 cells
and subjected to reciprocal co-
immunoprecipitation assays. Pull-
down using anti-HA antibodies
resulted in robust immunoprecipi-
tation of DHHCs 3, 5, 7, 9, and 17.
Immunoprecipitates were probed
for the GFP tag on the BK channel,
revealing co-immunoprecipitation
with each DHHC (Fig. 5a). Immu-
noprecipitation controls including
cells expressing STREX-GFP chan-
nel alone (Fig. 5, control) or beads
alone (not shown) did not result
in co-immunoprecipitation. Similar
results were observed with the
reciprocal pulldown in which chan-
nels were immunoprecipitated with
anti-GFP and probing for the HA
tag on the respective GFP (Fig. 5b),
except that under these conditions
we could not reliably co-immuno-
precipitate DHHC5.
Knockdown of DHHC3, 5, 7, 9, or 17 Prevents PKA-mediated
Inhibition of the STREX Channel—To address the functional
relevance of STREX domain palmitoylation controlled by
DHHC3, 5, 7, 9, and 17, we examined the functional cross-talk
between the palmitoylation andPKA-dependent phosphorylation
of the STREX channel reported previously (19). Phosphorylation
of the STREX domain by PKA leads to channel inhibition; how-
ever, this inhibition is conditional on the STREX domain being
palmitoylated and associated with the plasmamembrane (19).
In cells treated with the scrambled siRNA, application of
cAMP to the intracellular face of inside-out patches from
HEK293 cells expressing the full-length STREX channel
resulted in robust inhibition of STREX channel activity that is
entirely dependent upon endogenous PKA activity closely asso-
ciated with the channel (19, 25, 27), as reported previously in
control conditions (Fig. 6). However, in cells in which DHHCs
3, 5, 7, 9, or 17 were individually knocked down by siRNA,
cAMP-mediated inhibition of the channelwas completely abol-
ished (Fig. 6). To validate that the lack of cAMP-mediated inhi-
bition of STREX channel activity in cells inwhich theseDHHCs
have been knocked down does not result from disruption of
cAMP-dependent activation of PKA, we also analyzed the
effect of applying the PKAc to the intracellular face of the patch.
Under these conditions application of PKAc in control siRNA
FIGURE 3. DHHCs 3, 5, 7, 9, and 17 control STREX palmitoylation and membrane association. a, representative
low power confocal sections of HEK293 cells expressing the STREX-Cterm-GFP fusion protein and transfected with
siRNA against the indicated DHHC. The scale bars are 20 m. b, quantification of STREX-Cterm-GFP membrane
localization, expressed as a percentage of the membrane localization with the scrambled siRNA, following the
respective DHHC knockdown. The data are the means  S.E. where N  4 and n  350 for each siRNA knockdown.
c, fluorograph (upper panel) and corresponding Western blot (lower panel) of HA-tagged C-terminal constructs of the
BK channel expressed in HEK293 cells. The cells were labeled with [3H]palmitate (3H-palm) for 4 h, and the constructs
were immunoprecipitated using anti-HA magnetic microbeads. d, quantification of STREX-Cterm palmitoylation follow-
ing siRNA knockdown of DHHCs by siRNA as in c. The data are expressed as percentages of palmitate incorporation in the
STREX-Cterm construct in scrambled siRNA-treated cells. The data are the meansS.E., N 3–4. *, p 
0.05; **, p 
0.01,
compared with respective scrambled control group by analysis of variance with post-hoc Dunnett’s test.
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transfected cells inhibited STREX channel activity by 68  8%,
n  7. In contrast, in cells in which DHHC17 was knocked
down by siRNA, no significant change in activity was observed
(mean change in activity was 10.8  8.3%, n  5). Thus knock-
down of any of the DHHCs implicated in regulating palmitoy-
lation of the STREX domain also controls the regulation of
STREX channels by PKA-mediated phosphorylation.
DISCUSSION
Our data provide the first systematic analysis of the role of indi-
vidual DHHC palmitoyltransferases in the palmitoylation and
regulation of a voltage-gated ion
channel. We demonstrate that the
intracellular alternatively spliced
STREX domain of BK channels is
endogenously palmitoylated by mul-
tiple palmitoyltransferases (DHHCs).
Using siRNA knockdown, DHHCs 3,
5, 7, 9, and 17 were all shown to con-
trol STREX domain palmitoylation
and association of the STREX C ter-
minus with the plasma membrane.
Importantly, knockdown of these
DHHCs also controlled PKA-depen-
dent inhibition of the STREX BK
channel that we have previously
shown to be the major functional
effect of palmitoylation of STREX in
BK channels (19).
Previous analysis of ligand-gated
ion channels has revealed an impor-
tant role for DHHC3 (also known
as GODZ) in controlling channel
palmitoylation (6, 7, 10, 12, 30).
DHHC3 is rather promiscuous in its
palmitoylation of target proteins
(21, 22, 31), and DHHC3 controlled
palmitoylation of STREX. DHHC7,
which may heteromultimerize with
DHHC3 (10), was also implicated in
STREX palmitoylation. In addition
DHHC9, DHHC5, and DHHC17
also controlled STREX palmitoyla-
tion and function. The regulation of
STREX by DHHC17 is particu-
larly intriguing because DHHC17 is
also reported to palmitoylate other
cysteine-rich proteins including
SNAP25 (32), cysteine string pro-
tein (33), and huntingtin (34). Over-
expression assays suggested that
DHHC17 has the highest selectivity
for the palmitoylated dicysteine
motif of STREX (cysteines 12 and 13
in STREX). Taken together, because
Cys12-Cys13 falls within a cysteine-
rich domain, as a result of inclusion
of the alternatively spliced STREX
exon, this may suggest that DHHC17may preferentially palmi-
toylate cysteine residues within internal cysteine-rich domains
of proteins.
The ability of multiple DHHCs to target the same protein
appears to be a general recurring theme in protein palmitoyla-
tion.However, it is somewhat surprising that knockdownof any
one of these DHHCs (3, 5, 7, 9 or 17) has very similar effects on
palmitoylation status, membrane association, and the ability to
prevent PKA-mediated inhibition of STREX channels. Indeed,
although our attempts to simultaneously knock down all of
these DHHCs was unsuccessful, there was no significant addi-
FIGURE 4. DHHC overexpression enhances membrane localization of STREX-Cterm. a, representative low
power confocal sections of HEK293 cells 24 h after transfection with STREX-Cterm-GFP (left-hand panels) or co-
transfected with DHHC17 (right-hand panels). Under each condition the STREX-Cterm-GFP localization and HA tag
image planes are shown. The scale bars are 10 m. b and c, quantification of STREX-Cterm-GFP. d and e, C12A/C13A
(d) and C12A/C13A/C16A (e) membrane localization in cells co-expressing the corresponding DHHC, or the inactive
mutant (DHHS). In b– e, the data are expressed as percentages of STREX-Cterm-GFP membrane localization
observed in the absence of overexpressed palmitoyltransferase (100%, dashed line). The data are the means  S.E.
where N 5 and n 400 for each group. *, p 0.05; **, p 
0.01, compared with the STREX-Cterm-GFP construct in the
absence of overexpressed palmitoyltransferase by analysis of variance with post-hoc Dunnett’s test.
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tive effect onmultiplexing siRNAknockdown.Multiple distinct
mechanisms may be involved in this effect, resulting in each
DHHC having an effect in controlling palmitoylation and func-
tion, as has been suggested with other proteins. For example, it
may simply reflect that the normal cellular expression of each of
these DHHCs is required for efficient palmitoylation as the
channel traffics to the plasma membrane. It may also reflect
potential different localization of specific DHHC substrate
interactions occurringwithin the trafficking pathway. Thismay
be particularly important for tetrameric proteins like BK chan-
nels such that a combinatorial code of palmitoylation on mul-
tiple sites across multiple subunits is important for the overall
palmitoylation status and functional effect. For example, eight
cysteine residues (i.e. 4 Cys12 and Cys13 in STREX) would be
available for palmitoylation in the tetrameric homomeric chan-
nel. Although the majority of DHHCs that control STREX
palmitoylation are thought to beGolgi/endoplasmic reticulum-
localized upon overexpression (23), the localization of endoge-
nous DHHCs and their potential trafficking is poorly under-
stood because of the lack of available antibodies to characterize
many of the endogenous DHHC proteins. Additional mecha-
nisms may also exist. As already discussed, heteromultimeriza-
tion of DHHCs may occur as previously demonstrated using
overexpressed DHHC3 and DHHC7 (10), or the activity/local-
ization of DHHCs may themselves be controlled by palmitoy-
lation as has been shown for autopalmitoylation of some
DHHCs (2). However, the extent to which other DHHCs het-
eromultimerize, the role of heteromultimerization, and the
FIGURE 5. DHHCs 3, 5, 7, 9, and 17 co-immunoprecipitate with full-length
STREX BK channel. Western blots of co-immunoprecipitated HA-tagged
DHHCs with GFP-tagged full-length STREX BK channels expressed in HEK293
cells. In a, DHHCs were immunoprecipitated (IP) with anti-HA magnetic
microbeads, and in b, channels were immunoprecipitated using anti-GFP
magnetic microbeads, and immunoprecipitates were subjected to SDS-PAGE
and transferred to polyvinylidene difluoride. The immobilon and the respec-
tive tag were probed and detected by enhanced chemiluminescence.
FIGURE 6. DHHC knockdown prevents PKA-mediated inhibition of STREX
channels. a, representative single channel traces from excised inside-out
patches of HEK293 cells expressing full-length STREX BK channels before and
5 min after exposure to cAMP. Left- and right-hand panels are from cells co-
transfected with scrambled and DHHC17 siRNA, respectively. Patches were
held at 40 mV in physiological potassium gradients with intracellular free
calcium buffered to 0.1 M in the presence of 2 mM Mg-ATP. b, summary bar
chart of the effect of cAMP on STREX single channel open probability (Po)
expressed as the percentage of change in activity from pre-cAMP control
under each condition. The data are the means  S.E., N  6 –10/group. **, p 

0.01, compared with the scrambled siRNA group by nonparametric Kruskal
Wallis test with post-hoc test.
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functional effect of DHHC palmitoylation in native systems are
largely unknown.
An additional factor that may also be important is the stoi-
chiometry of BK channel palmitoylation that is required for the
functional effects of palmitoylation to be manifest. In this
regard, we have previously shown that phosphorylation of only
a single STREXdomain in the channel tetramer is important for
functional regulation (25). Whether this is also the case for
palmitoylation remains to be determined.
Increasing evidence suggests that DHHCs may assemble
with their target substrates. For example, DHHC3 and 17
assemble with SNAP25 (21), whereas DHHC3 has been shown
to form a complex with -aminobutyric acid, type A and
-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate recep-
tors (12, 30). Our data reveal that, at least in overexpression
systems, the cognate DHHCs that palmitoylate the STREX
domain also can assemble as a complex with the channel.
Clearly whether the interaction is direct or results from assem-
bly as amuch largermacromolecular complex in native systems
warrants further investigation. Furthermore, whether cycles of
palmitoylation/depalmitoylation are required as the channels
traverse different stages in the pathway leading to delivery to
the cell surface remains to be explored.
Intriguingly, overexpression of DHHCs that endogenously
control STREX palmitoylation (apart from DHHC17) also
allowed access of these DHHCs to a cysteine residue (Cys16)
immediately downstream of the Cys12-Cys13 site. This implies
that Cys16 may also be a target for palmitoylation in some cell
types in which these DHHCs have access to the site, thus
extending the potential repertoire by which STREX channels
may be regulated by palmitoylation.However, no other cysteine
residues within the entire C terminus of the channel were tar-
gets for palmitoylation in HEK293 cells because mutation of
Cys12-Cys13 completely abolished palmitate incorporation by
endogenous DHHCs.
In conclusion, our work reveals that DHHCs 3, 5, 7, 9, and 17
are important determinants of STREX BK channel palmitoyla-
tion, STREX domain interaction with the plasma membrane,
and functional regulation. Our approach thus represents the first
systematic analysis of ion channel palmitoylation by the multi-
member DHHC family of palmitoyltransferases. Our strategy
employing both loss and gain of function strategies and utilizing
fluorescent fusion proteins to screen for the effects of palmitoyla-
tion of plasmamembrane expression of palmitoylated domains of
transmembrane proteins may serve as an approach to further
interrogate the specificity and role of DHHCs in controlling ion
channel and other plasma membrane transmembrane protein
regulation by protein palmitoylation.
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S-Palmitoylation is rapidly emerging as an important post-
translationalmechanism to regulate ion channels.We have pre-
viously demonstrated that large conductance calcium- and volt-
age-activated potassium (BK) channels are palmitoylatedwithin
an alternatively spliced (STREX) insert. However, these studies
also revealed that additional site(s) for palmitoylationmust exist
outside of the STREX insert, although the identity or the func-
tional significance of these palmitoylated cysteine residues are
unknown. Here, we demonstrate that BK channels are palmit-
oylated at a cluster of evolutionary conserved cysteine residues
(Cys-53, Cys-54, and Cys-56) within the intracellular linker
between the S0 and S1 transmembrane domains. Mutation of
Cys-53, Cys-54, and Cys-56 completely abolished palmitoyla-
tion of BK channels lacking the STREX insert (ZERO variant).
Palmitoylation allows the S0-S1 linker to associate with the
plasma membrane but has no effect on single channel conduct-
ance or the calcium/voltage sensitivity. Rather, S0-S1 linker
palmitoylation is a critical determinant of cell surface expres-
sion of BK channels, as steady state surface expression levels are
reduced by 55% in the C53:54:56A mutant. STREX variant
channels that could not be palmitoylated in the S0-S1 linker also
displayed significantly reduced cell surface expression even
though STREX insert palmitoylation was unaffected. Thus our
work reveals the functional independence of two distinct palmi-
toylation-dependentmembrane interaction domains within the
same channel protein and demonstrates the critical role of
S0-S1 linker palmitoylation in the control of BK channel cell
surface expression.
Large conductance calcium- and voltage-gated potassium
(BK) channels play an important role in regulating diverse
physiological processes from neuronal excitability (1, 2) to the
control of blood flow (3, 4). Dysfunction of the BK channel has
been implicated in a number of disorders including epilepsy (5,
6), cerebellar ataxia (2), hypertension (3, 4), incontinence (7),
and tumor cell proliferation (8, 9).
The BK channel pore-forming -subunit, is encoded by a
single gene KCNMA1 (10), and assembles as tetramers, form-
ing a K-selective channel. Functional diversity of BK channels
is achieved by association with -subunits (3) and other pro-
teins (11), alternative splicing (12–14), and post-translational
modifications such as phosphorylation (15).
We have demonstrated previously that an alternatively
spliced variant of the BK channel, the Stress-regulated exon
(STREX),3 is palmitoylated within the STREX insert and regu-
lates protein kinase A-mediated inhibition of STREX channels
(16). These studies also revealed that channels lacking the
STREX insert (ZERO variant) could also be palmitoylated indi-
cating that additional cysteine residues are targets for palmitoy-
lation (16). Furthermore, BK channels were identified in a pro-
teomic screen for palmitoylated proteins in adult rat brain, (17)
a tissue with generally low level expression of STREX channels
when compared with the ZERO channel variant (5, 18). More-
over, a protein palmitoylation prediction algorithm (CSS-Palm)
(19, 20) indicates that the BK channel contains several evolu-
tionary conserved cysteine residues in the intracellular linker
that links the S0 and S1 transmembrane domains (S0-S1 linker)
that can be palmitoylated (Fig. 1A). Whether these residues are
in fact palmitoylated is not known and the functional role of
palmitoylation of the BK channel outside of the STREX insert
has not been addressed.
Increasing evidence points to an important role for palmitoy-
lation in the dynamic control of function, assembly or traffick-
ing of membrane proteins, including ion channels. Palmitoyla-
tion increases protein hydrophobicity by post-translational
thioester linkage of a saturated 16-carbon palmitic acid to spe-
cific cysteine residues, a reversible process that is dependent on
a large family of protein palmitoyltransferases (DHHCs) and
thioesterases (21). Palmitoylation can play a diverse role in con-
trolling ion channel function including: themodulation of volt-
age sensing in Kv1.1 channels (22); control of phosphorylation
status of BK channels (16) and the GluR6 receptor (23); assem-
bly of sodium channels (24); cell surface stability of GABAA
receptors (25); and trafficking of AMPA and NMDA receptors
(26, 27).* This work was supported by the Wellcome Trust.
1 Recipient of a BBSRC PhD doctoral training award.
2 To whom correspondence should be addressed: Centre for Integrative
Physiology, Hugh Robson Bldg., University of Edinburgh, Edinburgh EH8
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Here,we have identified evolutionary conserved cysteine res-
idues in the intracellular N-terminal S0-S1 linker of BK chan-
nels that can be palmitoylated and that allows the domain to
associate with the plasma membrane modulating cell surface
expression of the channel. Importantly, the functional role of
S0-S1 linker palmitoylation is distinct from that conferred by
palmitoylation of the previously characterized C-terminal
alternatively spliced STREX insert (16). Thus our work demon-
strates functionally distinct palmitoylation-dependent mem-
brane interaction domainswithin the same channel protein and
that palmitoylation of the BK channel S0-S1 linker is an impor-
tant determinant of cell surface expression.
EXPERIMENTAL PROCEDURES
Channel Constructs and Expression—The subcloning and
site directed mutagenesis was performed on the murine BK
channel-subunit as has been described previously (13, 28). All
amino acid numbering in full-length channel constructs is
based on the murine (mSlo) BK channel sequence with start
methionine at MDALI., accession number: AF156674. The
S0-S1 linker -YFP fusion constructs used in Fig. 2 (S0-S1-YFP)
incorporated the entire intracellular linker between the two
predicted transmembrane domains, S0 and S1, beginning at
residue Arg-44 and ending at residue Arg-114 cloned into a
pEYFP-N1 vector backbone. Extracellular N-terminal Flag tag
and intracellular C- terminal HA tag constructs of full-length
channels were created in pcDNA3.1 as described (13, 27). Site-
directed mutations were generated by standard procedures
using the QuikChange system (Stratagene).
HEK293 Cell Culture and Immunofluorescence—HEK293
cells weremaintained and transfected as described (13, 28). Cell
surface labeling of the N-terminal Flag tag epitope of BK chan-
nels in non-permeabilized HEK293 cells (28) was performed
using mouse monoclonal anti-Flag M2 antibody (5 g/l,
Sigma) and Alexa-594-conjugated anti-mouse rabbit IgG
(Molecular Probes). Cells were then fixed in 4% paraformalde-
hyde, permeabilized with 0.3%Triton X-100 in phosphate buff-
ered saline (PBS) for 10 min and blocked with 0.05% Triton
X-100 in PBS containing 3% BSA for 30 min. The intracellular
C-terminal HA epitope tag was detected using 1.25 mg/ml
anti-HA polyclonal rabbit antibody (Zymed Laboratories Inc.)
and Alexa-488-conjugated anti-rabbit chicken IgG (Molecular
Probes) and cells mounted using Mowiol. Confocal images
were acquired on a Zeiss LSM510 laser scanning microscope,
using a 63 oil Plan Apochromat (NA  1.4) objective lens, in
multitrackingmode (16). Quantification of Flag surface expres-
sion was done in two ways: (i) using a threshold method to
detect total number of transfected cells that displayed Flag sur-
face expression in each group; and (ii) using absolute measures
based on ratios of surface Flag (extracellular) fluorescence to
intracellular signal (HA) in a random subset of all cells analyzed
using Image J. 1.42q (Wayne Rasband, NIH). Data were then
normalized to the corresponding control group (100%) as
indicated in the respective figure legend. In these experimental
paradigms the data obtained for relative surface expression
using the threshold method was quantitatively the same as
using absolute ratio measures.
CSS-Palm Prediction—We used the published CSS-Palm
palmitoylation algorithm (19, 20), to predict cysteine residues
within the entire coding sequence of the murine BK channel
-subunit. Sequences were analyzed with the CSS-Palm v2.0
web interface. The palmitoylation prediction threshold was set
to the highest cutoff.
[3H]Palmitic Acid Incorporation—HEK293 cells were tran-
siently transfected in 6-well cluster dishes (3  106 cells per
well) with full-length channel constructs as previously de-
scribed (16). Briefly, 48 h after transfection, cells were washed
and 1 ml of fresh DMEM containing 10 mg/ml fatty acid-free
BSA was added for 30 min at 37 °C. Cells were incubated in
DMEM/BSA containing 0.5mCi/ml [3H]palmitic acid for 4 h at
37 °C, and then the medium containing the free label was
removed. Cells were lysed in 150 mM NaCl, 50 mM Tris-Cl, 1%
Triton X-100 (pH 8.0), and channel fusion proteins were cap-
tured by using magnetic microbeads coupled to HA/GFP anti-
body (MACS epitope tag isolation kits, Miltenyi Biotec). Cap-
tured proteins were eluted in SDS/PAGE sample buffer (50mM
Tris-HCl, pH 6.8, 5 mM DTT, 1% SDS, 1 mM EDTA, 0.005%
bromphenol blue, 10% glycerol) prewarmed to 95 °C. The
recovered samples were separated by SDS/PAGE, transferred
to nitrocellulose membranes, and probed with a polyclonal HA
antibody (1:1,000; Zymed Laboratories Inc.). A duplicatemem-
brane was dried, sprayed with En3hance fluorographic spray
(PerkinElmer-Cetus), and exposed to light-sensitive film at
80 °C by using a Kodak Biomax transcreen LE (Amersham
Biosciences).
Cell Surface Biotinylation Assay—Plasmids expressing HA-
tagged BK channels were transiently transfected into HEK293
cells with Exgen 500 (Fermentas). 48 h post-transfection, cells
werewashed 3withHank’s buffered salt solution (HBSS), and
incubated on ice for 2 h in the presence of 5 g/ml of Sulfo-
NHS-LC-biotin (Pierce). Cells were lysed in NLB buffer with a
protease inhibitor mixture after washing in ice-cold 100 mM
glycine in HBSS (Roche, Germany). Biotinylated cell lysates
were incubated with streptavidin-immobilized beads (Pierce)
overnight at 4 °C andwashed 3with coldHBSS and once with
water. The biotinylated membrane BK channel proteins were
removed from the beads by incubating at 45 °C for 15min in 2
Laemmli protein sample buffer, separated by SDS-PAGE and
detected with anti-HA antibody usingWestern blotting. Paral-
lel control biotinylation assays were conducted with mock
transfected cells.
Electrophysiology—Single channel recordings and macro-
patch recordingswere performed in the excised inside-out con-
figuration of the patch-clamp technique at room temperature.
The pipette solution (extracellular) contained 140 mM NaCl, 5
mM KCl, 0.1 mM CaCl2, 1 mM MgCl2, 20 mM glucose, 10 mM
Hepes (pH 7.3). The bath solution (intracellular) contained 140
mM KCl, 5 mM NaCl, 1 mM MgCl2, 1 mM BAPTA, 20 mM glu-
cose, 10 mMHepes, (pH 7.3) with free calcium [Ca2]i buffered
from 0.33 to 10 M, as indicated. Channel activity was deter-
mined during 100ms depolarizations over a voltage range from
120 mV to 120 mV in 20 mV increments from a holding
potential of 80 mV. Tail currents were then examined and
normalized to the peak current (100%) in 1 M Ca2 and plot-
ted as G/GMAX corresponding to channel activity. Voltage sen-
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sitivity was determined by a logarithmic transformation linear-
izing the activating component of the normalized (G/GMAX)
curves in 1 M Ca2. Data acquisition and voltage protocols
were controlled by anAxopatch 200 B amplifier and pCLAMP9
software (Axon Instruments). All recordings were sampled
at 10 kHz and filtered at 2 kHz. Channel activity was allowed
to stabilize for at least 10 min after patch excision before
recording.
Fluorescent Membrane Potential Assay—Membrane poten-
tial assays were performed in transfected HEK293 cells incu-
bated with FLIPR Membrane Potential Blue Dye (Molecular
Devices, Sunnyvale, CA) as described (29). Briefly, cells were
plated in black walled, clear bottom 96-well plates and loaded
with dye for 30 min at 37 °C to allow dye loading into the cell
membrane. Assays were performed as room temperature using
the Flexstation R II system (Molecular Devices) and channels
activated by 1 M ionomycin (a calcium ionophore), 16 s after
measurement began. Fluorescent changes were read over a
period of 3 min as relative fluorescent units (RFU). An increase
in BK channel activity caused a hyperpolarization which was
detected as a decrease in fluorescence. To compare between
mutants the RFUwere determined at t 70 s, and the response
of each channel mutant was then isolated by subtracting the
control HEK depolarizing response and normalizing the hyper-
polarization of the wild-type ZEROor STREX channel to 100%.
Statistics—All statistical analysis was performed using
GraphPad Prism using 1-way ANOVAwith Tukey post hoc test
for significance between groups.
RESULTS
The S0-S1 Linker Is Palmitoylated in BK Channels—Using a
palmitoylation prediction algorithm (CSS-Palm) (19, 20), the
murine ZERO BK channel variant sequence revealed three cys-
teine residues, Cys-53, Cys-54, andCys-56 that scored highly as
predicted palmitoylation sites within the BK channel, scoring,
1.54, 1.48, and 0.92, respectively (Fig. 1A).
Sequence alignment of the three cysteine residues in the
S0-S1 linker (Cys-53, Cys-54, and Cys-56) indicate strong evo-
lutionary conservation across vertebrates with conservation of
double cysteines (Cys-53 and Cys-54) extending across Dro-
sophila and Caenorhabditis elegans, suggesting that this region
may be of functional significance to the channel (Fig. 1A).
To directly assess whether the S0-S1 linker is in fact palmi-
toylated in the ZERO channel we assayed [3H]palmitate incor-
poration into full-length channel proteins in HEK293 cells (Fig.
1B). Full-length ZEROchannels were robustly palmitoylated by
endogenous palmitoyltransferases. Importantly,mutation of all
three cysteine residues in the S0-S1 linker to alanine (ZERO
C53:54:56A) completely abolished [3H]palmitate incorpora-
tion. Individual point mutation of cysteine residues demon-
strated a reduced [3H]palmitate incorporation but did not abol-
ish it, thus suggesting that the triple cysteine mutant (ZERO
C53:54:56A) is the key determinant for palmitoylation of the
ZEROchannel. Robust expression inWestern blot analysis sug-
gested that a change in palmitoylation status of the channels
was not the result of decreased synthesis or degradation of
channel protein (Fig. 1B). Together these data suggest that C53:
54:56 is the only site that is palmitoylated in the ZERO channel.
Palmitoylation Targets the S0-S1 linker to the Plasma Mem-
brane—Palmitoylation increases the hydrophobicity of a pro-
tein facilitating interaction with the intracellular plasma mem-
brane. To examinewhether the S0-S1 linker alonemay target to
the plasma membrane, constructs that incorporated the 70
amino acid S0-S1 linker fused in-frame with YFP (S0-S1-YFP
construct, Fig. 2A) were created to determine the functional
contribution of each cysteine residue within the identified
region. Transient expression of the S0-S1 linker constructs in
HEK293 cells resulted in robust expression at the plasmamem-
brane aswell as fusion protein trapped in intracellular compart-
ments (Fig. 2A). Site-directed mutagenesis of the cysteine resi-
dues predicted to be palmitoylated in the S0-S1 linker to alanine
resulted in significantly decreased expression at the plasma
membrane.Mutation of individual cysteine residues resulted in
significantly decreased plasmamembrane targeting of between
40–70% in relation to the S0-S1-YFP linker construct. Muta-
tion of the double cysteines, conserved from human to C.
elegans, also significantly decreased expression at the plasma
membrane. Mutation of all three cysteine residues (S0-S1 C53:
54:56A-YFP construct) resulted in near abolition (90%
decrease) ofmembrane targeting of the S0-S1 linker fusion pro-
tein (Fig. 2B).
FIGURE 1. The S0-S1 linker is palmitoylated in BK channels. A, schematic
illustrating the topology of the BK channel pore-forming -subunit.
Sequence alignments of cysteine residues in the S0-S1 linker indicate evolu-
tionary conservation (gray box) across vertebrates, Drosophila and C. elegans.
Murine sequence numbered starting from the initiation methionine (MDALI),
accession number: AF156674. CSS-Palm prediction scores were determined
with the CSS-Palm v2.0 platform. B, representative fluorographs (upper) and
Western blots (lower) of full-length ZERO-HA channels and ZERO channels
with mutation of key cysteine residues in the S0-S1 linker, expressed in
HEK293 cells. Constructs were labeled with [3H]palmitate for 4 h and immu-
noprecipitated (IP) by using -HA magnetic microbeads and detected by fluo-
rography. Ratios (normalized to the wild-type ZERO channel) of [3H]palmitate
detection in comparison to total protein expression are included.
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Wedemonstrated previously that palmitoylation-dependent
membrane association of C-terminal constructs containing the
alternatively spliced STREX insert of the BK channel could be
controlled by phosphorylation of neighboring consensus phos-
phorylation sites (16). Phosphoproteomic analysis of BK chan-
nels has demonstrated that serine residues Ser-70 and Ser-71,
that are immediately downstream of the S0-S1 palmitoylated
cysteine residues, are phosphorylated in vivo (30). However,
site-directed mutagenesis of these residues to either phospho-
mimetic (S70:71E) or phosphornull (S70:71A) had no signifi-
cant effect on membrane association of the S0-S1-YFP fusion
protein at the cell surface (3  6.4% and 3  9.5% reduction of
wild-type S0-S1 membrane expression, respectively). This sug-
gests that the phosphorylation status of these residues does not
determine S0-S1 linker membrane association.
The effect of inhibition of endogenous palmitoylation on
localization of the S0-S1 linker at the plasma membrane was
examined with cells incubated with a palmitoylation inhibitor,
2-bromopalmitate (2-BP, 100 M) for 24 h. This reduced asso-
ciation of the S0-S1 linker at the plasma membrane by 80%
(Fig. 2B). Together these data support the mutagenesis studies
that targeting of the S0-S1 linker to the plasma membrane is
controlled through palmitoylation of key cysteine residues.
S0-S1 Palmitoylation Has No Effect on Intrinsic Channel
Activity—To determine whether palmitoylation of S0-S1 cys-
teine residues influences channel function we used a mem-
brane-potential assay that has been previously shown to dis-
criminate between BK channel splice variants with different
calcium sensitivities (29). In this assay, BK channel activity is
driven by ionomycin-induced calcium influx and is reported by
movement of a fluorescent voltage-sensitive dye across the cell
membrane in response to changes in cell membrane potential.
FIGURE 2. Palmitoylation targets the S0-S1 linker to the plasma mem-
brane. A schematic of the short S0-S1 linker YFP fusion construct (S0-S1-YFP),
that encodes the 70 amino acid intracellular S0-S1 linker between amino
acids Arg-44 and Arg-11 fused in-frame with YFP, and relative position of the
palmitoylated cysteine residues. A, representative single cell confocal images
of the S0-S1-YFP linker, S0-S1 C53:54:56A-YFP linker, and the S0-S1-YFP linker
fusion proteins after incubation with the palmitoylation inhibitor 2BP (100
M) for 24 h, expressed in HEK293 cells (scale bars: 10 m). B, summary bar
graph illustrates the effect of site-directed mutagenesis of cysteine residues
in the S0-S1 linker on localization of the respective S0-S1-YFP fusion protein at
the plasma membrane expressed as a percentage of the wild-type S0-S1-YFP
fusion protein (where wild-type S0-S1-YFP membrane expression is normal-
ized to 100%). (For all S0-S1 linker constructs, N3, n330 cells analyzed). **,
p 	 0.01; ***, p 	 0.001 compared with wild-type S0-S1 (ANOVA with Tukey
post hoc test).
FIGURE 3. Ionomycin-driven activation of BK channels is attenuated in
S0-S1 mutant channels. A, representative time course plots of mean change
in relative fluorescence units (RFU) of the FLIPR-blue membrane potential dye
in HEK293 cells expressing ZERO (closed gray circles, F), ZERO C53:54A
(inverted triangles,ƒ), ZERO C53:54:56A (diamonds,), and mock-transfected
HEK293 (open circles,E), in response to calcium influx induced by 1 M iono-
mycin. B, summary bar chart of the membrane potential change for each
construct expressed as a percentage of the maximal hyperpolarization, fol-
lowing subtraction of the HEK293 response, in the ZERO (gray) variant (where
the ZERO response is normalized to 100%). Data were determined at the
maximum hyperpolarizing response in the wild-type ZERO channel (t  70 s)
in the time course plots in A. All data are means  S.E. (n  3, n24), ***, p 	
0.001, compared with ZERO (ANOVA with Tukey post hoc test).
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Activation of BK channels results in membrane hyperpolariza-
tion revealed by a decrease in relative fluorescence. We used
full-length ZERO variant channels with cysteine mutations in
the S0-S1 linker. The peakwild-type ZERO channel response at
the 70 s time point was taken as 100%, to which mutant chan-
nels could then be compared (Fig. 3A). Mutation of the triple
(C53:54:56A) cysteine residues within the identified palmi-
toylation site, significantly attenuated the activation driven by
ionomycin of mutant channels by 60% when compared with
the wild-type ZERO channel (Fig. 3B). Mutation of individual
and double cysteine residues (C53A, C54A, C56A, C53:54A)
had no significant effect.
The membrane potential assay cannot discriminate
between: shifts in the calcium/voltage sensitivity of the
channel; altered channel conductance; or changes in expres-
sion of functional channels at the plasma membrane. As the
C53:54:56A mutant channel showed the greatest change in
membrane potential, palmitoylation incorporation, and in
the imaging assays, the functional impact of the ZERO C53:
54:56A mutant channel was compared with that of the wild-
type ZERO variant channel hereafter.
Single channel slope conductance in excised inside-out
patches was unchanged between ZERO and ZEROC53:54:56A
channels (ZERO, 231  3.9 pS and ZERO C53:54:56A, 227 
5.4 pS) determined in symmetrical potassium gradients (Fig. 4,
A and B). Macropatch recordings over a range of calcium
(0.33–10 M [Ca2]i) showed no significant difference in the
half maximal voltage for activation of the channel (Fig. 4, C–E)
and voltage dependence of the ZERO C53:54:56A channel was
not significantly changed from wild-type ZERO channels (data
not shown). These data suggest that neither changes in single
channel conductance nor channel voltage and calcium sensitiv-
ity underlie the significantly reduced channel activity of the
C53:54:56A mutant channels observed in the membrane po-
tential assays. However, we noted that there appeared to be
fewer mutant channels (ZERO C53:54:56A channels were
reduced by 70%, n  26) at the plasma membrane compared
with wild-type ZERO channels (n  12) in our electrophysiol-
ogy assays (data not shown). Therefore, we examined cell sur-
face expression of the ZERO channel and the mutant (ZERO
C53:54:56A) channel in quantitative immunofluorescence and
cell surface biotinylation assays.
Palmitoylation Is an Important Determinant of BK Channel
Cell Surface Expression—Mutation of the C53:C54:56 palmi-
toylation site in the S0-S1 linker of the BK channel might dis-
rupt normal expression at the plasmamembrane. Channel con-
structs were created with extracellular N-terminal FLAG tag
epitopes that enabled detection on the extracellular surface of
transfectedHEK293 cells and with intracellular C-terminal HA
tag epitopes, to determine total protein expression. In non-
permeabilized cells, ZERO channels could be detected at the
plasma membrane however, in the palmitoylation-deficient
channels (ZERO C53:54:56A) surface expression was signifi-
cantly reduced despite total protein expression being unaf-
fected. Quantitative immunofluorescence analysis of N-termi-
nal Flag-tagged ZERO C53:54:56A mutant channels, showed a
significant 55% decrease in cell surface expression in relation
to the ZERO channel (Fig. 5, A and B). A similar reduction in
FIGURE 4. The intrinsic channel properties are un-affected in de-palmitoylated BK channels. A, representative single channel conductance recordings of
excised inside-out patches at 40 and 40 mV in 0.33 M Ca2. B, current (pA) voltage (V) plot for ZERO channels (closed gray circles, F) and ZERO C53:54:56A
(diamonds,), showing that single channel conductance is unaffected in 0.33 M Ca2 (n  3). C, representative macropatch recordings traces showing BK
currents in response to a depolarizing voltage step protocol (120 mV to 120 mV) from a holding potential of 80mV from excised inside-out patch
recordings in equimolar potassium gradients and 1 M free Ca2 (scale bars: 1 pA/25 ms). D, G/GMAX conductance curves show no change in channel activation
at 1 M free Ca2 between ZERO (closed gray circles, F) and ZERO C53:54:56A (diamonds,). E, summary bar graph illustrates no significant changes in V0.5max
across the physiological calcium range 0.33–10 M free calcium. All data are means  S.E. (n 3).
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cell surface expression of the C53:54:56Amutant channels was
also observed using cell surface biotinylation assays (Fig. 5C).
To investigate whether palmitoylation of the S0-S1 linker
controls cell surface expression in channels that are also palmi-
toylated at the distinct C-terminal alternatively spliced STREX
insert (16), STREX channels were also examined with muta-
tions in the S0-S1 palmitoylation site. Firstly, we examined the
S0-S1 linker mutation (C53:54:56A) in the STREX channel
using the membrane-potential assay as before. Mutation of the
S0-S1 palmitoylation site in STREX channel showed a 30%
attenuation of the ionomycin-induced activation of the chan-
nels, similar to that observed for the ZERO channel (Fig. 6, A
and B). Therefore, to determine whether the S0-S1 linker
palmitoylation site also controls cell surface expression of the
STREX splice variant of the BK channel quantitative immuno-
fluorescence analysis was performed. N-terminal Flag-tagged
STREX C53:54:56A mutant channels also showed a significant
reduction in channel surface expression of 55% when com-
pared with wild-type STREX channels (Fig. 7,A and B). STREX
channels that could not be palmitoylated at the S0-S1 linker
(STREX C53:54:56A) could still be palmitoylated via the
STREX insert as predicted (Fig. 7C). The reduction in cell sur-
face expression was further recapitulated in cell surface biotin-
ylation assays (data not shown). Taken together, these data
suggest that the S0-S1 linker palmitoylation site functions inde-
pendently of the C-terminal palmitoylation site in the STREX
insert and that the palmitoylation status of the S0-S1 linker is a
critical determinant of cell surface channel expression irrespec-
tive of C-terminal splice variation.
DISCUSSION
Wehave identified an evolutionary conserved palmitoylation
site within the intracellular N-terminal S0-S1 linker of BK
channels that plays a critical role in the control of channel cell
surface expression. Palmitoylation of the S0-S1 linker allowed
the association of this N-terminal intracellular domainwith the
plasma membrane and controlled surface expression even in
channel variants that express an additional palmitoylation-de-
pendent membrane association domain (STREX) in the intra-
cellular C terminus of the channel (16). As STREX palmitoyla-
FIGURE 5. Palmitoylation of the S0-S1 linker regulates cell surface expres-
sion of BK channels. A, representative confocal images of HEK293 cells
expressing Flag-ZERO-HA (top panels), and Flag-ZERO C53:54:56A-HA (bot-
tom panels). The extracellular Flag epitope was labeled (red) under non-per-
meabilized conditions (cell surface) with the C-terminal HA epitope tag
(green) labeled following cell permeabilization. Flag and HA labeling from the
same cell are then overlaid (merge) (scale bars: 10 m). B, quantification of cell
surface expression between ZERO (gray bars) and ZERO C53:54:56A (white
bars). Data are means  S.E. (n 3). **, p 	 0.01, ANOVA with post hoc Tukey
test compared with Flag-ZERO-HA construct. C, representative Western blots
of HA immunoreactivity from cell surface biotinylation assays (top panels) and
corresponding whole cell lysates (bottom panels) in HEK293 cells expressing
ZERO-HA and ZERO C53:54:56A-HA channels and control mock transfected
cells.
FIGURE 6. Disruption of the S0-S1 linker palmitoylation site in STREX
splice variant channels also attenuates the ionomycin-driven channel
activation. A, representative time course plots of mean change in relative
fluorescence units (RFU) of the FLIPR-blue membrane potential dye in
HEK293 cells expressing STREX (closed black circles, F), STREX C53:54:56A
(upright triangles, ‚), and mock-transfected HEK293 (open circles, E), in
response to calcium influx induced by 1 M ionomycin. B, summary bar chart
of the membrane potential change for each construct expressed as a percent-
age of the maximal hyperpolarization, following subtraction of the HEK293
response, in the STREX (black) variant (where the STREX response is normal-
ized to 100%). Data were determined at the maximum hyperpolarizing
response in STREX (t  70 s) in the time course plots in A. All data are means 
S.E. (n  3, n  24), ***, p 	 0.001, compared with STREX (ANOVA with Tukey
post hoc test).
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tion controls channel regulation by phosphorylation (16),
rather than surface expression, as demonstrated here for the
S0-S1 linker, our work demonstrates functionally distinct pal-
mitoylation-dependent membrane interaction domains within
the same channel protein.
The identified triple cysteine palmitoylation residues in the
S0-S1 linker (C53:54:56) are conserved across the vertebrate
phylum and are largely conserved inDrosophila andC. elegans,
suggesting evolutionary retention of a functionally important
region. This site would therefore be present in all functionally
expressed BK channel proteins and is not predicted to be
excluded by alternative splicing events. Indeed, proteomic
screens identified BK channels as palmitoylated in the adult rat
brain (17), a tissue in which the only other known site for BK
channel palmitoylation is located within the STREX insert,
which is expressed at relatively low levels. As protein palmitoy-
lation is a highly dynamic and reversible process this would
suggest that palmitoylation of the S0-S1 linker may be an
important determinant in controlling BK channel cell surface
expression under different physiological demands. For exam-
ple, cell surface expression of BK channels is modified in aging
coronary arteries (31), in smooth muscle cells of the uterus
during pregnancy (32), colonic epithelia in response to aldos-
terone (33), and during malignant glioma tumor cell prolifera-
tion (9). While multiple mechanisms may control steady state
surface expression the control of BK channel expression at the
plasma membrane by palmitoylation may be an important
determinant of a wide range of physiological functions.
Palmitoylation of the S0-S1 linker could modulate surface
expression bymultiple mechanisms including: (i) facilitation of
channel assembly or ER export, (ii) stabilization at the plasma
membrane, (iii) reduced retrieval from the plasma membrane,
(iv) increased recycling, or (v) reduced channel degradation.
Examination of the role of palmitoylation in each of these
mechanisms warrants further investigation. Importantly, the
S0-S1 linker per se appears to play an important role in control-
ling channel cell surface expression as revealed from analysis of
alternative splice variants that may be included in this region.
For example, a human splice variant of the BK channel called
mk44, introduces a 44 amino acid sequence immediately down-
stream of the C53:C54:C56 palmitoylation site in the S0-S1
intracellular linker (34). This mk44 splice variant introduces a
motif for endoproteolytic digestion and a site for N-myristoy-
lation. N-Myristoylation of mk44 results in trapping of the
channel in the ER. However, endoproteolytic cleavage allows
the S0 transmembrane domain to traffic independently of the
rest of the transmembrane andC-terminal domain of the chan-
nel to the plasma membrane (34). Another splice variant in the
human BK channel, SV1, has been implicated in ER retention.
The SV1 splice variant introduces 33 amino acids to the end of
the S0-S1 linker introducing an ER retention-retrieval motif,
CVLF (35). Although inclusion of these splice variants is not
predicted, using the CSS-Palm algorithm, to significantly
reduce palmitoylation of the C53:54:56 site,4 whether these
inserts disrupt palmitoylation of S0-S1 linker or its functional
regulation of channel cell surface expression remains to be
explored. The S0 transmembrane domain of BK channels is also
an important determinant of BK channel -subunit assembly
with the regulatory -subunits (36–40). Indeed, recent struc-
tural studies examining intra- subunit di-sulfide cross-link-
ing has demonstrated that the S0 transmembrane domain is
located outside of the voltage sensing S1-S4 domains (36) and
can form a major contact with the transmembrane domain 2
(TM2) of regulatory 1 (36) and 4 (40) subunits. Co-expres-
sion studies have also suggested a role for -subunits in con-
trolling BK channel cell surface expression. Indeed, 1-sub-
units have been suggested to decrease surface expression (41),
and the 2-subunit also appears to modulate BK surface
expression via a similar mechanism (42). Therefore, increasing
evidence supports an important role for the S0-S1 linker and
surrounding transmembrane domains in controlling BK chan-
nel cell surface expression.
4 O. Jeffries and M. J. Shipston, unpublished data.
FIGURE 7. S0-S1 palmitoylation site functions independently of addi-
tional STREX splice variant palmitoylation site to control BK channel sur-
face expression. A, representative confocal images of HEK293 cells express-
ing Flag-STREX-HA (top panels), and Flag- STREX C53:54:56A -HA (bottom
panels). The extracellular Flag epitope was labeled (red) under non-permeabi-
lized conditions (cell surface) with the C-terminal HA epitope tag (green)
labeled following cell permeabilization. Flag and HA labeling from the same
cell are then overlaid (merge) (scale bars: 10 m). B, quantification of cell
surface expression between STREX (black bars) and STREX C53:54:56A (white
bars). Data are means  S.E. (n 3). *, p 	 0.05, ANOVA with post hoc Tukey
test compared with Flag-STREX-HA construct. C, representative fluorographs
(upper) and Western blots (lower) of full-length STREX-HA channels and STREX
C53:54:56A channels expressed in HEK293 cells. Constructs were labeled with
[3H]palmitate for 4 h and immunoprecipitated (IP) by using -HA magnetic
microbeads and detected by fluorography. In this particular experiment pro-
tein expression of the two constructs was not equivalent; however, the C53:
54:56A mutations do not compromise STREX expression per se. These data
reveal the residual palmitoylation of the channel mediated via the STREX
insert in contrast to the ZERO variant (see Fig. 1). Ratios (normalized to the
wild-type STREX channel) of palmitate incorporation relative to total protein
expression are included.
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Palmitoylation of the S0-S1 linker had no significant effect on
the intrinsic single channel conductance or calcium/voltage
sensitivity of BK channels. Moreover, mutation of the S0-S1
linker cysteines C53:54:56 to alanine also reduced cell surface
expression of the STREX variant of the BK channel. We have
previously demonstrated that the C terminus alternatively
spliced STREX insert is palmitoylated and targets the STREX
insert to the plasma membrane (16). Palmitoylation status of
the STREX insert has no significant effect on channel cell sur-
face expression however, it affects the calcium/voltage sensitiv-
ity of the channel and more importantly determines whether
the STREX channel is inhibited by protein kinase A (PKA)-de-
pendent phosphorylation (16). In the latter case, PKA phos-
phorylation dissociates the STREX domain from the plasma
membrane through phosphorylation of an upstream serine res-
idue. In contrast, phosphomimetic or phosphornull muta-
tions of the S0-S1 linker at a tandem serine motif, shown to
be phosphorylated in vivo (30), immediately downstream of
the palmitoylated cysteine residues, have no effect of S0-S1
linker interaction with the plasmamembrane. Taken together,
these data demonstrate that BK channels may express two
functionally distinct palmitoylation-dependent membrane
interaction domains: the C-terminal alternatively spliced
STREX insert and the constitutively expressed S0-S1 linker.
The distinct functional consequence of the palmitoylation sta-
tus of these two separate palmitoylated domains within the
same channel protein also suggests that palmitoylation of
S0-S1 and STREX may be independently regulated.
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Kotagal, P., Lüders, H. O., Shi, J., Cui, J., Richerson, G. B., andWang, Q. K.
(2005) Nat. Genet. 37, 733–738
7. Meredith, A. L., Thorneloe, K. S., Werner, M. E., Nelson, M. T., and
Aldrich, R. W. (2004) J. Biol. Chem. 279, 36746–36752
8. Bloch,M., Ousingsawat, J., Simon, R., Schraml, P., Gasser, T. C.,Mihatsch,
M. J., Kunzelmann, K., and Bubendorf, L. (2007)Oncogene 26, 2525–2534
9. Weaver, A. K., Liu, X., and Sontheimer, H. (2004) J. Neurosci. Res. 78,
224–234
10. Butler, A., Tsunoda, S., McCobb, D. P., Wei, A., and Salkoff, L. (1993)
Science 261, 221–224
11. Tian, L., Chen, L.,McClafferty, H., Sailer, C. A., Ruth, P., Knaus, H. G., and
Shipston, M. J. (2006) Faseb. J. 20, 2588–2590
12. Shipston, M. J. (2001) Trends Cell Biol. 11, 353–358
13. Tian, L., Duncan, R. R., Hammond,M. S., Coghill, L. S.,Wen,H., Rusinova,
R., Clark, A. G., Levitan, I. B., and Shipston,M. J. (2001) J. Biol. Chem. 276,
7717–7720
14. Xie, J., and McCobb, D. P. (1998) Science 280, 443–446
15. Tian, L., Coghill, L. S., McClafferty, H., MacDonald, S. H., Antoni, F. A.,
Ruth, P., Knaus, H. G., and Shipston, M. J. (2004) Proc. Natl. Acad. Sci.
U.S.A. 101, 11897–11902
16. Tian, L., Jeffries, O., McClafferty, H., Molyvdas, A., Rowe, I. C., Saleem, F.,
Chen, L., Greaves, J., Chamberlain, L. H., Knaus, H. G., Ruth, P., and
Shipston, M. J. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 21006–21011
17. Kang, R., Wan, J., Arstikaitis, P., Takahashi, H., Huang, K., Bailey, A. O.,
Thompson, J. X., Roth, A. F., Drisdel, R. C., Mastro, R., Green, W. N.,
Yates, J. R., 3rd, Davis, N. G., and El-Husseini, A. (2008) Nature 456,
904–909
18. MacDonald, S. H., Ruth, P., Knaus, H. G., and Shipston, M. J. (2006) BMC
Dev. Biol. 6, 37
19. Ren, J., Wen, L., Gao, X., Jin, C., Xue, Y., and Yao, X. (2008) Protein Eng.
Des. Sel. 21, 639–644
20. Zhou, F., Xue, Y., Yao, X., and Xu, Y. (2006) Bioinformatics 22, 894–896
21. Fukata, Y., Iwanaga, T., and Fukata, M. (2006)Methods 40, 177–182
22. Gubitosi-Klug, R. A., Mancuso, D. J., and Gross, R. W. (2005) Proc. Natl.
Acad. Sci. U.S.A. 102, 5964–5968
23. Pickering, D. S., Taverna, F. A., Salter, M. W., and Hampson, D. R. (1995)
Proc. Natl. Acad. Sci. U.S.A. 92, 12090–12094
24. Schmidt, J. W., and Catterall, W. A. (1987) J. Biol. Chem. 262,
13713–13723
25. Rathenberg, J., Kittler, J. T., and Moss, S. J. (2004)Mol. Cell Neurosci. 26,
251–257
26. Hayashi, T., Thomas, G. M., and Huganir, R. L. (2009) Neuron 64,
213–226
27. Hayashi, T., Rumbaugh,G., andHuganir, R. L. (2005)Neuron 47, 709–723
28. Chen, L., Tian, L., MacDonald, S. H., McClafferty, H., Hammond, M. S.,
Huibant, J. M., Ruth, P., Knaus, H. G., and Shipston, M. J. (2005) J. Biol.
Chem. 280, 33599–33609
29. Saleem, F., Rowe, I. C., and Shipston, M. J. (2009) Br. J. Pharmacol. 156,
143–152
30. Yan, J., Olsen, J. V., Park, K. S., Li,W., Bildl,W., Schulte, U., Aldrich, R.W.,
Fakler, B., and Trimmer, J. S. (2008)Mol. Cell Proteomics 7, 2188–2198
31. Marijic, J., Li, Q., Song, M., Nishimaru, K., Stefani, E., and Toro, L. (2001)
Circ. Res. 88, 210–216
32. Song, M., Zhu, N., Olcese, R., Barila, B., Toro, L., and Stefani, E. (1999)
FEBS Lett. 460, 427–432
33. Sørensen, M. V., Matos, J. E., Sausbier, M., Sausbier, U., Ruth, P., Praeto-
rius, H. A., and Leipziger, J. (2008) J. Physiol. 586, 4251–4264
34. Korovkina, V. P., Fergus, D. J., Holdiman, A. J., and England, S. K. (2001)
Am. J. Physiol. Cell Physiol. 281, C361–C367
35. Zarei, M. M., Eghbali, M., Alioua, A., Song, M., Knaus, H. G., Stefani, E.,
and Toro, L. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 10072–10077
36. Liu, G., Niu, X., Wu, R. S., Chudasama, N., Yao, Y., Jin, X., Weinberg, R.,
Zakharov, S. I., Motoike, H., Marx, S. O., and Karlin, A. (2010) J. Gen.
Physiol. 135, 449–459
37. Liu, G., Zakharov, S. I., Yang, L., Deng, S. X., Landry, D.W., Karlin, A., and
Marx, S. O. (2008) J. Gen. Physiol. 131, 537–548
38. Meera, P.,Wallner,M., Song,M., and Toro, L. (1997) Proc. Natl. Acad. Sci.
U.S.A. 94, 14066–14071
39. Wallner,M.,Meera, P., andToro, L. (1996)Proc. Natl. Acad. Sci. U.S.A. 93,
14922–14927
40. Wu, R. S., Chudasama, N., Zakharov, S. I., Doshi, D., Motoike, H., Liu, G.,
Yao, Y., Niu, X., Deng, S. X., Landry, D. W., Karlin, A., and Marx, S. O.
(2009) J. Neurosci. 29, 8321–8328
41. Toro, B., Cox, N., Wilson, R. J., Garrido-Sanabria, E., Stefani, E., Toro, L.,
and Zarei, M. M. (2006) Neuroscience 142, 661–669
42. Zarei, M. M., Song, M., Wilson, R. J., Cox, N., Colom, L. V., Knaus, H. G.,
Stefani, E., and Toro, L. (2007) Neuroscience 147, 80–89
balt3/zbc-bc/zbc-bc/zbc04410/zbc3465-10z ZSUBMIT 8 xppws S1 26/8/10 10:51 4/Color Figure(s) F2,5,7 ARTNO: M110.153940
Palmitoylation of the BK S0-S1 Linker
8 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285 • NUMBER ?? • ???? ??, 2010
